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1.1 Intracellular Compartments and Transport
Bacteria, archaea and eukaryotes form the three kingdoms of life. The latter group includes 
protists, fungi, plants and animals. Compared to bacteria and archaea, eukaryotic cells are 
highly complex systems that are characterized by the presence of a nucleus, various 
membrane-enclosed compartments (organelles) and the presence of cytoskeletal structures 
including microfilaments, intermediate filaments and microtubules. The presence of 
specialized organelles provides the eukaryotic cell with the ability to compartmentalize 
many different intracellular processes with specific vital functions. For instance, 
mitochondria take care of the energy metabolism, peroxisomes function in fatty acid 
oxidation and neutralization of reactive oxygen species while the cell nucleus is the place of 
DNA storage, transcription and ribosomal RNA synthesis. Eukaryotes also contain an 
elaborate endomembrane system composed of various organelles including the 
endoplasmic reticulum (ER), Golgi apparatus, endosomes and lysosomes. The Golgi 
apparatus receives proteins made in the ER and functions in the modification, sorting and 
packaging of these proteins for either plasma membrane targeting, secretion or delivery to 
endosomes or lysosomes. Lysosomes are responsible for the intracellular degradation of 
endocytosed material. Due to the subcellular compartmentalization strategy, the eukaryotic 
cell also contains elaborate pathways to ensure proper targeting of proteins to various 
organelles and membranes. While specific protein sorting pathways exist to target proteins 
to mitochondria, peroxisomes and the nucleus, proteins that are destined for the 
endomembrane system are targeted to the rough ER. Communication and transport 
between organelles of the endomembrane system occurs via (tubulo-)vesicular transport 
intermediates that move along microtubule tracks from one place in the cell to another. In 
this thesis we focus on a protein complex called retromer, which is essential in vesicular 
endosome-to-Golgi transport, and functions in a very unique manner, due to its protein 
composition and interplay.
Secretory Pathway
Intracellular traffic occurs mainly via two routes: the outward biosynthetic secretory 
pathway and the inward endocytic pathway. Both pathways are interconnected and 
therefore endosomes are not only key players in the endosomal pathway, but also in the 
sorting of proteins in the biosynthetic secretory route (Figure 1). The secretory pathway is 
mainly used by newly synthesized proteins. Proteins are translated on ribosomes bound to 
the ER and co-translationally imported or inserted in the ER membrane. In the ER, N- 
glycosylation and disulfide bond formation can take place. Once these proteins are properly
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folded and assembled they are transported from the ER to the cis face of the Golgi 
apparatus, probably via maturation of an ER-Golgi intermediate compartment (ERGIC), 
which fuses with the Golgi to generate new Golgi cisternae (reviewed by [1, 2]). The Golgi 
has a peri-nuclear localization and consists of flattened cisternae, classified into cis, medial 
or trans cisternae where N-glycan processing and O-glycosylation takes place. By maturation 
of the Golgi, proteins reach the last station of the secretory pathway, the trans-Golgi 
network (TGN) (reviewed by [3, 4]). In the TGN soluble and membrane proteins are 
packaged into distinct transport intermediates and subsequently delivered to their 
destination: the plasma membrane, secretory granules, or endocytic/lysosomal 
compartments (reviewed by [5, 6]).
Figure 1 Intracellular transport pathways. The scheme depicts the compartments of the
outward biosynthetic secretory pathway and the inward endocytic pathway. Transport steps are 
indicated by arrows. Colours indicate the known or presumed locations of the coat proteins COPII 
(blue), COPI (red), and clathrin (orange). Additional coats or coat-like complexes exist, but are not 
represented in this figure [23].
Endocytic Pathway
The endosomal system is a major membrane-sorting apparatus for receptors and other 
plasma membrane proteins internalized from the cell surface. Understanding the details of 
the complex and interconnected endocytic trafficking pathways that can carry molecules 
within the endosomal system, is essential for analyzing many crucial cellular processes such 
as cell growth and cell signaling, immunity and viral infection, toxicity, nutrient uptake, and 
many other fundamental cell biological processes. The endosomal sorting starts at the 
plasma membrane of the cell. There are several mechanisms for internalizing molecules 
from the cell surface, including phagocytosis, caveolae formation, membrane ruffling, (non-) 
clathrin-coated pit formation and STEM (surface-connected tubules entering macrophages)
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formation [7]. From these different forms of endocytosis, receptor-mediated endocytosis is 
the best understood process and involves the internalization of ligand-bound receptors by 
clathrin-coated pits (reviewed by [8]). After removal of their clathrin coats, the newly 
formed endosomal vesicles can dock and fuse with each other to form sorting endosomes. 
Sorting endosomes, also referred to as early endosomes, are compartments located to the 
periphery of the cell with a tubular-vesicular structure and a luminal pH of ~6.0. As a 
consequence of this low pH, many ligands are released from their receptors. The main 
function of the sorting endosome is the targeting of proteins to their correct location. The 
predominant sorting in the sorting endosome is not based on the recognition of a specific 
sorting motif in the cargo proteins, but is based on organelle geometry. Up to 80% of the 
membrane surface area of sorting endosomes is present in tubules that bud out from the 
sorting endosome [9, 10] and carry with them a large fraction of membrane components. 
Many membrane components are recycled directly from the sorting endosome to the 
plasma membrane, while other components use an indirect pathway, which involves 
recycling via the endocytic recycling compartment (ERC). The preference for one of the 
pathways is likely to be dependent on specific sorting signals that are still unidentified, but 
that are necessary for the sorting of proteins into another compartment than the default 
pathway. A large fraction of membrane proteins pass through the ERC, which is mainly 
composed of narrow diameter tubules that are associated with microtubules [11-13]. In 
some cell types, the ERC is localized close to the microtubule-organizing centre (MTOC) [14]. 
The ERC can sort proteins to several destinations, whereby most molecules are returned to 
the plasma membrane and a minor fraction is sorted to the TGN.
Sorting endosomes are accepting endocytosed material for only 5-10 minutes and 
subsequently translocate along microtubules to the centre of the cell whereby the pH drops 
to 5.0-6.0 [15, 16]. This process is called maturation and results in the formation of late 
endosomes. Proteins that remain in the sorting endosomes are thus subsequently located in 
late endosomes. During maturation regions of the limiting endosomal membrane bud 
inwards, toward the compartment's lumen and pinch off to form internal vesicles. As a 
consequence of this morphology these endosomes are named multivesicular bodies (MVBs). 
The MVBs do no longer receive direct input of vesicles that have pinched off from the 
plasma membrane, and are therefore not on the main endocytic recycling route. They do 
not only contain molecules from the sorting endosomes, but also receive bio-synthetic cargo 
proteins from the TGN, including precursors of lysosomal enzymes. This results in the 
maturation of the MVBs into lysosomes. Lysosomes have an acidic lumen with pH 5.0-5.5 
and contain numerous acid-dependent hydrolases. Lysosomes, which are the terminal
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destination for many endocytosed molecules, serve as the major degradative compartments 
[17].
The pathways described are the main routes taken by the majority of the molecules. 
However, most likely none of the sorting mechanisms is 100% efficient, and so some 
molecules will always be found in alternative pathways. In addition, all of the organelles are 
dynamic structures and therefore molecules will not be permanent residents of a specific 
organelle. Individual molecules can be transported into or out of the organelle through 
transport vesicles, or alternatively the compartment itself can change over time 
(maturation). Due to these properties, defining and identifying organelles, especially 
endosomal, is often difficult and usually it is necessary to use more than one characteristic 
to classify an endocytic organelle experimentally.
In both the endosomal and biosynthetic pathways, forward traffic is counterbalanced by 
retrograde transport, in order to recycle various proteins and lipids that function in sorting 
or in the formation of transport intermediates or in order to retrieve resident proteins 
(reviewed by [7, 18]). Endocytosis at the plasma membrane followed by transport to the 
sorting endosome is thus counterbalanced by recycling, either directly or via the ERC. 
Similarly, anterograde TGN-to-endosome transport is counterbalanced by two independent 
pathways that return proteins from either the early or late endosomes to the TGN. 
Furthermore, there is also retrograde transport within the Golgi complex or from the Golgi 
to the ER [18].
Vesicle-Mediated Transport
Coat Proteins
The selective transfer of material (proteins, lipids) between the organelles that are part of 
the secretory and endosomal systems described above, is mediated by vesicular transport. 
This vesicle-mediated transport comprises the formation of a vesicle, transport towards its 
destination and docking and fusion with its target membrane. The budding of transport 
vesicles and the selective incorporation of cargo into the forming vesicles are both mediated 
by coat proteins [19-21]. These coats are supramolecular assemblies of proteins that are 
recruited from the cytosol. The coats accomplish budding of the membranes and the release 
of the formed vesicle. The coats also participate in cargo selection by recognizing sorting 
signals present in the cytosolic domains of cargo proteins.
Coat complexes COPI and COPII are involved in bidirectional traffic between the ER and 
Golgi (reviewed by [22, 23]). COPII coats are involved in vesicle budding at ER exit sites for 
anterograde transport to the cis-Golgi [24], whereas the COPI coat (also referred to as
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coatomer) appears to be responsible for retrograde intra-Golgi transport and retrograde 
transport of recycled proteins from Golgi and pre-Golgi compartments back to the ER [25], 
as shown in Figure 1. Activated small guanine triphosphatases (GTPases), such as ARF1 
(ADP-ribosylation factor) in the COPI and the related SAR1p in the COPII vesicle, recruit coat 
proteins to specific membrane export sites, thereby linking COPs to the export of cargo. 
When COP coat proteins polymerize, vesicles are formed and budded from membrane- 
bound organelles [26]. COPI is a heptameric protein complex and consists of two sub­
complexes, one of which is structurally homologous to the adaptin protein complexes (APs). 
This indicates that COPI, but also COPII, include their own integrated adaptin proteins, 
which contrasts the clathrin coats [27]. For recruitment of cargo into COPI vesicles, its 
subunits directly bind to cytoplasmic dilysine motifs that are typically represented by a KKXX 
or KXKXX (in which X represents any amino acid) sequence at the carboxy terminus of type I 
transmembrane proteins [28, 29]. For COPII a number of quite diverse sequence motifs 
involved in cargo recognition have been defined (reviewed by [23]). The final stage in vesicle 
formation is scission of the neck of the bud. No proteins have been identified which are 
specifically involved in this process for the COPI or COPII coat proteins, so in contrast to 
clathrin coats which require additional proteins, it seems that COP coat protein complexes 
drive vesicle formation by themselves.
Clathrin is the best known coat protein (reviewed by [27]) and functions at the plasma 
membrane and in transport between late endosomes and the Golgi (Figure 1). During 
vesicle formation, clathrin is recruited to a subdomain of a membrane and assembles itself 
into a polymeric mechanical scaffold on the cytosolic surface of the membrane, thereby 
forming a so-called clathrin-coated pit. This results in the shaping of the membrane into a 
vesicle. Pinching off the clathrin-coated domain requires the small GTPase dynamin and the 
support of accessory proteins such as epsins, endophilin and amphyphisin. Epsins and epsin 
homology-domain proteins link certain receptors to coat complexes, endophilin induces the 
bending of the membrane required for vesicle budding, while amphyphisin binds endophilin, 
clathrin, adaptor proteins and dynamin (reviewed by [7, 30]). Finally, the GTPase dynamin is 
assembled around the neck of the vesicle and upon hydrolysis of the dynamin-bound GTP 
the clathrin-coated vesicle is pinched off the membrane. Thus, in contrast to COP-mediated 
vesicle budding, clathrin-mediated vesicle budding requires the enzymatically active 
dynamin GTPase. After the budding is complete, the coat proteins disassemble.
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Adaptor Proteins
The recruitment of clathrin for the formation of clathrin-coated vesicles requires adaptor 
proteins, which bind to coat proteins as well as to specialized motifs in the cytoplasmic 
domains of membrane proteins, thereby linking specific cargo to sites of coat assembly 
(reviewed by [31, 32]). Examples of adaptors are the heterotetrameric AP complexes, the 
monomeric GGA (Golgi-localized, year-containing, ARF-binding) proteins and a number of 
cargo-specific adaptors such as Hrs (hepatocyte growth factor receptor tyrosine kinase 
substrate) and epsins. Adaptor proteins are recruited from the cytosol to membranes by 
members of the small GTPase ARF family in their GTP-bound form and/or by the local 
production of phosphoinositides (PIs) at a distinct membrane site (reviewed by [19, 33, 34]). 
The family of AP complexes comprises AP1-4 (reviewed by [35]), of which AP-1 is involved in 
trafficking between the TGN and endosomes; AP-2 functions at the plasma membrane; AP-3 
is involved in the formation of specialized lysosome-related compartments such as 
melanosomes while the function of AP-4 is currently unknown, but AP-4 might play a role in 
polarized epithelial cells [36]. All AP complexes consist of two large subunits of 100-130 kDa 
(a ß subunit and a more divergent subunit, either y , a, 5, or s), a medium-sized subunit of 
~50 kDa (^) and a small subunit of ~20 kDa (a). The ß subunits are particularly important for 
clathrin binding, while the n and ß subunits have been implicated in cargo selection. AP 
complexes bind transmembrane cargo proteins by recognizing YXXO motifs (in which X 
represents any amino acid and O represents a large hydrophobic residue) and dileucine or 
acidic dileucine [D/E]XXXL[L/I] motifs (reviewed by [37, 38]).
There are three GGA family members (GGA1-3), which are involved in trafficking from 
the TGN to the endosomal compartment [39-41]. GGAs are functionally very similar to AP 
complexes, but they are monomeric instead of heterotetrameric (reviewed by [42, 43]). 
GGAs have a unique four-domain structure consisting of a VHS (Vps27p, Hrs, STAM) domain, 
a GAT (GGA and TOM1) domain, a hinge domain and a GAE (Y-adaptin ear) domain. In the 
AP complexes the residues involved in cargo selection, membrane localization, clathrin 
binding and accessory protein recruitment have been localized in different subunits, 
whereas in GGAs the same four functions appear to be performed by the VHS, GAT, hinge 
and GAE domain, respectively. GGA proteins bind with their VHS domain to a distinct type of 
dileucine-based sorting signals: the cytoplasmic acidic-cluster-dileucine signal DXXLL (in 
which X represents any amino acid) [44]. This signal is present in several transmembrane 
receptors and other proteins that cycle between the TGN and endosomes: sortilin, which 
binds at least to GGA1 and GGA2 [45]; the cation-independent mannose 6-phosphate 
receptor (CI-M6PR), which binds all GGAs; the cation-dependent M6PR (CD-M6PR), which
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binds GGA1 and GGA3 [46-48]; LRP3 [44]; SorLa [49] and ß-secretase [50]. GGA proteins 
themselves also contain a DXXLL motif, and at least GGA1 and GGA3 are capable of binding 
to their own VHS domain. This binding is thought to be auto-inhibitory and an explanation 
for the poor binding activity of full length GGA1 and GGA3 relative to their isolated VHS 
domains. This inhibition depends on casein kinase II (CKII)-mediated phosphorylation of a 
serine residue three positions N-terminally of the critical aspartate: GGA1 Ser355 and GGA3 
Ser388 [51, 52]. Thus in order to activate GGA1 and GGA3, this serine should be 
dephosphorylated, thereby displacing the DXXLL ligand, and sets the VHS domain free for 
interactions with the cytosolic domains of receptors.
The GAT domain of GGAs interacts with activated forms of small GTPases of the ARF 
family on the TGN and therefore contributes to the recruitment of GGAs to TGN 
membranes. The hinge domain binds clathrin, whereas the GAE domain binds accessory 
factors including AP-1. In addition, GGA1 and GGA3 are able to recognize ubiquitin and can 
therefore also function as adaptor proteins for sorting of a number of ubiquitinated 
transmembrane proteins [53-55]. Cargo-specific adaptors often function in cooperation with 
AP complexes, which brings different types of cargo into the same population of coated 
vesicles [31, 56]. Similar to GGAs, Hrs also binds cargo by its VHS domain, but Hrs is targeted 
via its FYVE domain to endosomes. Arrestins, epsins, disabled-2 and ARH (autosomal 
recessive hypercholesterolemia protein) can also be classified as adaptors, since they also 
link cargo and membranes to the clathrin lattice (reviewed by [21]).
Cytoskeleton and Trafficking
Trafficking of vesicles between different organelles and the plasma membrane does not only 
involve adaptors and coat proteins, but also the participation of the cellular cytoskeleton. 
The cytoskeleton is framed by three types of protein filaments; intermediate filaments, 
microtubules and actin (or micro-)filaments. Intermediate filaments have great tensile 
strength and their main function is to enable cells to withstand mechanical stress. The other 
two networks, the microtubule and the actin network, support motor protein-driven 
intracellular transport. Microtubules are dynamic structures, formed by polymerization of a- 
and ß-tubulin heterodimers. They originate from the MTOC and interact with organelles and 
vesicles through associated proteins including microtubule-dependent motor proteins. 
Microtubule motors use energy derived from ATP hydrolysis to transport vesicles or 
organelles along the microtubules. These proteins function at various stages in the 
secretory, as well as endocytic, pathways in both anterograde and retrograde transport 
pathways. The microtubules are polar structures with a minus end in the MTOC and a plus
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end in the direction of the cells' periphery. Plus-end directed transport is mediated by 
kinesin motor proteins, whereas minus-end directed transport is mediated by dynein motor 
proteins [57, 58]. As the Golgi apparatus is located in the peri-nuclear area close to the 
MTOC and thus the minus-end of microtubules, transport towards the Golgi system is 
mediated by minus-end directed cytoplasmic dyneins whereas transport from the Golgi 
towards peripheral organelles is mediated by plus-end directed kinesin motor proteins.
Microtubules are involved in long-range transport of vesicles and organelles in the cell 
interior, but normally they do not extend into the cell cortex. The plasma membrane of 
eukaryotes is supported by a cortical actin network consisting of actin filaments, polymers 
formed by monomers of the protein actin. Vesicular transport through the cell cortex 
therefore involves remodeling of the peripheral cortical actin network. Moreover, vesicular 
transport in the cell cortex is also mediated by active transport on actin filaments with the 
support of the myosin family of ATPase motor proteins [59]. Actin filaments have an 
important function during endocytosis at the plasma membrane and subsequent transport 
to peripheral organelles. In animal cells, microtubules provide high-speed, long-range 
transport, whereas the actin network usually facilitates slower and short-range local 
transport events.
Docking and Fusion
The final docking and fusion of a vesicle with the membrane of its target is mediated by a 
wide range of proteins, including Rab and SNARE proteins. The Rab family consists of almost 
70 small GTPase regulatory proteins, which play key regulatory roles in most membrane­
transport steps (reviewed by [60, 61]). The membranes of the different organelles all 
contain specific Rab or Rab-effector enriched subdomains, resulting in the binding of a 
specific Rab family-member that is responsible for the distinct functions and fates of this 
organelle [62]. In the GTP-bound state, Rab proteins bind to membranes and recruit 
regulatory molecules and effectors necessary for docking and fusion of vesicles to their 
target compartment, leading to membrane fusion. Furthermore, Rab proteins have also 
been implicated in vesicle budding and, more recently, in the interaction of vesicles with 
cytoskeletal elements [63]. The precise role of the majority of the Rab proteins is presently 
unknown. Among the best characterized are various Rab proteins involved in endosomal 
transport, including Rab5, Rab4, Rab7, Rab9 and Rab11. Rab5 regulates fusion between 
primary endocytic vesicles and the sorting endosome, but also recruits microtubule motors 
and other proteins to the sorting endosome, thereby organizing microdomains in sorting 
endosomes [64, 65]. Rab4 associates with sorting endosomes and is involved in recycling
16 Chapter 1
[66]. Rab6a has a role in transport from endosome to the TGN [67]. Rab7 is located on late 
endosomes and important for late endosome-lysosome fusion events. Rab9 is also located 
on late endosomes and is thought to mediate M6PR recycling from late endosomes to the 
TGN. Rab11 is localized to membranes of the ERC and TGN and has a role in recycling to the 
plasma membrane [68, 69].
SNARE proteins (soluble W-ethylmaleimide-sensitive fusion protein attachment protein 
receptors) provide the specificity of docking and fusion (reviewed by [23, 70]), whereby 
SNARE proteins function in cognate pairs, with one set of the pair attached to the vesicle 
(called v-SNARE) and the other one localized on the target membrane (called t-SNARE). 
Most SNAREs are C-terminally anchored transmembrane proteins with their functional N- 
terminus facing the cytosol. Each of these proteins contains a heptad repeat 'SNARE motif' 
of 60-70 amino acids that can participate in coiled-coil formation [71]. Structural and 
biochemical studies showed that v-SNARE and t-SNARE can form a very stable complex 
consisting of a four-helix bundle with one helix derived from the v-SNARE and the other 
three helices derived from the t-SNARE [72, 73]. The resultant SNARE pair has a role in the 
fusion of the lipid bilayer by overcoming the energy barrier to fusion. Furthermore, 
assembly of the proper SNARE pair is also involved in establishing the specificity of fusion 
with the proper target organelle.
Sorting Motifs
The molecular machinery that organizes intracellular transport recognizes sorting motifs in 
cargo proteins aimed to guide them to their (ultimate) destination (reviewed by [38]). The 
cytoplasmic domains of many receptors, as well as other transmembrane proteins that 
selectively accumulate in vesicles, contain specific sequence information that facilitates 
coated pit formation. These signals are often degenerate, which makes it difficult to 
establish the precise motifs. In general, sorting signals consist of short, linear arrays of 
amino acid residues. These arrays are not exactly conserved sequences, but degenerate 
motifs of four to seven residues of which two or three are often critical for function. The 
critical residues are generally bulky and hydrophobic, although charged residues appear also 
important determinants of specificity for some signals. Two major classes of endosomal- 
lysosomal sorting signals are the tyrosine-based and dileucine-based sequences. Not all 
signals are short peptide motifs and in some cases the sorting determinants appear to be 
folded structures in which the critical residues are not necessarily colinear [74]. A striking 
example of this type of conformational determinant is the protein ubiquitin, which can
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function as an endosomal-lysosomal sorting signal upon covalent conjugation onto the 
cytosolic domain of transmembrane proteins [75].
As described earlier, sorting signals can be recognized by specific proteins, including 
adaptor proteins. The presence and accessibility of such sorting signals can be influenced by 
(i) the presence of additional amino acids, in particular acidic clusters, or (ii) by post- 
translational modifications, such as phosphorylation and ubiquitination, or (iii) by other 
factors as the oligomerization state of membrane proteins, the presence of accessory 
proteins and the lipid composition of membranes (reviewed by [35]).
1.2 Receptor Trafficking
We will now discuss the endosomal sorting of three different receptors and the role of their 
sorting motifs. These receptors cover the transport routes of many receptors and illustrate 
the principles of endosomal sorting. The first receptor, the transferrin receptor undergoes 
constitutively internalization and recycling. The second receptor, the epidermal growth 
factor receptor (EGFR), shows ligand-induced enhancement of internalization followed by 
lysosomal targeting. The third receptor, CI-M6PR, is a so-called cycling TGN protein which 
cycles between the TGN and endosomes.
Transferrin Receptor
The transferrin receptor (TfR) is a homodimeric transmembrane protein, which mediates 
iron uptake into the cell (reviewed by [8, 76]). The TfR is the prototype recycling receptor 
since the TfR cycles through the cell with a half-time of ~7 minutes and consequently the TfR 
is recycled 100-200 times during the lifetime of the receptor [77]. At the cell surface, the 
receptor binds its ligand, the iron transport protein transferrin (Tf), and the TfR-Tf complex 
is subsequently transported into the cell by clathrin-mediated endocytosis, as shown in 
Figure 2. The TfR has a small 5 kDa cytoplasmic domain, which contains an endocytic signal 
YTRF that is necessary for internalization [78, 79]. The cytoplasmic tail also contains several 
serine residues that can be phosphorylated, but point mutations revealed that they are not 
involved in the transport of the receptor [80]. The YTRF motif belongs to the YXXO motifs, 
which are recognized by clathrin-associated APs, and the binding of TfR to AP-2 results in 
the incorporation of the protein into a clathrin-coated vesicle. The endocytic accessory 
protein TTP (TfR trafficking protein), which binds to TfR, clathrin and dynamin, probably also 
plays a role in internalization of the TfR [81]. The TfR is subsequently delivered at the sorting 
endosome, where it colocalizes with Rab5. Iron will dissociate within the acidic environment
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of the sorting endosome. The complex of apo-transferrin and TfR is then transported 
towards the Rab11-positive recycling endosome and subsequently recycles back to the 
plasma membrane [82]. Moreover TfR-Tf complexes can also be recycled in a more rapid 
manner, which is indicative for the existence of a direct recycling route that bypasses the 
recycling endosome [83]. The delivery of TfR from sorting endosomes to the recycling 
compartment and exit from the recycling compartment to the plasma membrane appears 
devoid of specific cargo recognition motifs, indicating that this is the 'default' pathway for 
membrane components (reviewed by [8]). At the plasma membrane apo-transferrin is 
released due to the increased pH and the TfR is now ready for a new uptake cycle.
Epidermal Growth Factor Receptor
The epidermal growth factor receptor (EGFR, also referred to as ErbB1) is a transmembrane 
receptor and member of the ErbB tyrosine kinase family (reviewed in [84, 85]). The ErbB 
family of proteins comprises four receptors (ErbB1-4) and 11 extracellular protein ligands, 
which all contain a conserved epidermal growth factor (EGF) domain. Binding of EGF triggers 
homo- or heterodimerization of the EGFR and activation of the tyrosine kinase within the 
large cytoplasmic domain of the receptor, which subsequently activates downstream signal 
transduction pathways.
Ligand binding to the EGFR also triggers the internalization and subsequent degradation 
of the activated receptor. Endocytosis of the EGFR requires multiple signals, including 
intrinsic tyrosine kinase activity, endocytic sequence motifs located in the cytoplasmic 
domain of the receptor and receptor ubiquitination (reviewed by [86, 87]). Indeed, kinase 
activation strongly enhances endocytosis, while the tyrosine-based 973FYRAL motif is 
involved in AP-2 binding [88]. Furthermore, receptor internalization is enhanced by Cbl, a 
RING-finger E3 ubiquitin ligase, which binds to the activated EGFR, directly or via the 
adaptor protein GrbB2 (growth factor receptor-binding protein 2) [89]. Cbl promotes the 
sustained covalent attachment of multiple ubiquitin molecules to the receptor. It is a 
question of debate whether the EGFR is modified by mono-ubiquitin adducts on multiple 
lysines or by poly-ubiquitin chains [87]. Cbl subsequently recruits CIN85 (Cbl-interacting 
protein of 85 kDa) and endophilins, which promote endocytosis of the EGFR [90]. 
Furthermore, ubiquitination of the EGFR generates docking sites for proteins with a UIM 
(ubiquitin interacting motif), including the adaptor proteins Epsin and Eps15 (EGFR pathway 
substrate-15), which interact with clathrin and also assist in EGFR internalization.
General Introduction 19
Figure 2 Endocytic recycling pathways. The model shows the post-endocytic itineraries of
several molecules. The transferrin receptor binds its ligand, diferric transferrin; the low- 
densitylipoprotein receptor (LDLR) binds low-density lipoprotein (LDL); and the cation-independent 
mannose 6-phosphate receptor (CI-M6PR) binds lysosomal enzymes. All of these membrane proteins 
concentrate into clathrin-coated pits. The transmembrane proteins furin and trans-Golgi network 
(TGN)38 also enter through clathrin-coated pits. Most membrane proteins rapidly exit sorting 
endosomes and are either returned directly to the plasma membrane or are transported to the 
endocytic recycling compartment (ERC). Furin is retained in the sorting endosome as the sorting 
endosome begins to mature into a late endosome, and furin is delivered to the Golgi from late 
endosomes. From the ERC, essentially all of the LDLRs and transferrin receptors recycle to the cell 
surface. Transferrin, unlike most other ligands (for example, LDL), is not released from its receptor in 
the acidic environment of sorting endosomes. The two irons (Fe3+) are released from diferric 
transferrin at the acidic pH and transported into the cytoplasm, but iron-free transferrin remains 
bound to its receptor until it is returned to the cell surface directly or via the ERC. At the neutral 
extracellular pH, iron-free transferrin is released from the receptor. About 80% of the internalized
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TGN38 and CI-M6PR also returns to the cell surface, while the rest is delivered to the TGN. The CI- 
M6PR can go from the TGN to sorting and late endosomes, at the late endosome the ligand can 
dissociate as a result of exposure to low pH. From the late endosomes, furin and free CI-M6PR can 
move to the TGN, and molecules in the TGN can be delivered back to the cell surface. It is uncertain 
whether CI-M6PR and furin are transported in the same or different vesicles between the TGN and 
late endosomes. The t1/2 values are approximate and cell-type dependent [7].
After internalization into the sorting endosome, free EGFRs can be recycled to the 
plasma membrane using the ERC default pathway, but the occupied, actively signaling 
receptors are prevented from utilizing this default recycling pathway. Instead the EGF-EGFR 
complex undergoes lysosomal targeting and subsequent degradation, which represents a 
major mechanism for attenuation of EGF signaling. To ensure proper temporal and spatial 
signaling, the endocytic and lysosomal trafficking of EGF receptors are tightly regulated. 
Mutational analysis revealed that residues 945 to 991 in EGFR are required for lysosomal 
targeting. This region contains a tyrosine-based sorting signal (954YLVI) that has been 
reported to regulate receptor downregulation and to act as a lysosomal target signal [91]. It 
has been suggested that the sorting nexin/retromer complex component SNX1 (sortin nexin 
1) can bind this motif and is involved in receptor downregulation [92]. Furthermore, the 
dileucine 679LL motif might also be important for lysosomal targeting of the EGFR, although 
its function in the context of the full length EGFR is still controversial [93]. The group of 
Sorkin has hypothesized that another dileucine motif, 1010LL, is involved in lysosomal 
targeting [94]. Furthermore, the EGFR region between residues 1022 and 1063 contains 
additional lysosomal sorting signals. This region includes two serine residues (1046SS) that are 
phosphorylated upon EGFR activation and which have been reported to affect EGFR 
endosomal trafficking (see also Chapter 7). This region also includes the Cbl binding site 
(Tyr1045), which is required for efficient EGFR ubiquitination. Ubiquitination of the EGFR is 
probably the most important signal for lysosomal targeting of the EGFR [94]. The ubiquitin 
molecules attached to the EGFR can interact with Eps15, which can form a complex with 
STAM and Hrs (also called ESCRT-0, endosomal sorting complex required for transport) in 
the sorting endosome. This complex directs the EGFR to the ESCRT-I complex (TSG101, 
Vps28 and vps37) and subsequently to the ESCRT-II and -III complexes (reviewed by [95]). 
The enzymatic activity of the Vps4 AAA-ATPase is then required for dissociation of ESCRT-III 
complexes from the endosomal membrane, thereby allowing incorporation of the ligand- 
bound EGFRs in internal vesicles of the MVBs which results in the termination of receptor 
signaling (reviewed by [96]). MVBs can mature into lysosomes and in this organelle the 
receptor and its ligand are dissociated and both degraded.
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Mannose 6-Phosphate Receptor
Mammalian cells contain two mannose 6-phosphate receptors (M6PRs): the ~46 kDa cation- 
dependent M6PR (CD-M6PR) and the ~300 kDa cation-independent M6PR (CI-M6PR)/ 
insulin-like growth factor-II (IGF-II) receptor (reviewed by [97, 98]). Both receptors are 
involved in the delivery of newly synthesized acid hydrolases from the TGN to the 
endosomes for their subsequent delivery to lysosomes. Acid hydrolases, such as Cathepsin
D, are modified in the cis-Golgi with mannose 6-phosphate moieties on their N-glycan 
chains, which function as a sorting motif for transport of these luminal proteins from the 
TGN via endosomes to lysosomes. Fibroblasts devoid of both M6PRs secrete most of their 
newly synthesized lysosomal enzymes and consequently accumulate undigested substrates 
in their lysosomes [99]. The luminal/ extracytoplasmic region of the CI-M6PR has a 
repetitive structure that consists of 15 repeats of ~147 amino acids each. Two of those 
structures, repeating segments 3 and 9, are M6P-bindings sites and segment 11 is a single 
IGF-II binding site. The complete extracytoplasmic domain of the CD-M6PR consists of 159 
residues and is similar to the repeating segments of the CI-M6PR and contains a single M6P- 
binding site.
The M6PRs are present in the TGN, endosomes and at the plasma membrane, but not in 
lysosomes. Up to 10% of the CI-M6PR is normally expressed at the plasma membrane [100], 
where the interaction of the tyrosine-based 26YSKV sequence in the cytoplasmic tail of the 
CI-M6PR with AP-2 results in the rapid internalization of the receptor in clathrin-coated pits 
and the subsequent delivery to sorting endosomes [74, 101-104]. The CI-M6PR is 
transported from the sorting endosome to the ERC, from where a large fraction of CI-M6PR 
returns to the cell surface [105], as shown in Figure 2. During each cycle of internalization a 
fraction is transported to the TGN and endosomes, however, and continues to cycle 
between these organelles for a relatively long period of time, resulting in a predominantly 
TGN and endosome location of the CI-M6PR. The packaging of the CI-M6PR into clathrin- 
coated vesicles for anterograde transport, i.e. from the TGN to the endosomes, depends on 
two types of adaptor proteins: AP-1 and the GGAs (reviewed by [106]). It is not clear 
whether AP-1 and GGA work in parallel with each other or that, alternatively, GGAs facilitate 
CI-M6PR entry into AP-1 clathrin-coated vesicles [98, 107]. As depicted in Figure 3, the CI- 
M6PR has four binding sites for AP-1: the tyrosine-based sequence 26YSKV, a leucine-based 
motif 39ETEWLM and two sites that can be phosphorylated by casein kinase 2 (CK2): 84DSEDE 
and 154DDSDED [98, 108-112].
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Figure 3 Sorting signals on the CI-M6PR tail. A schematic representation of the cytosolic tail
of the CI-M6PR receptor, which shows the identified amino-acid sorting signals and their associated 
transport proteins. The bars indicate the residues that are important for the specific binding partner. 
The residues are numbered form 1 to 163, starting from the transmembrane domain (TMD). The 
casein kinase 2 (CK-2) sites are marked at the specific residues. GGA, Golgi-localized, y-ear- 
containing, ARF-binding protein; PACS-1, phosphofurin acidic cluster sorting protein-1; TIP47, tail- 
interacting protein of 47 kDa [98].
The cytosolic tail of the CI-M6PR receptor contains one binding site for the VHS domain 
of GGAs, i.e. 154DDSDEDLL, an acidic cluster dileucine motif [44, 47, 48]. The DXXLL signal in 
both the CI-M6PR and CD-M6PR mediates incorporation into clathrin-coated vesicles that 
bud from the TGN for transport to the endosomal system. Mutation of the Asp and Leu 
residues to Ala in these motifs inactivates the signal, which results in increased expression 
of the receptors at the plasma membrane and ERC [113]. Recently it has been demonstrated 
that these Asp and Leu residues may also play a role in transport form ERC to the Golgi, 
probably mediated by GGAs. In contrast TGN38, which also traffics from ERC to the TGN, 
lacks this domain and there is currently no evidence for binding of this protein to GGAs 
[113]. The crystal structure for the VHS domain of GGA1 and GGA3, both in complex with 
DXXLL signal peptides of the M6PRs, demonstrates that the critical Asp and Leu residues 
interact with an electropositive and two shallow hydrophobic pockets, respectively, in a 
groove formed by helices 6 and 8 of the VHS domain [114, 115]. The physiological 
significance of these interactions is demonstrated by the observation that CD-M6PR and 
GGAs exit the TGN by the same vesicular intermediates and that a dominant-negative GGA 
construct causes retention of the CI-M6PR and CD-M6PR at the TGN [47].
Another feature of this signal is the presence of one or more serines upstream of the 
acidic cluster. These serines often contain the [S/T]XX[D/E] consensus motif for 
phosphorylation by CKII. Indeed, Ser85 and Ser156 in the cytosolic tail of the CI-M6PR 
(Figure 3) and Ser57 in the cytosolic tail of the CD-M6PR have been shown to be 
phosphorylated both in vivo and in vitro by CKII or a CKII-like kinase [116-120]. The in vitro 
binding affinity of a DXXLL-containing peptide based on the CI-M6PR sequence increases 
approximately threefold by phosphorylation of the Ser156 residue [121]. Crystallographic
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analyses have revealed that phosphorylation of this serine residue allows electrostatic 
interaction between one of the negatively charged phosphate oxygens and two positively 
charged residues of the VHS domain [121]. The phosphorylation of the serines in the 
cytosolic tail of the CI-M6PR is associated with the exit of the CI-M6PR from the TGN [117].
Mutation analysis revealed that the conserved DDSDEDLL sequence near the C-terminus 
of the CI-M6PR is of paramount importance for receptor sorting, since point mutations of 
any of those residues into alanine results in markedly impaired lysosomal enzyme targeting 
[100, 122]. Mutations in critical residues could potentially affect one or more processes 
underlying receptor function. However, these mutants are most likely not defective in 
internalization from the plasma membrane, since deletion of residues C-terminal of the 
tyrosine-based internalization signal has little effect on endocytosis [101]. Indeed, the 
mutated receptors show no altered intracellular receptor levels or internalization rates 
[100], and the mutated residues are therefore most likely involved in the transport between 
the TGN and endosomes.
After release of lysosomal hydrolases in the endosome, which are subsequently 
transported to the lysosome, the M6PRs are recycled to the TGN. There are several 
sequence motifs and associated proteins that have been implicated in the retrograde 
transport of the M6PRs in mammalian cells (reviewed by [106]). Among these are AP-1 [123, 
124], which thus seems to be involved in both anterograde and retrograde transport, and 
two adaptor-like proteins: TIP47 (tail-interacting protein of 47 kDa) [74, 125, 126] and PACS- 
1 (phosphofurin acidic cluster sorting protein-1) [127].
TIP47 interacts with residues 48-74 in the cytoplasmic tail of the CI-M6PR and with a 
phenylalanine/tryptophan signal in the tail of the CD-M6PR [74, 126] and also with the GTP- 
bound form of Rab9, which increases the affinity of TIP47 for the CI-M6PR tail [128]. There 
are contradicting studies on the role of TIP47 in endosome-to-Golgi recycling. Pfeffer and 
colleagues have produced much in vitro evidence to support the hypothesis that TIP47 has a 
role in the recycling of M6PRs from late endosomes to the TGN [126, 128]. Furthermore, 
antisense-mediated knockdown of endogenous TIP47 expression caused an increased 
turnover of the CI-M6PR, suggesting that TIP47 is important for preventing lysosomal 
degradation of the receptor. Work from other groups has suggested, however, that TIP47 
might be a lipid droplet-binding protein [129, 130]. Lipid droplet-binding proteins play a role 
in the stabilizing of lipid droplets and in the regulation of lipid storage and utilization. This 
function is supported by crystal structure analysis of a domain of TIP47 which revealed that 
its structure is closely related to lipid droplet-binding proteins [131].
24 Chapter 1
PACS-1 interacts with the 154DDSDED sequence in the acidic cluster dileucine motif of the 
CI-M6PR (Figure 3) and mutation of any acidic residue from Asp154 to Asp159, but not of 
L160 and L161, reduces binding of PACS-1 to the CI-M6PR. In cells that lack PACS-1, both 
M6PRs accumulate in the endosomes, which is indicative for a role for PACS-1 in the 
retrograde transport of M6PRs [127]. Similar to GGA1 and GGA3, PACS-1 has an 
autoregulatory domain, and phosphorylation of Ser278 by CKII within this domain activates 
cargo binding and is required for the endosome-to-TGN transport of furin and the CI-M6PR. 
PACS-1 recruits and activates CKII, whereby CKII phosphorylation of the autoregulatory 
domain of PACS-1 promotes cargo binding [132], whereas CKII phosphorylation of the 
autoregulatory domains of GGA1 or GGA3 inhibits cargo binding [51]. Recently, Scott et al. 
[133] demonstrated that PACS-1 and GGA3 directly interact with each other through their 
cargo binding domains, while disturbing this interaction resulted in redistribution of both CI- 
M6PR and GGA3 from a peri-nuclear localization to a dispersed endosome location. This 
suggests that the interaction of PACS-1 with GGA3 might be required for CI-M6PR retrieval 
and for release of GGA3 from endosomal membranes [133].
PACS-1 is also able to bind AP-1 and AP-3 [127, 134]. Cells lacking AP-1 show 
accumulation of M6PRs in endosomes and secretion of lysosomal enzymes, similarly as in 
cells lacking PACS-1 [123, 124, 127]. Furthermore, disruption of the interaction between AP- 
1 and PACS-1 by introduction of a dominant negative PACS-1, which binds cargo but is 
defective in binding to AP-1, results in the mislocalization of furin and both the M6PRs from 
the TGN [134]. This indicates that PACS-1 and AP-1 may cooperate in the retrieval of these 
receptors. Moreover, both the M6PRs are redistributed to endosomes in cell lines derived 
from transgenic mouse that lack the |a1A protein, a subunit of the heterotetrameric AP-1 
adaptor complex, and thus have non-functional AP-1 complexes, although the steady state 
expression levels of the M6PRs was not affected [123]. This redistribution is caused by 
impaired retrieval from endosomes to TGN in case of the CD-M6PR, but not for the CI-M6PR 
[123]. Furthermore, the transport pathways of furin and CI-M6PR are also differentially 
affected by |a1A deficiency [124]. These findings might support observations that the two 
M6PRs use different endosome-to-Golgi retrieval systems [135].
It has been suggested that PACS-1 provides an indirect role in the retrograde transport 
of the CI-M6PR by connecting the CI-M6PR to the AP-1 adaptor for packaging into clathrin- 
coated vesicles in early endosomes [134]. However, an in vitro system of endosome-to-TGN 
transport demonstrated that CI-M6PR transport is independent of clathrin and thus of AP-1
[136]. The function of AP-1 in M6PR localization might also be an indirect one, whereby AP-1
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is required for the delivery of components to the endosomes that are critical for endosome- 
to-TGN transport.
The cytoskeleton of the cells might also play a role in the retrograde transport of the 
M6PRs, since in vitro experiments have shown that the initial rate of endosome-to-Golgi 
trafficking for M6PRs is enhanced by the presence of cytoplasmic dynein, mapmodulin and 
polymerized microtubules, which indicates a role for microtubules in this transport step
[137]. Recently, it has been demonstrated that the retromer complex has a vital role in the 
retrograde transport of the CI-M6PR [138, 139]. Moreover, in contrast to TIP47 and PACS-1, 
the role of the retromer complex is evolutionary conserved among all eukaryotes, since the 
complex also regulates retrograde transport of Vps10p, the functional homologue of the CI- 
M6PRs in yeast. This suggests that TIP47 and PACS-1 have adopted a role in retrograde 
endosome-to-TGN transport that is specific for higher eukaryotes.
Other Cycling TGN Proteins
In addition to the M6PRs there are also other proteins that cycle between the plasma 
membrane, endosomes and the TGN, such as TGN38 and furin, although they are 
predominantly located in the TGN. Mallet and Maxfield [140] have demonstrated that 
TGN38, furin and CI-M6PR are independently sorted in endosomes and use distinct routes 
for their return to the Golgi [140]. The selective sorting of these proteins at various steps 
depends on specific sequences in their cytoplasmic tails that are recognized by cytosolic 
factors.
Furin is a cellular endoprotease (reviewed by [141, 142]) that contains a tyrosine-based 
motif (YKGL) and a leucine-isoleucine (LI) motif in its cytoplasmic tail, which are involved in 
its transport from the cell surface to the sorting endosomes in clathrin-coated pits [143, 
144]. In contrast to the CI-M6PR or TGN38, furin is not translocated to the ERC, but is 
retained in the endosomes as they mature into late endosomes (Figure 2). This retention is 
influenced by phosphatase 2A (PP2A)-mediated dephosphorylation of two serines present in 
the SDSEEDE acidic-cluster motif of furin which are both substrates for CKII [142, 145]. This 
motif also regulates the transport of furin from endosomes to the TGN [144-147]. 
Phosphorylation of its serine residues induces the interaction with PACS-1, which 
subsequently interacts with AP-1. AP-1 then recruits clathrin, which is necessary to form a 
transport vesicle directed to the TGN [127, 134]. Furin can cycle between the Golgi and late 
endosomes, whereby a minor fraction is transported back to the cell surface probably upon 
dephosphorylation by PP2A. The distribution of furin in the cell is therefore modulated by 
the phosphorylation state of its serine residues. As observed for the CI-M6PR, the transport
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of furin from the TGN is dependent on AP-1, which interacts with the YKGL and LI motif 
[148], and maybe also on GGA3, which might interact with the DXXLI sequence in the 
cytoplasmic tail of furin [141].
The transmembrane protein TGN38 (reviewed by [149]) is also predominantly localized 
at the TGN, but cycles between the ERC and the TGN, as shown in Figure 2 [150]. TGN38 is 
internalized at the plasma membrane through the interaction of AP-2 with its cytoplasmic 
SDYQRL sequence [151]. After internalization, TGN38 is transported via the ERC to the TGN 
[150]. The SDYQRL motif has been found to be essential, but not sufficient for this sorting 
step, suggesting the presence of other, yet unidentified sequences [152-155]. Exit from the 
TGN might be regulated by GGAs, since the overexpression of GGA1 results in a reduced 
TGN staining of TGN38 [39]. TGN38 cycles between the ERC and the TGN, whereas furin 
bypasses the ERC and cycles between the late endosomes and TGN, indicating the presence 
of two functionally distinct routes for retrieval of proteins to the TGN.
1.3 Yeast Sorting Nexin/Retromer Complex
Vps Proteins in General
Genetic approaches in yeast have proven valuable for the identification of components 
involved in the cell's sorting mechanisms. The vacuole in yeast is equivalent to the lysosome 
in mammalian cells, since they are both acidic compartments primarily involved in the 
degradation of macromolecules. The presence of hydrolases in the vacuole/lysosome is 
essential for proper vacuolar/lysosomal degradation. Two major biosynthetic vacuolar 
sorting pathways are known in yeast, the CPY (carboxypeptidase Y) and the ALP (alkaline 
phosphatase) pathways, named according to the major known cargoes of each pathway. In 
addition, several pathways are now known to transport cytoplasmic material directly to the 
vacuole, including autophagy, the cytoplasm-to-vacuole (Cvt) pathway, and a fructose-1,6- 
bisphosphatase degradation pathway (reviewed by [156]). In the CPY pathway soluble 
vacuolar hydrolases are actively sorted away from the secretory protein pool in a late-Golgi 
compartment (equivalent to the TGN) and delivered to the vacuole via an endosomal 
intermediate. In contrast, the ALP pathway bypasses the endosomal targeting through 
direct vesicular transport from the TGN to vacuoles (reviewed by [157]). CPY is a soluble 
hydrolase that normally resides in the lumen of the vacuole. Several research groups have 
performed genetic selection screens to isolate mutants in yeast Saccharomyces cerevisiae 
that are unable to properly sort CPY to the vacuole, but instead secrete CPY from the cell. 
This resulted in the identification of over 70 vacuolar protein sorting (Vps) proteins [158-
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161]. More recent screens have identified even 146 mutant strains that secrete strong-to- 
moderate levels of CPY [162]. In addition mutants have been identified that have abnormal 
vacuole morphology (Vam), mutants that are defective for vacuolar protease activity (Pep), 
mutants defective for vacuolar segregation (Vac), mutants defective for endocytosis (End) 
and Golgi retention deficient mutants (Grd). It should be realized, however, that there is 
significant overlap of genes identified in these screens [158-167].
The number of genes involved in the sorting of hydrolases to the vacuole reflects the 
complexity of the vacuolar protein localization pathway. The Vps mutants have been divided 
into six classes (A-F) according to their vacuolar morphologies [166, 168]. Mutants that fall 
in the same class are often blocked in the same step of protein trafficking, and in several 
cases the proteins encoded by genes in the same class have been found to form complexes. 
Class A Vps mutants display almost wild-type morphology: one to three large vacuole 
structures are present in each cell. Mutations of Class A Vps genes specifically affect the 
soluble protein sorting apparatus and not other events in the vacuole assembly. Class B Vps 
mutants have numerous (10-30) fragmented vacuoles and lack genes that are generally 
involved in endosome-to-Golgi transport. Class C Vps mutants lack any identifiable vacuole 
structures, since the mutant gene products make up tethering complexes for membrane 
fusion in two different trafficking steps: fusion of late Golgi vesicles with the late endosome; 
and fusion at the vacuole. Class D Vps mutants have a single, large vacuole and many of 
them accumulate 40-60 nm vesicles, suggesting that the gene products defective in these 
mutants are required for vesicle fusion events, in the anterograde TGN-to-endosome 
trafficking pathway. Class E Vps mutants contain vacuoles larger than wild-type, with a very 
large, aberrant prevacuolar compartment (late endosome/MVB) adjacent to the vacuoles, 
which is called the Class E compartment. Class E mutants are unable to form and sort 
protein into the luminal MVB vesicles and inhibit the exit of proteins from the MVB 
compartment. There are four Vps Class E endosomal sorting complexes known that are 
required for MVB formation, designated the ESCRT-0, -I, -II and -III complexes. Class F Vps 
mutants contain a large central vacuole surrounded by a number of Class-B-like fragmented 
vacuolar structures [157, 166].
Vps10p Receptor
A key component in the sorting and transport of vacuolar hydrolases in S. cerevisiae is 
Vps10p, a transmembrane type I sorting receptor mainly localized in the late-Golgi [169]. 
Vps10p binds the precursor form of the soluble hydrolase CPY in the late-Golgi and is 
subsequently transported to the prevacuolar compartment, where its ligand dissociates
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from the Vps10p receptor and is further transported to the vacuole. Vps10p is retrieved 
from the prevacuolar compartment to the late-Golgi in order to carry out additional rounds 
of enzyme delivery [169-171]. Deletion strains of Vps10 result in aberrant localization and 
secretion of more than 90% of proCPY [166, 168, 169].
In contrast to the specific recognition of mannose 6-phosphate by the M6PRs, yeast 
vacuolar hydrolases are sorted similarly to CPY through an amino acid sequence signal that 
is present within their propeptides. Mutational analysis identified the residues QRPL in CPY 
as crucial elements of this sorting signal. These signal sequences are proteolytically cleaved 
off once the hydrolase precursors reach the vacuole (reviewed by [172]). Vps10p can be 
cross-linked to proCPY, but not to a sorting-defective mutant form of CPY. Such mutations 
result in delivery of proCPY to the cell surface [169]. Vps10 receptor-CPY complexes are 
packaged into transport vesicles and delivered to a prevacuolar endosomal compartment. 
Transport out of the Golgi is believed to be mediated by clathrin-coated vesicles [173, 174]. 
The recruitment of clathrin is accomplished by AP-1 [175] and GGA proteins [40, 176], but it 
is possible that AP-1 and GGA associate with distinct populations of clathrin-coated vesicles 
budding from the TGN [41, 176, 177]. Yeast GGAs bind clathrin in vitro [178] and knockout 
of the two GGA genes in yeast, which at the protein level are ~20% identical to mammalian 
GGAs, leads to partial missorting of proCPY to the cell surface, without affecting the level of 
Vps10p [40, 41, 178, 179]. Deletion of only one of the genes had no effect on CPY sorting, 
since they appear to be functionally redundant, which explains the absence of this gene in 
the Vps screens [41, 178]. The deletion of both GGA genes in yeast resulted in a fragmented 
vacuolar morphology which is comparable to Class F Vps mutants. It has been suggested 
that the dynamin-like protein Vps1p also acts in the formation of vesicular structures at the 
TGN [180-182]. Vps1p is essential for Vps10p-mediated CPY sorting [175, 183], but it is not 
certain whether Vps1 participates in vesicle formation during anterograde or retrograde 
traffic [170].
In the pre-vacuolar endosome Vps10p dissociates from proCPY as a result of the acidic 
environment, and Vps10o is subsequently retrieved in the late-Golgi to maintain sufficient 
Vps10p for several more rounds of CPY sorting. Consistent with this concept, Vps10p is 
synthesized at a rate which is 20-fold lower than that of its ligand CPY, while receptor and 
ligand bind at a 1:1 stoichiometry [169, 171]. Vps10p requires its cytosolic domain for Golgi 
localization and CPY sorting. Mutation of the cytoplasmic tail leads to delivery and 
subsequent degradation of the receptor in the vacuole [169-171]. The cytosolic domain has 
no role in exiting the Golgi and delivery to the vacuole [171], but instead is essential for 
recycling of Vps10p [169-171]. Therefore, the Vps10p cytosolic domain is likely to contain
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retrieval signals that play a role in the return of the receptor from the pre-vacuolar 
compartment to the Golgi complex. Multiple aromatic amino acid containing signals in the 
cytoplasmic tail of Vps10p have been shown to be important for the retrieval of Vps10p and 
Kex2p, a late Golgi resident protein [169-171]. Mutational analysis of the Vps10p cytosolic 
domain revealed that the sequence YSSL is an important component of the Vps10p recycling 
signal. Mutations in this signal sequence resulted in the missorting of 35-45% CPY, however, 
which suggests that at least a second signal may exist that contributes to the trafficking of 
Vps10p [171].
Vps Proteins in Retrograde Transport
Although most of the genes identified by screenings in yeast are involved in anterograde 
transport, there are also some proteins that function in retrograde trafficking. Among them 
are Vps52, Vps53 and Vps54, which form a docking complex called VFT (Vps fifty three) that 
is required for the fusion of endosomal vesicles with the TGN [184]. This VFT complex can be 
linked via an interaction with Vps51 to the t-SNARE Tlg1p, which is crucial for the membrane 
fusion [185-188]. Also Grd19, which is functionally homologous to mammalian SNX3, is a 
component of a retrieval machinery and functions by direct interaction with the cytoplasmic 
tails of certain TGN membrane proteins during the sorting/budding process at the 
prevacuolar compartment [189, 190]. The products of five Vps genes: Vps35, Vps29, Vps26, 
Vps5 and Vps17, which form the sorting nexin/retromer complex, have been shown to be 
required for the proper retrieval and recycling of Vps10p from the endosomal compartment 
to the late Golgi. Recently it has been suggested that Grd19 interacts with the retromer 
complex, but this interaction appears not to be involved in the transport of Vps10p, since 
downregulation of Grd19 does not affect recycling of Vps10p [191].
Vps35p
Vps35 is a hydrophilic protein located in the cytoplasm. Deletion mutants of Vps35 exhibit a 
selective missorting phenotype of CPY, which is similar to that seen in Vps10 mutants [192, 
193]. The same phenotype has also been observed for Vps29 and Vps30 mutants, of which 
the latter encodes a protein of the PI-specific PI3-kinase (PI3K) complex [193]. All these 
mutants have normal vacuoles and therefore belong to the Class A Vps proteins. Although 
CPY is missorted in these mutants, Proteinase A (PrA), another soluble hydrolase, is properly 
sorted [193]. By using a temperature conditional mutant of Vps35p it has been 
demonstrated that the CPY sorting defect observed in the Vps35 mutant is not due to 
secondary effects resulting from deletion of the protein, but that Vps35 has a direct role in
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sorting of CPY [193]. Inactivation of Vps35p has no effect on the exit of CPY from the Golgi 
and arrival at the endosome/Class E compartment [193]. Instead, mutation of Vps35 or 
Vps29 changes the localization of Vps10p from the late-Golgi to the vacuole and in addition 
also alters the subcellular location of the S. cerevisiae Kex2p protease.
A-ALP is a model TGN-membrane protein which has been designed by fusing the N- 
terminal cytosolic domain of dipeptidyl aminopeptidase-A (DPAP-A) with the 
transmembrane and luminal domain of alkaline phosphatase (ALP). A-ALP is a resident Golgi 
protein that cycles to and from the prevacuolar compartment, but is mislocalized to the 
vacuole when Vps35 is depleted. These data indicate that Vps35 plays a role in retrieval of 
Vps10p, Kex2p and A-ALP from the prevacuolar compartment to the Golgi [194]. Indeed, 
Vps35 interacts with the cytosolic domains of both Vps10p and A-ALP, probably through 
their aromatic retrieval signals [195]. In yeast, Vps35p directly interacts with Vps29p and co- 
immunoprecipitates with Vps5p, Vps17p and Vps26p. These five proteins assemble together 
to form a large, multimeric complex on a prevacuolar membrane [192]. BLAST searches 
revealed that Vps35p is conserved and has orthologues in mammals, which is indicative for 
a fundamental role in maintaining proper protein trafficking within cells [193, 196].
Vps29p
Vps29 protein belongs to the Class A Vps proteins and Vps29 mutants exhibit a selective 
missorting phenotype of CPY. In yeast, Vps29p directly interacts with Vps35p, such that the 
membrane association of Vps29p is fully dependent on its interaction with Vps35p [192]. In 
a Vps29 mutant, Vps35p will follow Vps10p to the vacuolar membrane [193]. These data 
strongly suggest that Vps29p binds to Vps35p and possibly to specific coat proteins, but not 
to cargo proteins, and consequently has a role in the exit of Vps35p and its bound cargo 
from endosomes. Furthermore, Vps29p possibly assists Vps35p in its binding of cargo 
proteins, most likely by enhancing its association with membranes and/or other sorting 
nexin/retromer proteins [192]. The assembly of the retromer proteins was studied in COS7 
cells in which the retromer proteins were overexpressed. These studies revealed that, in the 
absence of Vps29p, Vps35p cannot bind to Vps26p [197]. Furthermore, when both Vps29 
and Vps26 are mutated or knocked out in yeast, Vps35p becomes very unstable [192, 198]. 
It therefore appears that Vps35p and Vps29p assemble into a stable subcomplex, in 
association with Vps5p/Vps17p, whereby Vps26p is required for the interactions between 
these subcomplexes [192, 199-201].
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Vps26 deletion mutants are Class F mutants with an intermediate phenotype. In Vps26 
deletion strains, ~90% of Vps10p is sorted to the vacuole, resulting in a phenotype that is 
very similar to that of Vps29 or Vps35 mutants [192]. Also in the presence of dominant 
negative Vps26 mutants, a significant shift of Vps10p to the vacuole membrane has been 
observed [198]. Vps26p is not a key structural component of the retromer complex in yeast, 
because the remaining four members can still be cross-linked together in extracts from 
Vps26 knock-out cells. Vps26p is able to co-immunoprecipitate the other four sorting 
nexin/retromer components from extracts of wild-type cells, but none of the complex 
members co-immunoprecipitates with Vps26p from extracts of Vps35 knock-out cells [198]. 
This is indicative for a direct interaction of Vps26p with Vps35p, and an indirect interaction 
with other members of the sorting nexin/retromer complex. Interestingly, a significant 
fraction of Vps35p becomes cytoplasmic in Vps26 deletion strains [192, 198]. It has 
therefore been suggested that Vps26p has a function in the localization of Vps35p and 
thereby promotes cargo binding of Vps35p. Immunoprecipitation studies revealed that the 
interaction between Vps5p/Vps17p and Vps35p is facilitated by Vps26p [198].
Vps5p and Vps17p
Yeast deletion strains of Vps5p and Vps17p exhibit a less dramatic mislocalization for 
Vps10p than that observed in the Vps35 and Vps29 mutants. Vps5p and Vps17p null 
mutants have phenotypes indistinguishable from each other [200, 202] and their gene 
products are both classified as Class B Vps proteins, which suggests that these proteins act 
in a more general fashion than Vps26, Vps29 or Vps35. In Vps5 or Vps17 deletion strains, 
more than 90% of CPY is mislocalized, which is the consequence of a failure to maintain the 
localization of the Vps10p receptor [200-202]. Furthermore, it has been observed that 
Vps5p is required for localization of the resident late-Golgi proteins A-ALP and Kex2p [201].
It has been observed that the mGST-Vps5p fusion protein binds to Vps17p, Vps35p, and 
Vps29p [192], while Vps5p co-immunoprecipitates with the other four members of the 
sorting nexin/retromer complex when assayed in wild-type cell extracts under native 
conditions [203]. The N-terminal half of Vps5p is both necessary and sufficient to bind the 
other members of sorting nexin/retromer complex [203]. In the absence of Vps35 or Vps29, 
Vps5p will only co-immunoprecipitate with Vps17p, and when Vps26p is absent weak 
interactions with Vps35p/Vps29p are detected, in combination with a strong interaction 
with Vps17p. The Vps5p/Vps17p heterodimer therefore appears a subcomplex of the 
sorting nexin/retromer complex [192]. Truncation studies indicated that the C-terminus of
Vps26p
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Vps5p stably interacts with the C-terminus of Vps17p. Indeed, Vps17p is unstable in Vps5 
deletion strains, but not in other retromer mutants [203].
Vps5p and Vps17p are both members of the SNX family (described below), which are 
mainly defined by the presence of a Phox homology (PX) domain that binds to 
phosphatidylinositides (PI or PtdIns) [204]. Indeed, a fusion protein of GST with the PX 
domain of Vps5p or Vps17p specifically binds phosphatidylinositol 3-monophosphate (PI(3)P 
or PtdIns3P) [205]. The presence of a PX domain results in the localization of epitope-tagged 
Vps5p to an endosomal compartment, while wild-type Vps5p and Vps17p proteins co- 
fractionate with a dense pool of membranes [201, 202]. Deletion of Vps17p shifts almost all 
of the Vps5p to the cytosolic fraction, indicating that Vps17p is required for the membrane 
localization of the Vps5p/Vps17p subcomplex [192, 200, 203]. However, the association 
with Vps17p is not sufficient for proper localization of Vps5p, since deletion of the N- 
terminus of Vps5p also results in a significant shift of Vps5p to the cytosolic fraction [203]. 
Furthermore, the N-terminal half of Vps5p is necessary for self-assembly activity [203] since 
Vps5p shows intrinsic self-assembly activity, both in vitro and in vivo [192, 200].
Yeast Sorting Nexin/Retromer Complex
The studies described above have led to the hypothesis that the sorting nexin/retromer 
complex is a vesicle coat complex that mediates retrieval of Vps10p from endosomes to the 
Golgi. By both phenotypic and biochemical criteria, the sorting nexin/retromer complex can 
be dissected into two subcomplexes: the retromer complex itself consisting of Vps35p, 
Vps29p and Vps26p which performs cargo selection; and the sorting nexin complex 
comprising the Vps5p/Vps17p dimer, which has a structural and membrane targeting role. 
Vps35 is the core component of the sorting nexin/retromer complex to which all other 
retromer subunits assemble. Genetic and biochemical analysis have identified Vps35p as the 
cargo recognition component of the yeast retromer complex [195]. Vps35p coupled to 
Vps29p drives cargo selection via interactions with Vps10p. Loss of Vps35 or Vps29 function 
results in mislocalization of Vps10p to the yeast vacuole, where Vps10p is degraded [193]. 
Because of the resulting lack of sufficient receptor levels in the late Golgi, this 
mislocalization causes a defect in the sorting of CPY. It is important to mention that 
although the yeast retromer complex functions in retrograde transport from the pre­
vacuolar compartment to the Golgi, there is also another protein complex, consisting of 
SNX4, SNX41 and SNX42, that accomplishes retrieval from the post-Golgi endosomes to the 
Golgi [206].
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Yeast retromer subunit Vps26 interacts with Vps35 and facilitates assembly of the 
pentameric sorting nexin/retromer complex. Vps26 has been proposed to link cargo 
selection with the self-assembly activity of the Vps5p/Vps17p subcomplex [192]. The 
Vps5p/Vps17p dimer provides the mechanical impulse to bud a vesicle through the self­
assembly activity of Vps5p and has an important role in the membrane localization of the 
sorting nexin/retromer complex in yeast. Loss of the membrane association results in 
impaired function of the sorting nexin/retromer complex [192, 203]. Because Vps5p/Vps17p 
requires a specific pool of PI3P for membrane association, PI3Ks certainly play a role in 
recruitment and activation of the sorting nexin/retromer complex [205]. In yeast there is 
only one PI3K, Vps34p, which can be activated by Vps15p. Vps34p and Vps15p form a 
complex with Vps30p and Vps38p [205]. As mentioned before, mutation of Vps30p results in 
a similar phenotype as the mutations of Vps35p or Vps29p [193].
Most yeast sorting nexin/retromer subunits have their orthologues in mammals. Yeast 
Vps26, Vps29 and Vps35 have all three at least one orthologue, which share 30-42% 
sequence identity: hVps26, hVps29 and hVps35. Moreover, there are two orthologues of 
Vps5p (SNX1 and SNX2), while Vps17p has no closely related orthologue in mammals [200, 
207].
1.4 Mammalian Sorting Nexin/Retromer Complex
Sorting Nexins
Mammalian sorting nexins (SNXs) are a diverse family of cytoplasmic and membrane- 
associated proteins that are involved in various aspects of endocytosis and cellular protein 
trafficking (reviewed by [208-211]). The SNXs have not been grouped together on the basis 
of their protein function, but on the presence of a SNX-PX domain, a subfamily of the Phox 
homology (PX) domain family. This PX domain binds various phosphatidylinositol 
phosphates, which can result in targeting of these proteins to specific cellular membranes 
that are enriched in these phospholipids. In addition to the PX domain, most SNXs also 
contain an additional membrane interaction domain, known as the the BAR domain, as well 
as domains involved in protein-protein interaction, including SH3 domains, RGS (Regulators 
of G-protein Signaling) domains, RA (Ras Association) domains and PDZ (PsD95/Dlg/ZO1) 
domains, all of which may function to regulate the localization of SNXs (Figure 4). At the 
moment, 29 mammalian and 10 yeast SNXs have been identified. In yeast, endogenous SNXs 
have been consistently implicated in the regulation of protein retrieval from endosomes 
[212]. In mammals some members are clearly regulators of membrane traffic whereby SNXs
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participate in various trafficking events in the endocytic pathway including endocytosis (e.g. 
SNX9, -17), sorting to late endosome traffic (e.g. SNX15, -16), endosomal recycling (e.g. 
SNX17), traffic from the sorting to recycling endosome (e.g. SNX3) and endosome-to-TGN 
transport (SNX1). However, for the majority of the SNXs little is still known about their 
function.
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Figure 4 Domain analysis of mammalian SNXs. Coding sequences for the 29 assigned
mammalian SNXs were translated using the Translate tool (Expasy). Predicted amino acid sequences 
were used to interrogate the Simple Modular Architecture Research Tool (SMART) or Protein 
Families database of alignments and HMMs (PFAM) databases. Predicted domain structures are 
indicated as shown. The percentage similarity between the SNX1-PX domain and individual PX 
domains was obtained by calculating the percentage conserved, semi conserved or identical residues 
present (CLUSTALW alignment) and is given in brackets. Asterix (*) indicates that the domain is 
predicted, but is below threshold levels for identification [208].
Phox Homology Domain
The membrane phospholipid phosphatidylinositol is the precursor for a family of lipid 
second messengers, collectively known as phosphoinositides (PI or PtdIns). PIs contains a 
1D-myo-inositol phosphate group linked to diacylglycerol. The D-myo-inositol head group 
contains five hydroxyl groups, three of which (at positions 3, 4 and 5) can be reversibly
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phosphorylated with one, two or three phosphate groups, resulting in total in seven 
different PIs. The resulting PIs are not uniformly distributed among intracellular membranes, 
but appear enriched in different organelles. For example, the membrane of early 
endosomes consists mainly of PI(3)P, while the plasma membrane site involved in 
endocytosis is enriched in PI(4,5)P. PIs function both as signaling molecules and as 
localization cues, allowing the recruitment of PI-binding proteins towards PI-containing 
membranes [213]. To date, a number of distinct PI-binding motifs have been identified and 
characterized including the ENTH (epsin amino-terminal homology) domain, FYVE domain, 
FERM (band 4.1m erzin, radixin and moesin) domain and PH (pleckstrin homology) domain. 
In addition, various studies have shown that the PX domain is also capable of PI-binding 
[204, 214-218].
The PX domain was first identified as a conserved motif within the p40phox and p47phox 
subunits of the neutrophil NADPH oxidase superoxide-generating complex [219]. PX 
domains can be found in a wide variety of proteins involved in cell signaling (phospholipase 
D1 and D2, class II PI3Ks), control of yeast bud emergence and polarity (Bem1p and Bem3p), 
and vesicle trafficking (human sortin nexins, yeast Vam7p). The PX domain consists of a 
sequence of 100-140 residues [212]. There is relatively weak primary sequence identity 
within these PX domains among eukaryotes, which is restricted to a conserved proline-rich 
motif, P-X-X-P (where X is any amino acid) and in most PX domains a predicted SH3-binding 
motif [219]. However, all PX domains contain remarkably conserved two- and three­
dimensional structures [212, 220].
In many cases, PX domains have been shown to bind PI3P [204-206, 218, 221-223], a 
phosphoinositide enriched on the cytosolic face of sorting endosomes [224, 225]. As a 
result, many SNXs associate with endosomes in a PI3K dependent manner, but SNXs may 
also be involved in the control of other compartments, depending on the PI-binding capacity 
of their PX domain. For example, SNX5 is localized on both sorting endosomes and the 
plasma membrane, whereby the SNX5-PX domain was shown to bind two different PI 
species; PI(3)P and PI(3,4)P2 [222]. This suggests that SNXs can function at distinct 
subcellular sites by binding to different PI lipids. Only a minority of PX domains binds PIs 
with high affinity and thereby determine the proteins subcellular localization. For example, 
the PX domain of SNX3 and SNX5 is sufficient for endosomal targeting [218, 222]. In 
contrast, most PX domains display low affinity for PIs and are insufficient for targeting to 
endosomal membranes when expressed alone. In those cases, the binding affinity towards 
PIs for these PX domains is modulated by the presence of other motifs/domains. For 
efficient binding of SNXs to PIs in membranes most SNXs require both the PX domain and
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flanking coiled-coil regions and/or other sequences that mediate dimerization or interaction 
with other proteins [220, 223].
The crystal structure of several PX domains has been solved [189, 226-230] revealing 
that the overall structure consists of a positively charged PI-binding pocket of an N-terminal 
three-stranded ß-sheet situated next to a helical subdomain comprised of three a-helices. In 
this pocket the headgroup of PI(3)P can be positioned, which interacts with the PX domain 
by hydrogen bonds. In SNXs lipid binding is mediated by a region of highly conserved 
residues, R-R-(Y/F)-S-(D/E)-F, which is present in most SNXs. This sequence is part of the 
positively-charged pocket whereby the second arginine makes extensive contact with the 3- 
phosphate of PI(3)P [229]. Mutation of the R-R motif to G-S disrupted phospholipid 
interaction as well as endosomal location of SNX1 [223].
BAR Domain
Like most other SNXs, the PX domain of SNX1 displays affinity for PI(3)P binding and targets 
SNX1 to its endosomal location. Electron microscopy studies have demonstrated that SNX1 
is enriched on highly curved tubular structures emerging from the endosome. This has been 
suggested to result from the PX domain in combination with the recently identified BAR 
(Bin/Amphiphysin/Rvs) domain. The BAR domain was subsequently identified in SNX2, -4, - 
5, -6, -7, -8, -9, -18 as well, as depicted in Figure 4 [231]. This domain forms a banana­
shaped dimer that is positively charged on its concave face. In vitro studies demonstrate 
that it binds preferentially to liposomes with high intrinsic curvature. It has therefore been 
suggested that this domain can sense curvatures and, moreover, that this domain can 
induce curvature upon membranes by deforming liposomes [232]. In addition, the BAR 
domain can also function as a dimerization module, which may explain the ability of BAR- 
containing SNXs to form both homo- and hetero- oligomers [197, 207, 223]. Although the 
lipid binding capability by the PX domain of SNXs is considered to dictate its cellular 
destination, the BAR domain has been suggested to localize SNXs to specific highly curved 
microdomains of cellular membranes.
Mammalian Sorting Nexin/Retromer Components
SNX1
SNX1 was the first identified sorting nexin protein and was isolated in a yeast two-hybrid 
screen with the core tyrosine kinase domain of the EGFR as a bait, which interacts with the 
SNX1 C-terminal 58 amino acids [92]. Mapping of the interaction sites between SNX1 and 
the EGFR showed the involvement of EGFR residues 943-957, which contains the predicted
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EGFR lysosomal targeting code 954YLVI [233]. This motif is highly conserved among EGF 
receptors from various mammalian and invertebrate species, and has been reported to be 
critical for receptor downregulation [91]. This suggests that SNX1 plays a role in EGFR 
downregulation and subsequent trafficking to the lysosome. Indeed, several studies have 
shown enhanced ligand-induced downregulation of the EGFR upon overexpression of SNX1 
[92, 221, 234, 235], but not of ErbB2 or platelet-derived growth factor (PDGF) receptors 
[92]. Subsequent steady state expression analysis by Western blotting indicated that this 
enhanced downregulation was not caused by enhanced internalisation of the receptor, but 
by enhanced degradation of the EGFR [234].
Besides the reported interaction with the EGFR, SNX1 interacts with several other 
receptors of the tyrosine kinase family, including the PDGFR-ß and the insulin receptor. In 
addition, SNX1 co-immunoprecipitates with the long form of the leptin receptor and with 
transferrin receptors, which internalize and recycle constitutively [207]. Downregulation of 
G-protein-coupled protease-activated receptor 1 (PAR1) is also regulated by SNX1 [236, 
237]. Furthermore, SNX1 has been reported to interact with intestinal protein enterophilin-1 
(Ent-1) [235] and the ESCRT-0 subunit hepatocyte growth factor-regulated tyrosine kinase 
substrate (Hrs) [234]. The challenge in the case of all those receptors and related proteins is 
to determine the functional role of SNX1 in their cellular trafficking.
The subcellular localization of a protein is very indicative of its function. Both 
endogenous and transfected GFP-SNX1 are localized in tubular and vesicular structures 
inside cells [92, 199, 220, 221, 223, 238, 239]. SNX1 is localized primarily on early 
endosomes and colocalizes with EEA1, although the reports of the extent of colocalization of 
SNX1 with this protein vary [199, 221, 223, 236, 238]. Electron microscopy studies indicate, 
however, that SNX1 localizes to endosomal microdomains, which are distinct from EEA1 
containing microdomains, and which are characterized by two parameters: the presence of 
PI(3)P and high membrane curvature [240, 241]. As demonstrated by immuno-gold labelling, 
SNX1 is enriched on tubular elements of early endosomes [241]. Live imaging of GFP-SNX1 
expressing cells demonstrated SNX1-decorated tubules which exit depart from SNX1- 
labelled compartments [241]. Although the SNX1-positive vesicles fuse with each other, 
they do not fuse with SNX1-decorated tubules. This suggests that tubulation of SNX1 occurs 
vectorially, the direction being out of the endosome [238, 241]. Taken together, the live 
imaging and compartment marker studies indicate that GFP-SNX1 labels a transient 
compartment with properties common to sorting endosomes.
The most important domain for the subcellular localization of SNX1 is its PX domain 
(Figure 5), which displays specific binding to PI(3,4,5)P3 and weaker binding to PI(3,5)P2 in
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protein-lipid overlay assays [221, 223]. However, the mechanism of lipid binding by PX 
domains involves both headgroup interactions and insertion of hydrophobic loops into the 
lipid bilayer [242] and the method used lacks the ability for headgroup presentation and 
physiological bindings conditions. We therefore favor the more physiologically relevant 
liposome-based binding assays, which demonstrated binding of SNX1 to PI(3)P and PI(3,5)P2 
[221], in agreement with the endosomal localization of SNX1. Yu and Lemmon [204] 
proposed that 'low affinity' PX domains provide specificity in localization, while other 
targeting domains are needed to drive membrane association [204]. In the case of SNX1, 
mutation of the PX domain or truncation of the C-terminus abolishes wild-type vesicle 
localization, suggesting that both domains are necessary for correct cellular localization 
[204, 241]. Indeed, expression of only the PX domain of SNX1 or SNX2 did not result in 
localization to vesicular structures, as was observed for the PX domain of SNX3, but resulted 
in a diffuse distribution [240]. Structural analysis of the PX domain of SNX1 revealed that 
although residues capable of binding PIs are present within the appropriate area of the 
primary sequence of the SNX1 PX domain, parts of the binding site are not fully folded in 
absence of PIs [240]. This is in contrast to the high-affinity PX domains which are already 
largely preformed in the absence of PIs [189, 228, 229].
Cargo binding
Figure 5 Schematic representation of mammalian sorting nexin/retromer subunits. The
number of amino acids and molecular mass of each protein are indicated. The scheme also indicates 
the features of the different subunits or their domains [247].
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The C-terminus of SNX1 localizes to membranes, but not specifically to EEA1-positive 
endosomes, where full length SNX1 is localized. It is therefore accepted that the PX domain 
of SNX1 is necessary for proper endosomal localization, but that the C-terminal domain of 
SNX1 targets the protein to vesicles [240]. Indeed the BAR domain present in the C-terminus 
of SNX1 has a role in the proper localization of the protein. The BAR domain causes 
enhanced membrane association of SNX1 upon an increase of membrane curvature, and at 
high concentration SNX1 is able to induce membrane curvature. Point mutations of charged 
residues in either the PX domain or the BAR domain blocked the ability of SNX1 to tubulate 
liposomes and resulted in a cytosolic location [241]. Electron microscopy studies in HeLaM 
cells demonstrated the presence of SNX1 on tubular-vesicular elements of endosomes 
[139]. It has been suggested that dimerization of SNX1 via its BAR domain enhances PI 
affinity and thereby provides proper endosomal binding [240]. Dimerization of SNX1 has 
been studied extensively [207] and evidence has been presented that SNX1 can dimerize 
with at least other SNX1, -2, -4 ,-5 and -6 proteins [207, 223, 243, 244]. SNX1 exists as a 
dimer in solution [223, 238, 241], but recent data shows that the preferred oligomer of 
SNX1 is a tetramer, probably consisting of two dimeric intermediates [238]. This self­
assembly capability of SNX proteins is indicative for their structural role.
Recent studies using siRNA against SNX1 have shown that endogenous SNX1 plays no 
detectable role in the trafficking of EGF, EGFRs or transferrin, since their internalization, 
recycling and degradation were unaffected [199, 241]. These studies therefore contradicted 
the conclusions from studies based on SNX1 overexpression. It has been suggested that 
overexpression of SNX1 induces gross tubulation of the endosomal network which may 
perturb global transport and sorting of endosomal cargo, thereby artificially affecting 
receptor trafficking [241]. In contrast, in cells with reduced SNX1 mRNA levels the EEA1- 
positive compartment appeared morphologically normal, as was the internalization of EGFR 
and TfR [241]. Indeed, conclusions on the effects of SNX1 on the EGFR heavily rely on 
overexpression studies. Moreover, a putative role for SNX1 in EGFR degradation would be in 
contrast to the function of its yeast orthologue, Vps5p, which has a role in the regulation of 
hydrolase receptor retrieval from the endosomal system. In agreement with the function of 
Vps5p, cells exhibiting siRNA against SNX1 fail to return the CI-M6PR from early endosomes 
to the TGN and instead degrade this receptor [241]. A similar phenomenon has been 
observed in cells in which expression of the retromer components Vps26 or Vps35 is 
suppressed [138, 139]. In addition, SNX1 is enriched on endosomal tubular profiles that 
contain CI-M6PR [139, 241]. Taken together with the recent evidence for the existence of a 
mammalian retromer complex [138, 139, 197] and the ability of SNX1 to associate with its
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N-terminal region to other retromer components, [197, 199, 222], it appears likely that 
SNX1 plays an evolutionary conserved role as a subunit of the sorting nexin/retromer 
complex.
SNX2
SNX2 and SNX1 are paralogous genes which have arisen early in vertebrate evolution and 
are probably derived from a single ancestral gene upon whole genome duplication. They 
share 26% sequence identity in the amino acid sequence of their N-terminal regions and 
70% between their PX domain and BAR domain-containing C-terminus [207]. Given that i) 
SNX1 is part of the mammalian sorting nexin/retromer complex, similar to its yeast 
orthologue Vps5p and that ii) with the exception of Vps17p, mammalian orthologues have 
been identified for all yeast sorting nexin/retromer components [197], it has been proposed 
that SNX2 is a potential candidate for the mammalian role of Vps17p. This hypothesis is 
supported by the observation that, similar to SNX1 and SNX2, Vps5p and Vps17p can 
assemble both in vitro and in vivo as homo- and heterodimers [207, 223, 238]. However, 
there is conflicting biochemical and morphological evidence as to whether SNX2 is indeed a 
component of the mammalian sorting nexin/retromer complex [197, 199, 245-248].
Genetic evidence suggests that SNX1 and SNX2 have related functions. Mice lacking 
either SNX1 or SNX2 are viable and fertile, whereas embryos deficient in both SNX1 and 
SNX2 arrest at midgestation, demonstrating a similar phenotype as observed when the 
retromer component mVps26 is targeted for deletion [249, 250]. The results with these 
double knock-out mice suggest essential overlapping functions of SNX1 and SNX2 in 
vertebrate development [251], which may be indicative for redundancy between SNX1 and 
SNX2. However, in the same study it has been demonstrated that SNX1 and SNX2 exert 
different functions. Snx1+/~;Snx2~/~ mice are not developed normally and have a so-called 
runted phenotype and are underrepresented in litter frequency, whereas SnxT/~;Snx2+/~ 
mice are phenotypically normal [251]. Moreover, in cells in which the level of endogenous 
SNX1 was suppressed, no compensatory upregulation in the level of endogenous SNX2 was 
observed. Similarly, SNX1 levels were not upregulated in cells in which the level of 
endogenous SNX2 was suppressed [245] or overexpressed [237]. In contrast, 
downregulation of retromer components Vps26, Vps29 and Vps35 in mammalian cell lines 
affects the expression levels of each other [138, 139, 247, 252], demonstrating a different 
relationship between components of the two subcomplexes.
SNX2 colocalizes with Vps26, which supports the involvement of SNX2 in the sorting 
nexin/retromer complex [245] and moreover, interaction of SNX2 with retromer
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components has been demonstrated by yeast two-hybrid studies [197, 247]. In contrast, 
however, co-immunoprecipitation studies demonstrated interactions of SNX1, but not of 
SNX2, with retromer components [199]. SNX2 colocalizes with SNX1 on early endosomes 
[220, 223, 240, 241, 245], which is again indicative for overlapping functions. This 
colocalization might be the result of the highly similar PI-binding profiles of SNX1 and SNX2, 
when assayed under identical conditions [223, 245]. Although the BAR domains of SNX1 and 
SNX2 are both capable of sensing membrane curvature, SNX2 is incapable of inducing 
significant membrane tubulation [245]. Again analogous to SNX1, SNX2 interacts with Ent-1 
[235] and with several receptors including EGFR, PDGFR, insulin receptor (IR) and the long 
form of the leptin receptor, but not with the TfR [207]. Similar as for SNX1, a proposed role 
for SNX2 in EGFR degradation [199] was convincingly rejected by demonstrating that knock­
down of SNX2 expression alone or in combination with SNX1 did not significantly affect the 
degradative sorting of the EGFR [199, 245].
Similar as for retromer components, a role for SNX2 in CI-M6PR transport has been 
suggested, based on the observation that SNX2 is enriched alongside SNX1 on CI-M6PR- 
containing tubular elements of the early endosome [241, 245]. Carlton et al. [245] observed 
that in cells suppressed for SNX2 expression, the CI-M6PR retained a predominantly peri­
nuclear localization whereby no enhanced CI-M6PR degradation was observed. This is in 
contrast to cells suppressed for SNX1 [245] or retromer components [138, 139, 241]. 
However, Rojas et al. [247] recently demonstrated that individual depletion of SNX1 or SNX2 
had little or no effect on the level, distribution and staining of the CI-M6PR. In contrast, 
combined depletion of SNX1 and SNX2 caused a dramatic decrease in staining for the CI- 
M6PR, with residual staining on structures that appeared more disperse than juxta-nuclear. 
The reason for the observed differences is as yet unclear, but it is possible that the use of 
different strains of HeLa cells (HeLaM by Carlton et al. [245] and HeLa cells from ATCC by 
Rojas et al. [247]) contribute to the conflicting results.
An important role of Vps17p is to accomplish membrane localization of the yeast sorting 
nexin/retromer complex, since yeast cells deficient for Vps17p demonstrate a loss in 
membrane association for Vps5p. However, in mammalian cells SNX2 does not appear to 
function in a similar way, since in SNX2-suppressed cells SNX1 and mVps26p retained their 
membrane association [245]. It is possible that the mammalian retromer complex has 
evolved to a point that it no longer requires an additional SNX for its function or 
alternatively another SNX than SNX2 may constitute the mammalian orthologue of Vps17p. 
In order to examine whether another member of the SNX family may form the functional 
equivalent of Vps17p, Wassmer et al. [248] designed an RNAi loss-of-function screen of
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retromer-mediated endosome-to-Golgi retrieval of the CI-M6PR in HeLa cells. Targeting 
each individual SNX (SNX1-30), as well as each component of the mammalian retromer, 
resulted in a dispersed CI-M6PR localization in 50-70% of the cells for Vps26, Vps29 and 
Vps35 and in 35% of the cells for SNX1. This screen also revealed a major contribution of 
SNX5 and SNX6 on the steady-state distribution of the CI-M6PR (~60% of the cells) and a 
mild effect of SNX27, SNX28 and SNX30 (~40% of the cells). In cells in which SNX5 and/or 
SNX6 are suppessed, a clear redistribution of the CI-M6PR was observed from its normal 
steady-state TGN localization to peripheral punctae that co-localized with EEA1, while TGN 
markers showed an altered distribution in cells suppressed for SNX5. Antibody labelling of 
CD8-CI-M6PR at the cell surface and a subsequent incubation of 30 minutes, demonstrated 
a significant decrease in the amount of antibody present in the TGN for cells suppressed for 
SNX5 and/or SNX6 compared to wild-type cells. Furthermore SNX6, and to a lesser extent 
SNX5, colocalize with SNX1 on endosomes and also in the tubular elements of endosomes. 
Indeed, endogenous SNX1 co-immunoprecipitates with epitope-tagged SNX6, but the results 
for SNX5 were conflicting [243]. siRNA against SNX5 and/or SNX6 resulted in a significant 
reduction of endogenous SNX1. Such data suggest that these SNXs are either directly or 
indirectly associated with endosome-to-Golgi transport of CI-M6PR. Since SNX5 affects the 
morphology of the Golgi complex as well, its effect on CI-M6PR transport is probably more 
indirect.
In conclusion, the identity of a possible fifth mammalian sorting nexin/retromer complex 
subunit in mammals, as a counterpart of Vps17p in yeast, is still unclear. SNX2, SNX5 and 
SNX6 are all possible candidates, but as long as no conclusive evidence has been presented 
yet, the discussion will likely continue.
Mammalian Vps26
The subcellular localization of mVps26 has been studied using GFP-tagged Rab proteins 
stably expressed in HeLaM cells. Significant colocalization was observed between mVps26 
and GFP-Rab5, and modest colocalization between mVps26 and GFP-Rab7, but only very 
little overlap between mVps26 and GFP-Rab9 [139]. Additional immunofluorescence 
experiments revealed extensive colocalization of endogenous hVps26 with the TfR and the 
constitutively active Rab5Q79L mutant [253], but not with the TGN marker TGN46 or the 
late endosomal/lysosomal marker LAMP-1 [138]. Electron microscopy data demonstrated 
the presence of mammalian Vps26 on tubular profiles in the vicinity of organelles with the 
typical morphology of endosomes, some of these endosomes had a clear lumen whereas 
others contained intraluminal vesicles. A smaller fraction of hVps26 was detected on the
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limiting membranes of endosomes themselves [138, 139]. The multivesicular endosomes 
that contain hVps26 also labelled for TfR, but not for LAMP-1 [138]. Taken together these 
data indicate that Vps26 is localized on early endosomes or on intermediate structures 
during the maturation process from early to late endosomes. The association of sorting 
nexin/retromer subunits with tubules is consistent with the ability of SNX1 to sense highly 
curved membranes with its BAR-domain.
Bioinformatic analysis of the mouse genome identified an additional transcribed and 
translated paralogue of Vps26, which has been termed Vps26B and displays 69% identity 
and 82% similarity with Vps26 [254]. No mammalian paralogues have been identified for 
Vps29 and Vps35, but in vertebrates Vps29 is expressed in two different isoforms, one of 
which contains a 4-amino-acid insertion directly following the startcodon [255]. Vps26B co­
precipitates with Vps35 from transfected cells and yeast two-hybrid studies confirmed a 
direct interaction between these two proteins [254]. Within HeLa cells, Vps26B was found to 
be localized in the cytoplasm with low levels at the plasma membrane, while Vps26 was 
predominantly associated with endosomal membranes [254]. In A549 cells, which show 
pronounced lamellipodia, Vps26B is concentrated in actin-rich lamellipodia at the plasma 
membrane, which also contain the retromer components Vps26 and Vps35. Moreover, 
Vps26B and Vps35 colocalize, indicating that they associate with the same subdomain of the 
plasma membrane [254].
Recently, the crystal structure of hVps26 at 2.1 Á resolution has been published [256]. 
The hVps26 molecule consists of two domains, which both fold into a deeply curved ß- 
sandwich, and are connected to each other by a polar core and a flexible linker. Vps26 has a 
structural relationship to arrestins (see also Chapter 2), an important class of trafficking 
adaptor proteins involved in receptor internalization at the plasma membrane [256]. Vps26 
has the same overall fold, but contains an unusual polar core as well, which is mainly formed 
by highly conserved residues, indicating that this polar core is crucial in protein function. 
The N-terminal domain of hVps26 contains a combination of exposed hydrophobic and basic 
residues, which is too weak to localize to membranes on its own, but which could be part of 
a secondary interaction site involved in the formation of larger complexes at the membrane. 
Arrestins directly bind to clathrin, AP-2, the ubiquitin ligase Mdm2, the small GTPase ARF6, 
the nucleotide exchange factor ARNO, PI(4,5)P2 and a range of receptors and other signal 
proteins [207]. However, the sites of arrestin involved in clathrin-binding, phosphorylation, 
ubiquitination and PI-binding are absent in hVps26, although the receptor binding structures 
are present. Many arrestins can undergo a conformational change, and although this has
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not yet been demonstrated for hVps26, the similarities between both proteins are extensive 
enough to suggest that hVps26 can undergo a similar conformational change.
Vps26 interacts directly with Vps35 [197, 198], and extensive mutagenesis studies using 
a yeast two-hybrid system have revealed that the mutation I235D/M236D or a deletion of a 
loop consisting of residues 238-246, both located on the distal tip of the C-terminal domain 
of Vps26, abrogates interaction with Vps35. Moreover, these mutations also prevent the 
interaction of Vps26 with Vps29, and thereby block the incorporation of the mutant protein 
into the retromer complex. These Vps26 mutants do not colocalize with SNX1 on 
endosomes, in contrast to wild-type Vps26, but show diffuse cytosolic distribution, 
indicating that recruitment of Vps26 to endosomes requires its assembly with Vps29 and 
Vps35 [256]. Yeast Vps26 deletion strains transformed with Vps26 mutants that are unable 
to interact with the other retromer proteins, secrete higher amount of CPY than 
transfectants with wild-type Vps26, suggesting that incorporation of Vps26 into the 
retromer complex is essential for its function.
Insertional mutation analysis in mice revealed that expression of mVps26 is essential for 
the early post-implantation development, but its site of action is yet unclear [249, 250]. In 
mammalian cells in which Vps26 was knocked-down, the amount of CI-M6PR was reduced 
by ~50% compared to control cells. These findings suggest that in Vps26-depleted cells the 
retromer complex fails to retrieve CI-M6PR from endosomes, which results in lysosomal 
sorting and degradation of CI-M6PR, in agreement with recent experimental data [138, 139, 
237].
Mammalian Vps35
Colocalization experiments after transfection of YFP-hVps35 into HeLa cells showed a similar 
subcellular localization of hVps35 and hVps26 [138]. The YFP-hVps35 puncta often give rise 
to long fluorescent tubules, which according to fluorescence recovery after photobleaching 
experiments results form a dynamic association. The formation of these tubules is 
prevented by the induction of depolymerization of microtubules, which is indicative for the 
origin of those tubules [138].
Since yeast Vps35 is the cargo recognition subunit of the retromer in yeast, Arighi et al. 
[138] used the yeast two-hybrid system to test the interaction of mammalian Vps35 with 
M6PRs, the functional homologue of Vps10 in mammals [138]. A specific direct interaction 
of hVps35 with the cytosolic domain of CI-M6PR, but not of CD-M6PR was observed. 
Mapping analysis demonstrated that a region comprising residues 500-693 of hVps35 
interacts with two non-overlapping regions comprising the cytosolic domain residues 48-80
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and 80-100 of the CI-M6PR cytosolic domain. Subsequent studies indicated that each of 
these sites was sufficient for interaction with hVps35. Many amino acid substitutions within 
the two binding regions abrogated interaction with hVps35, indicating that the binding 
determinants are complex and probably conformational. These regions of the CI-M6PR does 
not contain the YSKV sequence involved in internalization or the C-terminal acidic cluster 
dileucine motif [138].
Mammalian Vps29
Mammalian Vps29 was the first retromer protein of which the crystal structure was solved. 
Both the group of Wang et al. [257] and that of Collins et al. [258] revealed the crystal 
structure of Vps29 with a 2.1 Á and 2.2 Á resolution, respectively [257, 258]. As depicted in 
Figure 6, mammalian Vps29 consists of two ß-sheets (five-stranded and six-stranded) and 
three a-helices, thereby adopting a four-layered a-ß-ß-a sandwich fold. The electrostatic 
potential of hVps29 demonstrates a negatively charged groove which stretches along one 
side of the molecule. This negative groove consists of highly conserved amino acids, 
suggesting that it is a general feature of Vps29 homologues [257, 258]. Despite low 
sequence identity, the structure of hVps29 revealed that this protein belongs to a family of 
metallo-phosphoesterases [257, 258] (see also Chapter 2 and 4). These enzymes are capable 
of dephosphorylating molecules by cleavage of the phosphoester bond. Metal ions in the 
active site are necessary to neutralize the incoming phosphate-group and to activate a 
water molecule into an attacking nucleophile. Based on structural comparison with metallo- 
phosphoesterases, it has been suggested that the presumed metal-binding site of hVps29p 
is located within the highly negatively charged groove, whereby residues Asp8, His10, Arg14, 
Asn39, Asp62, His86, His115, His117 and Asn140 are likely to be involved in metal binding 
[257, 258]. However, there are also several notable differences between mVps29 and 
previously characterized metallo-phosphoesterases; mVps29 contains a swapped 
aspartate/asparagine pair, while the catalytic histidine is replaced by phenylalanine which is 
highly conserved in Vps29 orthologues. In none of the crystal structures metal ions were co­
crystallized [257, 258], but experiments in which native mVps29 crystals were soaked in 
MnSO4 solutions, revealed that each Vps29 molecule is capable of binding two Mn2+ ions in 
its active site [258]. However, in vitro experiments with mVps29 failed to demonstrate 
phosphoesterase activity towards p-nitrophenylphosphate-based chemicals or 
phosphatidylinositol phosphates [258].
Wang et al. [257] suggested that hVps29 contains two possible protein-protein 
interaction sites, based on the presence of conserved residues at the exterior of the protein,
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which mainly cluster in two regions. One of those regions might interact with hVps35, while 
the other might interact with SNX1 or hVps26 [257]. Collins et al. [258] investigated the 
interaction between mVps29 and mVps35 more closely using site-directed mutagenesis. 
Several of the mVps29 mutants tested had a reduced ability to interact with GST-mVps35 in 
pull-down assays, although all of them showed residual affinity for Vps35. Particularly the 
Vps29 mutants I91S and V90D, which are both located in a conserved patch next to the 
metal-binding site, showed strongly reduced binding affinity for Vps35 [258]. Wild-type 
mVps29-GFP fusion proteins demonstrated a punctuate distribution, which is indicative for 
association with intracellular membranes with perfect colocalization with mVps35-positive 
membrane compartments in HeLaM cells [258]. The V90D and I91S mutations caused a 
complete dissociation of mVps29-GFP from endosomal membranes, whereas mVps35 
maintained a membrane-associated endosomal distribution. This indicates that association 
of mVps29 with membranes is regulated by the formation of complexes with mVps35. 
Furthermore, while wild-type mVps29-GFP was able to precipitate both mVps26 and 
mVps35, the mVps29-GFP V90D and I91S mutants were unable to do so [258].
Figure 6 Structure of mVps29. Ribbon representation of mVps29 shown in two perpendicular
orientations. The secondary structure elements are numbered correspondingly. mVps29 has a mixed 
a/ß-structure that contains a central ß-sandwich with two a-helices packed against one face and a 
single a-helix extending from the other. The central ß-sandwich consists of a six-stranded ß-sheet 
(ß1, ß2, ß3, ß9, ß10 and ß11) and a five-stranded ß-sheet (ß4, ß5, ß6, ß7 and ß8), both with mixed 
parallel and antiparallel topologies. Loop regions where yeast Vps29p protein is predicted to have 
large, unstructured loops are indicated [258].
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The Mammalian Sorting Nexin/Retromer Complex
The individual sorting nexin/retromer complex subunits form large stoichiometric 
complexes, as illustrated in Figure 7. Gel filtration analysis demonstrated overlapping 
elution profiles of the majority of endogenous SNX2, Vps26 and Vps29 with Vps35. Epitope- 
tagged hVps26, hVps29, hVps35 and SNX1 also formed cytosolic complexes upon 
transfection into COS7 cells: immunoprecipitation of epitope-tagged Vps26 co- 
immunoprecipitated hVps35, hVps29 and SNX1 [207]. Moreover, yeast two-hybrid analysis 
demonstrated that hVps35 interacts with SNX1, hVps26 and hVps29, but not with SNX2, 
while hVps29 interacts with hVps26 and to a lesser extent with SNX1 [207]. On the other 
hand, studies using GST-mVps29 as a bait did not show an interaction with mVps26 in the 
absence of mVps35, indicating that no direct interaction exists between mVps29 and 
mVps26 [258]. This suggests that Vps35 forms the platform for assembly of the sorting 
nexin/retromer complex. By mapping the interactions with other sorting nexin/retromer 
subunits it has been shown that different domains of hVps35 are involved in interaction 
with hVps26, hVps29 and SNX1 [207]. Indeed, a GST construct of wild-type mVps35 was 
found to interact with both Hisx6-myc-tagged mVps29 and mVps26, resulting in a 
heterotrimer containing equimolar amounts of mVps26 and mVps29. On the other hand, 
mVps26 bound equally well to an N-terminal segment of mVps35 (residues 1-390) as to 
wild-type mVps35, while mVps29 only interacted with the full length and not with the 
truncated construct, indicating that mVps29 binds to a C-terminal region of mVps35 [258].
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Figure 7 The sorting nexin/retromer complex and its interactions. Vps35p interacts with
Vps26p through its N-terminus and with Vps29p through its C-terminus. Vps35p also interacts with 
cargo such as Vps10p or CI-M6PR. Vps5p and Vps17p dimerize through their C-terminal (BAR) 
domains. Both Vps5p and Vps17p and their mammalian counterparts, SNX1 and possible SNX2, have
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PX domains that can bind to PI3P. Vps5p or SNX1 alone interacts with the Vps26p/Vps29p/Vps35p 
subcomplex through the N-terminal regions of both Vps35p and Vps5p [274].
In microsomal fractions prepared from rat liver, immuno-absorbed endogenous Vps26 
has been shown to interact with endogenous Vps35 [207]. This has led to the model that the 
sorting nexin/retromer complex consists of two subcomplexes; one formed by 
Vps26/Vps29/Vps35 and one consisting of SNXs. Recent findings provide evidence that 
assembly of these two subcomplexes is regulated independently. SNX1 (or SNX2) has not 
been found in co-immunoprecipitated Vps26/Vps29/Vps35 subcomplexes [247, 252, 259] 
while SNX1 has not been detected in pull-down assays of mammalian Vps29 [258]. Recently 
Rojas et al. [247] experimentally confirmed by immunoprecipitation-recapture, 
sedimentation velocity and gel filtration analyses that the sorting nexin/retromer complex 
consists of the above two subcomplexes [247]. Moreover, Seaman [139] demonstrated that 
in mVps26-/- cells not only mVps26 is ablated, but also the level of mVps35 is strongly 
reduced [139]. In addition, reduced expression of Vps26, Vps29 or Vps35 by siRNA all 
substantially decreased the levels of both hVps29 and hVps35, while the level of SNX1 or 
SNX2 was unaltered [138, 247, 252]. This indicates that Vps26, Vps29 and Vps35 are 
destabilized in the absence of any of their subcomplex partners and suggests that 
incomplete retromer complexes are targeted for degradation. In contrast, depletion of SNX1 
or SNX2 only affected the subunits that were directly targeted by the siRNA and not the 
other subunits [247], suggesting that both subcomplexes are independent in terms of 
protein stability. This suggests that the association between the two subcomplexes is 
transient and dynamic. Alternatively, it is possible that not only SNX1 or SNX2, but also 
other SNX family members associate with the retromer complex [248].
Localization of the Retromer Complex
The retromer complex is mainly located on endosomal tubules, as shown by colocalization 
experiments of the various retromer proteins [138, 247]. Human Vps26, Vps29 and Vps35 
are hydrophilic proteins and have no recognizable membrane-binding domain. In addition to 
a cytoplasmic pool, still some ~50% of the cellular mammalian Vps26 and Vps35 is 
membrane-associated [207]. It has been postulated that the localization of the 
Vps26/Vps29/Vps35 subcomplex on endosomal tubules is accomplished by the PI-binding 
capacity of SNXs. Indeed, targeting of the sorting nexin/retromer subunits to membranes 
depends on the presence of PI(3)P. Treatment with the PI3K inhibitor wortmannin resulted 
in loss of the punctate staining of the cytoplasm of HeLa cells for SNX1, but also of hVps26 
[138]. However, there are some conflicting observations as to whether the
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Vps26/Vps29/Vps35 subcomplex depends on SNXs for its membrane localization. Carlton et 
al. [245] demonstrated in HeLa cells that upon depletion of SNX1, SNX2 or concomitant 
suppression of both SNX1 and SNX2, mVps26 retained its early endosomal association [245]. 
This indicates that targeting of the mVps26/mVps29/mVps35 subcomplex to membranes of 
the early endosome does not appear to require SNX1 or SNX2. In contrast, Rojas et al. [247] 
demonstrated that siRNA treatment for either SNX1 or SNX2 did not affect staining for 
Vps26, but that a combined depletion of SNX1 and SNX2 indeed resulted in a reduction of 
the punctuate staining of Vps26. These authors observed that the total level of Vps26 
protein was unaffected under these conditions while EEA1 remained associated with 
endosomes, indicating that the reduction in Vps26 was caused by its dissociation from 
membranes. This suggests that efficient endosomal association of the Vps26/Vps29/Vps35 
subcomplex requires the PI(3)P-binding activity of either SNX1 or SNX2 [247]. The reason for 
the observed differences is as yet unclear, but it is possible that the use of different strains 
of HeLa cells (HeLaM by Carlton et al. [245] and HeLa cells from ATCC by Rojas et al. [247]) 
contributed to the conflicting results.
Substrates of the Mammalian Retromer Complex
Although there is no orthologue for Vps10p present in mammals, M6PRs perform an 
essentially similar task. It has previously been shown that the localization of the CI-M6PR 
shows a dynamic equilibrium between TGN and endosomes [135, 260]. Immunofluoresence 
microscopy of hVps26 showed partial colocalization with the CI-M6PR in endosomes, while 
electron microscopy analysis demonstrated the presence of CI-M6PR in intraluminal vesicles 
of the endosomes, as well as in the retromer-containing tubules emanating from these 
endosomes [138]. Localization studies with candidate substrate proteins for retrograde 
transport, as mediated by the retromer complex, have also been performed using fusion 
proteins in which the cytoplasmic tail of CD8 was substituted for the cytoplasmic tails of CI- 
M6PR, CD-M6PR or furin [139]. CD8 is a type I transmembrane protein which is normally 
located on the cell surface and lacks intrinsic targeting information in its luminal or 
transmembrane domain. Introduction of intrinsic signals into the C-terminus of the tested 
receptors resulted in altered subcellular localization for all three proteins; CD8-furin 
colocalized with the Golgi marker TGN46, but not with mVps26; CD-M6PR localized to 
endosomes and CI-M6PR to both Golgi and endosomes, while both CD8-M6PRs colocalized 
with mVps26 [139]. These data support a colocalization of Vps26 and endogenous CI-M6PR 
[138]. A similar degree of colocalization with CD8 reporter proteins has also been observed 
for SNX1 [139].
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In order to investigate the indicated role of the retromer complex in CI-M6PR trafficking, 
cells derived from mVps26-/- knockout mice [249, 250] and cells treated with siRNA against 
mVps26 were analyzed. Immunofluoresence studies revealed that the level of CI-M6PR was 
reduced concomitant with a dramatic change in CI-M6PR localization when compared to 
wild-type cells. The CI-M6PR was shifted towards the cell surface and showed colocalization 
with the early endosome marker EEA1 [138, 139]. Western blot analysis confirmed the 
observed reduced CI-M6PR expression, while metabolic labelling followed by pulse-chase 
experiments demonstrated that the protein had become unstable [138, 139]. These 
observations indicate an increased lysosomal turnover of the receptor in these cells. The 
altered localization and the reduced levels of the CI-M6PR also affected the transport of 
cathepsin D from the TGN to the lysosome. Metabolic labelling showed that no mature 
cathepsin D was detectable in the mVps26 knock-down cells [139]. Furthermore, Arighi et al.
[138] observed a decrease of lysosomal hydrolases in cells depleted of hVps26 or hVps35.
Labelling experiments showed that in mVps26 knock-down cells the CD8-CI-M6PR fusion 
protein is transported to a SNX1 positive endosome, but does not continue its route to the 
Golgi, as was observed in control cells. In contrast CD8-furin was able to reach the TGN 
under these conditions. Thus it appears that the CD8-CI-M6PR reporter requires mVps26 for 
its retrieval while CD8-furin does not, which is indicative for a cargo-selective function for 
the retromer complex during the retrieval process [139].
Working Mechanism of the Mammalian Retromer Complex
The sorting nexin/retromer complex seems to function as a vesicle coat, since it performs 
the two following essential functions: i) cargo selection, mediated by Vps35, and ii) self­
assembly, mediated by SNX1. So far there is no conclusive evidence, however, that the 
sorting nexin/retromer complex can mediate the production of vesicles in the same way as 
known vesicle coat proteins such as clathrin or COP coat proteins. Moreover, the 
localization of mammalian retromer at tubular structures suggests that retromer-mediated 
endosome-to-Golgi retrieval process might occur via tubules rather than via vesicles.
Dissociation of hydrolases from M6PRs only occurs at pH-values between 5.0 and 6.0 
[261, 262], and therefore some maturation of early endosomes must take place before the 
retromer complex can fulfill its role in the retrieval of the unoccupied receptors. It is 
possible that more than one endosomal compartment acts as an acceptor for TGN-derived 
carriers and that some CI-M6PR-hydrolase complexes may be delivered in at least part to 
the late endosomes. Alternatively, some CI-M6PR may traffic from early to late endosomes 
prior to retrieval to the TGN. Proteins such as AP-1, TIP47 and PACS-1 could cooperate with
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the retromer complex in CI-M6PR recycling form early endosomes or could be involved in CI- 
M6PR recycling from late endosomes, as previously proposed for TIP47 [126]. The existence 
of distinct TGN retrieval pathways originating from early and late endosomes is well 
established in both mammalian [140] and yeast [206] cells. The most logical interpretation 
of these observations is that the retromer complex keeps the CI-M6PR from going to 
lysosomes by mediating its removal from maturing endosomes.
Other Functions of the Retromer Complex
Besides the above described role for the retromer complex in retrograde endosome-to- 
Golgi transport of the Vps10p receptor in yeast or of CI-M6PR in mammals, there are also 
studies that indicate additional roles for this complex in protein sorting along the endocytic 
pathway. In plants, the retromer complex is probably located at the prevacuolar 
compartment where it interacts with Vacuolar Sorting Receptors (VSR), while in addition the 
retromer complex may play a role in efficient sorting of proteins from the prevacuolar 
compartment to the TGN, as shown in Aradopsis thaliana [263, 264]. In the enteric 
protozoan parasite Entamoeba histolytica a role for the retromer complex, associated with 
GTP-bound Rab7A, has been indicated in the transport of lysosomal cysteine proteases to 
phagosomes [265]. Moreover, hVps26 has been described as a possible component of the 
neuromuscular junction [266] and the retromer complex might play a role in Alzheimer 
disease, perhaps via interactions with the memapsin-2 receptor [267-269]. There are also 
indications that that the retromer proteins are functionally important in Wnt signal 
transduction [270-273]. The mammalian retromer complex might also have a function in the 
trafficking of the polymeric immunoglobulin receptor (pIgR), which transcytoses polymeric 
IgA from the basolateral to the apical surface in polarized cells. This interaction prevents 
recycling or degradation of pIgR-pIgA in a somewhat analogous way as CI-M6PR trafficking is 
regulated by the retromer complex [252]. The phenotypes in different cell types and 
developmental stages, as described above, probably all depend on the fundamental 
endosome-to-TGN transport function of the retromer complex.
1.5 Thesis Outline
The sorting nexin/retromer complex can be considered as a unique coat complex due to the 
interplay of its components. The data presented in this thesis elucidate further on the role 
of the mammalian retromer complex in receptor trafficking. In chapter two, we describe 
initial bioinformatics approaches in order to predict possible functions of the retromer
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proteins. In chapter three, we describe a comprehensive phylogenetic analysis of retromer 
components. In chapter four we show that the Vps29 subunit functions in vitro as a 
phosphoesterase for a phosphopeptide which is based on the retromer cargo CI-M6PR and 
demonstrate that hVps29 binds zinc ions in vitro. In chapter five we study interaction 
proteins of the retromer complex. We demonstrate that the retromer components interact 
with a- and ß-tubulins in vivo and with the microtubule-associated Hook proteins in vitro. In 
addition we describe interactions of the retromer components with an as yet unidentified 
47 kDa protein. In chapter six we give an overview of the expression of wild-type and 
mutant retromer proteins using a broad range of epitope tags and heterologous expression 
systems, which are valuable in the light of the recent developments in retromer studies. In 
chapter seven we investigate the role of endosomal trafficking signals on ErbB 
downregulation. Finally, in chapter eight we integrate our results with those published by 
others.
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Fold recognition predicts similarity of retromer subunits Vps26, 
Vps29 and Vps35 with ß-arrestins, metallo-phosphoesterases and 
ARM/HEAT repeat solenoid proteins, respectively
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Summary
Eukaryotic cells are characterized by an elaborate endomembrane system that consists of 
various organelles, including ER, Golgi, endosomes and lysosomes. Transport between 
different compartments of the endomembrane system occurs by vesicular transport and 
these pathways are highly conserved during evolution. The retromer complex is an 
evolutionary conserved heterotrimeric cytoplasmic complex, consisting of Vps26, Vps29 and 
Vps35, that associates with sorting nexins to regulate endosome-to-TGN retrograde 
transport of cargo proteins. However, the molecular function of these three retromer 
subunits has not been elucidated yet. Here, we used protein fold recognition algorithms to 
provide clues about possible molecular functions of these retromer subunits. Our results 
reveal previously unrecognized similarities of Vps26, Vps29 and Vps35 with ß-arrestins, 
metallo-phosphoesterases and ARM/HEAT helical repeat solenoid proteins, respectively. 
Moreover, we identified Vps29 motifs that are characteristic of metallo-phosphoesterases in 
general, and Vps29 active site residues that are predicted to coordinate metal ions and 
phosphate groups. Our findings provide the first insight into a possible molecular function of 
the retromer subunits.
Introduction
The eukaryotic cell is distinguished from bacteria and archaea by the presence of 
membrane-enclosed organelles, such as the nucleus, endoplasmic reticulum (ER), Golgi, 
endosomes/lysosomes, peroxisomes and mitochondria. The presence of these organelles 
requires appropriate sorting pathways to guide newly synthesized proteins to their final 
destination. Transport between organelles within the eukaryotic endomembrane system, 
which includes the ER, Golgi, endosomes and lysosomes/vacuoles, usually occurs through 
(tubulo-) vesicular intermediates on microtubule tracks. Transport between ER and Golgi, 
between Golgi and endosomes, and between (early and late) endosomes and the plasma 
membrane is usually bidirectional, with distinctive anterograde and retrograde transport 
pathways. Genetic screens in baker's yeast (Saccharomyces cerevisiae) have been 
instrumental in defining genes required for vesicular trafficking in the evolutionary 
conserved endomembrane system of eukaryotes [1-11]. Initial screens were performed to 
identify proteins involved in vacuolar protease activity (Pep) [3] and the secretory pathway 
(Sec) [1]. Subsequently, various screens have been performed that identified genes involved 
in post-Golgi endosomal trafficking and included screens for vacuolar protein localization 
(Vpl), transport (Vpt) and sorting (Vps) [2, 4, 5, 7, 11, 12], vacuolar morphology (Vam) [8],
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endocytosis (End) [9], vacuolar pH (Vph) [13], Golgi-retention (Grd) [10], and many more. 
Significant overlap has been detected between the various screens and many of these genes 
are currently designated according to the vacuolar protein sorting (Vps) nomenclature [2].
Retrograde vesicular transport from endosomes to the trans-Golgi network (TGN) is still 
poorly understood. Functional characterization of S. cerevisiae Vps26, Vps29 and Vps35 
gene products has led to the model that these cytosolic/peripheral membrane proteins 
form a heterotrimeric complex that is involved in the retrograde endosome-to-TGN pathway 
which is used by cycling TGN proteins. Specifically, the retromer complex is required for 
transport of Vps10, the receptor that transports vacuolar protease carboxypeptidase Y (CPY) 
from pre-vacuolar endosomes back to the TGN [14-19]. The retromer complex is also 
involved in the retrograde transport of other yeast late-Golgi proteins such as Kex2 and 
DPAP A, which cycle between the TGN and prevacuolar endosomes. It has been proposed 
that Vps35 interacts with cargo molecules that need to be transported back to the TGN [15­
17], whereas Vps26 interacts with a (hetero-)dimeric Vps5/Vps17 sorting nexin complex [10, 
18, 20-23], that associates with endosomal phosphoinositides through the PI3P specific 
phox homology (PX) domain [24-27] and thereby promotes vesicle formation [15].
Also in mammalian model systems Vps35 has been demonstrated to function as a 
scaffold for interaction with Vps26, Vps29 and SNX1 [28]. Mammalian sorting nexin-1 (SNX1) 
has initially been identified as an interacting partner for the EGFR tyrosine kinase domain in 
a yeast-two-hybrid screen [29]. Overexpression of various sorting nexins, including SNX1, in 
COS7 cells also allowed co-precipitation of various receptor tyrosine kinases including the 
EGFR [30]. Moreover, overexpression of SNX1 has been reported to enhance EGFR 
degradation in a PX domain-dependent manner [29-32]. However, in more recent studies 
using SNX1 and/or SNX2 knock-out mice no genetic interaction could be demonstrated 
between either SNX1 or SNX2 and the Waved-2 hypomorphic allele of the EGFR [33], 
suggesting that deletion of either or both sorting nexins does not affect EGFR signaling or 
degradation. Interestingly, the mouse Vps26 gene has been identified based on an an 
insertional mutation that affected post-implantation mouse development at the primitive 
streak stage. The resulting abnormalities in growth of the embryonic ectoderm, amnion and 
chorion [34] were indicative for the requirement of the Vps26 retromer subunit in early 
embryonic development. This is consistent with the phenotype of SNX1/SNX2 double knock 
out mice, which show growth retardation at day E7.5 and ultimately die at midgestation 
[33].
Although these studies begin to elucidate the functional role of the sorting 
nexin/retromer complex in endosomal trafficking, the molecular function of, in particular,
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retromer subunits remains unknown. So far, sequence analysis of yeast Vps26 [35], Vps29 
[14] and Vps35 [19] retromer proteins and their mammalian counterparts [28, 34, 36-40] 
revealed that these hydrophilic proteins displayed no obvious similarity to other proteins in 
the NCBI database, nor displayed any recognizable motifs. Edgar et al. [38] suggested 
similarity of Vps26 proteins to the ABC transporter family of bacterial ATPases, in part based 
on the presence of a GxSxxG ATP binding motif [38], but this motif has not been conserved 
during evolution. Yet, retromer proteins are highly conserved and orthologues can be 
detected among all eukaryotes.
Given the fundamental importance of retromer subunits in the endosomal trafficking of 
eukaryotes, it is important to elucidate the molecular function of the retromer subunits. 
Here, we present the results of various bioinformatics approaches that were performed 
before later functional studies became available. Our results show by the use of various 
protein fold recognition algorithms, that Vps26, Vps29 and Vps35 show significant similarity 
to the ß-arrestin fold, the metallo-phosphoesterase fold, and ARM/HEAT helical repeat fold, 
respectively.
Methods
Sequence Files
Bioinformatics analysis was performed using human Vps26A (NP_004887), human Vps26B 
(NP_443107), human Vps29 (NP_057310), and human Vps35 (NP_060676).
Blast Searches
Blast searches (BlastP, TblastN) were performed using the NCBI blast server [41].
Secondary Structure Prediction
Secondary structure prediction searches were performed as part of the PredictProtein META 
PP webserver [42]. Human retromer proteins were thus analyzed for transmembrane 
sequences using PHD [43], secondary structure prediction using PROF [44], presence of 
motifs using PROSITE [45], presence of domains using ProDom [46] and iterative PSI-blast 
searches [47], presence of coiled-coils using COILS [48], and protein globularity using GLOBE 
(http://cubic.bioc.columbia.edu/papers/1999_globe/paper.html).
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Fold Recognition
Fold recognition searches were performed using a variety of methods including 3D-PSSM 
[49], GenTHREADER [50], FUGUE [51], and Libellula [52]. Data are presented for 3D-PSSM 
only. Original searches were performed December 2002 and June 2003, using the Structural 
Classification Of Proteins (SCOP) fold library v.1.53.8466 [53], sequence database 
v.2003.6.13, 3D-PSSM binary v.2.2, Server version v.2.6.0 http://www.sbg.bio.ic.ac.uk/ 
~3dpssm/index2.html.
Patterns and Protein Families
hVps26, hVps29 and hVps35 protein sequences were also submitted to the MetaFAM 
webserver [54] which returns search results from PROSITE [45], SMART [55], Blocks [56], 
PRINTS [57], TIGRFAM [58], and ProtFAM [59] protein family databases.
Results
Blast Analysis
Although the nucleotide/protein sequence of retromer subunits from many species can be 
deduced from EST and genome sequencing programs, the molecular function of retromer 
subunits is poorly understood. Therefore, we initially used various bioinformatics tools to 
obtain clues about a possible molecular function of individual retromer subunits. First, we 
used blast similarity searches to identify proteins in the human genome that contain 
similarity to the human retromer proteins. A BlastP search using the hVps29 amino acid 
sequence did not reveal any protein with significant similarity (P<1) to hVps29 apart from 
Vps29 orthologues itself (data not shown). A BlastP search using hVps26A identified the 
hVps26B paralogue as well as the DSCR3 protein, which shows low sequence similarity to 
the hVps26 paralogues (Supplementary Figure S1). The DSCR3 protein is encoded by a gene 
in the Down syndrome critical region (DSCR) on chromosome 21, but its function is unknown 
[60]. A BlastP search using hVps35 also did not identify any other protein with significant 
similarity (P<1) to hVps35. These findings indicate that the primary amino acid sequence of 
the individual retromer subunits are highly unique in the human genome. Additional BlastP 
and TblastN searches of various other eukaryote genomes confirmed this conclusion (data 
not shown).
Secondary Structure Prediction
Subsequently we used various 2D secondary structure prediction algorithms to predict the 
secondary structure of the individual retromer subunits. In general, these secondary
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structure prediction programs are based (at least in part) on the tendency of individual 
amino acids to be part of a-helices, ß-sheets or random coils (no secondary structures). Use 
was made of the PHD/PROF secondary structure prediction server to determine whether 
retromer subunits can be classified as all-alpha (a-helices > 45%, ß-sheet < 5%), all-beta (a- 
helix <5%, ß-sheet > 45%), alpha-beta (a-helix >30%, ß-sheet >20%) or mixed (all others) 
proteins. The hVps26A and hVps26B proteins were predicted to contain predominantly ß- 
sheets and therefore they were classified as all-beta proteins. In contrast, the hVps29 
protein was classified as a mixed protein, containing 19% a-helix, 36% ß-sheet, and 45% coil. 
Interestingly, ß-sheet and a-helix were alternately present in the first 150 residues of the 
protein. The hVps35 protein was classified as an all-alpha protein, with 70% a-helix and only 
1.9% ß-sheet. The COILS program predicted a possible coiled-coil in hVps35 between amino 
acid residues 36-56 and 740-760. No coils were predicted for hVps26A, hVps26B or hVps29 
(data not shown). These findings indicate that hVps26A, hVps26B, hVps29 and hVps35 
belong to all-beta, all-beta, mixed and all-alpha protein classes, respectively.
Fold Recognition
Next, we used various tertiary structure prediction (threading or fold recognition) 
algorithms to identify any similarity of the retromer subunits to experimentally determined 
protein folds as submitted to the Protein Data Bank (PDB) [61]. Such searches often identify 
protein 3D structural relationships that cannot be deduced from simple primary sequence 
blast similarity searches, especially if sequence identity is below 25% [62, 63]. Various 
webservers are available to perform fold recognition searches including 3D-PSSM [49], 
genTHREADER [50], FUGUE [51] and Libellula [52]. Here we only present data obtained from 
the 3D-PSSM webserver, as (i) 3D-PSSM has been among the best fold recognition servers in 
the CASP4 (critical assessment of structure prediction) contest [64] and (ii) it yielded a 
representative impression of the predicted relation of the retromer subunits to various 
described protein folds (data not shown). The 3D-PSSM algorithm uses structural alignments 
of homologous proteins with similar three-dimensional structure in the Structural 
Classification of Proteins (SCOP) database [53, 65].
Fold Recognition of hVps26 Reveals Similarity to the ß-arrestin Fold
As shown in Tables 1 and 2, hVps26A and hVps26B are predicted to contain structural 
similarity to ß-arrestin proteins with >95% certainty, despite having only 14%-16% amino 
acid identity with ß-arrestins [66-68]. The genTHREADER server also identified ß-arrestins as 
the most similar structural fold for hVps26A and hVps26B proteins (data not shown).
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hVps26A and hVps26B also show similarity, although with much less significance, to the 
fibrinogen binding domain of Sdrg2 [69, 70], the 2nd domain of the |a2 adaptin subunit [71], 
the NFKB/Rel/Dorsal transcription factor C-terminal domain [72-74], the C2 Ca2+ and lipid 
binding domain of synaptotagmin (for hVps26A) [75] and the immunoglobulin domains of 
NCAM (for hVps26B) [76] among others (Table 1 and 2). All these proteins show all-beta 
folds. Interestingly, ß-arrestin, the |a2 subunit of adaptin and synaptotagmin have also been 
involved in endosomal trafficking processes. ß-Arrestin is an adaptor protein that links G- 
protein coupled receptors to the clathrin endocytosis machinery [77], while the |a2 adaptin 
subunit is part of the AP2 heterotetrameric clathrin adaptor protein that is involved in 
formation of clathrin-coated vesicles at the plasma membrane [78]. Synaptotagmin is an 
adaptor protein that functions in Ca2+-dependent rapid exocytosis of secretory vesicles and 
acts at a post-docking step [65]. It should be noted, however, that according to the 3D-PSSM 
server the similarity of hVps26 proteins to ß-arrestins stands out most prominently and that 
similarity of hVps26 proteins to other protein folds is below 50% certainty level.
SCOP
domain
Identity
%
Template
(aa)
PSSM
value
SCOP Family Protein ID Species
C 1g4m a 14 356 0.0269 Arrestin ß-arrestin-1 B. taurus
C 1ayr a 14 368 0.0438 Arrestin Arrestin rod outer 
segment
B. taurus
C1n67a 14 332 1.66 Fibrinogen binding 
domain
Clumping factor, 
bacterial adhesin
S. aureus
D 1cf1 a2 14 200 2.01 Arrestin Arrestin B. taurus
D 1bw8 a 19 256 2.04 2nd domain of ^2 
adaptin
2nd domain of ^2 adaptin 
(AP50)
R. norvegicus
C 1nfi c 21 301 2.49 NFKB/Rel/Dorsal TF C- 
term domain
NFkB p65 subunit of 
IKBa/NFKB complex
H. sapiens
C1dqv a 16 275 2.66 C2 domain (Ca2+, lipid 
binding)
Synaptotagmin III C2 
domain
R. norvegicus
C 1gji a 20 275 3.33 NFKB/Rel/Dorsal TF C- 
term domain
c-Rel bound to DNA G. gallus
C 1ram a 22 273 3.58 NFKB/Rel/Dorsal TF C- 
term domain
NFkB p65 homodimer M. musculus
C 1r19a 15 286 3.74 Fibrinogen binding 
domain
Sdrg2, bacterial adhesin S. epidermidis
Table 1 Top-10 3D-PSSM threading results for human Vps26A.
Arrestins can be subclassified in two groups, the highly specialized visual and cone 
arrestins that are exclusively expressed in rod and cone photoreceptor cells, respectively, 
and the ß-arrestins (-1 and -2) that are ubiquitously expressed and responsible for 
downregulation of nearly all G protein-coupled receptors (GPCRs) [77, 79]. The crystal 
structure of arrestins consists of two tandemly arranged anti-parallel ß-sheets that are
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connected through a polar linker. They contain a serine phosphorylation site which is 
essential for activation and GPCR binding. ß-Arrestins also contain clathrin and AP2 binding 
sites in their C-terminal domain [79-83] as well as a PIP2 binding site [84] and an NSF (NEM 
Sensitive Factor) binding site [85], thereby connecting GPCRs to the clathrin endocytosis 
machinery and vesicular transport. A 3D-PSSM sequence alignment of hVps26A and 
hVps26B with the crystallized bovine ß-arrestin is given in Supplementary Figures S2 and S3. 
The GPCR binding site of ß-arrestin is localized to the concave side of the N-terminal 
domain, in a region where multiple gaps and an insertion are present in the alignment with 
hVps26, which is consistent with divergent roles for Vps26 and ß-arrestins. The clathrin and 
AP2 binding site of ß-arrestins is located C-terminal to the region of similarity with hVps26 
[79-83], and is therefore not present in Vps26. The PIP2 binding site has been localized to 
arrestin3 Lys233, Lys251 and Arg237 [84]. Whether such a site is also present in Vps26 is at 
present uncertain. The NSF binding site in arrestins has not (yet) been localized [85]. In 
summary, fold recognition searches predict low but significant similarity of Vps26 to the ß- 
arrestin fold. hVps26 alignment with the GPCR binding site of ß-arrestins reveals various 
gaps and an insertion, suggesting that GPCR binding is not conserved in Vps26. Moreover, 
clathrin and AP2 binding sites of arrestins are located outside the region of similarity with 
hVps26.
SCOP
domain
Identity
%
Template
(aa)
PSSM
value
SCOP Family Protein ID Species
C 1g4m a 16 356 0.0259 Arrestin ß-arrestin-1 B.taurus
C 1ayr a 12 368 0.0289 Arrestin Arrestin rod outer 
segment
B.taurus
C 1qz1a 17 288 1.58 I-set domain Ig modules 1-2-3 
NCAM
R.norvegicus
C 1k28d 15 349 1.65 Bacteriophage T4 cell 
puncturing device
Bacteriophage T4
C1n67a 11 332 2.37 Fibrinogen binding 
domain
Clumping factor, 
bacterial adhesin
S.aureus
D 1bw8 a 13 256 2.52 2nd domain of ^2 
adaptin
2nd domain of ^2 
adaptin, AP50
R.norvegicus
D 1slu a 18 131 2.62 Ecotin, trypsin 
inhibitor
E.coli
D1poo a 20 353 2.71 Thermostable phytase B.amyloliquefaciens
D 1cf1 a2 14 200 3.74 Arrestin Arrestin B.taurus
C 1uf6 a 19 176 3.83 YceI-like Conserved hypothe­
tical protein2 tt1927b
T.thermophilus hb8
Table 2 Top-10 3D-PSSM threading results for human Vps26B.
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Fold Recognition of hVps29 Reveals Similarity to the Metallo-Phosphoesterase structural 
Fold
As shown in Table 3, hVps29 shows the highest (3D-PSSM P=6.38E-5) structural similarity to 
Pfu-1218608, a hypothetical protein with a metallo-phosphoesterase fold from the archaea 
P. furiosus (PDB entry 1NNW). Moreover hVps29 shows highly significant structural 
similarity to a number of (other) experimentally verified metallo-phosphoesterase enzymes, 
including (ii) MRE11, a Mn2+-dependent metallo-phosphoesterase with dsDNA break repair 
endonuclease activity [86], (iii) bacteriophage lambda Ser/Thr phosphatase [87], (iv) purple 
acid phosphatase [88] and (v) adenine nucleotide a-hydrolase [89]. Other fold recognition 
servers (FUGUE, GenTHREADER, Libellula) also identified these entries in addition to purple 
acid phosphatases from various other species [88, 90, 91], calcineurin [92], E. coli 5'- 
nucleotidase [93] and ß-lactamase [94] (data not shown). These proteins all belong to the 
calcineurin (PP2B)-like metallo-phosphoesterase enzymes. Subsequent analysis of the 
hVps29 protein sequence on the MetaFAM webserver [54] revealed that hVps29 showed 
similarity to (i) Blocks entry IPB000979 (P=1.5E-10) containing parts of the metallo- 
phosphoesterase active site (see below), (ii) the TIGRFAM YfcE putative phosphoesterase 
family (P=4.2E-24), and (iii) the PFAM calcineurin (PP2B)-like metallo-phosphoesterases 
family PF00149 (P=4.2E-11). The calcineurin-like metallo-phosphoesterase enzyme family 
includes a range of phosphoesterases, including protein phosphoserine phosphatases (PP1, 
PP2A, PP2B), nucleotidases, sphingomyelin phosphodiesterases, endonucleases (MRE11 and 
Sbcd), and 2'-3' cAMP phosphodiesterases (PFAM00149). These findings indicate that 
hVps29 shows highly significant structural similarity to metallo-phosphatase enzymes and 
suggest the possibility that Vps29 may contain phosphatase activity towards phosphorylated 
proteins substrates, phospholipids, or nucleic acids.
The metallo-phosphoesterase fold is characterized by a double ß-sandwich structure, 
that forms the hydrophobic core of the protein and is flanked on top and bottom by a- 
helices (Figure 1). The catalytic site containing the binuclear metal-centre is formed by 
residues from different loops connecting the core a and ß secondary structural elements, 
and consists mostly of His, Asn and Asp residues that are involved in metal coordination and 
catalysis. The catalytic site residues in these loops form five recognizable motifs (I-V), i.e. 
DXH(X)~25 GDXXD(X)~25 GNH[D/E] (motifs I to III [95, 96]) and GH(X)~50 GHX[H/X] (motifs IV to 
V [90]). A 3D-PSSM sequence alignment of hVps29 with MRE11 indicates that the 
corresponding motifs can be recognized within the Vps29 protein sequence (Figure 2).
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SCOP
domain
Identity
%
Template
(aa)
PSSM
value
SCOP Family Protein ID Species
C 1nnw a 19 251 6.38E-05 Metallo-phospho-
esterase-related
Hypothetical protein 
pfu-1218608
P.furiosus
C1g5ba 19 219 0.00453 S/T phosphatase Ser/Thr phosphatase BacteriophageA
C 1ii7 a 21 333 0.0215 DNA ds break repair 
nuclease
MRE11 P.furiosus
D 1ute a 15 302 0.634 Purple acid 
phosphatase
Purple acid 
phosphatase
S.scrofa
C 1jmv a 19 140 0.911 (Adenine nucleotide a- 
hydrolase-like)
Universal stress 
protein
H.influenzae
C 1uf3 a 16 222 0.997 (metallo-
phosphoesterase)
Tt1561 T.thermophilus
hb8
C 1hf2 a 16 196 1.06 Cell division inhibitor 
minc
T.maritima
D 1cer o1 17 169 1.72 Glyceraldehyde-3- 
phosphatase, N-domain
GAPDH T.aquaticus
C1b73a 18 252 1.87 Asp/Glu racemase Glutamate racemase A.pyrophilus
C1np6 a 17 158 1.97 (NTP hydrolase) MobB E.coli
Table 3 Top-10 3D-PSSM threading results for human Vps29.
A B
Figure 1 3D-PSSM Tertiary structure prediction for hVps29. (A) based on 1II7 Mre11
endonuclease (B) as the template.
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1 5C
hVps2 9__PSS CEEEEEEECC .......CCC HHHHHHHHHH HHHH...CCC CCEEEECCCC C.... CHHH H....HHHH.
hVps2 9__Seq MLVLVtGQLtI .......IPH RCNSLPAKFK KLLV...PGK IQHILCT^ ^  C.... 0KES Y....DYLK.
----------- --- MH— +— L+D+H -P+ RH— + + + + +FK + + L+ + + + ++— IL— +G+L - + + + + + + + L+
c1ii7a__Seq MKFAHL^ ^  LGYEQFHKPQ REEEFAEAFK NALEIAVQEN VDFILIA^ ^  ^^SSRPSPGT LKKAIALLQI
c1ii7a__SS CEEEEECCCC CCCCHHHCHH HHHHHHHHHH HHHHHHHHHC CCEEEECCCC CCCCCCCHHH HHHHHHHHHH
CORE 1C38C93C5C 6CCCCCCCCC CCCCC2C27C C86C371CCC 4C487851C7 4CCCCCCCC1 1CC41C49C1
71 1CC
hVps2 9__PSS ..HHCCCEEE EECCCCCHHH CC....................................... EEE E ......EEE
hVps2 9__Seq ..TLAGDVHI VR^ ^ ^ ENLN YP....................................... EQK V ......VTV
-----------  + — + + +V—+ + — G+ + DH---H —P E + + V + + +
c1ii7a__Seq PKEHSIPVFA IE^ ^ RTQR GPSVLNLLED FGLVYVIGMR KEKVENEYLT SERLGNGEYL VKGVYKDLEI
c1ii7a__SS HHHCCCCEEE CCCCCCCCCC CCCHHHHHHH HCCCEECEEE CCCCCCCCEE EEECCCCCEE EEEEECCEEE
CORE 3CCCC4C765 5CCCC1CCCC CCC14CC7CC CC37C1711C CCC1CCCC4C CCC1CCCCC3 1C4C1CC3C8
141 15C 2CC
hVps2 9__PSS ............................CCEEE EEEE...........CCCCCC CCCHHHHHHH HHHCCCCEEE
hVps2 9__Seq ............................GQFKI GLI^ ...........^ QVIP WGDMASLALL QRQFDVDILI
-----------  +H—  I + + + H GH--H + H--HH--HL — H + H--H--
c1ii7a__Seq HGMKYMSSAW FEANKEILKR LFRPTDNA.I LML^QGVREV SEAR^ DY.F EIGLGDL..... PEGYLYYA
c1ii7a__SS EEECCCCHHH HHHCCCHHHH HCCCCCCE.E EEEECCCHHH HHHCCCCC.C CCCHHHC..... CCCCCEEE
CORE C63CCCCCCC 1CCCCCC4CC 23CCCCCC.6 375CC12CCC CCCCCCCC.C C4C1CC4......1CCCC1C6
211 25C
hVps2 9__PSS ECCCCEEEEE EECCEEEECC CCC................ CC C...CCCCCC ..... CCCC EEEEEEECCC
hVps2 9__Seq S^ ^ KFEAF EHENKFYINP GSA................ TG A...YNALET ..... NIIP SFVLMDIQAS
----------- --- —GH — HK—H-- H — --H —  HH — P GSH — + + + + + + H--HP —FV—H--—
c1ii7a__Seq L^ ^ KRYET SYSGSPVVYP GSLERWDFGD YEVRYEWDGI KFKERYGVNK GFYIVEDFKP RFVEIKVRPF
c1ii7a__SS EECCCCCEEE EECCEEEEEC CCCCCCCHHH CCEEEEECCC CEEEEECCCC EEEEEECCEE EEEECCCCCE
CORE 22CCCCCCCC CCCCCC2CC2 1C9CCCCCCC CCCCCCCCCC C2CCCCCCCC 27C31CC2CC CC2C5CCCCC
281 3CC 341
hVps2 9__PSS EEEEEE...............  EEEC.CCEEE EEEEEEECC.........................
hVps2 9__Seq TVVTYV...............  YQLI.GDDVK VERIEYKKP.........................
----------------  +++++ HHLI —+++— —+—I—++KP
c1ii7a__Seq .IDVKIKGSE EEIRKAIKRL IPLIPKNAYV RLNIGWRKPF DLTEIKELLN VEYLKIDTWR I
c1ii7a__SS .EEEEEEECH HHHHHHHHHH HHHCCCCCEE EEEEEECCCC CHHHHHHHCC CCEEEEEEEE C
CORE .1C3C3CCCC CC2CC13CC3 CCC1CCCCC2 C4C2CCCCC1 C1CC3CCC3C 1CC2C2CCCC C
Figure 2 3D-PSSM sequence alignment of hVps29 with Mre11. Sequence motifs I-V are
indicated in white face on black background. Secondary structure is indicated by H (helix), E 
(extended ß-strand) or C (coil). Identities between aligned sequences are indicated in single letter 
amino acid code. Conservative and non-conservative substitutions in the alignment are indicated by 
'+' and '-', respectively. Dots represent gaps introduced into the aligned sequences. The CORE 
sequences shown below the aligned sequences provide an index for the contribution of residues to 
hydrophobic interactions (on a scale from 0 to 9) with the resolved Mre11 structure (PDB entry 1II7).
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High values indicate buried residues important for the CORE structure, whereas low values indicate 
residues on the surface of the protein.
Metallo-phosphoesterases contain two metal ions which are essential for their catalytic 
activity. An analysis of the active site residues that coordinate metal ion and phosphate 
binding in various metallo-phosphoesterases is given in Table 5. Various metallo- 
phosphoesterases use different metal ions (Mn2+, Zn2+, Fe2+, Fe3+) for catalytic activity (Table 
5). In general, metal #1 is coordinated by Asp and His residues from motif I, an Asp residue 
from motif II (this residue also coordinates metal #2 in a bidental manner) and a His residue 
from motif V, while metal #2 is coordinated by an Asp in motif II, an Asn residue from motif 
III and His residues from motif IV and V (Table 5). The active site also contains two water 
molecules, one of which coordinates both metal ions as a ^-(hydr)oxo-bridge (W1) and 
another that is bound to metal #1. The phosphate group of the substrate molecule is 
coordinated by the metal ions, an Arg in motif II, Asn and His residues from motif III, or 
various other residues (Table 5). The exact catalytic mechanism of various phosphoesterases 
is a matter of debate, but has been proposed to involve one of the surrounding active site 
His residues that acts as a base to deprotonate the catalytic water molecule (either W1 or 
W2) which is stabilized by metal binding [97]. The resulting hydroxyl-ion is responsible for 
the nucleophilic attack of the phosphoester bond of the phosphorylated substrate, leading 
to a transition state in which both metal ions bind the anorganic phosphate. The substrate 
with the free oxy-anion is stabilized by the positively charged binuclear metal centre, and 
this leaving group is subsequently protonated by a catalytic His residue (within motif III) that 
has acidic properties due to the presence of a nearby acid (usually Asp from motif II).
The catalytic site of various metallo-phosphoesterases shows considerable flexibility, 
and as a consequence their reaction mechanism may differ on details from this general 
picture. First, as illustrated in Table 5, amino acids other than His, Asp or Asn are sometimes 
used for coordination of, in particular, metal #1 (e.g. kidney bean and pig PAP and 5'NTase). 
Second, the charge of the metal ions differs between various phosphoesterases, which may 
have consequences for their ability to deprotonate the bound W2 water molecule. Third, 
the second Asp residue in motif II (GDxxD) may normally function as an acid in the Asp-His 
catalytic diad, but this residue is not always conserved and other mechanisms for 
protonation of the acid catalyst His have therefore been proposed [86]. Fourth, coordination 
of the phosphate may differ between different metallo-phosphoesterases (Table 5). The 
Asn/His pair of motif III is usually involved in phosphate coordination. In addition, in some 
cases motif II is followed by an Arg residue that is involved in phosphate coordination. In
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other cases, residues in motif IV or residues outside motif I-V may be involved in phosphate 
coordination.
Interestingly, a comparison of the predicted metal-coordinating and catalytic residues in 
Vps29 reveals that Vps29 shows very high similarity with the Mre11 active site (Table 5 and 
Figure 3). Based on the Mre11 template, hVps29 active site residues Asp8 and His10 (motif 
I), Asn39 (motif II), Asp62 (motif III), His86 (motif IV) and His115 and His117 (motif V) clearly 
correspond to Mre11 residues Asp8 and His10 (motif I), Asp49 (motif II), Asn84 (motif III), 
His173 (motif IV) and His206 and His208 (motif V). Nevertheless, hVps29 shows three 
unique features that distinguish hVps29 from MRE11 and other active metallo- 
phosphoesterases deposited in the PDB (Table 5 and Figure 3). First, Vps29 contains an 
asparagine in motif II (Asn39) instead of the usual aspartic acid that sits on the bottom of 
the active site and uses its carboxyl group to coordinate both metal ions in a bidental 
fashion. Second, Vps29 contains an Asp residue instead of an Asn in motif III (Asp62). 
Normally, this Asn residue uses its side-chain oxygen to coordinate metal #2 and its amino 
group to coordinate the phosphate. Third, the acid catalyst (His85 in Mre11, motif III), which 
serves as a proton donor for the leaving group, is replaced by Phe63 in Vps29 (Figure 2). 
Normally, this histidine is part of the Asp-His catalytic diad, in which the nearby Asp is 
responsible for protonation of the histidine that, in turn, serves as a general acid to 
protonate the leaving Ser/Thr oxy-anion. In summary, the Vps29 protein show highly 
significant similarity to the metallo-phosphoesterase structural fold. The predicted metal 
coordinating residues of Vps29 are most similar to the Mn2+ binding Mre11 endonuclease, 
suggesting the possibility that Vps29 may have similar metallo-phosphatase activity.
VJ
Oí
Protein 
PDB code
Vps29 Pfu-1218608
1NNW
M re ll
1117
Pv PAP 
1KBP
Sc PAP 
IUTE
BOA
1G5B
Calcineurin
1AUI/1TCO
PPIA
IFJM
5'NT 
1USH
Metal #1 Mn2+ Fe3+ Fe3+ Mn2+ Fe3+ Mn2+ Zn2+
Motif 1 Asp8, His 10 Asn9, A la li Asp8, HislO Aspl35 Asp 14 Asp20, His22 Asp90, His92 Asp64, His66 Asp41, His43
Motif II Asn39 Asn42 Asp49 Asp 164, Tyrl67 Asp52, Tyr55 Asp49 A sp ll8 Asp92 Asp 84
Motif V H is ll7 Metl76 His208 His325 His223 Gln254
HOH W I, W2 W I, W2 W I, W2 W I, W2
Metal #2 Mn2+ Zn2+ Fe2+ Mn2+ Zn2+ Mn2+ Zn2+
Motif II Asn39 Asn42 Asp49 Asp164 Asp52 Asp49 A sp ll8 Asp92 Asp 84
Motif III Asp62 Lys72 Asn 84 Asn201 CO Asn91 Asn75 Asn 150 CO Asn124 CO A sn ll6 , H isll7
Motif IV His86 Tyrl38 Hisl73 His286 Hisl86 Hisl39 Hisl99 Hisl73 His217
Motif V H is ll5 Serl74 His206 His323 His221 Hisl86 His281 His248 His252
HOH W I W I W I W I W I
Phosphate binding
Motif II Arg53 Argl22 Arg96
Motif III Asn84, His85 Asn201, His202 Asn91, His92 Asn75, His76 Asnl50, Hisl51Asnl24, Hisl25
Motif IV His296 Hisl95
Other Argl62 Arg254 Arg221 Arg410
Metals Mn#l, Mn#2 modeled Mn#l, Mn#2 Mn#l, Mn#2
Acid catalyst
Motif II His52 CO Aspl69 Phe56 CO Asp52 Aspl21 Asp95 Aspl20
Motif III His85 His202 His92 His76 Hisl51 Hisl25 H is ll7
Table 5 Catalytic site residues of various metallo-phosphoesterases. Data have been extracted from the respective PDB files.
1NNW Uncharacterized hypothetical protein (PF1291) from the archaeabacteria Pyrococcus furiosus
1117 Archaeabacteria P. furiosus M re ll, 3'-5' ssDNA endonuclease (DSB repair)
1G5B bacteriophage lambda PPase (Ser/Thr phosphatase)
1AUI/1TCO PP2B calcineurin Ser/Thr phosphatase
IFJM rabbit PP1 Ser/Thr phosphatase
1KBP kidney bean purple acid phosphatase (PAP)
IUTE Pig purple acid phosphatase (PAP)
1USH E. coli UDP sugar hydrolase/E. coli 5' nucleotidase (NT)
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A B
Figure 3 Comparison of the 3D-PSSM predicted catalytic site of hVps29 (top) based on the
catalytic site of the Mre11 template (bottom). In M r e l l ,  metal #1 is coordinated by Asp8, His10, 
Asp49, His208 as well as a bridging water (W1) molecule. Metal #2 is coordinated by Asp49, Asn84, 
His173, His206 and W1. Asn84 and His85 are also involved in phosphate coordination. The His85- 
His52 pair has been proposed to help destabilize the phosphoester bond and to function as a proton 
donor to protonate the oxy-anion of the leaving group. In the model of 3D-PSSM model of Vps29, 
Asp8, His10, Asn39 and His117 are predicted to coordinate metal #1, while Asn39, Asp62, His86 and 
His115 are predicted to coordinate metal #2.
Fold Recognition of hVps35 Reveals Similarity to the ARM/HEAT Helical Repeat Structural 
Fold
As shown in Table 4, the 3D-PSSM fold recognition server predicts significant similarity 
(>95% confidence) of hVps35 to the armadillo (ARM) repeat superfamily proteins importin-ß 
and ß-catenin, as well as to Cbp80, which is a component of the nuclear cap binding 
complex. Given the highly significant similarity of Vps29 to the metallo-phosphoesterase 
fold, it is also interesting to note that Vps35 shows predicted structural similarity to the 
PR65a regulatory subunit of PP2A which, like Vps35, associates with a phosphoesterase fold 
protein (Table 4). Interestingly, some similarity of Vps35 is also detected with the AP2 
clathrin core proteins a2 and ß1 (Table 4), particularly since Vps26 shows some structural 
similarity with the AP2 |a2 subunit (Table 1 and 2). However, the 3D-PSSM values of these 
similarities are low. The Libellula fold recognition server also identified PR65a, importin-ß, 
and ß-catenin as best hits (data not shown).
The proteins listed in Table 4 are all-alpha helical repeat proteins that contain tandem 
repeats of short sequence motifs of 20-40 amino acids including the HEAT and armadillo 
(ARM) repeat motifs that form elongated super-helices or solenoids [98, 99]. Interestingly,
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Andrade et al. [99] extracted proteins containing ARM or HEAT repeats from the SwissProt 
database, classified this group of repeats and distinguished ARM repeats (importin-ß, ß- 
catenin) from three groups of HEAT repeats, i.e. (i) AAA (PP2A PR65a subunit, Vps15 
(component of the Vps34 PI3K complex)), (ii) IMB (importin-ß family) and (iii) ADB (includes 
clathrin-associated a, ß- and y-adaptins as well as ß- and y-coatomer subunits). Indeed, the 
SCOP database (version 1.63, May 2003) [53] divides the ARM repeat superfamily into 12 
different families including the Armadillo repeat, clathrin adaptor core proteins, HEAT 
repeats, clathrin heavy chain proximal leg segment, the clathrin heavy chain linker domain, 
and the PI3K helical domain, among others. The ARM and HEAT repeats are also listed in 
SMART (ARM), ProtFAM (PF02985), and Prosite (PDOC50077) databases.
SCOP
domain
Identity
%
Template
(aa)
PSSM
value
SCOP Family Protein ID Species
D 1qgr a 10 871 0.0198 HEAT repeat Importin-ß H.sapiens
D 1b3u a 11 588 0.045 HEAT repeat PR65a regulatory 
subunit of PP2A
H.sapiens
C 1g3j a 9 522 0.307 Armadillo repeat ß-catenin H.sapiens
C1h6ka 16 728 0.684 MIF4G domain Nuclear cap binding 
complex
H.sapiens
D 3bct 11 444 0.827 Armadillo repeat ß-catenin M.musculus
D 1ibr b 9 458 0.982 HEAT repeat Importin-ß H.sapiens
C 1gw5 a 10 584 0.996 Clathrin adaptor core AP2 a2 clathrin 
adaptor core protein
R.norvegicus
D 1qbkb 9 856 1.06 HEAT repeat Karyopherin-ß2 H.sapiens
C 1ldj a 18 725 1.48 Cullin repeat SCF Ubiquitin ligase 
complex
H.sapiens
C 1gw5 b 14 579 1.78 Clathrin adaptor core AP2 ß1 clathrin 
adaptor core protein
H.sapiens
Table 4 Top-10 3D-PSSM threading results for human Vps35.
The HEAT motif is degenerate, but contains a consensus of hydrophobic residues with 
conserved Pro, Asp and Arg residues [98, 99]. It is a 37-43 amino acid repeat motif that 
forms a pair of anti-parallel a-helices (or helical hairpin), termed A and B. Helical pairs are 
stacked on top of each other forming an extended/elongated structure (variably described 
as hook-, horseshoe- or boomerang-shaped) in which the A and B helices form the outer 
(convex) and inner (concave) face of the structure, respectively. Stacking of consecutive 
helical pairs on top of each other is determined by the nature of the interaction between 
inter-helical amino acid side chains, including hydrophobic residues that form a core and a
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conserved Asp-Arg hydrogen-bond ladder. Loops connecting the a-helices form the outer 
protein-protein interaction surface.
The armadillo (ARM) repeat is a 42 amino acid motif that is found in ß-catenin and 
importin-ß, among others [98, 99]. It consists of three short a-helices of two turns (H1), 2-3 
turns (H2) and 3-4 turns (H3). H2 and H3 form an anti-parallel helical pair. H1 is 
perpendicular to H2/H3 due to the presence of a glycine residue in between H1 and H2. The 
concave face of the superhelix is formed by a ladder of H3 a-helices that are stacked parallel 
on top of each other, whereas the convex face is formed by H2 a-helices. However, neither 
ARM nor HEAT repeats form an independent folding unit. The ARM consensus sequence 
shows that in particular the hydrophobic core is conserved and forms the basis for the 
formation of the right-handed superhelical structure. Indeed, Andrade et al. [99] suggest 
that the hydrophobic core of an ARM or HEAT repeat would likely render a single repeat- 
containing protein highly insoluble [99].
It is noteworthy that Vps35 protein sequences were not included in any of the ARM or 
HEAT repeat classes distinguished by Andrade and coworkers [99], suggesting that Vps35 
does not contain bona-fide ARM or HEAT repeats. An alignment of Vps35 with importin-ß 
and PR65a as given in Supplementary Figures S4 and S5, supports this conclusion. As can be 
deduced from the alignment of hVps35 with human PR65a (Supplementary Figure S5), 
Vps35 does not contain a recognizable Pro or Asp-Arg ladder. In conclusion, Vps35 appears 
to be related to the a-helical ARM/HEAT repeat/solenoid structural fold, but it appears to be 
unique and distinct from the classical ARM and HEAT repeat classes described so far.
Discussion
The heterotrimeric retromer complex is composed of the proteins Vps26, Vps29 and Vps35 
and regulates retrograde transport of cargo proteins from early endosomes back to the TGN 
[14-19, 28]. It is a cytosolic complex that is recruited to endosomal membranes through 
interaction with a (hetero-)dimer of sorting nexins that contain a PI3P binding PX domain 
[24-27]. SNX1 has also been proposed to regulate endosomal trafficking and lysosomal 
degradation of the EGFR through binding of the C-terminal YLVI motif at the distal end of 
the EGFR kinase domain [29-32]. However, the molecular function of individual retromer 
subunits remains obscure. Here, we predict using 3D-PSSM and other fold recognition 
algorithms that Vps26, Vps29 and Vps35 show significant similarity to the ß-arrestin fold, 
the metallo-phosphoesterase fold, and the ARM/HEAT helical repeat fold, respectively. 
These relationships were detected by bioinformatics approaches, in spite of the fact that
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primary amino acid similarity was below the detection limit of Blast and Psi-Blast searches. 
Indeed, alignments of retromer proteins to the best hits revealed by the 3D-PSSM server 
generally showed sequence identity to be below 20% (Tables 1-4).
The similarity of hVps29 to the metallo-phosphoesterase fold of Pfu-1218608 was highly 
significant. It should be noted however, that the predicted active site of this hypothetical 
protein is unlikely to bind metal ions. Nevertheless sequence motifs I-V, which are 
characteristic of genuine metallo-phosphoesterases [90, 95, 96], were identified within the 
Vps29 amino acid sequence (Figures 1-3 and Table 5). The predicted metal coordinating 
residues were most similar to those of MRE11, an endonuclease. Despite these similarities, 
Vps29 appears unique among active metallo-phosphoesterase enzymes in three aspects. 
First, Vps29 motif II contains an Asn instead of an Asp. Second, Vps29 motif III contains an 
Asp instead of Asn. Third, the acid catalyst His in motif III has been replaced by a Phe in 
Vps29. The latter two substitutions relate to (i) the coordination of the phosphate group and 
(ii) the mechanism underlying protonation of the leaving oxy-anion group of the substrate. 
As discussed in the results section, flexibility of the metallo-phosphoesterase active site with 
respect to phosphate coordination and leaving group protonation is already evident (Table 
5). These findings suggest that Vps29 may possess metallo-phosphoesterase activity, 
possible towards phospholipids or phospho-Ser/Thr residues. Although sorting nexins-1 and 
-2 contain a phospholipid binding module (the PI3P specific PX domain), the latter possibility 
seems more likely as Vps35 has been proposed to recognise cargo proteins and none of the 
retromer subunits contains lipid binding modules.
The predicted structural similarity of Vps26 and Vps35 to the ß-arrestin fold and helical 
ARM/HEAT repeat fold was much lower, but still significant. In this context it is important to 
note that recognition of a structural fold (as performed here) is just the first step in the 
generation of a reliable structural homology model. In this respect it is important to realize 
that the 3D-PSSM alignments are not yet optimised structural alignments. Insertions, gaps, 
loops between secondary structure elements, non-conservative mismatches (buried 
charged side chains) etc. may need further optimization and adjustment. As can be judged 
from the alignments shown in Supplementary Figures S2, 3, 4 and 5, many of such 
difficulties arise. As a consequence generation of a reliable structural model for Vps26 and 
Vps35 by homology modelling was judged not feasible at present (E.Krieger, CMBI, personal 
communication). Nevertheless, these data provide the first glimpse of the molecular 
function of Vps26 and Vps35, and unravel a previously unrecognised relationship of Vps26 
and Vps35 to ß-arrestins and helical ARM/HEAT repeat proteins, respectively.
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The Supplementary Figures are available at http://www.celbi.science.ru.nl/downloads/ 
thesisdamen.zip.
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Summary
The sorting nexin/retromer complex is an evolutionary conserved complex involved in 
eukaryote endosome-to-Golgi (tubulo-)vesicular transport of cargo proteins. As such it is of 
fundamental importance to the cell biology of all eukaryotes. The retromer complex is 
composed of Vps26, Vps29 and Vps35 subunits. In various model organisms, the presence of 
multiple paralogues and alternative splicing of retromer subunits has been described, but a 
comprehensive analysis of retromer subunits across various eukaryote lineages to better 
define orthologue relationships has not yet been performed. Here, we analysed public 
databases of protists, viridiplantae, fungi, and metazoan species for the presence of 
retromer genes and performed Clustal phylogenetic analyses to define orthologue 
relationships.
For the Vps26 subunit, we demonstrate that (i) the presence of two Vps26 paralogues 
(Vps26A and Vps26B) is common to all jawed vertebrates, (ii) teleost fish contain two 
Vps26B paralogues in addition to Vps26A, (iii) non-vertebrate metazoans and fungi contain a 
single Vps26 gene, (iv) among viridiplantae, green algae contain a single Vps26 gene, 
whereas three Vps26 paralogues are detected in the bryophyte moss P. patens, whereas 
eucotyledons (monocotyledons and dicotyledons) contain at least two Vps26 paralogues, 
and (v) that most protist phyla contain a single Vps26 gene with the notable exception of 
Paramecium (up to 7 Vps26 paralogues), Trichomonas (up to 17 Vps26 paralogues), and 
Entamoebidae (up to 6 Vps26 paralogues).
For the Vps29 subunit, we demonstrate that (i) bony vertebrates contain a single Vps29 
gene with an evolutionary conserved alternatively spliced four amino acid encoding exon 2, 
(ii) non-vertebrate metazoans and fungi contain a single Vps29 gene, (iii) among 
viridiplantae, nearly all species contain a single Vps29 gene, with the notable exception of P. 
patens, Z. mays, and V. vinifera in which two Vps29 proteins are detected, and (iv) that most 
protists contain a single Vps29 gene with the exception of Trichomonas (three Vps29 
paralogues), and Paramecium (five Vps29 paralogues).
For Vps35, we demonstrate that (i) metazoans and fungi contain a single Vps35 gene, (ii) 
among viridiplantae, green algae and monocotyledons also contain a single Vps35 gene, 
whereas the bryophyte moss P. patens contains two Vps35 paralogues, and dicotyledons 
contain up to three Vps35 paralogues.
In summary, our studies provide ample evidence for the existence of multiple Vps26, 
Vps29, and Vps35 paralogues which could result in functionally diverse retromer complex 
isoforms in vertebrates, mosses, higher plants, and various unicellular protozoans. Distinct 
retromer complex isoforms may regulate transport of different cargo proteins, distinct
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vesicular transport pathways or they may interact with different protein interaction 
partners for differences in their regulation. Further studies are required to address possible 
functional differences between various retromer subunit isoforms.
Introduction
Eukaryotes show some distinctive features that are not shared by (archae)bacteria. First, 
they contain a nucleus containing chromosomal DNA, hence their name. Second, eukaryotes 
contain a complex cytoskeletal network including microfilaments (actin-based), 
intermediate filaments and microtubules. Third, eukaryotes contain an elaborate 
assortment of membrane-enclosed organelles including peroxisomes, mitochondria, 
chloroplasts (in viridaeplantae only), and organelles belonging to the endomembrane 
system. The latter consists of the rough endoplasmic reticulum (RER), the Golgi system with 
the plasma membrane, and the endosomal system, which is a complex network containing 
various compartments including sorting endosomes, multivesicular bodies, lysosomes and 
recycling endosomes [1, 2].
The complexity of eukaryote subcellular organization provides opportunities for a large 
variety of biological processes to take place in separate compartments, which would not be 
possible in organisms that contain only a single compartment. However, such a complex 
subcellular organization also necessitates the existence of specific and elaborate subcellular 
targeting mechanisms in order to deliver proteins to the exact subcellular destination/ 
compartment. Within the secretory and endosomal systems, protein transport between 
different organelles/compartments occurs mainly through distinct vesicular (or sometimes 
tubular) intermediates. Formation of vesicles involves the action of specific small GTPase 
proteins that - in concert with cargo proteins - recruit specific vesicular coat proteins (e.g. 
clathrin, COPI/II), and accessory proteins (e.g. dynamin) which ultimately culminates in the 
formation of vesicles. Coat proteins are subsequently removed and vesicles can then be 
captured by either microfilaments or microtubules for motor-driven transport to their (final) 
destination. Docking and fusion of these vesicular intermediates with their target organel is 
guided by the presence of specific small GTPase Rab, as well as SNARE proteins which 
interact with specific partner proteins present on the target organel only [3].
A recent analysis of proteins involved in the endomembrane system has revealed that 
core components of the endomembrane system are conserved in nearly all eukaryotes, 
indicating that the last common eukaryote ancestor contained a complete endomembrane
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system [4]. The molecular origin of many of the core components of the endomembrane 
system is, however, most often not clear.
One of the evolutionary conserved pathways is the retrograde endosome-to-trans Golgi 
network (TGN) pathway [5]. Although distinct routes may exist for endosome-to-TGN 
(tubulo-) vesicular transport, one of these pathways is mediated by the evolutionary 
conserved sortin nexin/retromer complex. The retromer complex consists of Vps26, Vps29 
and Vps35 subunits and associates with a homo- or heterodimer of sorting nexins. It has 
originally been identified in the yeast S. cerevisiae as a result of genetic screens to identify 
proteins involved in vacuolar proteins sorting (hence the acronym Vps) [6-9]. Apart from 
fungal orthologues, Vps26, Vps29 and Vps35 have also been identified among other 
eukaryote kingdoms including protists, plants (viridiplantae), and animals (metazoans).
In yeast, the retromer complex functions in endosome-to-Golgi retrieval of the vacuolar 
sorting receptor Vps10 and other cargo proteins (reviewed in [10, 11]). Similarly, in both 
mammals and plants, the retromer complex functions in endosome-to-TGN retrieval of the 
lysosomal hydrolase receptors CI-M6PR [12, 13] and the Vacuolar Sorting Receptor (VSR) 
[14], respectively. In the nematode C. elegans, retromer is involved in endosome-to-TGN 
retrieval of Wntless, and as a consequence, in the secretion of Wnt morphogens [15, 16]. 
This has also been demonstrated in mammalian systems [16-19]. The Vps26 C-terminal 
domain has been identified as a target for of the late endosomal small GTPase protein Rab7 
in the protist Entamoeba histolytica [20]. Interaction of the retromer complex with Rab7 has 
been extended to the mammalian system [21, 22], which also provided evidence for 
interaction of retromer proteins with the Rab-GAP [22]. Increasing evidence also suggests a 
link between retromer proteins and the microtubule cytoskeleton, including association of 
retromer subunits with tubulins, tubulin interacting Hook proteins [see thesis, Chapter 6] 
and dynein motor proteins [23].
The three-dimensional crystal structure of retromer subunits has been published. 
Mammalian hVps26A and mVps26B display a ß-arrestin fold containing two ß-sandwich 
subdomains connected by a linker sequence [24, 25]. Vps26A and Vps26B interact with 
Vps35 through a loop connecting strands ß15-ß16 in the C-terminal domain, i.e. Vps26A 
amino acids 235-246 and Vps26B amino acids 233-247. Conversely, the highly conserved 
PRLYL motif in the N-terminal domain of Vps35 is required for interaction with Vps26 [26­
28]. The crystal structure of Vps29 revealed that Vps29 contains a divalent metal binding 
phosphoesterase fold [29, 30]. Indeed, Vps29 was able to bind divalent Mn2+ metal ions 
[31]. Based on these results, we tested the hypothesis that Vps29 was a phosphoesterase 
and found that recombinant Vps29 was a metal-dependent phosphoesterase towards an
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acidic dileucine phosphorylated peptide substrate from the CI-M6PR cytoplasmic tail [31]. 
Subsequently, the crystal structure of the C-terminal half of Vps35 in complex with Vps29 
provided evidence for an alternative model in which Vps29 acts as an adaptor in the 
retromer complex, because the catalytic site of Vps29 was completely buried in the 
interface with Vps35 [32], whereby Vps35 displayed an elongated a-solenoid superhelical 
fold.
Our previous studies have demonstrated that blast searches do not reveal any significant 
sequence similarity of retromer subunits to other proteins in the human genome apart from 
similarity between Vps26 proteins and DSCR3, a predicted protein encoded in the Down 
syndrome critical region [33, 34]. Fold recognition studies and structural analysis indicates 
that Vps26, Vps29 and Vps35 show structural similarity to ß-arrestins, metallo- 
phosphoesterases and ARM/HEAT helical repeat proteins, respectively. Here, we provide a 
comprehensive phylogenetic analysis of all eukaryote kingdoms of life to define orthologue 
relationships among Vps26, Vps29 and Vps35 genes.
Methods
Database Searches
Publicly accessible eukaryote genomes at various stages of completion were searched for 
the presence of Vps26, Vps29 and Vps35 sequences using the BLAST tool [35] through 
various web portals including the NCBI blast home page (http://blast.ncbi.nlm.nih.gov/- 
Blast.cgi), the NCBI eukaryotic blast tree (http://www.ncbi.nlm.nih.gov/sutils/genom_- 
tree.cgi), the NCBI taxonomy home page (http://www.ncbi.nlm.nih.gov/sites/- 
entrez?db=taxonomy) [36], the Joint Genome Initiative (JGI) genome portal 
(http://genome.jgi-psf.org/), the Welcome Trust Sanger sequencing genome projects 
(http://www.sanger.ac.uk/Projects/), the Washington University School of Medicine 
Genome Center (http://genome.wustl.edu/), the Baylor College of Medicine Human 
Genome Sequencing Center (http://www.hgsc.bcm.tmc.edu/), and the Broad Institute of 
MIT and Harvard (http://www.broadinstitute.org/).
Multiple Sequence Alignment and Phylogenetic Tree Construction
Predicted amino acid sequences were compared and optimized relative to those obtained 
from closely related species in multiple sequence alignments using the EBI ClustalW2 
webserver (http://www.ebi.ac.uk/Tools/clustalw2/index.html) in combination with ClustalX 
software [37] and DNAMAN software package. Whenever applicable, alternative codon
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translation tables were used. Whenever possible, EST databases were searched to confirm 
the sequence and expression of predicted genes. It should be noted however, that for many 
species experimental evidence for the expression of predicted retromer genes is not 
available yet. Predicted amino acid sequences of Vps26, Vps29 and Vps35 are available 
upon request. A Phylip Neighbor Joining phylogenetic tree [38] was constructed starting 
from a ClustalW alignment, with distance correction and ignorance of gaps. Using Treeview 
software [39], the phylogenetic tree was visualized whereby an appropriate outgroup was 
used to define the likely root of the phylogenetic tree.
Results
Vps26
Previously, two Vps26 paralogues have been described in vertebrates. The mammalian 
Vps26 (also known as Hß58) gene was originally identified in the mouse as a gene that was 
necessary for post-implantation mouse development [40, 41]. More recently, Kerr et al. [42] 
described another Vps26 paralogue, denoted Vps26B to distinguish it from the previously 
described Vps26A gene. They showed that two Vps26 paralogues are present in fish and 
mammals, but that a single Vps26 gene is present in primitive metazoans such as C. elegans 
and Drosophila. Both Vps26A and Vps26B are able to interact with Vps35 [24, 42].
Extending these data, we show here that Vps26A and Vps26B paralogues are also 
present in birds (Gallus gallus, Taeniopygia guttata), reptiles (Anolis carolinensis), and 
amphibians (Xenopus tropicalis and Xenopus laevis). However, the tetraploid African clawed 
frog Xenopus laevis contains two of each Vps26A and Vps26B genes (Figure 1A). Similarly, 
we find that the genome of various bony fish species contain two different Vps26A (Esox 
lucius, Danio rerio, Oncorhynchus mykiss) and/or Vps26B (Danio rerio, Gasterosteus 
aculeatus, Tetraodon nigroviridis and Takifugu rubripes) paralogues (Figure 1A). The 
presence of these duplicated Vps26A and Vps26B genes is also supported by various EST 
sequences in these species (data not shown). Inspection of a multiple sequence alignment 
of bony fish Vps26A and Vps26B paralogous genes indicates that differences are present 
especially in the C-terminal 30 amino acids (data not shown). The Vps26 C-terminus region is 
the most divergent region between Vps26A and Vps26B genes [24, 42]. In the protist 
Entamoeba histolytica, the C-terminus of Vps26 has been implicated in binding of the Rab7 
small GTPase [20]. As the duplicated Vps26A and Vps26B paralogues in bony fish do not 
completely segregate in different branches upon ClustalX phylogenetic tree analysis, 
annotation and proper assignment of orthologue relationships among these duplicated fish
Phylogenetic analysis of retromer subunits 91
Vps26A and Vps26B genes remains somewhat speculative. More sequences from teleost 
fish are needed to better define their orthologue relationships. Nevertheless, it is clear that 
bony fish may contain up to four Vps26 paralogues, including two Vps26A genes and two 
Vps26B genes. Interestingly, in the cartilaginous shark Callorhinchus milii, blast searches 
suggest that a major part of the Vps26 gene as well as C-termini resembling Vps26A and 
Vps26B are present within the current low coverage (1.6x) whole genome sequence (WGS) 
of C. milii (data not shownj. Collectively, these findings indicate that Vps26A and Vps26B 
paralogues are common to all jawed vertebrates (gnathostomata), and that duplication of 
Vps26A and Vps26B genes has occurred in the teleost lineage of bony fish. We also find that 
a single Vps26 gene is present in the genome of urochordates (Ciona intestinalis and Ciona 
savignyi) and cephalochordates (Branchiostoma floridae, also known as Amphioxus or 
lancelet), which are both sister groups of the craniates. Similar to the urochordates and 
cephalochrodates, non-chordate metazoans contain only a single Vps26 gene (Figure 1B). 
These findings imply that duplication of an ancestral chordate Vps26 gene into Vps26A and 
Vps26B has probably occurred within the early chordate/craniate phylogenetic lineage. It 
will be interesting to determine whether two Vps26 paralogues are also present in craniate 
taxonomic groups other than jawed vertebrates, such as lampreys (e.g. Petromyzon 
marinus) and hagfishes (e.g. Eptatretus burgerii).
Two Vps26 orthologues (Vps26A and Vps26B) have also been described in the thale 
cress Arabidopsis thaliana [43]. Here we describe relationships between Vps26 paralogues 
in various taxonomic groups of viridiplantae (Figure 2). Our findings indicate that unicellular 
green algae (chlorophyta), including Ostreococcus, Volvox, Chlamydomona, Chlorella and 
Micromonas genera, contain a single Vps26 gene. However, the bryophyte haploid moss 
Physcomitrella patens contains instead three Vps26 paralogues (Figure 2). Monocotyledons 
including maize, rice, sorghum and others contain two Vps26 paralogues denoted Vps26A 
and Vps26B. Also various dicotyledons including G. raimondii, Populus trichocarpa and Vitis 
vinifera contain two Vps26 orthologues, denoted Vps26A and Vps26B. For some of these 
species multiple variants can be deduced from (assembled) EST sequences (data not 
shown). These may in fact represent polymorphisms or, alternatively, sequencing errors. 
Arabidopsis thaliana and Arabidopsis lyrata species also contain two separate Vps26 genes, 
which both cluster within the Vps26B clade, suggesting that they have arisen by duplication 
of the Vps26B gene.
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Figure 1A Phylogenetic tree of Vps26 orthologues in vertebrates. The urochordates Ciona 
intestinalis and Ciona savignyi were used to root the tree. Starting from a ClustalW alignment, a 
phylip NJ phylogenetic tree was constructed with distance correction and ignorance of gaps. Using 
Treeview software, an outgroup was defined to locate the likely origin of the phylogenetic tree.
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Figure 1B
choanozoan 
Figure 1A.
Phylogenetic tree of Vps26 orthologues in non-chordate metazoans. The
Monosiga brevicollis was used to root the tree. The tree was generated as described for
Within the fungal kingdom, only a single Vps26 gene is present in each species (data not 
shown), as well as in various protozoan phyla. Interestingly, however, several protozoan 
phyla appear to contain multiple Vps26 orthologues. Thus, Entamoebidae contain at least 5 
different Vps26-like genes (Vps26.1-5). Paramecium tetraurelia may contain up to 6 
different Vps26 genes, although some of them may actually represent polymorphisms. A 
striking example of expansion of the Vps26-family genes has occurred in T. vaginalis with up
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to 17 different Vps26-family proteins (Figure 3). T. vaginalis Vps26 genes cluster in two 
different groups, which we denote as Vps26.1-6 and Vps26.7-17.
In summary, heterogeneity in eukaryotic Vps26 isoforms results from the existence of 
multiple paralogues in various eukaryotic groups. Duplicated Vps26 genes are present in 
vertebrates, with additional Vps26 paralogues being present in bony fish. Various taxonomic 
groups within viridiplantae also contain duplicated or even triplicated Vps26 genes and 
within several protozoan phyla, multiple Vps26 genes exist.
Figure 2 Phylogenetic tree of Vps26 orthologues in viridiplantae. The aquatic green algae
Chlamydomonas reinhardtii was used to root the tree. The tree was generated as described for 
Figure 1A.
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Figure 3 Phylogenetic tree of Vps26 orthologues in protozoa. The diplomonad Giardia
lamblia was used to root the tree. The tree was generated as described for Figure 1A.
Vps29
Vps29 was first cloned in humans by Edgar et al. [44] and Haft et al. [45]. The human Vps29 
gene contains five exons, resulting in two isoforms. Exon 1 contains promoter sequences 
and the initiation methionine codon. Exon 2 is an alternatively spliced exon encoding four 
amino acids (AGHR) that can be inserted directly following the initiating methionine. The 
remainder of the protein is encoded by exons 3-5. Blast searches among vertebrate genomic
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and EST databases reveal that each vertebrate species contains a single Vps29 gene (data 
not shown). Nevertheless, Vps29 pseudogenes have be identified in many vertebrate 
genomes; they usually contain multiple premature stop-codons, frame-shifts or mutation(s) 
in splice acceptor/donor sites. Interestingly, exon 2 is conserved among all bony 
vertebrates, as Vps29 genomic or EST sequences encoding this 4 amino acid exon can be 
identified in mammals (AGHR), amphibians (PGHR), and teleost fish (AGHR, AVHR or ASHR).
So far, there is no evidence for the existence of exon 2 among cartilaginous fish 
(chondrichthyes), lampreys, hagfishes and non-vertebrate chordates including B. floridae 
(amphioxus or lancelet) and Ciona urochordate species, even though Vps29 sequences are 
readily detected in these groups (data not shown). The function of the alternative isoform 
containing four amino acids from exon 2 is not known, but its conservation among bony 
vertebrates suggests a function in (bony) vertebrate development.
Among the 141 known metazoan Vps29 amino acid sequences, the catalytic site residues 
Asp8, Arg14, Asn39, His86, and His88 are absolutely conserved. Among (a)coelomates His10, 
Asp62, His115 and Asn140 are also absolutely conserved, whereas His117 may be replaced 
by Gln in amphibians and by Tyr in certain dipteran insects, including Drosophila species. 
Pseudocoelomate nematodes show more variability in the Vps29 active site, whereby His10 
and Asp62 are replaced by aromatic Phe/Tyr residue and the negatively charged Glu 
residue, respectively; In addition, His115, His117 and Asn140 may also be replaced among 
nematodes. We conclude that the active site of Vps29 is highly conserved among 
(a)coelomate species and, to a lesser extent, pseudocoelomate nematodes [31].
A single copy of a Vps29 gene appears to be present in all fungal species (data not 
shown) as well as in viridiplantae, including Arabidopsis thaliana [43], with the exception of 
the haploid moss P. patens, in which two Vps29 genes are present (Figure 4).
A single copy of the Vps29 gene is also present in many protist phyla, with the exception 
of Trichomonas species T. vaginalis and T. foetus, in which three Vps29 genes are present, 
and Paramecium tetraurelia which contains five Vps29 genes (Figure 5). For Toxoplasma 
gondii, there is evidence for multiple EST Vps29 transcripts although there appears only a 
single Vps29 gene present in the genome, indicating that care must be taken in concluding 
the presence of multiple Vps29 genes based on EST data alone.
In summary, most eukaryotes contain only a single Vps29 gene. Heterogeneity in Vps29 
isoforms results from alternative splicing of exon 2 in vertebrates, the existence of two 
Vps29 genes in the bryophyte moss P. patens, and the existence of multiple Vps29 genes in 
protozoan Trichomonas and Paramecium species.
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Figure 4 Phylogenetic tree of Vps29 orthologues in viridiplantae. The green algae
C.reinhardtii was used to root the tree. The tree was generated as described for Figure 1A.
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Figure 5 Phylogenetic tree of Vps29 orthologues in protozoa. The diplomonad G.lamblia was
used to root the tree. The tree was generated as described for Figure 1A.
Vps35
Metazoan Vps35 has been implicated in endosome to Golgi trafficking in various species 
including C. elegans, Drosophila, and mammals. It has been reported to be involved in CI- 
M6PR retrieval from endosomes back to the TGN [12, 13], transcytosis of the polymeric IgA 
receptor [46], and Wnt secretion [15-19]. A partial mouse Vps35 cDNA (also called Mem3) 
was first reported by Hwang et al. [47]. Full length human Vps35 cDNAs were subsequently
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described by Edgar et al. [44] and Haft et al. [45]. They concluded that the Vps35 gene is 
conserved across the eukaryotic kingdom. As opposed to the existence of two Vps26 genes 
in jawed vertebrates, Vps35 is present as a single gene in all metazoan species (data not 
shown). Metazoan Vps35 is also not known to undergo alternative splicing, as has been 
demonstrated for Vps29. Apparently, a single Vps35 protein can assemble with different 
Vps26 and Vps29 proteins to form distinct isoforms of the retromer complex. Seaman and 
colleagues identified the PRLYL sequence within the N-terminal region of Vps35 as the motif 
that is required for interaction with Vps26 [48]. This motif is absolutely conserved among all 
metazoan Vps35 sequences (data not shown). Nearly all fungal species investigated also 
contain a single Vps35 gene, with the exception of Vanderwaltozyma polyspora and 
Saccharomyces castelli that contain two Vps35 paralogues (data not shown).
The Vps35 subunit has also been identified in plants [14, 43]. Indeed, Yamazaki et al. [14] 
demonstrated that A. thaliana contains three different Vps35 genes, denoted Vps35A-C. 
Moreover, these authors isolated Vps35 mutant alleles in each of these three genes and 
constructed double and triple mutants to investigate the relative contribution of the three 
Vps35 paralogues for plant growth and development. They concluded that the Vps35B gene 
is the most essential paralogue for plant growth and development. To determine Vps35 
orthologue relationships among viridiplantae, we searched other plant genomes for the 
presence of Vps35 genes. Chlorophytes (green algae) including Chlorella species, 
Ostreococcus species and Chlamydomonas, contain a single Vps35 gene (Figure 6). In 
contrast, the bryophyte moss Pyscomitrella patens contains two different Vps35 genes, 
suggesting gene duplication within this primitive lineage of viridiplantae. Monocotyledons 
including maize (Z. mays), rice (O. sativa), sorghum (S. bicolor) and others contain a single 
Vps35 gene. In contrast, several dicotyledons including Ricinus communis, Vitis vinifera and 
Populus trichocarpa contain two Vps35 paralogues. The phylogenetic tree (Figure 6) 
suggests that the two Vps35 paralogues of Ricinus and Vitis are orthologues of A. thaliana 
Vps35A and Vps35B, whereas the Vps35 paralogues of P. trichocarpa seem both related to 
Vps35B. Like A. thaliana, Arabidopsis lyrata also contains Vps35A-C genes. Arabidopsis 
Vps35C genes seem closely related to Arabidopsis Vps35A, suggesting that these two genes 
may have arisen by gene duplication. This may explain the observation of Yamazaki et al. 
[14], that mutants in A.thaliana Vps35A and Vps35C genes do not show severe defects 
whereas Vps35B mutants and Vps35B double mutants do so.
Among currently available protozoan genomes, the existence of multiple Vps35 genes is 
evident only in Entamoebidae, which contain four Vps35 genes, and Trichomonas vaginalis, 
which contains three Vps35 genes (Figure 7).
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In summary, a single Vps35 gene is present in most eukaryotic taxonomic groups, 
including metazoans, nearly all fungal species, and most protozoan phyla. Vps35 gene 
duplications are found frequently in various plants, as well as in protozoan Entamoebidae 
and Trichomonas species.
PHYLIP 1
C.reinhardtii Vps35
Chlorella.sp NC64A Vps35
C.vulgaris Vps35
M pusilla Vps35
M.sp RCC299 Vps35
Ostreococcus.sp.RCC809 Vps35
O. tauri Vps35
O.ludmarinus Vps35
P patens Vps35A
P patens Vps35B 
A.thaliana Vps35A 
A lyrata Vps35A
A thaliana Vps35C 
A lyrata Vps35C 
R.communis Vps35A 
V.vinifera Vps35A 
Z. mays Vps35 
S.bicolor Vps35 
O sativa Vps35 
I H vulgare Vps35 
* T.aestivum Vps35 
V.vinifera Vps35B
A.thaliana Vps35B 
A lyrata Vps35B 
R.communis Vps35B
0.1
Figure 6 Phylogenetic tree of Vps35 orthologues in viridiplantae. The green algae
C.reinhardtii was used to root the tree. The tree was generated as described for Figure 1A.
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Figure 7 Phylogenetic tree of Vps35 orthologues in protozoa. The diplomonad Gardia
lamblia was used to root the tree. The tree was generated as described for Figure 1A.
Discussion
Retromer Gene Duplication and Whole Genome Duplication Events
In this study we provide evidence for duplication of many different retromer genes. 
Variation in gene numbers may result from whole genome (WGD), chromosomal (CGD) or 
single gene duplication (SGD) events, followed by gene diversification and variable loss of 
duplicated genes. Whole genome duplication has been proposed to provide a driving force 
for evolution of the gene repertoire [49, 50] .
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Within the animal kingdom, we find that the presence of Vps26A and Vps26B genes is 
common to all jawed vertebrates, whereas non-vertebrate chordates including 
urochordates and cephalochordates, as well as non-chordates contain a single Vps26 gene 
(Figure 1). These findings are consistent with the occurrence of two WGD events within the 
early chordate lineage, in between the split of urochordates and jawed vertebrates [51, 52]. 
We also provide evidence for the existence of two Vps26A and Vps26B paralogues in teleost 
fish (Figure 1), an observation that is consistent with the occurrence of another WGD event 
in the early teleost fish lineage [53-55]. Multiple retromer paralogues also exist in the 
tetraploid genome of X. tropicalis (Figure 1). We also demonstrate that jawed vertebrates 
exhibit evolutionary conservation of alternative splicing of Vps29 exon 2. Given the presence 
of a single Vps35 gene in all metazoan species investigated so far, the combination of 
duplicated Vps26 genes and alternative splicing of Vps29 may result in four different 
retromer complex isoforms.
Within the fungal kingdom, Vps26, Vps29 and Vps35 appear to exist as single genes, 
arguing that in fungi only a single retromer complex isoform can be generated. One 
exception to this rule is the presence of two Vps35 paralogous genes within the genome of 
the hemiascomycotan fungi S. castelli and V. polyspora. Here, a WGD event has been 
proposed to have occurred in the early hemiascomycota lineage [56], which may explain the 
presence of two Vps35 genes.
Within the kingdom of viridiplantae the situation appears even more complex. 
Polyploidization and diploidization are common events among plants [57]. Our analysis 
shows that aquatic green algae (chlorophyta), including C. reinhardtii, V. carteri, and others 
contain a single gene for Vps26, Vps29 and Vps35. The bryophyte haploid moss P. patens, 
however, contains three Vps26 paralogues, two Vps29 paralogues and two Vps35 
paralogues. This could potentially result in the formation of 12 different retromer complex 
isoforms in P. patens! The duplication of Vps26, Vps29 and Vps35 genes in P. patens could 
have been the result of a WGD event which most likely has occurred after the emergence of 
green algae but before the emergence of bryophyte mosses [58]. During the evolution of 
flowering plants (angiosperms), which include the major taxonomic groups of 
monocotyledons (including cereals such as rice, maize, sorghum, wheat) and eudicotyledons 
(including arabidopsis, populus, vitis etc), various WGD and/or CGD events have been 
postulated [57, 59]. One WGD event has occurred prior to divergence of monocot cereals, 
which may explain the presence of two Vps26 paralogues within the monocotyledons 
(Figure 2). An additional WGD event has been proposed to have occurred in the Zea maize 
lineage, which may explain the presence of duplicated Vps29 genes in Z. maize, but not in
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the other cereal crops. WGD events have also been proposed in the early eudicotyl lineage, 
which may explain the presence of Vps26A and Vps26B genes as well as Vps35A and Vps35B 
genes in various dicotyledons (Figures 2 and 6). Additionally, a WGD event has been 
proposed in the early Arabidopsis lineage, which may explain the presence of two Vps26B 
paralogues in Arabidopsis (Figure 2). Finally, a more recent analysis of the genome of 
grapevine (Vitis vinifera) even suggested that most dicotyledons (including Arabidopsis, Vitis 
vinifera, and Populus trichocarpa) have emerged from an palaeo-hexaploid ancestral 
genome [59]. This may explain why the poplar P. trichocarpa [60] contains five Vps26 
paralogues, one Vps29 gene and two Vps35B paralogues. These findings suggest a complex 
situation whereby dicotyledons may contain a variable number of retromer genes 
depending on specific loss of hexaploid ancestral retromer genes in certain dicotyledon 
taxonomic groups.
Here, we also demonstrate that several unicellular eukaryotes, in particular 
Paramecium, Trichomonas, and Entamoebidae, contain multiple isoforms of Vps26, Vps29 
and/or Vps35. Paramecium is known as a model system for studying endosomal trafficking 
routes and contains a well developed endomembrane system [61]. Our identification of six 
Vps26 genes and five Vps29 genes in P. tetraurelia may correlate with the complex 
endomembrane system of this species and the presence of two Rab7 isoforms [62, 63]. 
Moreover, recent analyses have provided evidence for three consecutive WGD events in 
Paramecium [64]. The expansion of Vps26 genes in T. vaginalis correlates with the large 
number (65) of Rab GTPases identified in this species [65]. Similarly, the presence of five 
different Vps26 genes and four different Vps35 genes in Entamoebidae also correlates with 
the large number (91) of Rab GTPases that are present in Entamoeba histolytica [66], two of 
which represent Rab7 isoforms [67]. Our finding that these unicellular eukaryotes contain a 
large number of retromer subunits and could therefore form many different retromer 
complex isoforms, further adds to the complexity of the endosomal membrane system in 
these unicellular eukaryotes.
One could also question why, as a consequence of a WGD, CGD or single gene 
duplication event, some duplicated retromer genes survive to acquire divergent functions, 
whereas for other retromer genes one of the duplicated genes is lost. Apparently, none of 
the retromer subunits is resistant to duplication, as gene duplication events have now been 
demonstrated for each of the retromer subunits. Given these whole genome and/or gene 
duplication events, determination of orthologue relationships is essential to extrapolate 
findings on retromer subunit function from one species to another. Especially within
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viridiplantae, where polyploidization and diploidization are common events, establishment 
of proper orthologue relationships is essential for interspecies comparisons.
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Summary
The retromer complex is involved in the retrograde transport of the cation-independent 
mannose 6-phosphate receptor (CI-M6PR) from endosomes to the Golgi. It is a hetero- 
trimeric complex composed of Vps26, Vps29 and Vps35 proteins, which are conserved in 
eukaryote evolution. Recently, elucidation of the crystal structure of Vps29 revealed that 
Vps29 contains a metallo-phosphoesterase fold [1, 2]. We demonstrate that recombinant 
human (h)Vps29 displays in vitro phosphatase activity towards a serine phosphorylated 
peptide, containing the acidic-cluster dileucine motif of the cytoplasmatic tail of the CI- 
M6PR. Efficient dephosphorylation required the additional presence of recombinant hVps26 
and hVps35 proteins, which interact with hVps29. Phosphatase activity of hVps29 was 
greatly reduced by alanine substitutions of active site residues that are predicted to 
coordinate metal ions. Using inductively coupled plasma mass spectrometry and 65Zn- 
binding overlay assays we demonstrate that recombinant hVps29 binds zinc. In addition we 
show the zinc-binding capacity of catalytic site residues of hVps29. Moreover, hVps29- 
dependent phosphatase activity is greatly reduced by nonspecific and zinc-specific metal ion 
chelators, which can be completely restored by addition of excess ZnCl2. The binuclear Zn2+ 
centre and phosphate group were modelled into the hVps29 catalytic site and pKa 
calculations provided further insight into the molecular mechanisms of Vps29 phosphatase 
activity. We conclude that the retromer complex displays Vps29-dependent in vitro 
phosphatase activity towards a serine phosphorylated acidic-cluster dileucine motif that is 
involved in endosomal trafficking of the CI-M6PR. The potential significance of these 
findings with respect to regulation transport of cycling TGN proteins is discussed.
Key words: Vps29, Retromer, cation-independent mannose 6-phosphate receptor (CI- 
M6PR), metallo-phosphoesterase, zinc-binding protein.
Introduction
Eukaryotic cells contain several membrane-enclosed compartments (organelles), each of 
which has a unique function that is maintained by correct localisation and retention of its 
resident proteins. Eukaryote subcellular organization therefore requires the existence of 
specific protein sorting and transport pathways to and between various organelles. Genetic 
screens in Saccharomyces cerevisiae have identified several Vps (vacuolar sorting proteins) 
genes whose products are involved, directly or indirectly, in anterograde or retrograde 
transport between the Golgi and the lysosome-like vacuole [3-5]. Three of those gene
hVps29 is a metallo-phosphoesterase 109
products form the retromer complex in yeast; Vps26, Vps29 and Vps35, which colocalize on 
early endosomes [2, 6, 7] and are involved in retrograde endosome-to-Golgi transport [8].
In yeast, the Vps35 subunit interacts with the cargo protein Vps10p, which is a type I 
transmembrane receptor that is involved in the sorting of newly synthesized soluble 
vacuolar hydrolases, such as carboxy-peptidase Y (CPY), from the trans-Golgi network (TGN) 
to the prevacuolar compartment. In the acidic environment, CPY dissociates from Vps10p 
and is then transported to the vacuole [9-11]. In contrast, Vps10p is recognized by the Vps35 
subunit of the retromer complex, which functions in the retrograde transport of Vps10p 
from the pre-vacuolar compartment back to the TGN [12]. In the TGN, Vps10 can carry out 
additional rounds of enzyme delivery [10, 11].
Orthologues of the yeast retromer proteins appear to be conserved in nearly all 
eukaryotes, including mammals. Given the role of the retromer complex in yeast, it is likely 
that the mammalian retromer functions in transport between the endosomes and the TGN. 
Although yeast protein Vps10p does not have an orthologue in mammals, mannose 6- 
phosphate receptors (M6PRs) function in an essentially similar manner. Indeed, retromer 
subunits colocalize with the cation-independent M6PR (CI-M6PR) cargo protein [6, 7] and 
hVps35 directly interacts with the CI-M6PR in the prelysosomal compartment [6]. The CI- 
M6PR is involved in the sorting and transport of newly synthesized lysosomal hydrolases 
that contain mannose 6-phosphate moieties on their N-glycan chains, which serve as sorting 
signals for TGN-to-endosome transport [13]. One of the triggers of this anterograde 
transport is the phosphorylation of Ser2492 in the cytoplasmic tail of the CI-M6PR [14]. This 
serine is part of the acidic-cluster dileucine sequence DDSDEDLLHI, present in the C- 
terminus of the CI-M6PR. GGA (Golgi-localizing, gamma-adaptin ear domain homology, ARF- 
binding) proteins, which constitute a family of clathrin coat adaptor proteins [15-19], bind 
with their so-called VHS (Vps27, Hrs and Stam) domain to these acidic-cluster dileucine 
sorting signals. GGA proteins transport the CI-M6PR, in clathrin-coated vesicles, from the 
TGN to an endosomal compartment en route to lysosomes [20-22]. Mutational analysis 
reveals that Ser2492 itself is likely to play a role in GGA binding [23] and GST pull-down 
assays have demonstrated that phosphorylation of this serine increases the affinity of the 
CI-M6PR for the VHS domains of GGA1 and GGA3 [24].
In the endosomal compartment, the CI-M6PR is able to bind hVps35 [6]. hVps35 is not 
only the cargo recognition component, but also the scaffold protein of the retromer 
complex, interacting directly with hVps26 and hVps29 [2, 25]. So far, the role of Vps29 and 
Vps26 is less clear; Vps29p probably assists Vps35p in cargo binding and Vps26p promotes 
the interaction between Vps35p and the sorting nexins Vps5p/Vps17p to form the sorting
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nexin/retromer complex [26]. Vps5p binds with its C-terminal domain to Vps17p to form a 
dimer [27] which is able to form oligomeric structures, due to the self-assembly activity of 
Vps5p [8, 28]. This dimer is likely to have a structural role in vesicle budding. In mammals 
the Vps5p/Vps17p dimer is replaced by its orthologue sorting nexin (SNX) 1 and probably 
another SNX protein [25]. In the case of the CI-M6PR the cooperation of all components of 
the retromer complex results in the retrograde transport of the receptor from the 
endosome to the TGN, where it can continue the transport of hydrolases [6, 7].
Recently, two crystal structures of mammalian Vps29 have been published [1, 2], which 
revealed that Vps29 contains a metallo-phosphoesterase fold. Metallo-phosphoesterases 
are enzymes involved in the hydrolysis of phosphate esters [29] that contain two metal ions 
in their active site. In this study we analyze the function of Vps29 in more detail. Here, we 
tested the hypothesis that hVps29 acts as a metallo-phosphoesterase for the CI-M6PR. We 
demonstrate that hVps29 is a zinc-binding protein that acts in vitro as a phosphatase on a 
synthetic phosphopeptide sequence, which is based on the serine phosphorylated C- 
terminus of the CI-M6PR.
Materials and Methods
Constructs
hVps29 catalytic site point mutants were constructed by PCR, using the pCIneo hVps29 
mammalian expression vector (kindly provided by C.R. Haft, National Institutes of Health, 
Bethesda, Maryland) as a template. For the hVps29 D8A mutation the following forward and 
reverse primers (5'-to-3') were used: CCACTTTGCCTTTCTCTCCA and GTTGCACCGGTGTGG- 
GATGTGCAGAGCTCCTAATACCAA. The PCR product was sub-cloned using EcoRI and AgeI 
sites. For all other mutations a two-step PCR strategy was used with the following forward 
and reverse primers: CCACTTTGCCTTTCTCTCCA and ACTGCATTCTAGTTGTGGTT and in 
addition, for hVps29 R14(K/Q) CTGCACATCCCACAC(A/C)AGTGCAACAGTTTGCCA and 
TGGCAAACTGTTGCACT(T/G)GTGTGGGATGTGCAG; for hVps29 N39(A/N) ATTCTCTGCACAGG- 
AG(C/A)TCTTTGCACCAAAGAG and CTCTTTGGTGCAAAGA(G/T )CTCCTGTGCAGAGAAT; for 
hVps29 D62(A/N) CATATTGTGAGAGG(CGC/AAA)CTTCGATGAGAATCTG and CAGATTCTCATC- 
GAAG(GCG/CGC)CCTCTCACAATATG; for hVps29 H86A AAAATTGGTCTGATCGCTGGACATCAA- 
GTTAT and ATAACTTGATGTCCAGCCATCAGACCAATTTT; for hVps29 H88F GGTCTGATCCATG- 
GATTTCAAGTTATTCCATGG and CCATGGAATAACTTGAAATCCATGGATCAGACC; for hVps29 
H117A ATCTCGGGACACACAGCCAAATTTGAAGCATT and AATGCTTCAAATTTGGCTGTGTGTCC- 
CGAGAT; for hVps29 N140A GCCACTGGGGCATATGCAGCCTTGGAAACAAAC and GTTTGTTTC-
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CAAGGCTGCATATGCCCCAGTGGC. PCR products were sub-cloned using EcoRI and NotI sites. 
All mutations were verified by sequencing.
YFP and GST-fusion constructs of the retromer subunits were constructed using the 
pEYFP-C1 vector (Clontech) or pGEX4T1/3 vector (Amersham Biosciences). For hVps26, the 
N-terminal Myc-tag in the pCIneo Myc hVps26 expression construct was replaced by a 
unique EcoRI cloning site followed by an initiation codon, and the C-terminal EcoRI site was 
replaced by a unique NotI restriction site. For hVps29, a unique EcoRI cloning site was 
introduced at the 5'end of the pCIneo hVps29 Myc cDNA, while the C-terminal Myc-tag was 
replaced by a stop codon and a unique NotI cloning site. The hVps26 and hVps29 cDNAs 
were cloned in frame into pEYFP-C1 and pGEX4T3 using EcoRI and NotI/Bsp120I enzymes. 
For hVps35, the Myc-tag was removed from the pCIneo Myc hVps35 construct and the 
hVps35 cDNA was cloned in frame into the pEYFP-C1 and pGEX4T1 vector using XhoI and 
NotI/Bsp120I enzymes.
MycHis fusion constructs of hVps26, hVps29 and hVps35 were constructed by 
introducing a KpnI restriction site before the GST cDNA of the pGEX vectors and replacing 
the GST coding sequence by a myc-His coding sequence using linked primers.
Production of GST-Fusion Proteins
GST-fusion proteins were produced in the Escherichia coli XL-2 blue strain containing the 
appropriate pGEX plasmid. Cultures (0.5-5.0 L) were grown to log phase (OD600 of 0.6-0.8) 
and protein expression was induced by addition of isopropyl-1-thio-ß-D-galactopyranoside 
(Invitrogen) to 0.1 mM final concentration. After 1-3 hour of induction, cells were harvested, 
rinsed with Tris-buffered saline (TBS) pH 7.4, and resuspended in TBS containing 1% Triton X- 
100, 100 ng/ml lysozyme and 10 ng/ml each of leupeptin, pepstatin, and aprotonin. The 
suspension was frozen at -20 °C for at least 16 hours and subsequently thawed at 42 °C 
followed by sonication. Lysates were cleared by centrifugation for 15 min at 12,000 x g and 
then incubated with 0.5-3 ml of a 50% slurry of glutathione-Sepharose beads (Sigma) for 2­
4 hours at 4 °C with rotation. The glutathione-Sepharose beads were washed four times with 
TBS pH 7.4.
Production of mycHis Fusion Proteins
MycHis fusion proteins were produced in the Escherichia coli XL-2 blue strain containing the 
appropriate mycHis plasmid. Cultures of 200 ml were grown to log phase (OD600 of 0.6-0.8) 
and protein expression was induced by addition of isopropyl-1-thio-ß-D-galactopyranoside 
(Invitrogen) to 0.1 mM final concentration. After 4-5 hours of induction, cells were frozen at
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-20 °C for 16 hours. Cells were thawed on ice and resuspended in 4 ml lysisbuffer (10 mM 
imidazole, 150 mM NaCl, 50 mM Tris-Cl, pH 8.0) and lysozyme was added to a final 
concentration of 1 mM. The lysates were sonicated and cleared by centrifugation for 15 min 
at 12,000 x g. Cleared lysates were incubated with 1 ml Ni-NTA beads (Qiagen) for 2-3 hours 
at 4 °C with rotation. The Ni-NTA beads were washed three times (10 mM imidazole, 300 
mM NaCl, 50 mM Tris-Cl, pH 8.0) and subsequently eluted with elutionbuffer (250 mM 
imidazole, 300 mM NaCl, 50 mM Tris-Cl, pH 8.0) and dialysed against H2O.
Pull Down Assays
NIH3T3 cells were cultured on dishes coated with 0.1% gelatin and grown at 37 °C in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% newborn calf serum. 
pEYFP-C1 vector, Vps26-, Vps29- and Vps35- YFP-fusion constructs were transiently 
transfected into NIH3T3 cells using lipofectamin (Invitrogen) according to the 
manufacturer's instructions. After 22-24 hours of transfection, the cells were lysed in lysis 
buffer (150 mM NaCl, 25 mM Tris pH 7.5, 5 mM EDTA pH 8.0, 1 mM Na3VO4, 1 mM NaF, 1 
mM phenylmethylsulfonyl fluoride, 1 ng/ml leupeptin, 1 ng/ml aprotinin, 1 ng/ml pepstatin) 
and the lysates were transferred to Eppendorf tubes and centrifuged for 10 min at 4 °C at 
13,000 x g in an Eppendorf centrifuge to remove nuclei and cell debris. The cleared lysates 
were added to purified GST-fusion proteins of hVps26, hVps29, hVps35 or to GST alone that 
were bound to GSH agarose beads and incubated for at least 2 hours at 4 °C. Unbound 
proteins were then removed by washing two times with lysis buffer and once with 
phosphate-buffered saline.
In case of the pull down experiments with the mycHis fusion proteins, mycHis-tagged 
hVps29 and hVps35 were purified on Ni-NTA beads, eluted and incubated for at least 2 
hours at 4 °C in the presence of hVps26-GST immobilized on GSH agarose beads. Unbound 
proteins were then removed by washing three times with TBS. Samples were then subjected 
to in vitro phosphatase assays or Western blot analysis.
For Western blot analysis, the nitrocellulose membranes were blocked with 5% bovine 
serum albumin, incubated with a-GFP antibody or a-c-myc(9E10) antibody (Santa Cruz), 
incubated with appropriate peroxidase-linked secondary antibodies and the 
immunocomplexes were visualized with enhanced chemiluminescence.
In Vitro Phosphatase Assays
For in vitro phosphatase assays on GST-fusion proteins alone, GST-fusion proteins were 
separated from their GST tags by incubating the proteins with 10 units of thrombin
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(Amersham Biosciences) in TBS pH 7.4 in a total volume of 100 ^l for at least 16 hours. To 
each sample, 55 ^g (1.1 mg/ml) serine phosphorylated peptide SFHDDpSDEDLLHI (>95% 
purity, Sigma Genosys) and 100 .^l Ser/Thr Assay Buffer (50 mM Tris-Cl pH 7.0, 100 ^M 
CaCl2) (Upstate) were added. The proteins were incubated with the phosphopeptide at 37 °C 
for 30 min or 16 hours. From each sample 35 .^l were added to 100 ^l Biomol Green 
(Biomol) in a 96-wells dish (Nunc). To analyze the amount of free phosphate, OD630 nm was 
measured with a Wallac Multilabel counter 1420.
In case of the metal ion chelator experiment, GST-fusion proteins were incubated with 5 
mM EDTA, EGTA or TPEN (N,N,N9,N9-tetrakis(-2-pyridylmethyl-)ethylene-diamine) 
(Molecular Probes) for 15 min and washed 3 times with TBS prior to thrombin cleavage. For 
the experiments in the presence of zinc and for the experiments using mycHis constructs, 
ZnCl2 was added to the Ser/Thr Assay Buffer at a final concentration of 1 mM.
The volume of the remaining supernatant of the samples was reduced by means of a 
speed vac concentrator, subjected to SDS-PAGE and proteins were visualized using 
Coomassie blue staining according to standard procedures.
Inductively Coupled Plasma Mass Spectrometry
GST alone and hVps29 GST-fusion proteins were eluted from glutathione-Sepharose beads 
by incubation with 5 mM reduced glutathione in 50 mM Tris-Cl pH 8.0. The amount of 
protein in the supernatant was measured using Bio-Rad Protein Assay Dye Reagent 
Concentrate (Biorad). A small amount of the samples was subjected to SDS-PAGE and 
proteins were visualized using Coomassie blue staining to confirm expression of the protein. 
In order to perform accurate measurements, mg quantities of protein should be analyzed. 
Series of equal amounts of GST alone and hVps29-GST molecules were prepared by dilution 
with 5 mM reduced glutathione in 50 mM Tris-Cl pH 8.0. HNO3 was added to a final 
concentration of 2 M to destroy the proteins. The final volume of the samples was 5 ml. 
Samples were centrifuged for 30 min at 5,000 x g and the supernatant was analyzed by ICP- 
MS (X Series ICP-MS) (Thermo Electron Corporation) controlled with PlasmaLab software 
v.2.3.0 according to manufacturer's instructions. The measured amount of Mg, Ca, Cr, Fe, 
Mn, Ni, Co, Cu and Zn metal ions in the samples was quantified in parts per billion (ppb) 
using dilution series of CentiPur standard solutions (Merck). The number of measured metal 
molecules was determined using atomic mass numbers (zinc: 65.37 g.mol-1) and a ratio 
between protein molecules and metal molecules was calculated.
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Zinc-Binding Overlay Assay
Samples of GSH-agarose purified GST-fusion proteins of wild-type or mutant hVps29 or GST 
alone were split in two equal parts in order to correlate the level of 65ZnCl2 binding capacity 
to the amount of protein in the sample. Both parts were subjected to SDS-PAGE. The 
proteins on the polyacrylamide gels were either visualized using Coomassie Blue staining 
according to standard procedures or transferred onto nitrocellulose membranes. 
Membranes were incubated three times for 20 min in renaturing-buffer (100 mM Tris/HCl 
pH 6.8; 50 mM NaCl, 10 mM dithiothreitol (DTT)) and subsequently incubated for 1 hour in 
labelling-buffer (100 mM Tris/HCl pH 6.8; 50 mM NaCl, flushed with N2). Membranes were 
probed for 30 min with 80 ^Ci 65ZnCl2 (Perkin Elmer) in 20 ml labelling buffer and washed 
five times with wash-buffer (100 mM Tris/HCl pH 6.8; 50 mM NaCl, 1 mM DTT) for a total of 
1 hour [30]. Nitrocellulose membranes were exposed to XAR films (Kodak) with an 
intensifying screen at -80 °C. Calculations of the ratio between the amount of protein, 
detected by Coomassie staining, and the amount of 65Zn bound to the protein, detected by 
fluorography, were carried out using the 'volume report' function of the BioRad Quantity 
One version 4.2.2 program (BioRad), which accompanies the BioRad Gel Doc 2000 apparatus 
(BioRad).
Molecular Modelling
Molecular modelling of the hVps29 active site was done with YASARA (www.yasara.org) 
starting from the crystal structure with two bound Mn2+ ions (PDB entry 1Z2W, [2]). The 
highly similar structure of the human Ser/Thr protein phosphatase 5 [31] containing two 
Mn2+ ions plus a bound phosphate was structurally aligned using the SHEBA plugin [32], and 
subsequently the phosphate coordinates were transferred to Vps29. The Mn2+ ions were 
replaced by Zn2+ ions to match our experimental findings. The phosphate was modelled as a 
mono-anion with one hydrogen on O4 (the leaving group) and one on O2, stabilized by the 
interaction with Asp62. The bridging water molecule was turned into a hydroxide ion. Finally 
the protein side chains were energy minimized with the Yamber2 force field to 
accommodate the changes [33].
pKa Calculations
pKa calculations were carried out using the WHAT IF pKa (WIpKa) calculation package as 
described earlier [34] with the modification that the protein was described by a single 
dielectric constant of 8. WIpKa relies on DelPhi II [35] to solve the linear form of the Poisson- 
Boltzmann equation (PBE). The remaining PBE parameters were set as follows: probe radius
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1.4 Á; solvent dielectric: 80; final grid resolution 0.25 Á/grd point. Charges and radii were 
assigned using the OPLS force field [36].
Results
Retromer Complex Performs Phosphoesterase Activity on a CI-M6PR Based Substrate
Vesicular transport between various membrane-enclosed compartments is a fundamental 
characteristic of all eukaryotes. Most proteins involved in fundamental vesicular trafficking 
processes are evolutionary conserved. Indeed, phylogenetic analysis (Supplementary Figures
S1 and S2) demonstrates that Vps29 is found in nearly all eukaryotes, including higher 
eukaryotes (metazoans, plants, fungi) as well as protozoan groups such as diplomonadida, 
apicomplexa, entamoebidae and kinetoplastidae. Interestingly, BLAST searches also reveal 
similarity of eukaryote Vps29 proteins to hypothetical archaeal proteins with (putative) 
phosphoesterase activity (e.g. MJ0936), even though archaea do not contain organelles. 
Vps29 shows extremely high sequence conservation among vertebrates; only 14 out of the 
182 amino acids show sequence variations, most of which are conservative substitutions 
(Supplementary Figure S3).
Recent crystallographic studies demonstrate that Vps29 belongs to the PPP family of 
calcineurin-like metallo-phosphatases, although Vps29 enzymatic activity has yet to be 
established [1, 2]. This family is not only found in eukaryotes, but also in archaea and 
prokaryotes [37]. The crystal structures of members of this family are characterized by a 
double ß-sandwich, surrounded by a-helices (reviewed by [38]). Metallo-phosphoesterases 
contain two metal ions in their catalytic site, which stabilize a highly reactive hydroxyl ion at 
physiological pH that is in position for nucleophilic attack of the phosphoester bond. The 
positively charged metal ions can also serve as an electrophilic catalyst and stabilize 
developing negative charge(s) of the metal-PO4 transition state. The oxy-anion of the 
substrate leaving group is usually protonated by a catalytic histidine that forms a catalytic 
dyad with a neighbouring aspartic acid, which provides the histidine with acidic properties. 
Efficient regeneration of catalytic hydroxyl ions is required for the active status of the 
enzyme, which has been proposed to occur through a network of hydrogen bonded water 
molecules in the active site, leading to protonation of a surrounding basic histidine residue 
and release of the proton into bulk solvent [29].
The metal coordinating and catalytically important residues, mostly aspartates and 
histidines, are conserved among metallo-phosphoesterase family members and are located 
within five conserved motifs (I through V) (Supplementary Figure S3) in loops connecting the
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core a and ß secondary structure elements, i.e. DXH(X)~25 GDXXD(X)~25 GNH[D/E] (motifs I to 
III [39, 40]) and GH(X)~50 GHX[H/X] (motifs IV to V [41]). The corresponding motifs of hVps29 
start with Asp8, Gly38, Gly61, Gly87 and Gly114, respectively (Supplementary Figure S3). 
Interestingly, hVps29 shows three unique features that distinguish hVps29 from other 
metallo-phosphoesterases with a known crystal structure (Supplementary Figure S3). First, 
an aspartic acid is normally found on the position of Asn39 (motif II). Second, an asparagine 
is normally found on the position of Asp62 (motif III). Third, the catalytic histidine (motif III), 
which serves as a proton donor for the leaving group, is replaced by Phe63.
In order to determine whether the retromer complex contains phosphatase activity, we 
first assessed whether the retromer subunits interact using in vitro affinity precipitations 
(Figure 1A). Mammalian expressed YFP-fusion proteins (Figure 1B) were incubated with GST- 
fusion proteins of hVps26, hVps29 and hVps35 (Figure 1C). As seen in Figure 1A, hVps26-GST 
and hVps35-GST interact with Vps29-YFP but not with YFP alone. Vice versa, hVps29-GST 
interacts with hVps26-YFP as well as with hVps35-YFP and not with YFP alone. Thus, these 
findings are consistent with earlier reports [2] that interaction between retromer subunits 
can be demonstrated by in vitro affinity precipitation.
Figure 1 Interaction of hVps29 with hVps26 and hVps35 in vitro. (A) GST-fusion proteins
were used as an affinity matrix for hVps26-, hVps29- and hVps35- YFP-fusion proteins present in the 
lysates of transiently transfected NIH3T3 cells. Affinity precipitated proteins were visualised by 
Western blotting with anti-GFP antibodies. (v: vector; 26: Vps26; 29: Vps29 and 35: Vps35) (B) 
Western blot of whole cell lysate samples of NIH3T3 cells transfected with vector encoding the YFP- 
fusion constructs, detected with anti-GFP antibodies. (C) Coomassie staining of the GST-fusion 
constructs used for the pull down assay.
To determine whether hVps29 is an active metallo-phosphoesterase, we assayed 
recombinant hVps29 for in vitro phosphatase activity. GST-fusion proteins of hVps26, 
hVps29 and hVps35 were separately produced in E. coli and the respective recombinant 
proteins were separated from their GST tags using the thrombin cleavage site (Figure 2A).
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Given that (i) the mammalian retromer complex functions in the retrograde transport of 
cycling TGN proteins, (ii) retromer subunits colocalize with the CI-M6PR and that (iii) 
mammalian Vps35 directly interacts with the CI-M6PR in the prelysosomal compartment [6, 
7], we used the serine phosphorylated peptide SFHDDpSDEDLLHI, containing the acidic- 
cluster dileucine motif of the CI-M6PR C-terminal tail, as an in vitro phosphatase substrate. 
Recombinant hVps26, hVps29, hVps35 or a mixture of non-stoichiometric amounts of all 
three proteins was incubated with the phospho-peptide at 37 °C. The amount of free 
phosphate, which correlates with the phosphatase activity, was measured in each sample 
after 30 min and after 16 hours. Figure 2B shows that there was no dephosphorylation 
activity detectable after 30 min for the individual retromer proteins. Interestingly, only 
hVps29 showed phosphatase activity on its own after 16 hours of incubation. The detected 
amount of free phosphate was considerably higher than the amount of free phosphate 
measured in the vector control, or measured in hVps26 and hVps35. Importantly, when the 
three retromer subunits were added simultaneously to the phosphatase reaction, the 
phosphatase activity was already detectable after 30 min of incubation. Protein expression 
in the phosphatase reaction was confirmed by Coomassie brilliant blue staining of the 
remaining supernatant of the samples used in the assay (Figure 2C).
Figure 2 Phosphatase activity of hVps29 on a CI-M6PR phosphopeptide. (A) Coomassie blue
staining of recombinantly expressed GST-fusion proteins of vector (26 kDa), hVps26 (36 kDa), hVps29 
(20 kDa) and hVps35 (87 kDa) before and after thrombin cleavage. (B) Detected amounts of free
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phosphate in an in vitro phosphatase assay on the SFHDDpSDEDLLHI phosphopeptide using 
recombinantly expressed vector, hVps26, hVps29, hVps35 or a mixture of these three proteins. 
Levels of free phosphate were determined after 30 min and 16 hours of incubation. (C) Coomassie 
blue staining of the remaining supernatant of the protein samples used for the in vitro phosphatase 
assay.
To further confirm phosphatase activity of the retromer subunits as a complex, we used 
GST-Vps26 or GST alone coupled to GSH-agarose beads as an affinity matrix for recombinant 
mycHis-tagged Vps29 and Vps35 proteins that were purified by metal chelation affinity 
chromatography (MCAC) from bacterial lysates. Consistent with the results shown in Figure 
1, both mycHis-tagged Vps29 and Vps35 were detected by anti-Myc Western blotting in 
GST-Vps26 affinity precipitates (Figure 3A), indicating that retromer subunits were able to 
form a complex in vitro. To determine whether these complexes contained phosphatase 
activity, the GST-Vps26 affinity precipitates containing mycHis-tagged Vps29 and Vps35 
were used for an in vitro phosphatase assay using the serine phosphorylated 
SFHDDpSDEDLLHI peptide as a substrate (Figure 3B). Protein expression in the phosphatase 
assay was confirmed by Coomassie blue staining of the remaining supernatant of the 
samples used in the assay (Figure 3C). As shown in Figure 3B, affinity precipitates of GST- 
Vps26 but not GST alone contained phosphatase activity towards the CI-M6PR substrate 
peptide. The amount of phosphatase activity detected in the GST-Vps26 affinity precipitates 
was consistently much lower than observed when phosphatase activity was assayed on a 
mixture of GSH-agarose bound GST-Vps26, -Vps29 and -Vps35 protein following thrombin 
cleavage (3rd bar). It is likely that the reduced phosphatase activity detected in the GST- 
Vps26 affinity precipitates is due to the presence of reduced amounts of mycHis-tagged 
Vps29 and Vps35 proteins, since we were unable to detect mycHis-tagged Vps29 and Vps35 
in GST-Vps26 affinity precipitates by Coomassie blue staining (Figure 3C).
Collectively, the data shown in Figure 1-3 demonstrate that (i) Vps26, Vps29 and Vps35 
can co-precipitate in vitro, (ii) Vps29 alone but not Vps26 or Vps35 contains phosphatase 
activity, (iii) Vps29 phosphatase activity is greatly enhanced by the additional presence of 
Vps26 and Vps35 retromer subunits, and (iv) GST-Vps26 affinity matrices acquire 
phosphatase activity following affinity precipitation of - and complex formation with - 
mycHis-tagged Vps29 and Vps35 retromer subunits. We conclude that the retromer 
complex contains in vitro phosphatase activity towards the serine phosphorylated peptide 
SFHDDpSDEDLLHI, containing the acidic cluster dileucine motif of the CI-M6PR cytoplasmic 
tail.
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Figure 3 Phosphatase assay on affinity precipitated retromer complex. (A) Western blot
with anti-c-Myc antibody. Lane 1-3, expression of purified mycHis constructs following metal 
chelation affinity chromatography with Ni-NTA beads. Lane 4-5, hVps26-GST affinity precipitation 
following incubation with mycHis vector or with purified mycHis hVps29 and hVps35 proteins. (v: 
vector; 29: Vps29 and 35: Vps35) (B) Detected amounts of free phosphate in an in vitro phosphatase 
assay on the SFHDDpSDEDLLHI phosphopeptide using GST vector (bar 1), an affinity precipitation of 
Vps26-GST containing Vps29 and Vps35 mycHis fusion proteins (bar 2) or as a positive control, a 
mixture of hVps26, hVps29, hVps35 proteins (bar 3), as used in Figure 2. Levels of free phosphate 
were determined after 30 min of incubation. (C) Coomassie blue staining of the remaining 
supernatant of the protein samples used for the in vitro phosphatase assay.
Catalytic Site Mutations of hVps29 Inhibit its Phosphoesterase Activity
To analyze the phosphoesterase activity of hVps29 in more detail, we generated a model 
based on the published mVps29 structure [2] of the hVps29 catalytic site containing a 
binuclear Zn2+ centre (vide infra) and a bound phosphate (Figure 4). If the substrate 
phospho-peptide is bound, both metal ions are coordinated by six ligands; metal #1 is 
coordinated by Asp8, His10 (motif I), Asn39 (motif II), His117 (motif V), a bridging hydroxide­
ion (W1), and O1 of the bound phosphate, whereas metal #2 is coordinated by Asn39 (motif 
II), Asp62 (motif III), His86 (motif IV), His115 (motif V), W1 and O2 of the bound phosphate 
(Figure 4). In this model, the phosphate group is further positioned by the interaction of the 
absolutely conserved Arg14 with the leaving group oxygen (O4) of the phosphorylated 
peptide.
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Figure 4 Molecular model of the hVps29 active site. The catalytic site of hVps29 showing
two Zn2+ ions, the coordinating amino acid side chains and a bound phosphate. The hydroxide ion 
bridging the two metal ions is labelled 'W1' and hydrogen-bonded to the backbone oxygen of 
His115. Only polar hydrogens are shown. The serine residue of the substrate peptide has been 
omitted, but should be connected to the now protonated phosphate oxygen. Image was created 
with YASARA (www.yasara.org).
Catalytic Site Residues Involved in Metal-Binding
To study the role of these catalytic site residues in the phosphoesterase reaction, we 
constructed D8A, N39A, D62A, H86A and H117A mutants as well as a D8A/H86A double 
mutant of hVps29. GST alone or GST-fusion proteins of hVps26, hVps35, wild-type and 
mutant hVps29 were produced in E. coli and the respective recombinant proteins were 
separated from their GST tags using thrombin cleavage. Equal amounts of hVps26 and 
hVps35 proteins were added to samples containing GST alone, wild-type hVps29 or mutant 
hVps29. Bacterial expression of several catalytic site mutants was less efficient when 
compared to the wild-type hVps29 protein, as previously reported by Collins et al. [2]. To 
compare phosphatase activity of different amounts of mutant hVps29 protein with wild­
type hVps29 protein, we used a dilution series of the wild-type protein. Recombinant 
protein expression of each of the mutant constructs was within the range of the dilution 
series of the wild-type hVps29 protein (Figure 5B). At all concentrations tested, wild-type 
hVps29 displayed robust in vitro phosphatase activity towards the phosphorylated 
SFHDDpSDEDLLHI substrate after 30 min (Figure 5A).
Each of the catalytic site mutants showed greatly reduced phosphatase activity towards 
the CI-M6PR serine phosphorylated peptide (Figure 5A), demonstrating that phosphatase 
activity of the retromer complex can be blocked by introduction of mutations in the catalytic
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site of hVps29. These findings directly demonstrate that hVps29 is a phosphatase. Based on 
the crystal structure of other metallo-phosphatases, we conclude that mutations in Asp8, 
Asn39, Asp62, His86 and His117 disrupt binding of one of the metal ions to the catalytic site 
of hVps29, leading to ablation of enzymatic activity.
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Figure 5 Inhibition of the phosphatase activity of hVps29 by catalytic site mutants. (A)
Detected amounts of free phosphate in an in vitro phosphatase assay on the SFHDDpSDEDLLHI 
phosphopeptide using recombinantly expressed hVps26 and hVps35 in combination with vector, 
wild-type hVps29 in increasing concentrations or hVps29 mutants D8A, N39A, D62A, H86A, H117A or 
D8A/H86A. Levels of free phosphate were determined after 30 min of incubation. (B) Coomassie 
blue staining of the remaining supernatant of the protein samples used for the in vitro phosphatase 
assay.
Residues Surrounding the Metal-Binding Site
In addition to residues that directly interact with metal ions, several surrounding residues 
may also be involved in the enzymatic function of hVps29, including conserved residues 
such as Arg14, His86 and Asn140 (Supplementary Figure S3). The positively charged Arg14 
side chain is positioned above the metal-binding pocket (Figure 4), similarly to many other 
metal-binding phosphoesterases, and could potentially coordinate the negatively charged 
phosphate group of the substrate during the phosphoesterase reaction. Asn140 is also close 
to the active site, but located on the periphery of the hVps29 protein. Although not strictly 
conserved, Asn140 is invariably replaced in higher eukaryotes by residues capable of 
hydrogen bonding (His, Ser, Thr). As such it may interact with or stabilize binding of other 
retromer subunits or even the substrate peptide. His88 is also located on the outside of the 
catalytic site and is strictly conserved in metazoan and plant species, while being highly 
conserved in yeast and protozoan species. His88 has a calculated pKa value of 5.0 in the 
presence of a phosphate residue and a pKa value of 3.0 after its removal. His86 is localized 
between His88 and the catalytic site and therefore His88 is positioned on the periphery of 
the catalytic site and not likely to participate directly in the dephosphorylation reaction.
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In order to study the role of Arg14, His88 and Asn140 in the phosphoesterase activity of 
hVps29, we generated R14K, R14Q, H88F and N140A mutants of this protein which were 
subjected to phosphatase assays as described above for the catalytic site metal-binding 
residues. At all concentrations tested, wild-type hVps29 displayed robust in vitro 
phosphatase activity towards the phosphorylated SFHDDpSDEDLLHI substrate (Figure 6A).
The hVps29 R14K mutation showed greatly reduced phosphatase activity towards the CI- 
M6PR based serine-phosphorylated peptide, while the phosphatase activity of the R14Q 
mutant was only slightly decreased (Figure 6A). These findings are in contrast with 
modelling studies which suggest that Lys14 could reach the phosphate substrate equally 
well as Arg14, while Gln14 would not be able to coordinate the phosphate group. 
Introducing the H88F or N140A mutation in hVps29 resulted in a 40-50% reduction of the 
enzymatic activity of the retromer complex on the SFHDDpSDEDLLHI phosphorylated 
peptide (Figure 6A). Protein expression in the phosphatase reaction was confirmed by 
Coomassie Blue staining of the remaining supernatant of the samples used in the assay 
(Figure 6B).
These mutation studies indicate that Arg14, His88 and Asn140 contribute to the 
phosphoesterase activity of hVps29 towards the CI-M6PR based phosphopeptide. However, 
the observed inhibition is much less pronounced than the inhibition of the catalytic site 
metal-binding residues. Further studies are necessary to define the exact role of these 
residues in hVps29 enzymatic activity.
A B
Figure 6 Inhibition of the phosphatase activity of hVps29 by point mutants of conserved, 
catalytic site surrounding residues. (A) Detected amounts of free phosphate in an in vitro 
phosphatase assay on the SFHDDpSDEDLLHI phosphopeptide by recombinant hVps26 and hVps35 in 
combination with vector, wild-type hVps29 in increasing concentrations or hVps29 mutants R14K, 
R14Q, H88F and N140A. Levels of free phosphate were determined after 30 min of incubation. (B) 
Coomassie Blue staining of the remaining supernatant of the protein samples used for the in vitro 
phosphatase assay.
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Recombinant hVps29 is a Zinc-Binding Protein
The geometry of the catalytic site of hVps29 best resembles that of the Mn2+/Mn2+ binuclear 
metal centre of MRE11, a 3'-5' endonuclease from Pyrococcus furiosus (PDB entry 1II7) [42], 
so we hypothesized that Vps29 bound metal ions, possibly Mn2+, although other metal ions 
(Cr, Fe, Co, Ni, Cu, and Zn) are known to be present in the active site of metallo- 
phosphatases as well. To identify metal ions bound to native hVps29, we performed 
inductively coupled plasma mass spectrometry (ICP-MS) on the hVps29-GST fusion protein 
and on GST alone (see materials and methods). Figure 7A shows that the amount of zinc 
present in samples containing hVps29-GST was much higher than in the samples containing 
GST alone. This difference was not detected for Mn, Cr, Fe, Co, Ni or Cu (Table 1) or any 
other element (data not shown). The amount of zinc in samples containing hVps29-GST 
increased linearly with the amount of hVps29-GST analyzed (Figure 7B), correlating with a 
relatively constant calculated molar ratio between hVps29-GST and zinc of about 1:0.3. 
Although a molar ratio of 1:2 is expected, there may be an overestimation of the presence 
of hVps29-GST in the measured samples, due to the presence of a small amount of GST 
alone and other contaminating proteins (Figure 7C). Moreover, it is possible that a fraction 
of the hVps29-GST fusion proteins, produced in E. coli, has an incorrect folding or is not able 
to acquire zinc molecules co- or post-translationally. Nevertheless, we conclude that 
recombinant hVps29 is a zinc-binding phosphoesterase.
GST protein molecules x 1015
2.58 6.45 12.9 19.4
metal ions in ppb
Mg GST 0.757 0.058 0.436 0.681
Vps29 0.978 2.372 0.034 1.125
Ca GST 111.7 62.8 81.7 122.1
Vps29 116.2 217.4 51.1 77.5
Cr GST 0.337 0.212 0 0.549
Vps29 0 0.222 0 0.164
Fe GST 20.56 0 0 102.8
Vps29 0 0 0 0.9
Mn GST 0.212 0 0 1.268
Vps29 0 0 0 0.02
Ni GST 0.499 0.134 0 1.548
Vps29 0 0.183 0 0.002
Co GST 0.036 0.006 0.006 0.021
Vps29 0.006 0.013 0.025 0.036
Cu GST 0.515 0 0 0.346
Vps29 0.062 1.458 0.181 0.656
Zn GST 3.229 2.682 1.933 0.886
Vps29 25.08 52.58 84.08 135.3
Table 1 Detected amounts of metal ions in hVps29-GST by ICP-MS. Samples of
recombinantly expressed hVps29-GST fusion protein and GST alone with an increasing amount of
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molecules were analysed by ICP-MS. Depicted are the amounts in parts per billion (ppb) of those 
metal ions which were the best candidates for binding to hVps29-GST.
Figure 7 Detected amounts of zinc ions in hVps29-GST by ICP-MS. (A) Binding of zinc ions in
ppb to increasing amounts of recombinantly expressed hVps29-GST fusion protein or GST alone. (B) 
Linear increase of the amount of zinc by increasing amounts of recombinantly expressed hVps29- 
GST fusion protein corrected for binding to GST alone. The slope of the line indicates the molar ratio 
of hVps29-GST: zinc. (C) Coomassie blue staining of a small amount of the recombinantly expressed 
proteins used in the ICP-MS analysis. The protein amount was measured by photo-spectrometric 
analysis (data not shown), but also by comparison with BSA levels.
Impaired Zinc Binding for Catalytic Site Mutants of hVps29
In order to determine whether catalytic site mutations of metal binding residues affected 
the Zn-binding ability of GST-hVps29 fusion proteins, we also aimed to subject hVps29 
mutants to ICP-MS analysis. We focused on hVps29 D8A, N39A and D62N in order to 
observe differences in zinc-binding capacities of residues involved in the coordination of 
metal #1 (D8A), metal #2 (D62N) or in the coordination of both catalytic site metal ions 
(N39A). Unfortunately, the relatively poor expression levels of these proteins in E. coli 
prevented us from performing extensive ICP-MS analyses. To illustrate these impaired 
expression levels: 4 liter of bacteria culture were needed to produce approximately 200 |ag 
of protein in the case of both GST-hVps29 D8A and GST-hVps29 N39A, indicating that these
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proteins were expressed at a 20-fold lower level than wild-type hVps29 (Figure 8D). We 
were therefore unable to obtain the protein quantities needed for analysis of a series of 
protein molecules by ICP-MS and therefore we measured the zinc-binding capacity of these 
mutants only at a single protein level. In order to do so, the amount of zinc ions present in 
2.58 x 1015 wild-type GST-hVps29 molecules was corrected for the amount of zinc ions 
present in GST alone and compared to the zinc-binding capacity of a similar number of the 
D8A and N39A mutant molecules. As illustrated in Figure 8A, both hVps29 mutants were 
found to bind less zinc ions than the wild-type protein. The zinc-binding capacity was 
approximately 75% for GST-hVps29 D8A and 50% for GST-hVps29 N39A. Expression of GST- 
hVps29 D62N was relatively high (only six fold less than that of wild-type GST-hVps29), 
which allowed us to measure the zinc-binding capacity of this mutant at different protein 
amounts. As illustrated in Figure 8B, the zinc-binding capacity of the GST-hVps29 D62N, 
corrected for GST binding, was approximately 40% of wild-type. The amount of zinc in both 
the samples containing GST-hVps29 and the D62N mutant increased linearly with the 
amount of protein analyzed (Figure 8C), resulting in a relatively constant calculated molar 
ratio between GST-hVps29 and zinc of approx. 1:0.46 for the wild-type protein and 1:0.21 
for the D62N mutant. We therefore conclude that mutant D8A, N39A and D62N GST-hVps29 
proteins show impaired zinc binding, indicating that these residues are directly involved in 
zinc binding in the catalytic site of hVps29. These ICP-MS findings further support the 
hypothesis that the observed impairment of the catalytic function of these mutants is due to 
decreased zinc-binding capacity.
To further analyze the zinc-binding capacity of other hVps29 mutants that are proposed 
to bind zinc ions, we used a 65Zn-binding overlay assay. The metal-binding capacity of 
purified GST alone, GST-hVps29 wild-type and mutant proteins was assayed. The zinc- 
binding protein BSA (bovine serum albumin) was used as a positive control. The R14K and 
N140A mutants, which showed impaired phosphatase activity, were also included in the 
experiment, since Arg14 and Asn140 are not supposed to interfere with zinc binding. As 
illustrated in Figure 9A, not only GST-hVps29 was able to interact with the 65Zn ions, but also 
all tested GST-hVps29 mutants. However, our studies indicated that, GST alone also bound 
65Zn ions. When comparing the level of 65Zn-binding relative to the amount of GST-fusion 
protein (Figure 9B) and normalizing these values relative to the GST-hVps29 wild-type 
protein, we observed that 65Zn-binding was severely reduced or comparable to GST alone 
for catalytic site mutants that are predicted to coordinate the metal ions, i.e. D8A, N39A, 
D62A, H86A, H117A and D8A/H86A. On the other hand, the R14K and N140A mutants did 
not show reduced zinc binding, consistent with the argument that Arg14 and Asn140 are not
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involved in metal coordination (Figure 9C). Furthermore the N39A mutant shows reduced 
zinc-binding capacity, while that of N39D is intact, in agreement with their catalytic activity 
measured in the phosphatase assays showing impaired phosphatase activity for N39A and 
wild-type activity for N39D (Figure 11A). The impaired phosphatase activity of the 
N39D/D62N double mutant (Figure 11A) most likely results from a reduced zinc-binding 
capacity, as demonstrated in Figure 9C.
Figure 8 Impaired zinc binding of hVps29 catalytic site mutants detected by ICP-MS. (A)
Binding of zinc ions (in ppb) to recombinantly expressed GST-hVps29 wild-type, D8A and N39A 
mutants, corrected for binding to GST alone. (B) Binding of zinc ions (in ppb) to GST-hVps29 wild­
type and the D62N mutant corrected for binding to GST alone. (C) Linear increase in the amount of 
zinc by increasing amounts of GST-hVps29 wild-type or D62N mutant proteins, corrected for binding 
to GST alone. The slope of the lines indicates the molar ration of GST-hVps29:zinc. (D), (E) Coomassie 
Blue staining of a small amount of the recombinantly expressed GST-hVps29 proteins used in the 
ICP-MS analysis. The protein amount was measured by photospectrometric analysis (data not 
shown), but also by comparison with BSA levels.
As a final and alternative strategy, we also performed the zinc-binding assay on immuno- 
precipitated YFP-hVps29 wild-type and mutant proteins. Unfortunately the signal of 65Zn
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binding to the YFP-hVps29 proteins was disturbed by the high background signal as a result 
of zinc-binding to the antibody heavy chain (data not shown). Collectively, the ICP-MS and 
zinc overlay assays provide evidence that mutation of metal coordinating Asp8, Asn39, 
Asp62, His86 and His117 residues results in severely reduced zinc binding, whereas Arg14 
and Asn140, which are not directly involved in metal binding, retain wild-type zinc-binding 
capacity.
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Figure 9 Impa ired z inc b ind ing of hVps29 po int-mutants detected by 65Zn-b ind ing assays.
(A) Fluorography of 65Zn bound to GST-hVps29 wild-type or mutant proteins. The zinc-binding 
protein BSA (bovine serum albumin) was used as a positive control. (B) Coomassie Blue staining of 
the corresponding GST-hVps29 fusion proteins. (C) Calculated ratios between the amounts of 
detected 65Zn: amount of analysed GST-hVps29 fusion proteins.
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Inhibition of the Phosphatase Activity by Metal Ion Chelators
To investigate the role of the presence of metal ions in the catalytic site of hVps29 on its 
phosphoesterase activity, we performed phosphatase assays after treatment with several 
metal ion chelators. Treatment of the recombinantly expressed retromer proteins with 
nonspecific metal ion chelators such as EDTA or EGTA prior to thrombin cleavage, resulted 
in a 80% reduction of the enzymatic activity of the retromer complex on the 
SFHDDpSDEDLLHI phosphorylated peptide (Figure 10A). More interestingly, pre-treatment 
of the recombinantly expressed retromer proteins with the zinc-specific chelator TPEN 
(N,N,N9,N9-tetrakis(2-pyridylmethyl-)ethylenediamine) led to a reduction of the 
phosphatase activity by about 50% (Figure 10A). Re-addition of ZnCl2 restored the 
phosphatase activity of the TPEN treated samples to the level of untreated wild-type hVps29 
(Figure 10A). Addition of ZnCl2 without TPEN treatment did not increase the phosphatase 
activity of the retromer complex on the SFHDDpSDEDLLHI phosphorylated peptide. Protein 
expression in the phosphatase assay was confirmed by Coomassie blue staining of the 
remaining supernatant of the samples used in the assay (Figure 10B). We conclude that 
hVps29 contains zinc ions which are essential for phosphatase activity of the retromer 
complex.
A B
vector vvt EDTA EGTA TPEN TPEN+Zn Zn
Figure 10 Inhibition of the phosphatase activity of hVps29 by metal ion chelators. (A)
Detected amounts of free phosphate in an in vitro phosphatase assay on the SFHDDpSDEDLLHI 
phosphopeptide using recombinantly expressed hVps26 and hVps35 in combination with vector as a 
control or wild-type hVps29. Samples were treated with 5 mM of the indicated metal ion chelators 
prior to thrombin cleavage. When indicated, ZnCl2 was added to the reaction mixture to a final 
concentration of 1 mM. Levels of free phosphate were determined after 30 min of incubation. (B) 
Coomassie blue staining of the remaining supernatant of the protein samples used for the in vitro 
phosphatase assay.
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Functional Significance of the Asn39/Asp62 Switch in hVps29
As previously discussed, Vps29 is unique among PPP-type metallo-phosphatases because of 
the presence of Asn39 (instead of Asp), Asp62 (instead of Asn) and Phe63 (instead of a 
catalytic histidine). To determine the functional significance of the Asn39/Asp62 switch for 
hVps29 phosphatase activity, we introduced the N39D, D62N as well as a N39D/D62N 
double mutation into pGEX4T3-hVps29 and evaluated the phosphatase activity of these 
mutants. Recombinant protein expression of each of the mutant constructs was within the 
range of the dilution series of the wild-type hVps29 protein (Figure 11B). As expected, the 
N39D mutation had no effect on the phosphatase activity (Figure 11A). Interestingly 
however, the D62N mutation blocked hVps29 phosphatase activity, which was also seen for 
the N39D/D62N double mutant. These results indicate that hVps29 Asn39 can be replaced 
by an aspartic acid, because both side chains can contribute a metal bridging oxygen at this 
position. In contrast, Asp62 cannot be replaced by an asparagine, indicating that both 
oxygens in the carboxyl group are functionally important in hVps29. This is surprising, as the 
amino group of asparagine would be ideally suited to bind the phosphate O2 oxygen, an 
interaction found in all available X-ray structures of ligated metallo-phosphatases.
Figure 11 Effect of the Asn39/Asp62 pair on the phosphatase activity. (A) Detected amounts 
of free phosphate in an in vitro phosphatase assay on the SFHDDpSDEDLLHI phosphopeptide using 
recombinantly expressed hVps26 and hVps35 in combination with vector, wild-type hVps29 in 
increasing concentrations, hVps29 mutants N39A, N39D, D62A, D62N and N39D/D62N. Levels of free 
phosphate were determined after 30 min of incubation. (B) Coomassie blue staining of the 
remaining supernatant of the protein samples used for the in vitro phosphatase assay.
Since Vps29 lacks the catalytic histidine in motif III, we considered the possibility that 
Asp62 might help to replace it. To investigate whether Asp62 could take the role of the 
general acid and neutralize the oxy-anion of the leaving group, we performed pKa 
calculations for the active site residues and found that protonation of Asp62 is highly 
unlikely: due to the presence of the metal ions and the strong hydrogen bond between 
Asn39 and Asp62, the predicted pKa of Asp62 is below zero. The same is true for the
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histidines close by, which are all involved in metal binding. A more plausible explanation for 
the importance of Asp62 is depicted in Figure 4: Asp62 may help to stabilize a proton on the 
phosphate O2 atom by forming a hydrogen bond. In the trigonal bipyramidal transition state 
of the reaction [31], the proton could come sufficiently close to reach the leaving group 
directly, or alternatively jump via an associated water molecule. Another possible role of 
Asp62 might involve protein binding, and its importance is best illustrated by the 
conservation of a charged residue on this position among several plant and fungal species 
(Supplementary Figure S3). Although the complete function of hVps29 Asp62 remains 
unclear, its importance for the catalytic activity of hVps29 is clearly demonstrated.
Discussion
hVps29 Functions as a Phosphoesterase In Vitro
In this study we have characterized the function of the retromer component hVps29. 
Recently published crystal structures of Vps29 by Wang et al. [1] and Collins et al. [2] 
indicate that Vps29 contains a metallo-phosphoesterase fold, but these authors could not 
experimentally show its phosphoesterase activity. Here, we demonstrate in vitro 
phosphatase activity for the hVps29 containing retromer complex towards a serine 
phosphorylated peptide SFHDDpSDEDLLHI substrate, containing the acidic-cluster dileucine 
motif of the CI-M6PR tail. There was no phosphatase activity measured towards the 
threonine phosphorylated peptide KRpTIRR, which can be dephosphorylated by PP2A 
(protein phosphatase 2A), demonstrating substrate specificity for the hVps29 containing 
retromer complex (data not shown).
The discrepancy between the studies with respect to mammalian Vps29 phosphatase 
activity, may be explained by several differences in the experimental conditions. First, we 
observed that the phosphatase activity of hVps29 alone was only detectable after prolonged 
overnight incubation. Moreover, we demonstrated by affinity precipitations that hVps29 
interacts with the other retromer subunits, consistent with Collins et al. [2] , and that the 
addition of hVps26 and hVps35 to the reaction mixture greatly enhanced the phosphatase 
activity. These results indicate that the retromer complex functions as a holo-enzyme 
complex. Indeed, using hVps26-GST as a bait, we were able to affinity precipitate the 
hVps29 and hVps35 retromer subunits, which resulted in acquisition of phosphatase 
activity. The requirement for the other retromer subunits may be due to the involvement of 
Vps26 and/or Vps35 in (i) substrate recognition [6, 7, 9-11], (ii) contributions of active site 
residues (vide infra), and/or (iii) assembly, folding or stability of the active retromer complex
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[11, 21, 26]. Vps35p is very unstable when either Vps29 or Vps26 is mutated or deleted [11, 
21]. Moreover, anti-Vps26 siRNAs treatment of mammalian cell lines does not only lead to 
depletion of endogenous Vps26, but also to depletion of Vps29 and Vps35 [6, 7], indicating 
that all retromer subunits must be present to form a stable complex. Second, we avoided 
any influence of the GST protein on the assembly and activity of the retromer complex. We 
used recombinant proteins only (i) after the recombinant retromer protein was cleaved 
from the GST moiety by thrombin or (ii) after replacing the GST moiety by the smaller 
mycHis-tag.
Third, we demonstrated hVps29 phosphatase activity towards the serine 
phosphorylated peptide SFHDDpSDEDLLHI substrate. Collins et al. [2] could not detect 
phosphatase activity of hVps29 towards p-nitrophenylphosphate (pNPP)-based substrates 
and several soluble phosphatidylinositol phosphates.
hVps29 is a Zinc-Binding Protein
Apart from the Asn39/Asp62 switch, the catalytic site of hVps29 best resembles that of the 
MRE11 endonuclease which contains a binuclear Mn2+ centre [42]. Collins et al. [2] soaked 
mVps29 crystals in MnSO4 and observed that the mVps29 catalytic site can bind bivalent 
metal ions. However, these studies did not identify the metal ions bound to native Vps29 or 
the metal ions required for enzymatic activity. ICP-MS analysis revealed that native hVps29 
contains Zn2+. We demonstrated that zinc binding is involved in the enzymatic activity of 
hVps29 by performing phosphatase assays with the specific zinc metal chelator TPEN, which 
reduces the phosphatase activity. Moreover, we demonstrated that addition of ZnCl2 after 
TPEN treatment restores the phosphatase activity.
More than 300 enzymes, covering all six classes of enzymes, have been discovered which 
require zinc ions for their activity [43]. Moreover, zinc is the most common metal used in 
metallo-enzymes that catalyze hydrolysis or hydration reactions [29]. Importantly, other 
PPP-type phosphatases, including purple acid phosphatase (PDB entry 4KBP) [44], 
calcineurin (1AUI) [45] and 5'nucleotidase (1USH) [46] also contain Zn2+ ions in their catalytic 
site.
To directly determine whether mutation of zinc-coordinating catalytic site residues is 
associated with loss of zinc binding, we analysed mutant GST-hVps29 fusion proteins by 
both ICP-MS studies and zinc-binding overlay assays [30]. Results obtained by both 
techniques support the hypothesis that mutation of zinc-coordinating residues results in loss 
of zinc binding, indicating that the loss of enzymatic activity seen for these mutants is likely 
the consequence of impaired zinc-binding activity. We did note, however, that the reduction
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in zinc-binding capacity as detected by ICP-MS or zinc overlay assay does not always reflect 
the reduction in enzymatic activity as found in the in vitro phosphatase assay. We attribute 
these minor inconsistencies to difficulties in the expression of recombinant mutant hVps29 
proteins in E.coli, as well as to background zinc binding observed in the zinc overlay assay 
for GST alone.
Implications for the Catalytic Mechanism
Even though we were able to demonstrate phosphatase activity for the retromer complex, 
many questions regarding the enzymatic reaction remain. First, the identity of the 
nucleophile that attacks the phosphate is unclear. The active site of metallo- 
phosphoesterases contains water molecules, one of which is invariably involved in the 
coordination of both metal ions in a ^-hydroxo bridge (W1) (Figure 4). Frequently, a second 
water molecule (W2) is detected bound to metal #1. Which of these water molecules acts as 
the nucleophile during catalysis is a question of debate [47]. In general, the pKa of W1 is 
sufficiently low to be deprotonated and to become a hydroxide ion. Opposite of the leaving 
group, W1 is also in an ideal position for in-line attack of the phosphorus atom. However, as 
W1 binding to both metal ions reduces its nucleophilicity, it has been suggested that metal 
#1-bound W2 is the nucleophile that attacks the phospho-ester bond [41]. However, this 
mechanism was proposed for purple acid phosphatase coordinating two different metal 
ions, Zn2+ and Fe3+ [44]. Binding of trivalent Fe3+ to W2 can lower the pKa of W2 sufficiently 
such that W2 exists as a hydroxide ion at physiological pH. In contrast, bivalent Zn2+ ions 
cannot lower the pKa of terminally ligated water molecule sufficiently to create a hydroxide 
ion by itself at physiological pH [48]. In that case, a general base may be required to further 
lower the pKa of W2. Although we cannot exclude that W2 (if existing) is the nucleophilic 
hydroxide molecule, we favour the hypothesis that the hydroxide ion W1 is the one that is 
involved in the nucleophilic attack, as discussed in detail by Swingle et al. [31]. His88 may 
function in concert with His86 as a relay system to transport the proton, which results from 
the deprotonation of bridging hydroxide-ion (W1), away from the active site.
The second question that remains concerns the identity of the proton donor that protonates 
the oxy-anion of the leaving group. Unlike most other eukaryotic PPP-type metallo- 
phosphatases, Vps29 lacks a catalytic histidine in motif III. Building on their negative results 
with respect to Vps29 phosphatase activity, Collins et al. [2] suggested that another cofactor 
(such as Vps26 or Vps35) might contribute a catalytic histidine to the Vps29 active site. 
Based on current (draft) whole genome sequencing programs, both Vps26 and Vps35
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retromer proteins contain histidine residues that are nearly absolutely conserved among all 
eukaryotes and could be candidates for the delivery of the missing histidine (data not 
shown). However, the low but measurable in vitro phosphatase activity of hVps29 in the 
absence of hVps26 and hVps35 seems inconsistent with such a model. In addition, 
molecular modelling suggests that there is very little space to insert a histidine in the gap 
that is created by the outward movement of Phe63 that occurs upon metal binding (E. 
Krieger, data not shown). It should be noted that we cannot exclude the possibility that 
conformational changes occur in the Vps29 catalytic site upon assembly of the holo- 
retromer complex. Importantly, despite lacking a catalytic histidine in motif III, the archaeal 
protein MJ0936 is also an active metallo-phosphoesterase [49], indicating that a catalytic 
histidine is not absolutely required for phosphoesterase activity. Yet another possibility that 
needs to be considered is that there is no specific proton donor for the leaving group, and 
that the leaving group slowly retrieves a proton from bulk water. Finally, it is important to 
realise that the pKa calculations must be interpreted with caution: they were performed on 
hVps29 alone, in the presence of the binuclear Zn2+ centre and in the presence or absence 
of bound tri-anionic phosphate, even though it is clear that the enzymatic activity of hVps29 
is greatly enhanced when bound to hVps26 and hVps35. Given that mVps35 binds close to 
the mVps29 active site [2], it is conceivable that the immediate environment of the Vps29 
active site, i.e. the charge distribution and thus the predicted pKa values, is changed upon 
incorporation of Vps29 in the holo-retromer complex. Crystallization of the holo-retromer 
complex will probably be necessary to answer some of these questions.
A third question that remains concerns the evolutionary conservation of Vps29 enzymatic 
function. Although metal coordinating catalytic site residues of Vps29 are highly conserved 
in most metazoans, there are multiple substitutions in those residues among pseudo­
coelomate nematodes, various fungal and protozoan species (Supplementary Figure S3). It 
remains to be demonstrated whether the retromer complex displays phosphatase activity in 
yeast and other species or whether there may be functional differences in the retromer 
complex among species.
Trafficking of the CI-M6PR Depends on the Phosphorylation Status of the Receptor
We demonstrate that the retromer component hVps29 interacts with hVps26 and hVps35 
retromer subunits and functions in vitro as a phosphoesterase for a phosphopeptide based 
on the sequence of the CI-M6PR tail. A working model for the in vivo role of hVps29- 
mediated dephosphorylation of the acidic-cluster dileucine motif of the CI-M6PR is
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presented in Figure 12. After binding to mannose 6-phosphate-tagged lysosomal hydrolases 
in the TGN, the phosphorylation of Ser2492 within the acidic-cluster dileucine motif acts as 
a sorting signal for anterograde transport by binding to GGA1 and GGA3 [24]. The GGA 
proteins will transport the CI-M6PR via clathrin-coated vesicles to the endosome. In the 
endosome the CI-M6PR will dissociate from its ligand, which is subsequently transported to 
the lysosome. On the endosome, the CI-M6PR colocalizes with the retromer complex [6, 7]. 
It is tempting to speculate that after binding of mammalian Vps35 to the CI-M6PR in the 
endosome, Vps29 will dephosphorylate the receptor. Dephosphorylation of this trafficking 
motif might be the trigger for the CI-M6PR to recycle back to the TGN to carry out additional 
rounds of enzyme delivery. This model remains to be confirmed by in vivo data of 
dephosphorylation of the CI-M6PR by hVps29. In addition, the exact role of 
dephosphorylation of the CI-M6PR on the transport of the receptor remains to be 
investigated. Other proteins that have been implicated in endosome-to-Golgi retrieval of the 
cycling TGN proteins are TIP47 (tail-interacting protein of 47 kD) [51] and PACS-1 
(phosphofurin cluster sorting protein-1) [52]. However, neither of these proteins is 
evolutionary conserved among eukaryotes and therefore may not be fundamental for the 
eukaryote retrograde endosome-to-TGN vesicular transport pathway.
Figure 12 Model of phosphate dependent transport of the CI-M6PR. The CI-M6PR binds 
cathepsin D in the TGN. Binding of GGAs to the phosphorylated CI-M6PR causes the transport of the 
ligand-receptor complex to the endosome. In the endosome, the ligand dissociates from the 
receptor and after binding to Vps35, Vps29 is able to dephosphorylate the receptor. The retromer 
recycles the CI-M6PR to the TGN.
In addition, it is interesting to note that Vps29 may function as a phosphoesterase 
for other substrates as well. Mutational analysis of the serine phosphorylated peptide
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SFHDDpSDEDLLHI could reveal a minimal sequence motif required for Vps29 dependent 
dephosphorylation. In yeast, Vps35 does not only bind the Vps10p receptor but also A-ALP 
(alkaline phosphatase) [12, 53], so its cytosolic tail DPAP A (dipeptidyl aminopeptidase A) is 
also an interesting candidate for dephosphorylation by Vps29. Since mammalian Vps35 is 
known to interact with the CI-M6PR [6, 7, 10], it is tempting to speculate that Vps29 may be 
involved in dephosphorylation of other acidic-cluster dileucine motifs as well, many of which 
are regulated by serine phosphorylation like the CD-M6PR and furin [54, 55].
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Summary
The retromer complex is a heteromeric multi-subunit protein complex conserved from yeast 
to mammals, which is involved in retrograde transport of the mammalian cation­
independent mannose 6-phosphate receptor (CI-M6PR) from endosomes to the trans-Golgi 
network (TGN). This transport step appears to be a highly regulated and complex process. 
We used metabolic labelling procedures and performed mass spectrometry to investigate 
interactions of retromer components hVps26, hVps29 and hVps35 in HeLa cells. Metabolic 
labelling studies suggest that all three retromer proteins are able to interact with a protein 
of approximately 47 kDa. Mass spectrometry studies revealed a specific interaction of 
retromer components with a- and ß-tubulins in vivo. GST affinity precipitation experiments 
confirmed interaction of hVps35 and hVps26 with tubulins in vitro. Using GST-hVps35 
truncation constructs, we further localized the interaction of hVps35 with tubulins to the N- 
terminal 384 amino acids of hVps35. Finally, we demonstrate that microtubule-associated 
mammalian Hook proteins associate with retromer components in vitro. Based on these 
studies, we propose that the retromer complex acts as an adaptor between cargo proteins 
on tubulo-vesicular endosomal intermediates and microtubule tracks in order to facilitate 
their microtubule-dependent retrograde transport to the TGN.
Keywords: retromer, microtubule, Hook, endosome, sorting nexin
Introduction
One essential feature of eukaryotic cells is the presence of intracellular membrane-enclosed 
compartments (organelles). Interaction and transport between organelles is necessary for 
the targeting of proteins to the correct organelle for their function, modification, and/or 
destruction. The biosynthetic secretory pathway delivers newly synthesized proteins from 
the rough endoplasmic reticulum via the Golgi system to the plasma membrane, 
extracellular space, endosomal or lysosomal compartments. This anterograde traffic is 
counterbalanced by retrograde transport, by which endocytosed proteins are transported to 
the early endosome from where they can be (i) recycled to the plasma membrane, (ii) 
transported to late endosomes and subsequently targeted for degradation in the lysosome, 
or (iii) transported to the trans-Golgi network (TGN) (reviewed by [1, 2]).
Bidirectional transport between the TGN and endosomal compartments is critical for the 
proper targeting of newly synthesized lysosomal enzymes. These enzymes are modified in 
the cis-Golgi with the mannose-6-phosphate sorting signal, which is recognized in the TGN 
by the cation-independent mannose 6-phosphate receptor (CI-M6PR). The CI-M6PR
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contains endosomal trafficking signals in its cytoplasmic tail and is transported, together 
with its mannose-6-phosphate labelled cargo proteins, along the anterograde TGN-to- 
endosome pathway. Due to endosome acidification, lysosomal hydrolases are released into 
the endosomal lumen and subsequently transported to lysosomes. The CI-M6PR is recycled 
via the retrograde endosome-to-Golgi pathway to the TGN. The anterograde vesicular 
transport of the CI-M6PR from the TGN to the endosome is regulated by a family of clathrin 
coat adaptor proteins, GGA (Golgi-localized, y-ear-containing, ADP-ribosylation factor- 
binding proteins) proteins. The GGA proteins bind to an acidic-cluster dileucine sequence, 
DDSDEDLLHI, in the C-terminus of the CI-M6PR. Phosphorylation of the Ser2492 in this 
sequence is a trigger for anterograde transport of the CI-M6PR [3], probably by increasing 
the affinity of the CI-M6PR for binding to GGA1 and GGA3 proteins [4, 5]. Binding studies 
revealed a direct interaction between the hinge domains of the GGAs and the y-ear domain 
of AP-1, which interact to incorporate the CI-M6PR into clathrin-coated vesicles that are 
transported to the endosome [6].
Retrograde transport of the CI-M6PR from endosomes to the TGN is regulated by the 
sorting nexin/retromer complex which was first identified in Saccharomyces cerevisae 
where it consists of the products of five Vps (vacuolar sorting proteins) genes, namely 
Vps26, Vps29, Vps35, Vps5 and Vps17 [7-9]. The sorting nexin/retromer complex is 
conserved in mammals [10] and the mammalian retromer proteins are mainly located on 
tubulo-vesicular structures [11, 12]. Several lines of evidence demonstrate that it is involved 
in CI-M6PR endosomal transport. First, the mammalian retromer component hVps35 
interacts directly with the CI-M6PR in the pre-lysosomal compartment [11, 13]. Second, 
siRNA of several retromer components resulted in mislocalization of the CI-M6PR towards 
endosomes and the cell surface as well as increased lysosomal degradation of the CI-M6PR 
[11, 13]. Third, we demonstrated that the hVps29 subunit functions as a phosphoesterase 
for a CI-M6PR based substrate in vitro [14].
To identify novel in vivo interaction partners of the retromer complex, we used mass 
spectrometry analysis and metabolic labelling techniques. Metabolic labelling studies 
suggest that all three retromer proteins are able to interact with a protein of approximately 
47 kDa. Mass spectrometry studies which revealed a specific interaction of retromer 
subunits with tubulins. We also identified interactions of tubulins and microtubule- 
associated Hook proteins with retromer components in vitro. Our studies suggest a model in 
which the retromer complex functions as an adaptor between cargo proteins on tubulo- 
vesicular endosomal structures and microtubule tracks to facilitate the retrograde transport 
from endosomes to the TGN.
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Materials and Methods
Antibodies
Use was made of mouse monoclonal antibodies against c-myc (9E10; Santa Cruz), 
hemagglutinin protein (HA) (12CA5; Roche), and a-, ß- and y-tubulin (DM1A, TUB2.1, and 
GTU-88; Sigma-Aldrich), as well as rabbit polyclonal antibody against Green Fluorescent 
Protein (GFP) (Santa Cruz).
Recombinant Constructs
The pCINeo myc-hVps26, -hVps29-myc and -hVps35-myc expression vectors were kindly 
provided by Dr. C.R. Haft (National Institutes of Health, Bethesda, Maryland, USA). YFP- 
fusion constructs of Vps26 and Vps29 were described previously [14]. We removed the C- 
terminal myc-tag of pCINeo hVps35-myc using forward primer (5'-3') 5'-CCAGGTGGATTCC- 
ATAATGAATTTGG-3' and reverse primer 5'-CCGGGCCCGGGCGGCCGCTTAAAGGATGAG- 
ACCTTCATAAATTGGCCC-3' using PpuMI and NotI restriction sites and constructed the 
pEYFP-C1 hVps35 using the pEYFP-C1 vector XhoI and NotI/Bsp120I restriction sites. pCINeo 
HA-hVps35 was constructed by introducing an HA-tag and a XhoI restriction site into the 
pCINeo vector by introducing a linker consisting of the forward primer (5'-3') 5'- 
CTAGCATGGCCTACCCTTATGATGTGCCAGATTATGCCCTCGAGT-3' and reverse primer 5'- 
CTAGACTCGAGGGCATAATCTGGCACATCATAAGGGTAGGACATG -3' using NheI and XbaI 
restriction sites. We then removed the sequence of the C-terminal myc-tag from pCINeo 
hVps35-myc using forward primer 5'-CCAGGTGGATTCCATAATGAATTTG-3' and reverse 
primer 5'-CCGGGCCCGGGCGGCCGCTTAAAGGATGAGACCTTCATAAATTGGCCC-3', and 
constructed the pCINeo HA-hVps35 using XhoI and NotI restriction sites. hVps35 GST-fusion 
truncation constructs were made by PCR (PfuTurbo DNA polymerase, Stratagene), using the 
pGEX 4T/1 hVps35 construct as a template and primers containing appropriate restriction 
sites for subsequent cloning procedures. Primer sequences are available upon request. All 
constructs were verified by restriction digest and sequencing.
pOTB7-hHook1, pCMV-SPORT6-hHook2 and pCMV-SPORT6-hHook3 plasmids 
(Invitrogen) were used for the construction of C-terminally -MycHis-tagged fusion 
constructs of hHook1, hHook2 and hHook3 into pcDNA4/TO/MycHis/C. We first cloned the 
hHook1, hHook2 and hHook3 cDNA into pcDNA4/TO/MycHis/C by using the Acc65I-XhoI, 
EcoRI-XhoI and Acc65I-NotI fragments respectively. After transformation and clone 
selection, the different hHook isoforms were fused in frame with the C-terminal Myc-His tag 
of pcDNA4/TO/MycHis/C using PCR. Primer sequences are available upon request. 
Constructs were verified by restriction digest and sequencing.
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Cell Culture and cDNA Transfection
Human HeLa and HEK293 cells were maintained in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% (vol/vol) newborn calf serum (NCS), penicillin (100 U/ml) 
and streptomycin (100 ng/ml) at 37 °C in a humidified atmosphere at 5.0% CO2.
For cDNA transfections, cells were grown to 75-90% confluence on 60 or 100 mm 
(diameter) dishes coated with 0.1% gelatin and were transiently transfected with 6 or 20 |ag 
cDNA, respectively, using Lipofectamin-2000 (Invitrogen) according to the manufacturer's 
instruction.
Metabolic Labelling
After 22-24 hours of transfection, cells were washed twice with phosphate-buffered saline 
(PBS) and incubated with methionine/cysteine-free DMEM supplemented with 10% (vol/vol) 
NCS, for 15 min at 37°C. Cells were labelled with methionine/cysteine-free DMEM 
containing 1 mCi [35S] methionine/cysteine (PerkinElmer) for each 100 mm dish for 30 min 
at 37°C. Cells were washed twice with ice-cold PBS and then chased at 37°C for various 
periods of time in the presence of DMEM plus excess unlabelled methionine (10 mM) and 
cysteine (5 mM).
Immunoprecipitation
Cells were washed twice with ice-cold PBS and then lysed using 1 ml of lysis buffer 
containing 150 mM NaCl, 25 mM Tris pH 7.5, 5 mM EDTA pH 8.0, 1% Triton X-100, 1 mM 
Na3VO4, 1 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 1 ng/ml leupeptin, 1 ng/ml 
aprotonin and 1 ng/ml pepstatin. After 30 min of incubation at 4°C, the lysate was cleared 
by centrifugation for 10 min at 13,000 g. The supernatant was added to 50 |al of protein G- 
Sepharose (Amersham) coupled to appropriate antibodies and allowed to incubate 
overnight at 4 °C on a rotating wheel. Following immunoprecipitation, the beads were 
washed twice with lysis buffer and once with ice-cold PBS, and subsequently resuspended in 
Laemmli sample buffer and subjected to SDS-PAGE.
SDS-PAGE and Fluorography
Proteins were separated on SDS 8% or 11% polyacrylamide gel electrophoresis using a 
Hoefer SE 400 Sturdier vertical gel unit (Isogen). Gels were incubated in fixing solution 
containing isopropanol 25% (vol/vol) and acetic acid 10% (vol/vol) for 30 min and soaked in
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Amplify fluorographic reagent (Amersham). The gels were dried under vacuum at 70°C and 
exposed to an X-ray film at -80°C.
Pull Down Assays and Western Blot
Cleared lysates of HEK293 cells were incubated with purified GST proteins of hVps26, 
hVps29, hVps35 or to GST alone [14], immobilized on GSH agarose beads, for 2 hours at 4°C. 
Unbound proteins were then removed by washing twice with lysis buffer and once with PBS, 
and the beads were subsequently resuspended in Laemmli sample buffer. The pull-down 
samples were subjected to SDS-PAGE and proteins were subsequently transferred to 
nitrocellulose membranes. The membranes were blocked with 5% bovine serum albumin 
(Sigma), incubated with primary antibodies, followed by incubation with an appropriate 
peroxidase-linked secondary antibody and the proteins were then visualized with enhanced 
chemiluminescence.
FTMS Analysis
Immunoprecipitated myc-hVps26, hVps29-myc, HA-hVps35 or vector alone, were separated 
by 8% polyacrylamide SDS gel electrophoresis using a Hoefer SE 400 Sturdier vertical gel unit 
(Isogen). Next to each protein sample a Dual Colour prestained marker (Bio-Rad) was 
loaded. From each sample, proteins with sizes between 37 kDa and 75 kDa were excised and 
reduced in-gel by treatment with 10 mM dithiothreitol (Merck) and subsequently alkylated 
with 50 mM iodoacetamide (Sigma-Aldrich) before overnight in-gel digestion with trypsin 
(Sequencing grade modified, Promega Madison). Prior to nanoLC-MS/MS analysis, samples 
were purified and desalted using Stage tips [15]. One fourth of each sample was analyzed on 
an Agilent 1100 nano-HPLC system (Agilent) connected online to a linear quadrupole ion 
trap-Fourier transform mass spectrometer (LTQ FTMS, Thermo Electron). Peptides were 
loaded on a 15 cm 100 |am ID PicoTip (New Objective) column packed with 3 ^m Reprosil 
C18 beads (Dr. Maisch GmbH, Ammerbuch, Germany) and eluted with a gradient increasing 
from 3% solvent B (80% acetonitrile in buffer A (0.5% acetic acid)) to 10% solvent B in 5 min, 
10-30% solvent B in 55 min and 30-50% solvent B in 7 min. A flow of 600 nl/min during 
loading and 300 nl/min during elution was used. Peptides eluting from the column tip were 
electro-sprayed directly into the mass spectrometer with a spray voltage of 2.2 kV. Full-scan 
MS spectra of intact peptides (m/z 300-2000) were acquired in the Fourier transform ion 
cyclotron resonance (FT ICR) cell with a resolution of 100.000. Data-dependently, the four 
most abundant ions were sequentially isolated and fragmented in the linear ion trap by 
applying collision-induced dissociation. A dynamic exclusion of previously sequenced ions
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within 180 sec was applied. All unassigned charge states and singly charged ions were 
excluded from sequencing. RAW spectrum files were converted with the aid of DTA 
supercharge (http://msquant.sourceforge.net/) into a Mascot generic peak list. Peptides 
and proteins were identified using the Mascot (Matrix Science Inc.) algorithm to search a 
local version of the NCBI database (http://www.ncbi.nlm.nih.gov). The search algorithm was 
set to perform a tryptic peptide search allowing two miscleavages and searched for 
carbamido-methyl modifications on cysteine residues and possible oxidation of methionine 
and deamidation of glutamine and asparagine, with a mass accuracy of 20 ppm for the FTMS 
and 0.8 Da for the LTQ. First ranked peptides were parsed from Mascot database search 
html files with MSQuant (http://msquant.sourceforge.net/) to generate unique peptide lists. 
Proteins were identified when either two or more unique peptides with an average peptide 
score >30 were found or one peptide with a score over 50 and a delta score over 10 was 
found. Redundancy in identified protein sequences in the analyzed samples was removed by 
reassigning the validated peptides to uniform protein sequences.
Results
Retromer Components Interact with a 47-kDa Protein
To examine protein interactions for the retromer complex in vivo, we transiently transfected 
human HeLa cells with either vector control or vector encoding retromer components 
tagged with myc or YFP epitope tags. Since the expression of hVps35-myc was poor, we 
used instead an N-terminal HA epitope tagged hVps35 construct. Transfected cells were 
labelled with [35S] methionine/cysteine for 30 min. In order to discriminate between 
metabolically labelled proteins derived from the transfected retromer constructs and those 
derived from interacting proteins we analyzed metabolically labelled HeLa cells transfected 
with vector encoding retromer constructs containing the relatively small HA or myc epitope- 
tag as well as the 22 kDa YFP protein. The tagged retromer components were immuno- 
precipitated and the proteins were analyzed by SDS-PAGE and fluorography. As illustrated in 
Figure 1A, metabolic labelling of the 37 kDa Myc-tagged hVps26 transfected cells resulted in 
a specific protein band of about 40 kDa, while cells transfected with vector encoding YFP- 
hVps26 proteins revealed a specific protein band of about 60 kDa. Analysis of metabolic 
labelling of YFP-hVps29 resulted in a 37-40-42 kDa triplet, while hVps29-myc was relatively 
poorly expressed and resulted in a 20 kDa protein band (Figure 1A). Metabolic labelling of 
HA-hVps35 resulted in a protein band of about 85 kDa and YFP-hVps35, which was relatively 
poorly expressed, resulted in a band of 105 kDa (Figure 1B). These results therefore identify
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the metabolically labelled proteins derived from the transfected retromer constructs. 
Unfortunately, we did not identify proteins that specifically interact with one of the 
retromer proteins during the 30 min labelling period (Figure 1). We therefore performed 
pulse-chase experiments in which transfected cells, labelled with [35S] methionine/cysteine 
for 30 min are subsequently chased for various periods of time in medium containing an 
excess of unlabelled methionine and cysteine. We analyzed the metabolic labelling of the 
hVps26 on an 8% acryl-amide gel rather than an 11% acryl-amide gel as used for Figure 1. 
We observed that the protein band of 40 kDa originated from the myc-hVps26 construct in 
the previous experiment, is actual a dual band of two proteins of about 40 and 42 kDa 
(Figure 2), while the 60 kDa protein band originated from the YFP-hVps26 construct consists 
of three bands of about 57, 59 and 63 kDa (Figure 2). Moreover, we also detected a 47kDa 
protein band of a co-immunoprecipitating protein, which interacts with both myc-hVps26 
and YFP-hVps26, but not with the vector alone. In this experiment, the interaction between 
myc-hVps26 and this protein was already formed during the 30 minutes of labelling. This 
interaction may not have been visible in the experiment depicted in Figure 1 because of the 
use of an 11% acryl-amide gel in that experiment and the presence of background proteins 
bands around the size of 50 kDa. The chase time-points indicate that the interaction 
between myc-hVps26 and the 47 kDa protein is stable for at least 7 hours. The shift in the 47 
kDa band during time suggests that the interacting protein is post-translationally modified.
37
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Figure 1 Expression patterns of metabolic labelled epitope-tagged retromer proteins. HeLa
cells transfected with vector encoding YFP-, HA-, or myc-epitope tagged retromer proteins or vector 
alone (pCIneo) were labelled with [35S] methionine/cysteine for 30 min. Indicated proteins were
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immuno-precipitated against their epitope-tag, separated by SDS-PAGE, and subsequently analyzed 
by fluorography and X-ray exposure. A. Fluorograph of metabolically labelled HeLa cells transiently 
transfected with vector encoding YFP- and myc-tagged hVps26 and hVps29 proteins. B. Fluorograph 
of YFP- and HA-tagged hVps35 proteins in HeLa cells.
Figures 2-4 Metabolic pulse-chase labelling demonstrates interactions of retromer proteins
with a 47-kDa protein. HeLa cells transfected with vector encoding YFP-, HA-, or myc-epitope 
retromer proteins or vector alone were labelled with [35S] methionine/cysteine for 30 min and 
subsequently chased in medium containing an excess of unlabelled methionine and cysteine for the 
indicated time points. Indicated proteins were immuno-precipitated and separated by SDS-PAGE. 
Figure 2. Fluorograph of a pulse chase study of myc-hVps26 and YFP-hVps26. Expression of YFP- 
hVps26 and myc-hVps26 are marked with three and two arrows, respectively. The remaining arrow 
points at the interacting 47 kDa protein band. The nonspecific band around 75 kDa can be used as an 
indication for loading control. Figure 3. Fluorograph of a pulse chase study of hVps29-myc and YFP- 
hVps29. The upper arrow indicates the interacting 47 kDa band. Figure 4. Fluorograph of a pulse 
chase study of HA-hVps35. The lower arrow indicates the interacting 47 kDa band.
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As illustrated in Figure 3, pulse-chase metabolic labelling studies of hVps29 not only 
resulted in the faint 20 kDa protein band derived from the hVps29-myc construct (lane 2-7) 
and the 37-40-42 kDa triple band originated from YFP-hVps29, but again we detected a co- 
precipitating protein of about 47-kDa. This 47-kDa protein might be the same interacting 
protein as we observed for hVps26 and seems to interact with both the hVps29-myc and the 
YFP-hVps29 protein, but not with vector alone. The 47-kDa protein shows a molecular shift 
during the chase, suggesting that this protein is post-translationally modified, but in contrast 
to the experiments performed with hVps26 the interaction of the hVps29 constructs with 
this protein was formed after the 30 min pulse labelling of the cells with [35S] 
methionine/cysteine. The interaction of hVps29 with the 47-kDa band is stable for at least 7 
hours.
25­
20- t 
Figure 3 Fluorograph of a pulse chase study of hVps29-myc and YFP-hVps29.
As illustrated in Figure 4, analysis of cells transfected with vector encoding HA-hVps35 
proteins not only resulted in the protein band of 85 kDa, but also in a protein band of 47 
kDa. This protein displayed a molecular shift during time and did not co-precipitate with 
vector alone, but displayed a stable interaction with HA-hVps35 after the 30 min labelling 
period, which lasts for at least 7 hours. We also performed pulse-chase metabolic labelling
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studies for cells transfected with vector encoding YFP-hVps35 proteins, but were unable to 
obtain significant results due to the relative poor expression of this protein.
In conclusion, all three retromer components, hVps26, hVps29 and hVps35, were able to 
interact with a protein with a molecular mass of approximately 47 kDa. This interaction was 
already detected for hVps26 during labelling and for hVps29 and 35 during the first 30 min 
of chase. The interactions were stable for at least 7 hours. The molecular shift of the 47-kDa 
protein suggests that it might concern a protein that is post translationally modified.
Figure 4 Fluorograph of a pulse chase study of HA-hVps35.
Analysis of Retromer Interacting Proteins by FTMS
To identify in vivo interaction partners of the retromer complex, we performed FTMS 
analysis of immunoprecipitated myc- or HA-tagged retromer proteins from transiently 
transfected HeLa cells after separation of the protein samples by SDS-PAGE. We did not 
visualize the proteins in the acrylamide gel, since the heavy chain of the antibody used for 
immunoprecipitation disturbed the 50 kDa region on silver staining (data not shown). We
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focussed on the area between 37 and 75 kDa, as initial metabolic labelling studies suggested 
potential interaction partners in that region. The immunoprecipitated and gel-purified 
proteins were trypsinized into peptides and subsequently identified by FTMS. For each of 
the detected peptides the corresponding original protein is described in Table 1. Apart from 
cytoskeletal proteins and molecular chaperones, nearly all of the proteins identified by 
FTMS have a subcellular location or have functions that are difficult to reconcile with 
retrograde endosome-to-Golgi transport (Table 1 and Supplementary Table S1). Purification 
of these proteins is probably the result of nonspecific interaction with our protein of interest 
(e.g. after cell lysis). Importantly, tubulins were found to specifically associate with retromer 
components, but not with the vector control (Tables 1 and 2). The retromer components 
interact with both a- and ß-tubulins, which share 40% amino-acid sequence identity and 
form obligate heterodimers that are assembled into microtubules. In immunoprecipitated 
hVps35 samples, five different a-tubulin peptides were identified that are located along the 
entire coding sequence of a-tubulin (Figure 5A). In total, three different ß-tubulin peptides 
were identified in hVps29 and hVps35 samples (Tables 1-2 and Figure 5B). We conclude that 
mass spectrometry identified both a- and ß-tubulin as in vivo interaction partner for the 
mammalian retromer complex.
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Figure 5 Sequence coverage of tubulin peptides identified by FTMS after 
immunoprecipitation of retromer subunits. Human tubulin peptides measured by FTMS are 
highlighted in their amino acid sequences. A. Amino acid sequence of human a-tubulin. B. Amino 
acid sequence of human ß-tubulin. In bold face with gray background: peptide sequences measured 
in the HA-hVps35 sample; underlined: peptide sequences measured in the hVps29-myc sample.
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accession no. protein description kDa peptides/protein
Total v 26 29 35
g |21264428 human mitochondrial hsp70 75 51 11 5 14 21
g |1143492 Burkitt's lymphoma polypeptide-binding protein 73 41 6 2 9 24
g |123648 Heat shock cognate 71 kDa protein (HSP7C) 71 20 3 1 5 11
g |12653055 Actin, gamma 1 propeptide 42 16 3 1 5 7
g |425518 anti-colorectal carcinoma heavy chain 51 14 6 1 6 1
g |133250 52-kDa Ro/SSA antigen ribonucleoprotein 52 9 2 1 5 1
g |12803275 Heat shock 70kDa protein 1A 70 7 1 2 4
g |21752739 unnamed protein product 52 7 2 1 4
g |12653815 Tubulin, alpha 50 5 5
g |1090507 ATP Synthase alpha Subunit 60 4 1 3
g |12803087 Tubulin, beta 50 4 2 2
g |135191 tryptophanyl-tRNA synthetase 53 4 2 2
g |113576 Serum albumin precursor 69 3 3
g |1167843 alpha-enolase 47 3 3
g |121617 Granulins precursor (Proepithelin) 64 3 1 2
g |12803195 Galectin 3 binding protein 66 3 1 2
g |129383 Probable ATP-dependent RNA helicase DDX5 68 2 2
g |13097201 Heterogeneous nuclear ribonucleoprotein U, isoform b 89 2 2
g |185143 Ig H-chain (V region) 3 2 2
g |37777877 Ig H-chain variable region 17 2 1 1
g |12228916 unnamed protein product 37 1 1
g |124490 Interferon-induced protein with tetratricopeptide repeats 1 56 1 1
g |13623543 unnamed protein product 52 1 1
g |14043291 Pyruvate kinase 3, isoform 1 58 1 1
Table 1 FTMS results of retromer interacting proteins. Protein description of the peptides
measured by FTMS in the retromer samples. Immunoprecipitation samples of myc-hVps26, myc- 
hVps29, HA-hVps35 or vector alone were separated by SDS-PAGE and we analysed the 37-75 kDa 
region for the presence of interacting proteins by FTMS. For each of the detected peptides the 
corresponding original protein is described with its unique Genbank identifier number and the  
calculated molecular weight. Descriptions of the function and subcellular locations of these proteins 
are listed in the Supplementary Table S1. Intermediate filament proteins (keratins), well known 
contaminants during mass spectrometric analyses, were excluded from the list.
tubulin
subunit sample sequence
nr pept/ 
protein
sequence
coverage score
peptide 
delta score
MA
(ppm)
alpha Vps35 AVFVDLEPTVIDEVR 5 18% 97 70.7 1.7
alpha Vps35 LDHKFDLMYAK 5 18% 21 7.2 3.4
alpha Vps35 NLDIERPTYTNLNR 5 18% 53 39.8 0.76
alpha Vps35 TIGGGDDSFNTFFSETGAGK 5 18% 88 78.3 4.3
alpha Vps35 VGINYQPPTVVPGGDLAK 5 18% 54 45 3.4
beta Vps35 IMNTFSVVPSPK 2 7% 61 48.8 2.3
beta Vps35 MAVTFIGNSTAIQELFK 2 7% 36 28.8 1.3
beta Vps29 IMNTFSVVPSPK 2 5% 54 29.9 1.0
beta Vps29 IREEYPDR 2 5% 25 12.7 4.2
Table 2 Tubulin peptides identified by FTMS obtained from immunoprecipitates of
hVps29-myc or HA-hVps35 in HeLa cells. MA: absolute calibrated mass relative error.
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In Vitro Interaction of Retromer Proteins with Endogenous Tubulins
To confirm that tubulins interact with retromer components we performed in vitro pull­
down experiments. GST-fusion constructs of individual hVps26, hVps29, hVps35 retromer 
subunits or GST alone were incubated with HEK293 cell lysates and analysed by SDS-PAGE 
and Western blot. As illustrated in Figure 6, hVps35 displayed prominent and specific 
interaction with endogenous a- as well as ß-tubulin, consistent with the results from mass 
spectrometry. hVps26 also showed some interaction with a-tubulin, but we could not detect 
significant interaction of hVps26 with ß-tubulin. hVps29 did not show detectable interaction 
with either a- or ß-tubulin. For hVps26 and hVps35 a reproducibly enhanced interaction 
with Y-tubulin was detected, compared to the GST control. These results support our FTMS 
data indicating that retromer subunits interact with tubulins in vivo. Moreover, our results 
suggest that in particular hVps35 strongly interacts with tubulins, suggesting that hVps35 is 
the prime interaction partner.
To better define the region of hVps35 that is responsible for interaction with 
tubulins, we generated a number of C-terminal truncation mutants, as well as an N-terminal 
truncation mutant, of hVps35, which were used to affinity-precipitate endogenous tubulins 
from HEK293 cell lysates. As illustrated in Figure 7A, hVps35 wild-type, as well as hVps35 1­
384 and 1-480, efficiently bound to a-, ß- and Y-tubulin in vitro. On the other hand, the N- 
terminal hVps35 truncation mutant 476-796 did not show reproducibly enhanced 
interaction with tubulins compared to the GST control (Figure 7A and data not shown), 
indicating that interaction of hVps35 1-384 and 1-480 with tubulins is specific. These 
findings demonstrate that the tubulin interacting region of hVps35 is located within the first 
384 amino acids of hVps35. To further delineate this region, we also used hVps35 1-165, and 
hVps35 1-244 and hVps35 1-315. Although hVps35 1-315 retained some interaction with a- 
and Y-tubulin, association of the hVps35 1-165 and 1-244 constructs with a-, ß- and y- 
tubulins was markedly reduced (Figure 7A). Densitometric scanning analysis also revealed 
that the relative mean pixel value of the tubulin signals with respect to the amount of GST- 
fusion protein present in the sample was markedly decreased for the hVps35 1-315, 1-244 
and 1-165 constructs, when compared to the hVps35 wild-type and the 1-384 and 1-480 
constructs (Figure 7B). Overall, these findings demonstrate that the region of hVps35 that is 
responsible for interaction with microtubules is located within hVps35 amino acids 1-384, 
and that the hVps35 region 244-384 plays a particularly prominent role in this interaction.
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Figure 6 In vitro interaction of retromer proteins with tubulins. GST-fusion proteins of
hVps26, hVps29, hVps35 or GST alone were incubated with whole cell lysates of HEK293 cells. GSH 
agarose affinity precipitates were separated on SDS-PAGE and immunoblotted with antibodies 
against endogenous a-, ß-, or Y-tubulin or GST as indicated. Representative of three separate 
experiments.
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Figure 7 The N-terminal half of Vps35 is required for interaction with tubulins. A. GST-
fusion proteins hVps35 (deletion) constructs or GST alone were incubated with whole cell lysates of 
HEK293 cells. GSH agarose affinity precipitates were separated on SDS-PAGE and immunoblotted 
with antibodies against endogenous a-, ß-, or Y-tubulin or GST as indicated. Representative of three  
separate experiments. B. Densitometry scanning graph as determined by Adobe Photoshop 
(histogram command) representing relative mean pixel values of the tubulin:GST signal ratio 
(background corrected signal from the tubulin blot divided by the signal of the GST-fusion protein) 
(n=2) plotted as mean±standard error of the mean (SEM) and normalized against the Vps35 wild­
type protein.
Our findings that retromer components interact with the microtubule cytoskeleton is 
interesting in view of the recent identification of retromer proteins as interaction partners 
of the S. cerevisiae microtubule-binding protein Btn2, in yeast-two-hybrid studies [16]. 
Consequently, we asked whether retromer proteins could also interact with mammalian 
orthologues of Btn2. Blast searches of the NCBI database identified Drosophila and 
mammalian Hook and Hook Related Proteins (HkRP) as putative orthologues (data not 
shown). To investigate whether retromer proteins interact with the human Hook proteins, 
hHook1, hHook2 and hHook3, we performed in vitro pull down experiments. GST-fusion 
proteins of hVps26, hVps29, hVps35 and GST alone were incubated with whole cell lysates 
of HEK-293 cells that were transiently transfected with vector encoding hHook1-MycHis, 
hHook2-MycHis, hHook3-MycHis, SNX1-Myc or MycHis proteins. As the hVps35 N-terminal 
region has previously been demonstrated to interact with sorting nexin 1 (SNX1) [9, 17, 18], 
we also included SNX1-Myc as a positive control. As illustrated in Figure 8, hVps35 showed a 
specific interaction with all Hook isoforms as well as with SNX1 when compared with the 
GST background alone. hVps26 and hVps29 show significantly enhanced binding to Hook2 
compared to the GST control, but not with the other Hook isoforms. We therefore conclude 
that particularly the hVps35 retromer subunit shows strong interaction with human Hook 
microtubule-binding proteins in vitro. These findings support the model that the retromer 
complex acts as an adaptor between cargo proteins, such as the CI-M6PR, and microtubule
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tracks in order to facilitate tubulo-vesicular retrograde transport of cargo proteins from 
endosomes to the TGN.
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Figure 8 In vitro interaction of retromer proteins with Hook proteins. GST-fusion proteins of
hVps26, hVps29, hVps35 or GST alone were incubated with whole cell lysates of HEK293 cells 
transiently transfected with vector encoding MycHis-tagged hHook1, hHook2, hHook3 or SNX1 
proteins or vector alone. GSH agarose affinity precipitates were separated on SDS-PAGE and 
immunoblotted with antibodies against Myc or GST as indicated. Representative of two  
experiments.
Discussion
Here we describe metabolic labelling studies of epitope-tagged retromer subunits in order 
to identify retromer interacting proteins. Using metabolic labelling techniques, we have 
shown that all three retromer components, hVps26, hVps29 and hVps35, interact in vivo 
with an as yet unidentified 47 kDa protein. We and others have previously demonstrated 
interactions between the retromer subunits and between retromer subunits and sorting 
nexins [9, 10, 12, 14, 17-22]. Rojas et al. [12] recently demonstrated interactions between 
the sorting nexin/retromer components using an immunoprecipitation-recapture assay after 
metabolic labelling. Endogenous hVps26 was immunoprecipitated from metabolic labelled 
HeLa cells and hVps29 and hVps35, but not SNX1, were recaptured using antibodies raised
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against endogenous sorting nexin/retromer subunits. Their experimental conditions differ 
from ours in several aspects. Rojas et al. [12] labelled HeLa cells with 0.05 mCi [35S] 
methionine/cysteine for 6 hours and analyzed endogenous retromer proteins with the use 
of antibodies raised against endogenous retromer subunits in a recapture assay, while we 
labelled HeLa cells transfected with vector encoding epitope-tagged retromer proteins with 
1 mCi [35S] methionine/cysteine for 30 min and analyzed retromer proteins with antibodies 
directed against their epitope tags. As we did not identify additional retromer interacting 
proteins upon longer pulse labelling (up to 3 hours; data not shown), we think it is unlikely 
that interactions between retromer subunits were not identified because of short pulse 
labelling. Rather it seems more plausible that the use of antibodies against endogenous 
Vps26 might have been crucial for detection of interaction between retromer subunits using 
metabolic labelling techniques. Although epitope-tagged retromer proteins were 
demonstrated to be capable of binding to other endogenous or epitope-tagged retromer 
components in vivo [10-12, 20, 22, 23], there is no data available yet about the efficiency of 
incorporating epitope-tagged retromer components into the retromer complex. It is 
possible that the presence of an epitope-tag disfavors the protein for incorporation into the 
retromer complex. The availability of anti-Vps26 antibodies also allows highly specific 
immunoprecipitation-recapture assays to be performed [12].
Our metabolic labelling studies indicate that all retromer subunits co-immuno- 
precipitate with a protein of approximately 47 kDa. It should be noted, however, that we 
have no conclusive evidence that it is the same 47 kDa protein that co-precipitates with the 
different retromer subunits. We considered several candidate proteins as being the 47-kDa 
protein that interacts with the retromer components, including the CD-M6PR (47 kDa), 
TIP47 (47 kDa), the |j. subunit of the AP-1 complex (49 kDa) and SMAP2 (47 kDa). SMAP2 
(stromal membrane-associated protein) exhibits GAP activity, interacts with clathrin and it 
has been suggested that SMAP2 functions in the retrograde, early endosome-to-TGN 
pathway [24]. However none of these proteins was identified in the FTMS analysis. We also 
performed both in vivo and in vitro interaction studies for hVps26, hVps29 and hVps35 with 
the endogenous CD-M6PR and GFP-tagged CD-M6PR, but so far we have not yet been able 
to demonstrate an interaction for one of the retromer components with the CD-M6PR in 
vivo (data not shown).
Another interesting possibility is that the unidentified 47 kDa band represents 
tubulin proteins as we demonstrated that, in particular, hVps35 retromer subunits interact 
with tubulins and microtubule-binding Hook proteins in vitro and in vivo. Due to shifts in the 
molecular weight of the 47 kDa protein during chase incubation, we suggested that this
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protein is post-translationally modified. Interestingly, various posttranslational 
modifications of tubulins have been described, including (i) tyrosination, a unique post­
translational modification in which a tyrosine residue is reversibly added to the C-terminus 
of the a-tubulin subunit, (ii) acetylation of lysine side chains, (iii) serine phosphorylation, (iv) 
palmitoylation, (v) polyglycylation (addition of glycine residues) of glutamate side chains, 
and (vi) polyglutamylation (addition of glutamate residues) of glutamate side chains 
(reviewed by [25]). Some of these post-translational modifications only slightly affect the 
molecular mass of tubulin since tyrosination, acetylation or phosphorylation of a protein 
increases the protein mass with 181, 42, 80 Da, respectively. However, in the absence of 
other changes (e.g. conformational or charge effects), such small increases in the molecular 
mass are usually not sufficient to change the mobility of a protein on SDS-PAGE. However, 
polyglycylation and polyglutamylation can change the apparent mobility of tubulins 
significantly. In conclusion, additional experiments should be performed to identify this 
approximately 47 kDa protein including (i) metabolic labelling in combination with 
immunoprecipitation-recapture experiments with antibodies raised against potential 
candidate proteins, (ii) metabolic pulse chase experiments in cells with reduced expression 
(e.g. by RNAi) of candidate proteins or (iii) FTMS analysis of this specific metabolically 
labelled protein band.
Here, using mass spectrometry and GST affinity precipitation, we present evidence 
for interaction of retromer subunits with tubulins both in vitro and in vivo. The absence of 
co-immunoprecipitating retromer proteins in the FTMS analysis might be due to the fact 
that we restricted FTMS analysis to proteins of 37-75 kDa. This excludes the presence of 
hVps29 (22 kDa), hVps35 (85 kDa) and perhaps of hVps26 (37 kDa). This strategy also 
excluded mammalian Hook (~85 kDa) and HkRP proteins (>200 kDa) from the FTMS samples. 
However, we did expect to detect SNX1 (66 kDa) in FTMS samples (at least in the HA-hVps35 
sample), since the in vivo interaction of these proteins has been described before [23]. On 
the other hand, the steady state interaction between retromer subunits and SNX1 might 
have been too weak for detection by FTMS, or SNX1 peptides might have co-eluted with 
peptides from other proteins and might therefore not have been selected for sequencing 
[26].
We further demonstrate that, in particular, hVps35 shows prominent interactions 
with a-, ß- and, to a lesser extent, ytubulins in vitro (Figure 6). In addition, hVps26 also 
shows some interaction with ytubulins. The interaction between hVps35 and tubulins is 
mediated by the first 384 amino acids of hVps35 and requires at least the region between 
amino acids 244-384 (Figure 7). In contrast, hVps26 interacts with hVps35 amino acids 1-165
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and hVps29 interacts with hVps35 376-796. Whether hVps35-tubulin interaction is direct or 
indirect, is currently unknown. Indeed, we also demonstrated interactions between hVps35 
and Hook1, -2 and -3 proteins and between hVps26 and hVps29 and Hook2 proteins in vitro 
(Figure 8). Because Hook proteins are microtubule-binding proteins, Hook proteins could be 
responsible for the interaction between the retromer complex and tubulins.
Microtubules, cylinder-shaped polymers composed of heterodimers of a- and ß- 
tubulin, which are assembled with the aid of the ytubulin ring complex, are involved in 
many vesicular transport processes in the cell (reviewed by [27, 28]). Interestingly, Itin et al. 
[29] described a role for microtubules in the retrograde endosome-to-Golgi transport, and 
demonstrated that microtubules stimulate the initial rate of endosome-to-TGN transport. 
Indeed, the transport of CI-M6PR between TGN and endosomes might be mediated by 
tubular elements [30]. In addition, Shiga toxin normally requires microtubules and dynein 
for its retrograde transport from endosomes to the juxta-nuclear Golgi complex [31]. Also 
Rab9, which might play a role in CI-M6PR in association with TIP47, is present on endosomes 
that display bidirectional microtubule-dependent motility [32]. Furthermore, the small 
GTPase Rab6A', which interacts with dynein and dynactin, is involved in endosome-to-Golgi 
transport and regulates microtubule-dependent recycling at the TGN [33].
Accumulating evidence also points to a specific role of the sorting nexin/retromer 
complex in coupling to microtubule-dependent endosome-to-TGN transport. Kama et al. 
[16] described a direct interaction of Vps26p and Vps35 to Btn2p, which facilitates late 
endosome-to-Golgi retrieval of the Golgi-resident protein Yif1p in yeast. The mammalian 
Hook1 protein has a role in endocytic membrane trafficking in the late endosomes and 
interacts with endocytic Rab proteins [34]. The Hook-related protein1 (HkRP1) colocalizes 
with the retromer-associated protein SNX1 on tubular elements of early endosomes, while 
overexpression of the membrane associated C-terminus of HkRP1 resulted in a complete 
redistribution of SNX1 localization [35]. Moreover, Seaman [36] reported that SNX1-labelled 
tubules can be ablated in the presence of the microtubule-depolymerizing agent 
nocodazole. In addition, ectopic expression of YFP-hVps35 resulted in a punctate 
distribution of the protein in the cytosol. The YFP-hVps35 puncta often give rise to long 
fluorescent tubules, which could be prevented by nocodazole treatment, indicating that 
microtubules are required to stabilize these retromer-initiated tubules [11]. Vps26 has also 
been demonstrated to interact with EHD1 (Eps15 homology domain-containing protein-1), 
which is required to stabilize SNX1 tubules and facilitate endosome-to-Golgi transport [37, 
38].
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Collectively, these data support our findings of an interaction between the sorting 
nexin/retromer complex and microtubules, which might be accomplished by the Hook 
(related) proteins. Association of the sorting nexin/retromer complex with microtubules 
might be necessary for the formation and localization on endosome related tubules as we 
modelled in Figure 9. After binding to cargo proteins in the TGN, the CI-M6PR is transported 
to the endosome. In acidifying endosomes, the ligand dissociates from the receptor and 
after CI-M6PR binding to Vps35, Vps29 is able to dephosphorylate the receptor. The 
retromer complex interacts via Hook1 to microtubules and recycles the CI-M6PR to the TGN. 
Thus, the retromer complex might have a double function, i.e. i) to couple Vps29-dependent 
dephosphorylation of acidic dileucine motifs of cycling TGN cargo proteins, which prevents 
them from interacting with GGA proteins and ii) to facilitate microtubule-dependent 
endosome-to-TGN transport of cargo molecules through interaction with tubulin and/or 
tubulin-associated proteins such as Btn2p/Hook (related) proteins. This process might be 
further aided by the membrane curvature which is induced by the BAR domain of sorting 
nexins. Further studies are required to determine the functional significance of the 
interactions between the sorting nexin/retromer complex and microtubule (-associated) 
proteins.
Figure 9 Model of microtubule-dependent retrograde transport of the CI-M6PR. The CI-
M6PR binds cathepsin D in the TGN. Binding of GGA to the phosphorylated CI-M6PR causes the 
transport of the ligand-receptor complex to the endosome. In acidifying endosomes, the ligand 
dissociates from the receptor and after binding to Vps35, Vps29 is able to dephosphorylate the 
receptor. The retromer complex could then interact via Hook1 to microtubules to recycle the CI- 
M6PR back to the TGN.
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Summary
The retromer complex is involved in the retrograde transport of the cation-independent 
mannose 6-phosphate receptor (CI-M6PR). The mammalian retromer protein complex is 
formed by Vps26, Vps29 and Vps35 and interacts with SNX1 and probably other SNX 
proteins. The SNXs form a subcomplex involved in membrane binding, while Vps35 is 
involved in cargo binding. Vps29 may have enzymatic phosphoesterase activity on cycling 
TGN proteins, while the role of arrestin-like Vps26 in the retromer complex needs to be 
elucidated. In order to study the function of the individual retromer proteins in more detail 
and to identify their interaction domains, studies with epitope-tagged mutant versus wild­
type proteins are essential. Here, we present an overview of the expression of wild-type and 
mutant retromer proteins using a range of epitope-tags and heterologous expression 
systems. In mammalian cells, we observed the highest steady-state expression levels after 
transfection with genes for retromer proteins fused to an N-terminal YFP tag, in comparison 
with HA and myc epitope-tagged retromer proteins. The use of the bacterial E. coli host 
resulted in high expression levels for the retromer proteins, both with a GST tag and with a 
myc-His tag, but less degradation products were observed for the myc-His-tagged retromer 
proteins. Furthermore, we observed impaired expression for all hVps29 point mutants as 
demonstrated by dynamic expression techniques. These observations should be taken in 
account for further studies with mutant versus wild-type retromer proteins.
Introduction
The retromer complex consists of cytosolic proteins that mediate retrograde transport of 
cargo proteins from endosomes to the trans-Golgi network (TGN). In yeast, the retromer 
complex consists of three vacuolar sorting proteins (Vps): Vps26, Vps29 and Vps35 which 
interact with the Vps5/Vps17 subcomplex to form the sorting nexin/retromer complex. By 
means of Vps35 the complex binds to Vps10p, a type I transmembrane receptor which sorts 
newly synthesized carboxypeptidase Y (CPY) from the TGN to the pre-vacuole [1, 2]. In the 
acidic pre-vacuole, CPY dissociates from Vps10p and is transported to the vacuole, after 
which Vps10p subsequently binds to Vps35 and the retromer complex mediates the 
recycling of this receptor to the TGN [1, 3, 4].
Mammalian orthologues have been identified for all yeast sorting nexin/retromer 
proteins [5], with the exception of Vps17 [5-12]. The mammalian sorting nexin/retromer 
complex is formed by Vps26, Vps29, Vps35, SNX1 and probably other SNX proteins, and is 
involved in the retrograde transport of the cation-independent mannose 6-phosphate
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receptor (CI-M6PR) [13, 14]. The CI-M6PR performs a similar role as Vps10p by binding 
newly synthesized lysosomal hydrolases in the TGN that have been modified by the addition 
of the mannose 6-phosphate sorting signal in the cis-Golgi, and subsequently delivers these 
enzymes to the endosomes. The CI-M6PR and its ligand, e.g. cathepsin D, dissociate in the 
endosome and the hydrolases are further transported to the lysosomes. hVps35, the core 
protein of the retromer complex, binds directly to the cytoplasmic tail of the CI-M6PR in the 
endosome [13]. The retromer protein complex is subsequently involved in the retrograde 
transport of the receptor to the TGN, where the CI-M6PR starts additional rounds of enzyme 
delivery.
The direct interaction between hVps35 and CI-M6PR suggests that hVps35 is the cargo­
recognition subunit of the retromer complex. Recently, crystallographic studies have been 
performed to solve the function of the other retromer components Vps26 and Vps29. Shi et 
al. [15] demonstrated that hVps26 has an arrestin fold, while both Collins et al. [16] and 
Wang et al. [17] showed that mVps29 and hVps29 have a phosphoesterase fold, which is 
unique among other metallo-phosphoesterases [16, 17]. These structural data are in 
agreement with our observation that hVps29 acts in vitro as a phosphatase on a synthetic 
phosphopeptide sequence, which is based on the serine phosphorylated C-terminus of the 
CI-M6PR [18]. Phosphorylation of Ser2492 within this motif acts as a sorting signal for 
anterograde transport from the TGN to the endosome by binding to GGA1 (Golgi-associated 
Y-adaptin ear homology domain Arf-interacting protein) and GGA3 [19-22]. Therefore, we 
have proposed that dephosphorylation of this trafficking motif by hVps29 in the endosome 
might be the trigger for retrograde transport of the CI-M6PR to the TGN [18]. In order to 
test this model in intact cells, it is necessary to express recombinant Vps29 proteins carrying 
mutations in the catalytic site in mammalian cell lines.
Most research on the retromer complex carried out so far has been based on the use of 
antibodies against endogenous proteins [13-15, 23-25] or on deletion of retromer genes in 
yeast or addition of siRNAs to hVps26, hVps29 or hVps35 in mammalian cell lines, which has 
been shown to lead to decreased stability of the other retromer subunits as well [2, 11, 13, 
14, 25, 26]. Due to recent developments in retromer studies [15-18, 27] the focus is 
currently on (i) the role of Vps29 activity on cycling TGN proteins and the catalytic 
mechanism of hVps29, (ii) the role of arrestin-like hVps26 in the retromer complex, (iii) 
identification of interaction domains between the retromer subunits, and (iv) the function 
of the two Vps26 paralogues. In order to address these questions and to study the 
functional significance of specific domains and individual amino acids in retromer 
components, it is essential to express the various retromer components as epitope-tagged
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wild-type and mutant proteins. So far, data on the ectopic expression of epitope-tagged 
retromer constructs in mammalian model systems are scarce. Because of the increasing 
demand for well-expressed epitope-tagged retromer proteins, we here present an overview 
of the expression of wild-type and mutant retromer proteins using a broad scale of epitope- 
tags and heterologous expression systems.
Materials and Methods
Recombinant Constructs
pCIneo vectors containing myc-hVps26, hVps29-myc and hVps35-myc were kindly provided 
by Dr. C.R. Haft (National Institutes of Health, Bethesda, Maryland). The pEYFP-C1 vector 
(Clontech) was used for the construction of YFP fusion constructs, and the pGEX4T1 or 
pGEX4T3 vector (Amersham) for the construction of the GST- and myc-His fusion constructs, 
as described before [18].
An HA-tag and an XhoI restriction site were introduced into the pCIneo vector, while the 
originally present myc-tags of hVps26, hVps29 and hVps35 were removed. The pCIneo HA- 
hVps26 and HA-hVps29 were constructed using EcoRI and NotI restriction sites and the 
pCIneo HA-hVps35 was constructed using XhoI and NotI restriction sites. HA-hVps26 was 
subcloned into the pcDNA3.1 vector (Invitrogen) using NheI and NotI restriction sites to 
construct pcDNA3.1 HA-hVps26.
A modified pLXSN vector (Clontech), which lacks the BamHI but contains a NotI 
restriction site, was used for the construction of retroviral sorting nexin/retromer 
constructs. An XhoI restriction site was introduced in front of hVps26 and pLXSN myc- 
hVps26, pLXSN hVps29-myc and pLXSN hVps35-myc were constructed using XhoI and NotI 
restriction sites and pLXSN myc-SNX1 using EcoRI and NotI restriction sites.
Linkers were introduced into pMSCV hygro and puro (Clontech), with the forward primer 
5'-GATCTCTCGAGGGGCCCGCGGCCGCG-3' and reverse primer 5'-TCGACGCGGC- 
CGCGGGCCCCTCGAGA-3' and into pMSCV neo (Clontech), with 5'-TCGAGGGGCCCGCG- 
GCCGCA-3' and 5'-GATCTGCGGCCGCGGGCCCC-3' primers, using BglII and XhoI restriction 
sites to create a NotI site after the XhoI restriction site. The myc-tagged retromer coding 
sequences were subcloned from the pLXSN constructs to create pMSCV puro myc-hVps26, 
pMSCV hygro hVps29-myc and pMSCV neo hVps35-myc using XhoI and NotI restriction sites.
The hVps29 catalytic site mutants were subcloned from pGEX4T3 [18] into pEYFP-C1 
using EcoRI and NotI/Bsp120I restriction sites. pCIneo hVps29 H86A-myc was constructed
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with the primers as described for pGEX4T3 hVps29 H86A [18] and EcoRI en NotI restriction 
sites.
Cell Culture, cDNA Transfection and Pretreatment with Inhibitors
Human HeLa cells [28], mouse NIH3T3 [29] or HER14 fibroblasts [30], monkey COS7 
fibroblasts [30] and Phoenix ecotrophic packaging cells were maintained in Dulbecco's 
modified Eagle's medium (DMEM; Life Technologies, Paisly, UK) supplemented with 10% 
(vol/vol) newborn calf serum (NCS; HyClone Laboratories, Logan, UT, US), penicillin (100 
U/ml) and streptomycin (100 ng/ml) at 37 °C in a humidified atmosphere at 5.0% CO2.
For cDNA transfections, cells were grown to 90% confluence on 60 cm2 dishes coated 
with 0.1% gelatin and cells were subsequently transiently transfected with 20 |ag cDNA using 
Lipofectamin-2000 (Invitrogen) according to the manufacturer's instruction. Bafilomycin A1, 
lactacystin and MG132 (Calbiochem) proteasomal and/or lysosomal inhibitors were 
dissolved in dimethyl sulfoxide (DMSO) and used at a final concentration of 0.25 |aM, 10 ^M 
and 50 |aM, respectively, for 7 hours, prior to cell lysis.
Retroviral Infections
A total of 2.0 x 106 ecotrophic Phoenix cells (kindly provided by Dr. G.P. Nolan) were seeded 
on 60 cm2 dishes coated with 0.1% gelatin. After 24 hours cells were transfected using the 
calcium phosphate method by adding 20 |ag of DNA and 125 mM CaCl2 in HEPES-buffered 
saline solution (HeBS: 280 mM NaCl, 50 mM HEPES, 1.5 mM Na2HPO4, pH 6.95). After 16 
hours the medium was replaced by DMEM with supplements as described above and after 
another 48 hours the virus-containing medium was collected and filtered (45 |am). 
Polybrene (Sigma) was added to the virus-containing medium at a concentration of 5 ng/ml. 
The mixture was incubated for 15 min on ice and was subsequently added to 90% confluent 
NIH3T3 cells in 10 cm2 dishes. In the case of antibiotic selections puromycin (1 |ag/ml), 
neomycin (800 ng/ml) and hygromycin B (400 |ag/ml), alone or in combination, were added 
to the culture medium. NIH3T3 cells were lysed 1-7 days after infection and analyzed for 
protein expression.
Genomic DNA Analysis
A total of 1.0 x 106 retrovirally infected NIH3T3 cells were seeded in a 10 cm2 well. After 24 
hours, the culture medium was removed and genomic DNA was isolated using the Wizard 
Genomic DNA Purification Kit (Promega) according to the manufacturer's instructions. The 
presence of the pLXSN hVps35-myc construct was evaluated by PCR with a forward primer
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matching hVps35 (5'-GCCCACCAGACTATCAGTGC-3') and a reverse primer matching the 
pLXSN vector (5'-GAGCCTGGGGACTTTCCACACCC-3'). PCR mixtures contained 1x PCR buffer, 
1 mM MgCl2, 1 unit of Biotherm DNA polymerase (GeneCraft), 0.4 mM of each dNTP 
(Fermentas), 100 ng of each primer and 15 ng of genomic DNA in a total volume of 25 |al. 
PCR products were subsequently analysed on 1% agarose gels.
Metabolic Labelling
After 22-24 hours of transfection, cells were washed twice with phosphate-buffered saline 
(PBS) and incubated in methionine/cysteine-free DMEM supplemented with 10% (vol/vol) 
NCS, for 15 min at 37 °C. Cells were labelled by adding 1 mCi of [35S] methionine/cysteine 
(Perkin Elmer) to each 10 cm2 dish for 30 min at 37 °C. Cells were then washed twice with 
ice-cold PBS and subsequently chased for several time periods at 37 °C with DMEM 
supplemented with 10 mM unlabelled methionine and 5 mM unlabelled cysteine.
Cell Lysis and Immunoprecipitation
For immunoprecipitation of recombinant proteins, transfected cells were washed twice with 
ice-cold PBS and then lysed using 1 ml of lysis buffer containing 150 mM NaCl, 25 mM Tris-Cl 
pH 7.5, 5 mM EDTA pH 8.0, 1% Triton X-100, 1mM Na3VO4, 1 mM NaF, 1 mM 
phenylmethylsulfonyl fluoride, 1 ng/ml leupeptin, 1 ng/ml aprotonin, and 1 ng/ml pepstatin. 
After 30 min of incubation at 4 °C, the lysate was cleared by centrifugation for 10 min at 
13,000 x g. To the supernatant 50 |al of protein G-Sepharose (Amersham), coupled to 
appropriate antibodies, were added and the mixture was allowed to incubate overnight at 4 
°C on a rotating wheel. Following immunoprecipitation, the beads were washed twice with 
lysis buffer and once with ice-cold PBS, and subsequently resuspended in reducing Laemmli 
sample buffer, heated for 5 min at 95 °C, and after centrifugation at 13,000 x g for 1 min the 
samples were subjected to SDS-PAGE.
Recapture Assay
For immunoprecipitation-recapture assays, immunoprecipitated samples were split into two 
equal parts. One part was denatured by adding 50 |al of a mixture of 1% SDS, 0.1 M Tris-Cl pH 
7.4 and 10 mM dithiotreitol (DTT) and subsequently incubated for 5 min at 95 °C. The other 
half was diluted by addition of 950 |al of lysis buffer supplemented with 10 mM 
iodoacetamide, to release the proteins from the protein G-Sepharose, after which the 
suspension was cleared by centrifugation at 13,000 g. Supernatants were transferred to 50 
|al of protein G-Sepharose (Amersham) coupled to 2 |ag of appropriate antibodies and
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allowed to incubate for 2-4 hours at 4 °C on a rotating wheel. Following subsequent 
immuno-precipitation, the beads were washed three times with lysis buffer and once with 
ice-cold PBS. All samples were resuspended in Laemmli sample buffer and were subjected to 
SDS-PAGE.
SDS-PAGE, Western Blotting and Antibodies
Protein samples were subjected to reducing SDS-PAGE and subsequently transferred to 
nitrocellulose membranes according to standard procedures. The membranes were blocked 
with 5% bovine serum albumin TBST (Tris-Buffered Saline Tween-20) and subsequently 
incubated with a primary antibody. Mouse monoclonal antibodies were used against c-myc 
(9E10; Santa Cruz) and hemagglutinin (HA) protein (12CA5; Roche), while a rabbit polyclonal 
antibody was used against Green Fluorescent Protein (GFP) (Santa Cruz). Membranes were 
rinsed and incubated with an appropriate goat-anti-mouse or goat-anti-rabbit peroxidase- 
linked secondary antibody, after which the proteins were visualized using enhanced 
chemiluminescence.
Production of GST-Fusion Proteins
GST-fusion proteins [18] were produced in the Escherichia coli XL-2 blue or BL-21 strains 
containing the appropriate pGEX plasmid. Cultures (0.5-5.0 liter) were grown to log phase 
(OD600 of 0.6-0.8) after which protein expression was induced by addition of isopropyl-1- 
thio-ß-D-galactopyranoside (Invitrogen) to a final concentration of 0.1 mM. After 1-3 hours 
of induction cells were harvested, rinsed with Tris-buffered saline (TBS) pH 7.4, and 
resuspended in TBS containing 1% Triton X-100, 100 ng/ml lysozyme and 10 ng/ml 
leupeptin, 10 ng/ml pepstatin, and 10 ng/ml aprotonin. The suspension was frozen at -20 °C 
for at least 16 hours and subsequently thawed followed by sonication. Lysates were cleared 
by centrifugation for 15 min at 12,000 x g and then incubated with 0.5-3 ml of a 50% slurry 
of gluthathione-Sepharose beads (Sigma) for 2-4 hours at 4 °C with rotation. The 
gluthathione-Sepharose beads were subsequently washed four times with TBS pH 7.4.
Production of myc-His Fusion Proteins
Myc-His fusion retromer proteins [18] were produced in the E. coli XL-2 blue strain 
containing the appropriate myc-His plasmid. Cultures of 200 ml were grown to log phase 
(OD600 of 0.6-0.8) and protein expression was induced by addition of isopropyl-1-thio-ß-D- 
galactopyranoside (Invitrogen) to 0.1 mM final concentration. After 4-5 hours of induction, 
cells were frozen at -20 °C for 16 hours. Cells were thawed on ice and resuspended in 4 ml of
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lysis buffer (10 mM imidazole, 150 mM NaCl, 50 mM Tris-Cl, pH 8.0) after which lysozyme 
was added to a final concentration of 1 mM. The lysates were sonicated and cleared by 
centrifugation for 15 min at 12,000 x g. Cleared lysates were incubated with 1 ml Ni-NTA 
beads (Qiagen) for 2-3 hours at 4 °C with rotation. The Ni-NTA beads were washed three 
times (10 mM imidazole, 300 mM NaCl, 50 mM Tris-Cl, pH 8.0) and subsequently eluted with 
elution buffer (250 mM imidazole, 300 mM NaCl, 50 mM Tris-Cl, pH 8.0) and dialysed against 
H2O.
Results
Expression of Epitope-Tagged Retromer Constructs in Mammalian Cell Lines
In order to obtain pCIneo myc-hVps26, hVps29-myc and hVps35-myc, mammalian 
expression plasmids were transfected using the Lipofectamin transfection method into HER- 
14 cells and the expression of the proteins was analysed in immunoprecipitates (Figure 1A) 
and in whole cell lysates (Figure 1B). Expression of the myc-hVps26 protein was detectable, 
both after immunoprecipitation and in whole cell lysates, but this was not the case for 
hVps29-myc and hVps35-myc proteins. Therefore various transfection procedures (calcium­
phosphate and Lipofectamin transfection methods with varying amounts of DNA and 
DNA:Lipofectamin ratios) were tested as well as several different host cell lines (HER14, 
NIH3T3 and COS7 cells). N-terminally tagged myc-hVps26 could be expressed following 
calcium-phosphate transfection in all three cell lines (data not shown). In contrast, C- 
terminally tagged hVps29-myc and hVps35-myc were not detectably expressed under these 
conditions. Since Vps26, Vps29 and Vps35 protein form a complex in vivo, we considered 
the possibility that ectopic expression of multiple retromer subunits may be required to 
obtain high expression levels. Indeed, downregulation of a single retromer subunit in 
mammalian model systems by transfecting siRNAs to hVps26, hVps29 or hVps35 has been 
shown to result in decreased expression of the other retromer subunits as well [11, 13, 14]. 
However, simultaneous transfection of vectors encoding the three retromer subunits did 
not improve expression of any of the subunits (data not shown).
In general, the advantage of N-terminal tags is that they often improve the yield of 
recombinant proteins by providing a reliable context for efficient translation initiation [31]. 
Since only expression of the N-terminally tagged hVps26 was detected and not of the C- 
terminally tagged hVps29 and hVps35, retromer constructs were made with an N-terminal 
HA epitope-tag. Expression studies in NIH3T3 cells using the Lipofectamin transfection 
method resulted in the expression of HA-hVps35, as detected both in immunoprecipitates
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(Figure 1C) and whole cell lysates (Figure 1D), but not of HA-hVps26 or HA-hVps29. 
Alterations in transfection protocols were tested, as well as the use of other host cell lines, 
similarly as described above for the myc-proteins, but this did not result in improved protein 
expression of the N-terminally HA-tagged retromer proteins (data not shown). Also, 
expression of HA-hVps26 did not improve when expressed from the pcDNA3.1 vector, as 
opposed to the pCIneo vector.
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Figure 1 Expression of epitope-tagged retromer proteins in mammalian cell lines. Western
blots of steady state expression levels of epitope-tagged retromer proteins in mammalian cell lines. 
Vectors encoding myc-tagged retromer proteins were transfected into HER14 cells and their 
expression levels were analysed in anti-myc immunoprecipitates (A) and whole cell lysates (B). 
Vectors encoding HA-tagged retromer proteins were transfected into NIH3T3 cells and their 
expression levels were analysed in anti-HA immunoprecipitates (C) and whole cell lysates (D). 
Expression of YFP-tagged retromer proteins in HeLa cells was measured in whole cell lysates (E).
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In contrast to the expression of HA and myc epitope-tagged retromer proteins, 
addition of a N-terminal YFP-tag resulted in high expression levels for hVps26 and hVps29 
and to a lesser extent for hVps35 (Figure 1E). The YFP-tag is approximately 22 kDa in size, 
which is relatively large compared to hVps26 (37 kDa) and hVps29 (22 kDa), and therefore 
incorporation of the YFP-tag could possibly disturb complex formation between the 
retromer components. The fact that these proteins are not rapidly degraded might indicate 
that these are incorporated in the retromer complex, however the YFP-tagged protein might 
be more stable compared to endogenous retromer proteins due to the relatively large YFP- 
tag or degradation might be avoided if addition of the YFP tag results in an alternate 
subcellular location. Although we have previously demonstrated interaction of YFP-retromer 
fusion proteins with GST-fusion retromer proteins in vitro [18], there is presently no 
experimental evidence that YFP-tagged retromer subunits are capable of retromer complex 
formation in vivo.
The retromer proteins hVps26, hVps29 and hVps35 form a complex in vivo [5, 16] and 
therefore newly translated retromer proteins may be rapidly degraded if they are unable to 
incorporate directly into the retromer complex. In order to study whether the low 
expression level of retromer subunits is due to constitutive protein degradation, cells 
transfected with vectors encoding HA epitope-tagged retromer proteins were preincubated 
with either (i) lactacystin (a proteasomal inhibitor), (ii) bafilomycin A1 (an inhibitor of the v- 
ATPase proton pump, which is required for lysosome acidification and function), or (iii) the 
peptide aldehyde MG132 which inhibits both proteasomal and lysosomal proteases. 
Unexpectedly, protein expression was detected in this experiment in all samples, even when 
treated with the DMSO carrier alone (Figure 2A and 2B). This may be caused by the 
prolonged time period (8 hours) between transfection and cell lysis, which was needed to 
allow 7 hours incubation with inhibitors (see Materials and Methods). In particular a 
substantial increase in protein expression was observed for all three HA-tagged retromer 
proteins upon addition of MG132 or lactacystin. Addition of MG132 also resulted in 
detectable expression of the myc-tagged retromer proteins (data not shown). In contrast, 
bafilomycin treatment did not significantly affect expression levels relative to mock-treated 
samples. These findings suggest that retromer proteins are translated, but that a significant 
fraction of HA or myc epitope-tagged retromer subunits is degraded in the proteasomes.
In conclusion, high level expression of YFP-tagged wild-type retromer proteins could be 
obtained in mammalian cells, but significant difficulties were encountered when expressing 
myc and HA epitope-tagged retromer proteins. Expression of HA-tagged retromer subunits
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could be enhanced in the presence of proteasomal inhibitors, indicating that these 
recombinant proteins undergo constitutive proteasomal degradation.
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Figure 2 Proteasomal inhibitors enhance the expression of epitope-tagged retromer
proteins. Effect of addition of proteasomal and/or lysosomal inhibitors on the expression of epitope- 
tagged retromer proteins, as detected on Western blots. Whole cell lysate expression of NIH3T3 cells 
transfected with vectors encoding HA-tagged retromer proteins is shown after treatm ent with 
proteasomal and/or lysosomal inhibitors for 7 hours. -: DMSO; MG: MG132; B: bafilomycin A1; L: 
lactacystin.
Retroviral Expression of Retromer Proteins
As an alternative for transient transfections using calcium-phosphate or Lipofectamin, 
retroviral expression was evaluated to enhance the expression of retromer subunits. 
Therefore myc-hVps26, hVps29-myc, hVps35-myc and myc-SNX1 were subcloned into the 
retroviral pLXSN vector and virus was produced in ecotrophic Phoenix cells. Following 
infection of NIH3T3 cells with these viruses, sorting nexin/retromer subunit expression 
levels were analyzed by Western blotting. Figure 3A shows that expression of myc-SNX1 was 
readily observed, but expression of the retromer proteins was not detected. No increase of 
protein expression levels was detected upon increasing the virus concentrations or upon 
prolonged infection up to 7 days. After selection for infected cells using antibiotics, a 
substantial difference in survival was observed for infected cells in comparison with non­
infected cells, which suggests expression of the retromer subunits. However, steady state 
expression techniques did not reveal any expression of the retromer subunits in these 
infected cells.
Addition of siRNAs to hVps26, hVps29 or hVps35 in HeLa cells not only reduces the 
expression level of the target retromer subunit, but also repress the expression level of the 
other two retromer proteins [13, 14]. We therefore hypothesized that a triple infection of 
hVps26, hVps29 and hVps35 could positively affect the expression level of all three proteins.
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In order to do so, the three myc-tagged retromer subunits were subcloned into pMSCV 
retroviral vectors linked to different antibiotic resistance genes (i.e. pMSCV puro myc- 
hVps26, pMSCV hygro hVps29-myc and pMSCV neo hVps35-myc). Subsequently, NIH3T3 
cells were virally infected either with a single construct or with a combination of the three 
retromer constructs, after which the infected cells were treated with the appropriate 
antibiotics for selection. A substantial difference was observed in the amount of cells that 
are resistant for the three selection markers between the non-infected controls and triple 
infected cells. However, Western blot analysis showed no expression of any of the retromer 
components (data not shown).
In order to study whether the low expression level of retromer subunits is due to 
protein instability and constitutive protein degradation, cells infected with single retromer 
constructs were preincubated with MG132 at different time points after infection or after 
subsequent antibiotic selection. MG132 did not improve expression of the retromer 
proteins, indicating that under the present conditions the absence of retromer protein 
expression was not caused by constitutive protein degradation. As a control, genomic DNA 
of cells infected with hVps35-myc was isolated and the insertion of the infected DNA was 
verified by PCR (Figure 3B).
Figure 3 Retroviral infection of epitope-tagged retromer proteins does not result in protein
expression. Retroviral expression of NIH3T3 cells infected with retroviral vectors encoding myc- 
tagged retromer proteins. (A) Western blot of whole cell lysate expression of myc-tagged retromer 
proteins. (B) PCR product of genomic DNA of cells infected with hVps35-myc separated on a 1% 
agarose gel.
The above data show that NIH3T3 cells can be infected with retroviral retromer 
constructs, but that expression of the retromer proteins is insufficient to be detected by
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steady state Western blotting techniques. This appears to be related to the expression of 
the retromer subunits itself and not to the procedure used, because expression of retroviral 
infected myc-SNX1 could readily be detected under these conditions.
Metabolic Labelling of Retromer Proteins
To study the biosynthesis, complex formation and degradation of the retromer proteins in 
more detail, metabolic labelling studies were performed, in which NIH3T3 and HeLa cells 
were transfected with vectors encoding retromer YFP-constructs and the proteins were 
labelled 16 hours after transfection by incubation for 30 min with [35S] methionine/cysteine. 
The hVps26, hVps29 and hVps35 proteins contain 12, 6 and 33 methionines/cysteines, 
respectively, while the YFP protein tag contains 8 methionines/cysteines. Immuno­
precipitated proteins were separated on relatively large gel-systems and radiolabelled 
proteins were detected by fluorography. Figure 4A shows the specific bands for each of the 
retromer proteins, which appear quite similar in HeLa and NIH3T3 cells. The expected 
protein bands (approximately 22 kDa, 59 kDa, 44 kDa and 107 kDa for YFP, YFP-hVps26, YFP- 
hVps29 and YFP-hVps35, respectively) were indeed observed, although in the case of YFP- 
hVps26 and YFP-hVps29 two additional bands were detected. In order to investigate if these 
bands are interacting proteins or derived from the retromer constructs itself, the 
metabolically labelled proteins from cells transfected with vectors encoding retromer 
constructs fused to the 22 kDa YFP protein tag, were compared with those from cells 
transfected with vectors encoding myc-tagged constructs (Figure 4B). Since the expression 
of hVps35-myc was relatively poor, an N-terminal HA epitope-tagged hVps35 construct was 
used (Figure 4C). We observed that the protein bands corresponding to the YFP-constructs 
were not detectable in samples of metabolically labelled myc-tagged proteins, indicating 
that the additional bands observed for YFP-hVps26 and YFP-hVps29 were derived from the 
YFP-retromer fusion protein itself. As the actual molecular size was smaller than the 
calculated size of the YFP-fusion proteins, these additional bands could represent protein 
degradation products of the YFP-fusion proteins. To ascertain that the 37 kDa band, 
observed in the YFP-hVps29 protein samples, is not the similarly sized hVps26, a recapture 
assay for this protein was performed in which YFP alone was used as a control. Since we 
were able to recapture the 37 kDa with antibodies against the YFP tag, we thus confirmed 
that the 37 kDa band indeed originated from YFP-hVps29 (Figure 4D).
As mentioned above, we observed difficulties when expressing myc-tagged and HA- 
tagged retromer proteins in mammalian cells. Since myc-hVps26, hVps29-myc, HA-hVps35 
and to a lesser extent hVps35-myc, demonstrated detectable expression by metabolic
176 Chapter 6
labelling studies, however, we used metabolic pulse-chase studies to analyze time- 
dependent degradation of newly synthesized retromer proteins. Cells were pulse-labelled 
for 30 min with [35S]-methionine/cysteine and subsequently incubated (chased) in complete 
medium with excess unlabelled methionine and cysteine for several time points up to 7 
hours (Figure 5A, B and C). Since metabolic labelling is a very sensitive technique, the 
difference in protein signal between the individual lanes was corrected by correlating the 
expression of the proteins of interest to an nonspecific protein band of 75 kDa which 
appears in every lane. A rapid decrease in the signal of the YFP-tagged constructs was 
observed, suggesting that both YFP-hVps26 and YFP-hVps29 were fully degraded after 4 
hours. In contrast, the myc- and HA-tagged variants appeared to be more stable and only a 
small fraction of the proteins was degraded after 7 hours.
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Figure 4 Expression of epitope-tagged retromer proteins is detectable after metabolic
labelling. HeLa or NIH3T3 cells were transfected with vectors encoding epitope-tagged retromer 
proteins and subsequently labelled for 30 min with 1 mCi [35S] methionine/cysteine. Retromer 
proteins were subsequently immunoprecipitated with an antibody against their epitope-tag. 
Fluorographs demonstrating metabolic labelling of retromer proteins in mammalian cell lines. (A) 
Expression of YFP-tagged retromer proteins transfected into HeLa (H) or NIH3T3 (N) cells. (B) 
Expression of YFP- and myc-tagged hVps26 and hVps29 proteins transfected into HeLa cells. (C) 
Expression of YFP- and HA-tagged hVps35 transfected into HeLa cells. (D) Proteins 
immunoprecipitated with anti-YFP antibodies from HeLa cells transfected with vectors encoding YFP 
alone (lane 1) or YFP-hVps29 (lane 3) were uncoupled from the antibody- protein G-Sepharose 
complex and recaptured by an additional round of immunoprecipitation with anti-YFP antibodies 
(lane 2 and 4).
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Figure 5 Expression profiles of epitope-tagged retromer proteins over time. Fluorographs of
SDS-gels after metabolic pulse-labelling studies of epitope-tagged retromer proteins. HeLa cells 
transfected with vectors encoding epitope-tagged retromer proteins were labelled for 30 min with 1 
mCi [35S] methionine/cysteine and the label was subsequently chased in complete medium with 
excess unlabelled methionine and cysteine for the indicated time points. (A) Pulse chase study of 
hVps26. Upper panel: three bands derived from YFP-hVps26 protein and a nonspecific band of about 
75 kDa which we used as a loading control. Middle panel: two bands derived from myc-hVps26 
protein. Lower panel: 75 kDa loading control. (B) Pulse chase study of hVps29. Upper panel: YFP- 
hVps29 protein; second panel: 75 kDa loading control; third panel hVps29-myc and lower panel: 75 
kDa loading control. (C) HA-hVps35 protein and the 75 kDa loading control protein band. *:75 kDa 
loading control protein.
In conclusion, metabolic labelling studies demonstrated protein expression of myc- 
hVps26, hVps29-myc and HA-hVps35, as well as YFP retromer fusion proteins. YFP-retromer 
fusion proteins appeared more unstable than their myc- or HA-tagged counterparts, which
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contrasts our previous observation that YFP-tagged retromer proteins were easily 
detectable by steady state Western blot analysis while their HA- and myc epitope-tagged 
counterparts were not (Figure 1). Since expression profiles detected by Western blotting are 
the sum of protein translation and degradation, the present data might suggest that the 
translation rate of YFP-tagged retromer proteins differs substantially from their myc- and HA 
epitope-tagged counterparts.
Expression of GST- and Myc-His Fused Retromer Proteins in E. coli
In order to generate high quantities of wild-type and mutant retromer proteins, for example 
to study the amount of zinc ions bound to mutant hVps29 by coupled plasma mass 
spectrometry (ICP-MS), Escherichia coli was tested as putative host. This bacterium is the 
most widely utilized prokaryotic system for the expression of recombinant proteins because 
of its relative ease and low costs involved. However, successful expression of mammalian 
recombinant proteins in E. coli may be limited by poor solubility and inefficient translation. 
Insoluble proteins obtained from E. coli are often inactive, and in fact protein solubility 
appears a good indicator for correct folding as determined by functional binding [32, 33] 
and enzymatic [34] assays. Furthermore, many mammalian proteins require functionally 
relevant post-translational modifications which are not carried out in E. coli, including 
glycosylation, phosphorylation on tyrosine, threonine and serine residues, or addition of 
fatty acid chains.
One of the most successful generic strategies to enhance the expression of soluble 
proteins is the fusion with solubility enhancing tags, such as maltose binding protein (MBP), 
thioredoxin (Trx) and gluthathione-S-transferase (GST) [35-37]. In the present study we 
produced GST-fusion proteins of the various human Vps proteins in E. coli XL-2 blue strain 
which were subsequently analysed by Coomassie blue staining (Figure 6A). Although all 
three proteins were expressed under these conditions, much lower levels of full length GST- 
hVps26 and GST-hVps35 proteins were obtained than of GST-hVps29. In addition many 
putative degradation products were observed in GST-hVps26 and GST-hVps35 producing 
bacteria. Therefore another host, E. coli BL21(DE3) was tested, which contains 
chromosomally integrated T7 RNA polymerase gene (Ä.DE3 lysogen) under the control of the 
lacUV5 promoter and might increase expression due to promoter selectivity [38], but the 
use of this strain did not significantly improve the expression levels of GST-hVps26 and GST- 
hVps35 (data not shown).
In order to test if concomitant transformation of multiple retromer proteins could 
improve the expression levels of the proteins, both an ampicillin resistant pBR and a 
kanamycin resistant pUC expression construct were transformed into E. coli. Although
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bacterial clones resistant to both antibiotics were selected, subsequent analysis showed 
that always only one of the expression constructs could be detected in the DNA isolated 
from these clones (data not shown). This is probably due to plasmid incompatibility, which 
can occur when E. coli is transformed with two plasmids carrying the same origin of 
replication.
We also tested another way of protein purification to verify if this affects the quantity of 
retromer proteins isolated after expression in E. coli. Replacement of the relatively large GST 
moiety for the smaller myc-His tag [18], allows purification of retromer fusion proteins by 
means of metal chelation affinity chromatography (MCAC). Retromer proteins are well 
expressed using this technique, as shown in Figure 6B. In addition much less degradation 
bands were observed for myc-His-tagged than for GST-tagged retromer proteins. These 
degradation bands observed in the GST-tagged retromer proteins may result from 
premature termination of translation, failure of a newly synthesized chain to reach a correct 
conformation or from loss of structure triggered by environmental stress.
Figure 6 Epitope-tagged retromer protein expression in E. coli. Coomassie Blue staining of
epitope-tagged retromer proteins expressed in E. coli. (A) GSH-agarose purified GST-tagged retromer 
proteins. (B) Increasing concentrations of Ni-NTA purified myc-His-tagged retromer proteins.
We assessed whether the GST-fusion retromer proteins were able to interact with 
YFP- and myc-His-tagged retromer proteins, using in vitro affinity precipitations. Mammalian
180 Chapter 6
expressed YFP-fusion proteins (Chapter 4 Figure 1B) were incubated with GST-fusion 
proteins of hVps26, hVps29 and hVps35 (Chapter 4 Figure 1C). hVps26-GST and hVps35-GST 
interact with Vps29-YFP but not with YFP alone. Vice versa, hVps29-GST interacts with 
hVps26-YFP as well as with hVps35-YFP and not with YFP alone (Chapter 4 Figure 1C). 
Consistent with the results both myc-His-tagged hVps29 and hVps35 were detected by anti- 
Myc Western blotting in GST-hVps26 affinity precipitates (Chapter 4 Figure 3A), indicating 
that retromer subunits were able to form a complex in vitro and that their epitope tags do 
not impair their ability to form complexes.
Impaired Expression of hVps29 Catalytic Site Mutants
Recently, the crystal structure of Vps29 has been solved by Wang et al. [17] and Collins et al. 
[16] demonstrating that Vps29 has a metallo-phosphoesterase fold. We were able to 
complement these data with functional evidence [18]. hVps29 has a catalytic core, which is 
unique among phosphoesterases since its catalytic site contains a switched Asn-Asp pair 
while a catalytic His residue is replaced by Phe. Point mutation analysis of these residues in 
hVps29 may help to study the structure-function relationship of its phosphoesterase 
activity. Based on our observation that hVps29 can be well expressed as a YFP-fusion protein 
in mammalian expression systems and as a GST- or myc-His fusion protein in E. coli, we 
subsequently set out to express mutant forms of hVps29 in both systems. For unknown 
reasons, however, the expression of catalytic site point mutants of hVps29 appeared 
strongly impaired, both as YFP-fusion protein in mammalian cells (Figure 7A) and as GST- 
fusion protein in E. coli (Figure 7B). Intriguingly, the reduction in expression of these 
mutants was comparable in the two different host expression systems. The highest 
reduction in protein expression was observed for the D8A and N39A mutants, while the 
expression level of the H117A and D62A mutants was less reduced, and that of D62N 
mutant hardly impaired. These results agree with those of Collins et al. [16] who also 
observed impaired expression of Vps29 catalytic site mutants, including N39A [16]. These 
findings strongly suggest that the reduced expression level of Vps29 catalytic site mutants 
does not result from the expression method, the epitope tag or detection method used, but 
is intrinsic to the mutation itself.
We subsequently investigated if the observed difference in protein expression level 
between wild-type YFP-hVps29 and its catalytic point mutants results from proteasomal or 
lysosomal degradation. Addition of the lysosomal inhibitor bafilomycin did not affect 
expression, but the proteasomal inhibitors lactacystin and MG132 clearly improved protein 
expression levels, although not to the level observed for the wild-type protein (Figure 7C).
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The present data might suggest a difference in protein stability or translation rate between 
wild-type and the YFP-hVps29 catalytic point mutants.
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Figure 7 hVps29 catalytic site point mutants have reduced expression levels. (A) Western
blot of whole cell lysate YFP-tagged hVps29 point mutants expressed in NIH3T3 cells (B) Coomassie 
Blue staining of purified GST-tagged hVps29 point mutants expressed in E. coli. (C) Western blots of 
whole cell lysate expression of NIH3T3 cells transfected with vectors encoding YFP-tagged hVps29 
point mutants after treatment with proteasomal and/or lysosomal inhibitors for 7 hours -: DMSO; B: 
bafilomycin A1; L: lactacystin; MG: MG132.
In order to study the difference in the rate of biosynthesis and degradation of hVps29 
wild-type and catalytic point mutants in more detail, metabolic pulse-chase labelling studies 
were performed. Three bands of approximately 44, 41 and 37 kDa were detected for YFP- 
hVps29 and its catalytic point mutants, although the relative intensity of the three bands 
differed for individual mutants (Figure 8A). The D62N mutant showed a very comparable 
expression pattern as wild-type YFP-hVps29. The latter two proteins also showed the 
highest expression levels after 2 hours of chase, suggesting that decreased steady state 
expression level of the other catalytic site point mutants is due to decreased protein 
stability. It is important to note, however, that the underlying reason for the appearance of 
the three different bands is currently unknown and that their identity remains speculative.
The degradation rate of newly synthesized hVps29-myc wild-type and its H86A catalytic 
site mutant was also analyzed. As illustrated in Figure 8B, the hVps29 H86A mutant protein 
is degraded faster than the wild-type protein. In conclusion, highly decreased protein levels 
were measured for the catalytic site point mutants of hVps29, which does not appear to 
result from their epitope-tag, expression method or the detection procedure, but appear to 
be induced by the mutation itself.
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Figure 8 Metabolic labelling studies demonstrate aberrant expression patterns for hVps29 
catalytic site point mutants. Fluorographs after metabolic pulse-labelling studies of wild-type 
hVps29 and several catalytic site point mutants. Mammalian cells transfected with vectors encoding 
wild-type or catalytic site point mutants of hVps29 were labelled for 30 min with 1 mCi [35S] 
methionine/cysteine and subsequently chased in complete medium with excess unlabelled 
methionine and cysteine for the indicated time points. (A) YFP-tagged hVps29 wild-type and mutant 
proteins expressed in NIH3T3 cells. (B) hVps29-myc and hVps29-myc H86A expressed in HeLa cells.
Discussion
In the present study we have given an overview of our attempts to express epitope-tagged 
mammalian retromer proteins using a broad scale of expression hosts and methods. 
Epitope-tagged protein expression is needed to study important issues on retromer 
functioning, including the role of Vps29 on cycling TGN proteins, the catalytic mechanism of 
hVps29 [16-18], the role of arrestin-like hVps26 in the retromer complex [15], the 
interaction domains between the retromer subunits [15-17] and the role of the two 
paralogues of Vps26 [27].
We tested the expression of retromer proteins fused to three different epitope-tags, 
myc, HA and YFP, in mammalian cell lines. Steady state expression analysis by Western 
blotting demonstrated protein expression of myc-hVps26, but not of hVps29-myc and 
hVps35-myc. Although an advantage of N-terminal tags is that they often improve the yield
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of recombinant proteins by providing a reliable context for efficient translation initiation 
[31], the constructed N-terminal HA epitope-tag only resulted in the detectable expression 
of HA-hVps35. We demonstrated by using proteasomal and lysosomal inhibitors that the 
impaired expression is likely the effect of proteasomal degradation. In the same expression 
system, we showed high expression levels of the YFP-tagged retromer proteins and we used 
dynamic expression techniques in order to explain these differences. Surprisingly, the YFP- 
proteins degraded faster than their myc or HA epitope-tagged counterparts. Since 
expression profiles detected by steady state expression techniques such as Western blotting 
are the sum of protein translation and degradation, it is likely that the YFP-tagged retromer 
proteins are much faster translated than their myc and HA epitope-tagged counterparts. 
From the study of epitope-tagged proteins in mammalian cell lines, it appeared that the myc 
and HA retromer proteins are more stable than their YFP counterparts. This may be caused 
by the smaller size of the epitope-tag, which could be an advantage in assembly of the 
retromer complex. Indeed, Shi et al. [15] have recently demonstrated interaction of myc- 
tagged hVps26 proteins with endogenous hVps29 and hVps35 proteins in HeLa cells, using a 
pCDNA3.1 Vps26-myc-His construct [15] instead of the pCIneo myc-hVps26 construct. On 
the other hand, we have demonstrated that YFP-tagged retromer proteins are able to bind 
GST-fusion retromer proteins in vitro [18] whereby the differences in steady state 
expression level are clearly in favor of the YFP epitope-tags. Before we can use these 
proteins to study e.g. the role of Vps29 activity on cycling TGN proteins, conclusive evidence 
is needed that YFP-tagged retromer subunits are capable of retromer complex formation in 
vivo.
The use of the bacterial E. coli host resulted in high expression levels for the retromer 
proteins, both with the large, soluble GST tag and with the myc-His tag. Both methods 
resulted in soluble proteins, which appears a good indicator of correct folding as determined 
by functional binding [32, 33] or enzymatic assays [34]. Indeed we were able to demonstrate 
that myc-His- or GST-tagged hVps29 proteins produced in E. coli are enzymatic active in vitro 
[18]. We and others have previously demonstrated that myc-His-tagged retromer proteins 
are capable of binding to GST-fusion retromer proteins [16, 18] while on the other hand 
GST-fusion retromer proteins are capable of binding to both YFP and myc-His-tagged 
retromer proteins in vitro [18]. Due to difference in size of the fusion proteins, as well as the 
other tags and/or purification method used, we detected far less degradation products for 
the myc-His-tagged retromer proteins than for their GST-tagged counterparts and therefore 
we preferred the use of myc-His-tagged retromer proteins. Unfortunately, we were not able
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to enhance retromer expression by co-transfection or co-infection in mammalian host cells 
or by co-transformation in the E. coli expression system.
Besides studying the protein expression of epitope-tagged wild-type retromer proteins, 
we also studied the expression of catalytic site point mutants of hVps29. We observed 
impaired expression for all point mutants tested with a similar reduction in expression level 
in two independent ectopic expression systems with different host, epitope-tag and 
detection method. Although the reason for the impaired expression of catalytic site mutant 
hVps29 is unclear, our data are supported by Collins et al. [16], who also mutated Asn39 in 
Vps29 and detected a reduction in protein expression of about 80% compared to wild-type 
levels. Proteasomal inhibitors are partly able to reduce the impaired expression levels of the 
catalytic site point mutants and in addition we observed by dynamic expression techniques 
that the point mutants show a different expression pattern and are faster degraded than 
wild-type hVps29 proteins. The large impact of a single amino acid mutation on the 
expression of hVps29 may be indicative for the importance of these residues for the 
complex formation and function of hVps29 [18]. Indeed complex formation might 
contribute to the protein expression levels since Collins et al. [16] demonstrated that the 
ability of Myc-mVps29N39D to bind to GST-mVps35 is reduced, which might subsequently 
result in protein degradation. In order to study effects of retromer proteins on trafficking of 
TGN proteins in intact cells, comparable levels of epitope-tagged hVps29 mutants are 
needed. We therefore consider stable cell lines containing hVps29 mutations fused to an 
epitope-tag, that have been proven to be capable of complex formation in vivo, and that are 
selected for comparable steady state expression levels, as the ideal model system.
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Summary
Poor downregulation of ErbB receptors is associated with enhanced downstream signaling 
and tumorigenesis. It has been suggested that poor downregulation of ErbB-2, -3 and -4 
receptors when compared to ErbB1 is due to decreased recruitment of Cbl E3 ligase 
proteins. However, a highly conserved Cbl binding site is not only present in ErbB1/EGFR 
(FLQRpY1045SSDP), but also in ErbB2 (PLQRpY1091SEDP) and ErbB4 (STQRpY1103SADP). 
We therefore replaced the ErbB1 Cbl binding site by that of ErbB2 and ErbB4. Whereas 
retrovirally infected NIH3T3 cells containing the EGFR Y1045F mutation showed dramatically 
impaired Cbl recruitment, EGFR ubiquitination and delayed EGFR degradation, replacement 
of the EGFR Cbl binding site by that of ErbB2 or ErbB4 did not affect Cbl recruitment, 
receptor-ubiquitination, -degradation, -downregulation or ligand degradation. We conclude 
that poor downregulation of ErbB2 and ErbB4 receptors is not due to sequence variations in 
the Cbl binding site of these receptors.
Keywords: EGFR, Cbl, Ubiquitin, Endosome, Degradation
Introduction
The ErbB receptor tyrosine kinase family is involved in various cell biological processes such 
as mitosis, rescue from apoptosis, cell differentiation, cell migration, epithelial mesenchymal 
transition, and stimulation of angiogenesis [1, 2]. ErbB receptor tyrosine kinases are one of 
the main targets for anti-cancer therapy as the ErbB receptor system is involved in many 
solid tumors in humans, including colon cancer, lung cancer, breast cancer, prostate cancer, 
brain tumors etc [1, 2]. The involvement of the ErbB receptor system in tumorigenesis varies 
from (i) overexpression of ligands leading to enhanced autocrine or paracrine growth, (ii) 
overexpression of receptors leading to enhanced constitutive ligand-independent activation, 
(iii) mutation, deletion or shedding of the extracellular domain of the ErbB receptors leading 
to a constitutively active truncated receptor, (iv) mutational activation of the tyrosine kinase 
domain, and (v) inhibition of receptor downregulation [1, 2].
ErbB receptor downregulation (the removal of ErbB receptors from the cell surface) is 
mediated by both constitutive and ligand-induced endosomal sorting signals. Ligand binding 
greatly enhances EGFR internalization and lysosomal targeting through the activation of the 
EGFR tyrosine kinase activity and specific downstream signaling pathways. In contrast to 
ErbB1 (also known as the EGFR) which is efficiently downregulated following EGF- 
stimulation, other ErbB receptors (ErbB-2, -3 and -4) show poor ligand-induced 
downregulation [3-5]. Also, heterodimerization of the EGFR with ErbB2 has been reported
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to inhibit ligand-induced EGFR downregulation [6-9]. The EGFR has been intensively studied 
as a model system for ligand-induced receptor mediated endocytosis. However, the 
molecular basis for differences in downregulation of various ErbB receptors remains poorly 
understood. Nevertheless, it has been proposed that poor recruitment of the Cbl E3 ligase 
adaptor protein to ErbB2-4 receptors may be responsible for poor ligand-induced 
downregulation of these receptors [10-12].
Constitutive endosomal sorting signals that have been identified in the EGFR cytoplasmic 
tail include binding sites for clathrin AP2 adaptor proteins (974YxxO and 1010LL) [13, 14] and 
the 996QQGFF ß-turn motif [15, 16]. However, the role of AP2 adaptor proteins in EGFR 
downregulation is not entirely clear. Although the AP2^ subunit associates with the EGFR 
via the 974YxxO motif, the EGFR Y974A mutation does not affect EGFR internalization [14]. 
Moreover, overexpression of a dominant negative AP2^ subunit inhibits transferrin receptor 
but not EGFR internalization [17]. Depletion of clathrin heavy chain through RNA 
interference techniques has been reported to inhibit EGFR internalization [18, 19] or to have 
no effect [20], perhaps depending on the level of clathrin heavy chain knock down achieved. 
The AP2ß subunit may associate with the EGFR dileucine sequence 1010LL and has been 
hypothesized to be involved in lysosomal targeting [14].
Ligand-induced downregulation of the EGFR has been reported to be regulated through 
ligand-induced post-translational modifications such as EGFR tyrosine-, threonine-, and 
serine-phosphorylation as well as EGFR ubiquitination. Simultaneous mutation of multiple 
major tyrosine autophosphorylation sites has been reported to affect ligand-induced EGFR 
downregulation [16, 21], an effect that may be due to loss of Grb2 adaptor protein 
recruitment, which is known to associate with dynamin and the Cbl family of E3 ligase 
adaptor proteins. Indeed, Grb2 associates with the EGFR either directly or indirectly (via 
Shc) through multiple major EGFR autophosphorylation sites [16, 21]. In addition, Cbl 
proteins (c-Cbl, Cbl-b and Cbl-c) can bind the EGFR directly via their N-terminal tyrosine 
kinase binding (TKB) domain to EGFR phosphoTyr1045 and indirectly via Grb2 (vide supra) 
[16, 22-24]. Phosphorylation of Thr654 has also been reported to affect endosomal 
trafficking by inhibiting the kinase activity of the EGFR [25] through an as yet unknown 
mechanism. Various serines are known to undergo phosphorylation including Ser1046 and 
Ser1047 within the Cbl binding site of the EGFR and these have been reported to affect 
endosomal trafficking [26-32]. Finally, recruitment of Cbl proteins leads to ligand-induced 
ubiquitination of the EGFR. In turn, ubiquitin moieties serve as binding sites for ubiquitin- 
binding domains of various proteins involved in endosomal trafficking, such as Eps15, Hrs, 
and various ESCRT proteins [33]. Moreover, Cbl proteins function as adaptors for
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recruitment of additional proteins to the activated receptor such as the Cin85-endophilin 
complex [34-36]. Thus, the role of EGFR post-transcriptional modifications on endosomal 
trafficking appears to be very complex.
The role of Cbl proteins in internalization, recycling and lysosomal targeting of ErbB 
receptors is under debate. The EGFR Y1045F mutation profoundly reduces but does not 
completely eliminate Cbl recruitment and ligand-induced receptor ubiquitination, as Cbl 
may still bind EGFR indirectly through Grb2 [16, 22-24]. Evidence supporting a role for EGFR 
ubiquitination in EGFR downregulation has therefore remained indirect. Although it was 
initially assumed that EGFR stimulation leads to Cbl-mediated poly-ubiquitination, 
subsequent experiments using antibodies that distinguish between mono- and poly- 
ubiquitin adducts suggested that the EGFR is mainly modified by mono-ubiquitin on multiple 
lysines (multi-ubiquitination) [37, 38]. More recently however, mass spectrometry analysis 
has suggested that the EGFR contains predominantly Lys63-linked poly-ubiquitin chains [39]. 
Strikingly, even mutation of up to nine different lysine residues in the kinase domain of the 
EGFR does not completely abolish ligand-induced EGFR ubiquitination [39]. The EGFR 
Y1045F mutation has been reported to decrease receptor internalization and degradation 
and to enhance receptor recycling in Chinese Hamster Ovary (CHO) cells [24, 40], although 
differences with the wild-type receptor are (relatively) small and such differences have not 
been universally reported in all cell types [24, 32, 40, 41]. Overexpression of a dominant 
negative Cbl has also been reported to inhibit internalization, enhance recycling, and inhibit 
lysosomal targeting of the EGFR [16, 23, 42-44]. Studies using c-Cbl deficient mouse 
embryonic fibroblasts suggested that c-Cbl is not required for EGFR internalization, but is 
required for lysosomal targeting and degradation of the EGFR [41], although redundancy 
with Cbl-b may still occur in this setting. On the other hand, RNA interferences studies 
against both c-Cbl and Cbl-b have suggested that Cbl proteins are required for 
internalization [39].
In this study, we (i) demonstrate that the Cbl binding sites of ErbB-1, -2 and -4 receptors 
are highly conserved during vertebrate evolution, and (ii) tested the hypothesis that ErbB2 
and ErbB4 Cbl binding sites are functionally impaired. Our results demonstrate that the Cbl 
binding sites of ErbB2 and ErbB4 are fully functional, and that the EGFR Cbl binding site is 
not essential for endosomal trafficking.
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Materials and Methods
Cell Culture and Reagents
Parental NIH3T3 cells and HER14 cells (NIH3T3 cells stably transfected with vector encoding 
the human EGFR protein) were kindly provided by Dr. J. Schlessinger (Yale University, New 
Haven, CT) [45]. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% newborn calf serum (NCS; Hyclone) in flasks coated with 0.1% 
gelatin. Cells were trypsinized when confluent and seeded in flasks for regular maintenance. 
Lipofectamine™ 2000 was purchased from Invitrogen. EGF was obtained from BD 
Bioscience. The following antibodies were used in these studies: a-EGFR monoclonal 
antibody (mAb) 528, a-EGFR polyclonal antibodies (pAb) 1005, a-Cbl mAb C15 (all Santa 
Cruz), a-EGFR mAb 13G8 (Alexis Biochemicals), a-EGFR mAb cocktail Ab12 (Neomarkers), a- 
EGFR mAb LA22 and a-phosphotyrosine mAb 4G10 (Upstate Biotechnology), a-GAPDH 
ab9485 (Abcam), a-ubiquitin pAb U5379 (Sigma). Goat anti-rabbit (GARPO) and goat anti­
mouse (GAMPO) mAbs linked to horseradish peroxidase were purchased from Signal 
Transduction Laboratories. Sepharose beads coupled to protein A were obtained from 
Amersham Biosciences. All PCR primers were obtained from Sigma.
Recombinant DNA Technology and Constructs
pcDNA3 EGFR Cbl Binding Site Mutants
pcDNA3 EGFR and pcDNA3 EGFR Y1045F were kindly provided by Dr. Y. Yarden (Weizmann 
Institute of Science, Rehovot, Israel). Mutations of the EGFR Cbl binding site were made 
using a modified pcDNA3 EGFR expression construct containing an AgeI site directly 3' of the 
codon for Pro1049, which was introduced by two-step PCR. The AgeI site was then used for 
the design of 3' primers carrying various mutations in the Cbl binding site (Table 1) followed 
by PCR amplification of the unique BstEII-AgeI fragment. Silent diagnostic restriction sites 
were introduced whenever feasible to facilitate screening of transformed bacteria. Primer 
sequences are available upon request. All mutations were verified by DNA sequencing.
Constructs for Retroviral Infection
pLXSN Neo was obtained from Dr. G. P. Nolan (Stanford University School of Medicine, CA, 
USA) [46]. The VspI site present in the ampicillin resistance gene of pLXSN Neo was removed 
by PCR-mediated site directed mutagenesis using the NdeI and PvuI sites. A linker containing 
a VspI site (5' AATTCCATTAATCCGCATC 3' and 5' TCGAGATGCGGATTAATGG 3') was 
introduced into the multiple cloning site of pLXSN Neo using EcoRI and XhoI. The EGFR 
constructs containing Cbl binding site variations (vide supra) were cloned into the modified
192 Chapter 7
pLXSN Neo vector using VspI and XhoI restriction sites. Primer sequences are available upon 
request. All mutations were verified by DNA sequencing.
Recombinant Protein Expression in NIH3T3 Cells
NIH3T3 cells were either transiently transfected using Lipofectamine™ 2000 according to 
the manufacturer's protocol or retrovirally infected with (mutant) EGFR constructs. Phoenix 
ecotrophic cells were kindly provided by Dr. G. P. Nolan (Stanford University School of 
Medicine, CA, USA) and Y. E. Noordman (Dept. Cell Biology, Nijmegen Centre for Molecular 
Life Sciences, Faculty of Medicine, Radboud University Nijmegen). To produce ecotrophic 
retroviral particles for subsequent infection of mouse NIH3T3 cells, 2x106 Phoenix cells were 
seeded in 10 cm diameter dishes (day 0). Next day (day 1) Phoenix cells were transfected 
with 20 |ag DNA of the appropriate constructs by standard calcium phosphate transfection 
procedures. NIH3T3 cells were seeded in 6-well plates at 2x105 cells/ well. On day 2, 6 ml of 
Phoenix media containing viral particles were collected and filtered through 0.45 |am filters 
to which 6 |al of polybrene (Sigma) (5 mg/ml) were added. After 10 min incubation on ice, 
NIH3T3 cells were infected with 2 ml virus containing media. On day 3, infected NIH3T3 cells 
were washed twice with media and subsequently kept on culture medium containing 800 
Hg/ml G418 for 7 to 10 days to ensure death of uninfected cells. Infected G418 resistant 
cells were subsequently cultured on medium without G418 and used in experiments.
125I-EGF Ligand Binding Assays
EGFR Downregulation
EGFR downregulation was performed exactly as previously described [47]. On day 1, cells 
were seeded at 1x105 cells per well and grown to confluence in gelatinized 24-well plates. 
The next day, cells were chilled on ice, medium was aspired and growth factors were added 
in 1 ml of serum-free 50 mM BES containing DMEM (pH 6.8) containing 0.5% BSA for 2 hours 
on ice to prevent receptor internalization during EGF loading. Cells were then transferred to 
37 °C for various lengths of time (0-120 min) in the presence of 0.3 mM monensin (Sigma) to 
prevent recycling of internalized EGFRs. At the end of the incubation period, the extent of 
ligand-induced downregulation of the EGFR was quantified by measuring the decrease in 
the ability of [125I]-murine (m)EGF to bind to the cells. This was carried out by washing the 
cells twice with ice cold acid buffer (135 mM NaCl, 5 mM HAc and 2.5 mM KCl, pH 2.5) to 
remove all non-internalized receptor-bound ligand. The cell medium was then neutralized 
by rinsing twice with DMEM, after which incubation was continued for an additional 1 hour 
at 37 °C in 1 ml DMEM/10% NCS to allow any internalized intact receptors to return to the
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cell surface. Subsequently, cells were put on ice and after the medium was aspired, they 
were incubated for 2 hours on ice with 100 |al 1 ng/ml of [125I]-mEGF in binding buffer. Cells 
were then rinsed with ice-cold PBS, followed by a 1 hour incubation with 250 |al/well 1% 
(v/v) Triton X-100. Extracted radioligand was measured in a y-counter (Packard Cobra II).
EGFR Recycling
EGFR recycling assays were performed as previously described [47]. Cells were seeded in 
gelatin-coated 24 well plates, 1x105 cells per well. The following day, the cells were chilled 
on ice, the medium was aspired and cells were incubated in the presence of TGFa (60 
ng/ml) for 2 hours on ice (indicated as time point -60  min). Subsequently, cells were 
transferred to room temperature for 1 hour to allow receptor internalization. Cells were 
quickly rinsed with PBS to remove unbound ligand and after addition of 200 |al of 
prewarmed DMEM plus 10% NCS, transferred to 37 °C for various lengths of time (0-120 
min). Ligand binding was measured by incubating the cells with 1 ng/ml of [125I]-mEGF in 
binding buffer for 2 hours on ice as described in the previous paragraph.
EGFR Internalization
EGFR internalization was performed as previously described [47]. Briefly, cells were seeded 
in gelatin-coated 24 well plates, 1x105 cells per well. The following day, the cells were chilled 
on ice and incubated with EGF (60 ng/ml) in 50 mM BES containing DMEM (pH 6.8) for 2 
hours on ice. Receptor internalization was subsequently induced by transferring the cells to 
room temperature for various lengths of time (0-120 min). Receptor internalization was 
quantified by measuring the decrease in cellular [125I]-mEGF binding after removal of all 
non-internalized receptor-bound ligand by a mild acid wash, as described above.
EGF Degradation
EGF degradation assays were performed as described previously [47]. Briefly, cells were 
seeded in gelatin-coated 24 well plates, 1x105 cells per well. The following day, the cells 
were chilled on ice and incubated with 1 ng/ml [125I]-mEGF in binding buffer for 2 hours on 
ice to allow ligand binding in the absence of endocytosis. Cells were then transferred to 
room temperature for 60 min to induce ligand internalization. The medium was aspired and 
cells were rinsed twice with ice-cold PBS. After removal of all receptor-bound ligand from 
the cell surface by a short incubation with 250 |al of acid buffer at 4 °C, cells were rinsed with 
ice-cold binding buffer, and incubated at 37 °C in 250 |al DMEM plus 10% NCS. After various 
incubation times (0-240 min), medium was collected and cells were lysed in 1 M NaOH.
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Acetone precipitations were performed on both cell lysates and medium, as described 
previously [47]. Ligand degradation was calculated from the percentage of non-precipitable 
radioactivity present in both cell lysate and medium at a given time point.
Cell Lysis, Immunoprecipitation, Immunoblotting and Densitometry
Cell lysis, immunoprecipitation and immunoblotting were performed exactly as described 
previously [48]. Signals on X-ray films of immunoblots were quantified using Adobe 
Photoshop 5.5 software. Briefly, 8-bit grayscale images were inverted and a small 
predefined rectangle was used to measure the mean pixel value of relevant signals and 
background using the histogram command. Background signals were subtracted from 
relevant signals leading to a corrected mean pixel value. Values obtained from post- 
translational modifications were then divided by the corrected mean pixel values of the 
immunoprecipitated material and subsequently normalized relative to a given sample 
(either EGFR wild-type or T =0). These normalized background-corrected relative mean pixel 
values (crMPVs) are indicated at the bottom of relevant figure panels. It should be noted 
that quantification of EGFR ubiquitin signals relative to EGFR levels is inherently difficult 
because the variable increase in EGFR molecular weight is associated with a concommitant 
decrease in the 180 kDa EGFR band.
Results
Evolutionary Conservation of ErbB Receptor Cbl Binding Sites
It has previously been reported that the Cbl variant SH2 domain selects a D[N/D]XpY motif 
from a degenerate phosphopeptide library containing variable amino acids at position -3, 
-2, -1 , +1, +2, and +3 relative to the phosphotyrosine [49]. However, subsequent structural 
analysis of the interaction between the Cbl TKB domain and a tyrosine phosphorylated 
substrate peptide derived from the cytoplasmic tyrosine kinase ZAP-70 revealed that the 
primary specificity determinants are likely to be C-terminal to the phosphotyrosine [50].
Specifically, a proline in the +4 position of the phosphopeptide packs in a shallow 
hydrophobic pocket of the Cbl TKB domain. It was concluded that additional contributions 
are provided by a negatively charged glutamic acid at position +3 and possibly an asparagine 
at position -2  of the substrate peptide. Comparison of the human ErbB receptor Cbl binding 
sites (Table 1) reveals that the Cbl binding site of ErbB-1, -2 and -4 proteins all contain a Cbl 
binding site with sequence XXQRpYSXDPT, with conservation of the central tyrosine, the 
proline at position +4, a negatively charged aspartate at position +3, and an arginine and
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glutamine at positions -1  and -2, respectively. Multiple sequence alignment (data not 
shown) indicates that the corresponding sequence of ErbB3 is HSQRHSLLTP, lacking the 
central tyrosine and replacement of the proline at +4 by a threonine, consistent with lack of 
Cbl binding to the tyrosine kinase deficient ErbB3 receptor [5, 42].
Receptor Cblbinding site
hErbBI FLQRpY1045SSDPT
hErbB2 ELQRpY1045S|lDPT
hErbB3 iB3nRiiil045snnmi
hErbB4 SjQRpY,o45S0DPT
ErbBl Mutants used in this study
Wild type FLQRpYl045SSDPT
Y1045F FLQR U ^ S S D P T
S1046A FLQRpY,o450SDPT
S1047A FLQRpY,o45S 0 )P T
S1046/1047A FLQRpY,o4503D Fr
S1046E ELQRpY,045@SDPT
S1047E FLQRpY1045S@DPT
S1046/1047E FLQRpYlü45gä3PT
F1041P ELQRpYl045SSDPT
F1041 P/Si 047E Ü.QRpY,045S|3DPTa
F1041 S/Ll 042T SjQRpY,045SSDPT
FLIÍST/S1047A g¡¡QRpY,045sED P Tb
Table 1 ErbB receptor Cbl binding sites and EGFR Cbl binding site mutants used in this
study aSequence identical to hErbB2 Cbl binding site. bSequence identical to hErbB4 Cbl binding site.
So far it is not clear whether variations in positions -4 , -3  and +2 between human ErbB 
paralogues are functionally significant. However, functional sites in proteins are usually 
highly conserved during evolution [51]. We therefore searched public ongoing draft and 
completed genome sequences deposited at the NCBI genbank database for the Cbl binding 
sites of ErbB receptors. As seen in Table 1 and the Supplementary Table S1, the ErbB 
receptor Cbl binding sites appear to be absolutely conserved among 21 species of placental 
mammals (only 3 amino acid substitutions are observed, which are likely due to low (2x) 
sequence coverage of the specific genome projects). Moreover, ErbB Cbl binding sites are 
highly conserved among other tetrapods. Bony fish contain 2 paralogues for each of the 
ErbB1, ErbB3 and ErbB4 genes. The ErbB4 Cbl binding site (STQRYSADPT) is also highly 
conserved among bony fish, with variations seen mainly at positions -4  and -3. In contrast, 
the EGFR (F[L/I/V]QRYS[S/T]DPT) and ErbB2 (PLQRYSEDPT) Cbl binding sites are less 
conserved among bony fish. These findings indicate that sequence variations among human 
ErbB Cbl binding sites are highly conserved during tetrapod -and to a lesser extent 
vertebrate- evolution, suggesting that sequence variations among ErbB receptor paralogues 
in the Cbl binding site are functionally important. The motif RpYXXDPT appears to be nearly 
absolutely conserved among all vertebrate ErbB-1, -2 and -4 receptor Cbl binding sites.
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Serine 1046 and 1047 Phosphorylation Sites
Given that (i) phosphorylation of EGFR Ser1046 and Ser1047 has previously been reported to 
play a role in endosomal trafficking of the EGFR [27-29, 32, 52, 53], (ii) it has been 
hypothesized that poor Cbl binding to ErbB2 and ErbB4 correlates with poor downregulation 
of these ErbB receptors [3, 10], and that (iii) amino-acid substitutions among ErbB receptor 
Cbl binding sites are highly conserved among tetrapods, we investigated the functional 
significance of Cbl binding site variations seen among human ErbB receptors with respect to 
ErbB receptor ubiquitination and endosomal trafficking. Initially, we simultaneously 
replaced the two serine residues for (i) alanine, or (ii) glutamate (to mimic a constitutively 
phosphorylated serine residue) (see also Table 1) and investigated the effect of these 
mutations on ligand-induced Cbl recruitment and EGFR ubiquitination. We also used EGFR 
Y1045F mutant as a negative control for ligand-induced Cbl recruitment and EGFR 
ubiquitination. Recombinant proteins were transiently transfected into NIH3T3 cells. As 
shown in Figure 1A, the EGFR Y1045F and the S1046/1047A and S1046/1047E double 
mutants displayed EGF-induced tyrosine phosphorylation, similar to the wild type EGFR. 
Anti-EGFR immunoblotting also showed that both wild-type and mutant EGFRs display a 
characteristic upward mobility shift upon stimulation with ligand (Figure 1A). As shown in 
Figure 1B, the Y1045F mutant displayed severely reduced ubiquitination, as expected. In 
contrast to a previous publication [32], EGF-induced ubiquitination of the S1046/1047A and 
S1046/1047E double mutants was readily observed and similar compared to wild type 
(Figure 1B). It should be noted that ubiquitination of the EGFR results in a variable upward 
shift in the molecular weight of the protein and a concomitant decrease in the amount of 
the 180 kDa protein band. Consistent with normal EGF-induced ubiquitination, co­
precipitation analysis demonstrated that the S1046/1047A and S1046/1047E double 
mutants also showed normal binding of c-Cbl to the EGFR, while Cbl interaction with the 
Y1045F mutant was strongly reduced (Figure 1C). Quantification of bands from multiple 
experiments further confirmed these conclusions (Figure 1D). Similar results were also 
obtained when either Ser1046 or Ser1047 alone were substituted for alanine or glutamate 
(data not shown).
To better investigate ligand-induced EGFR degradation and endosomal trafficking of the 
mutant EGFR proteins, we established retrovirus infected NIH3T3 cell lines of the EGFR wild­
type and mutant constructs. EGFR expression was analyzed by Western blotting and flow 
cytometry and compared to HER-14 cells that express approximately 3x105 EGF receptors at 
the cell surface [45]. As seen in Supplementary Figure S1 (top panel), EGFR cell surface 
expression of the retrovirus infected wild-type and mutant EGFR cell lines was very similar
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compared to HER-14 cells. EGFR expression of the retroviral cell lines was also evaluated by 
flow cytometry (Supplementary Figure S2 A-C). All EGFR mutant cell lines showed expression 
comparable to HER-14 (Supplementary Figure S2 A, C) or EGFR wt (Supplementary Figure S2 
B, C). As seen in Supplementary Figure S2 C, HER14 and NIH3T3/EGFR wt cell lines also show 
similar expression levels. We therefore conclude that all these cell lines show similar EGFR 
expression levels, which are comparable to the expression seen in HER14 cells, thereby 
allowing a fair comparison between different cell lines.
Figure 1 Role of EGFR Ser1046 and Ser1047 in EGFR tyrosine phosphorylation,
ubiquitination and Cbl recruitment. (A), (B) and (C) NIH3T3 cells were transiently transfected with 
vector encoding EGFR wt, Y1045F, S1046A/S1047A or S1046E/S1047E EGFR proteins. Cells were 
starved overnight and stimulated with EGF (100 ng/ml) for 20 min. Anti-EGFR (528) 
immunoprecipitates (IPs) and whole cell lysates were analyzed by Western blotting using anti- 
phosphotyrosine (4G10), anti-EGFR (1005), anti-ubiquitin (Ubq) or anti-Cbl (C15) antibodies. 
Densitometric corrected relative mean pixel values (crMPVs) for EGFR tyrosine phosphorylation, 
EGFR ubiquitination and EGFR-Cbl recruitment are normalized relative to the wild-type and indicated 
below each lane. (D) Densitometric corrected relative mean pixel values of EGFR tyrosine 
phosphorylation (n=3), EGFR ubiquitination (n=3) and EGFR-Cbl recruitment (n=2) are plotted as
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mean±standard error of the mean (SEM). Note that the SEM of the EGFR WT+EGF group is equal to 
zero as this category was used for normalization (crMPV=1).
Figure 2 Role of EGFR Ser1046 and Ser1047 residues in EGF-induced EGFR degradation. (A)
and (B): Retroviral infected NIH3T3 cell lines expressing the indicated constructs were starved 
overnight and stimulated for various periods of time with 60 ng/ml EGF or they were left 
unstimulated. Whole cell lysates were analyzed by electrophoresis and Western blotting with a- 
EGFR (1005) or anti-GAPDH antibodies. Densitometric corrected relative mean pixel values are 
normalized for each constructs at timepoint 0 and indicated below each lane. (C) Densitometric 
corrected relative mean pixel values of EGFR degradation in HER14 (n=2), EGFR WT (n=3), EGFR 
Y1045F (n=3), EGFR S1046/1047A (n=2) and EGFR S1046/1047E (n=2) are plotted as mean±standard 
error of the mean (SEM). Note that the SEM at T =0 hour is equal to zero as this category was used 
for normalization (crMPV=1).
To determine whether Cbl-mediated EGFR ubiquitination correlates with EGFR 
degradation, we analyzed whole cell lysates for EGFR expression following EGF stimulation. 
As seen in Figure 2A and C, EGF-induced EGFR degradation is delayed (but not blocked) in 
the Y1045F mutant relative to the wild-type EGFR. However, EGF-induced EGFR degradation 
of the S1046/1047A and S1046/1047E double mutants was similar as wild-type EGFR and 
HER-14 cells (Figure 2B and C). Similar results were also obtained when either Ser1046 or 
Ser1047 alone were substituted for alanine or glutamate or when using lower EGF 
concentrations (data not shown). These findings demonstrate that phosphorylation of
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Ser1046 or Ser1047 does not profoundly affect EGF-induced tyrosine phosphorylation, 
ubiquitination or degradation of the EGFR in NIH3T3 cells.
Retroviral cell lines were then used to evaluate endosomal trafficking of the EGFR 
mutant constructs by standard 125I-EGF labelled ligand binding assays, as detailed in the 
Materials and Methods section. As a negative control, we used the truncated EGFR C'957 
construct, which contains a stop codon after the last residue (Ile957) of the EGFR kinase 
domain (Supplementary Figure S2 C). It has been demonstrated that this truncated EGFR 
fails to undergo significant EGF-induced internalization. As seen in Figure 3 (top panel), the 
truncated EGFR C'957 construct failed to undergo significant EGFR downregulation, while 
the S1046/1047A and S1046/ 1047E double mutants showed EGFR downregulation similar 
to wild type, EGFR Y1045F mutant and HER-14 cells. Consistent with our previously 
published data [54], we could not detect EGF-induced recycling of the wild-type EGFR in 
HER-14 cells, nor could we detect EGF-induced EGFR recycling for the Y1045F, S1046/1047A 
and S1046/ 1047E double mutant constructs (data not shown). In contrast to EGF, TGFa 
displays pH-dependent binding to the EGFR leading to premature dissociation of TGFa from 
the EGFR in acidifying endosomes [54]. As a result, a significant fraction of internalized 
EGFRs is recycled to the plasma membrane after TGFa stimulation [7, 54] and we previously 
demonstrated that this correlates with decreased ubiquitination and decreased degradation 
of the receptor [48]. The EGFR S1046/1047A and S1046/1047E double mutant constructs 
were also indistinguishable from wild-type EGFR and the Y1045F mutant following TGFa- 
induced EGFR recycling (Figure 3, middle panel). Analysis of 125I-EGF ligand degradation 
(Figure 3, bottom panel) also revealed no significant differences between EGFR wt, Y1045F, 
S1046/1047A and S1046/1047E double mutant constructs. Thus, our findings demonstrate 
that phosphorylation of the EGFR Ser1046 and Ser1047 residues within the Cbl binding site 
does not affect EGFR-internalization, -downregulation, -recycling or ligand degradation in 
NIH3T3 cells. These findings also demonstrate that the EGFR Y1045F mutation, despite 
severely hampering Cbl recruitment and EGFR ubiquitination, does not affect ligand-induced 
EGFR downregulation, -internalization, -recycling or ligand degradation in NIH3T3 cells. 
Nevertheless, the EGFR Y1045F mutation does slow down EGFR degradation as assessed by 
Western blotting. We speculate that this may be due to prolonged retention times of the 
EGFR Y1045F protein on the limiting membrane of acidifying endosomes [55], leading to 
premature dissociation of (part of) the bound EGF which, in turn, may be transported to the 
lysosome for degradation.
200 Chapter 7
o - - - - - - - - - - 1- - - - - - - - - - 1- - - - - - - - - - !- - - - - - - - - - 1
0 30 60 90 120
time (min)
0 -I------- 1------- 1------- 1------- 1------- 1------- 1
-60 -30 0 30 60 90 120 
time (min)
o H-- - - - - - - - - p- - - - - - - - - - 1- - - - - - - - - - 1- - - - - - - - - - 1
0 60 120 180 240
t im e  (m in)
Figure 3 Role of EGFR serine1046/1047 residues in ligand-induced receptor-
downregulation, recycling and ligand degradation. NIH3T3 cells were infected with retrovirus 
containing EGFR w t (closed squares), Y1045F (open triangles), S1046A/S1047A (open circles), 
S1046E/S1047E (open squares) or truncated EGFR C'957 (closed circles). HER14 cells (closed 
diamonds) were used as a control. Data points represent the mean of triplicate measurements. Top 
panel, EGF-induced EGFR downregulation; middle panel, TGFa-induced EGFR recycling; and bottom  
panel, 125I-EGF degradation. Results are representative of 3 independent experiments.
ErbB2 and ErbB4 Cbl Binding Sites
It has previously been reported that ErbB2 and ErbB4 receptors poorly bind Cbl proteins [10, 
12]. However, the molecular basis for this observation has not been established. As 
phylogenetic analysis has demonstrated that variations in the Cbl binding site of ErbB-1, -2 
and -4 receptors are highly conserved among tetrapods, it is possible that such variations 
cause decreased Cbl binding and ErbB receptor ubiquitination. Furthermore, it has
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previously been suggested that amino acids N-terminal of the phosphorylated Tyr1045 
residue of the EGFR may contribute to the specificity and affinity of Cbl binding [49, 50]. 
Moreover, secondary structure prediction of the EGFR cytoplasmic tail using the SOPM 
secondary structure prediction server [56] suggests the possibility that the Cbl binding site 
in ErbB1 -but not in ErbB2 or ErbB4- is preceded by a short a-helix, i.e.EDSFLQR. It is 
therefore interesting to note that, nearly all vertebrate ErbB2 receptors contain a proline 
residue at -3  or -4  positions which likely distorts such a putative a-helix. On the other hand, 
ErbB4 receptors contain a branched threonine residue which has a low propensity to form 
a-helices.
To further investigate the functional significance of Cbl binding site variations, we 
introduced single, double and triple mutations into the EGFR Cbl binding site to resemble 
amino acid substitutions seen in ErbB2 and ErbB4 (Table 1). We then established retroviral 
cell lines of these constructs, verified similar EGFR expression levels of the mutant cell lines 
by Western blotting (Supplementary Figure S1, 2nd panel) and flow cytometry 
(Supplementary Figure S2 B), and subsequently used them for analysis. The EGFR 
F1041P/S1047E double mutation, which mimics the ErbB2 Cbl binding site (Table 1) did not 
abolish EGF-induced EGFR ubiquitination (Figure 4A), EGFR tyrosine phosphorylation (data 
not shown) or Cbl binding (Figure 4A). Similarly, the EGFR F1041S/L1042T/S1047A triple 
mutation, which mimics the ErbB4 Cbl binding site (Table 1), also did not abolish EGFR 
ubiquitination, EGFR tyrosine phosphorylation or Cbl binding (Table 1, Figure 4A). Similar 
results were also obtained for the EGFR F1041P single and F1041S/L1042T double mutations 
(data not shown). Indeed, we did not observe severely decreased ubiquitination or Cbl 
binding for any of the mutants except for the EGFR Y1045F mutation (Figure 4A and C). 
Please note that co-precipitation of Cbl with the EGFR F1041P mutant was established by 
anti-phosphotyrosine blotting (Figure 4A, 3rd panel, lane 6) although it was not seen by anti- 
Cbl blotting in the experiment shown in Figure 4A, (Figure 4A, 2nd panel, lane 6). Duplicate 
experiments confirmed co-precipitation of the EGFR F1041P mutant with Cbl (data not 
shown). Introduction of the ErbB2 Cbl binding site (F1041P/S1047E) or the ErbB4 Cbl binding 
site (F1041S/L1042T/S1047A) into the EGFR also did not significantly affect EGF induced 
EGFR degradation as assessed by Western blotting (Figure 4B and D). 125I-ligand binding 
assays using these cell lines further demonstrated that introduction of the ErbB2 Cbl binding 
site (F1041P/S1047E) or the ErbB4 Cbl binding site (F1041S/L1042T/S1047A) did not affect 
EGF-induced EGFR downregulation (Figure 5, top panel), TGFa-induced EGFR recycling 
(Figure 5, middle panel), or 125I-EGF ligand degradation (Figure 5, bottom panel). These 
findings demonstrate that ErbB2 and ErbB4 Cbl binding sites (as defined from positions -4  to
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+4) cannot be distinguished from the wild-type EGFR Cbl binding site in terms of ligand- 
induced EGFR tyrosine phosphorylation, EGFR ubiquitination, EGFR degradation, Cbl 
recruitment, EGFR downregulation and EGF ligand degradation. We therefore conclude that 
the molecular basis for the reported poor downregulation of ErbB2 and ErbB4 receptors is 
unlikely to be due to evolutionary conserved variations in the Cbl binding site of these 
receptors relative to the EGFR.
EGFR ubiquitination
O T- 
IU >■
- + - +
Cl
I
W
CL (/)
2
w 3 00
% 2.50
i 2.00
S 1.50 0>
2  1.00
J  0.50
«5 o.oo
180 kDa 
120 kDa
120 kDa
B
■ ■ •4
0.25 1.00 0 23 0 33 0 23 1 62 0 24 1 96 034 1.31 0 30 1 86
IB  IH  IB  Bk 
• * * *4. h
0.29 1.00 0.26 0.32 0.42 1.14 0.41 2.33 0.31 2.20 0.45 2.63
--►
0.07 1.00 0 06 0.12 0 06 0.76 0 00 1.47 000 1.97 0 0 0 1 20
— ------- - - - - —
100 ng/ml EGF
IP: EGFR  
IB: Ubq
IP: EGFR  
IB: c-Cbl
IP: EGFR 
IB: pTyr
IP: EGFR 
IB: EGFR
M ±
O k  O
LU I LU
WT
• ok o
LU I LU
Y1045F
• ok o
HI I LU
F1041P
■ ok o
LU I LU
FS-PE
ok o
FL-ST
• O
LU
FLS
♦ O
UJ
STA
EGFR-Cbl interaction
0 2 4 6 hr EGF 
«  »  — WT
1 00 0 58 0 28 0.31
^  n  A  F1041P/S1047E
1.00 0.66 0.41 0.33
• •  " * " *  « F1041S/L1042T/S1047A
1.00 0.76 0.43 0.25
WCL 
IB: EGFR
■5 3.50
^  3.00O)
.5 2.50 ^ 2.00
S 1.50
s  1.00 0>
Z  0 .50
I  0.00
an
¡ i I
1 i i i 1 . 1I • M
O k  O 
LU I LU O k  O LU I UJ O k  OUJ I UJ OLU I oLU I oUJ I
EGFR degradation
■i 1-20 5Z  1.00 4 
3~  0.80
g 0.60
I  0.40 a>£ 0-20
7 0.00 Q¿
1 1 1 . 1 1 1  è 11 i
1 2 1 4 6 0 2 1 4 6 0 1 2 1 4 1
WT FS-PE FLS-STA
i
Figure 4 ErbB2 and ErbB4 Cbl binding sites support efficient EGFR ubiquitination and
degradation. NIH3T3 cells were retrovirally infected with EGFR wt, Y1045F, F1041P/S1047E (= ErbB2 
Cbl binding site) or F1041S/L1042T/S1047A (= ErbB4 Cbl binding site). (A) Cells were starved 
overnight, and stimulated with EGF (100 ng/ml) for 20 min. Anti-EGFR immunoprecipitates were 
analyzed by electrophoresis and Western blotting with the indicated antibodies. (B) Cells were 
starved overnight and stimulated with EGF (60 ng/ml) EGF for 2, 4 and 6 h, or left unstimulated. Cell 
lysates were analyzed by electrophoresis and Western blotting with anti-EGFR. Densitometric 
corrected relative mean pixel values are normalized relative to the wild-type (A) or timepoint 0 (B) 
and indicated below each lane. (C) Densitometric corrected relative mean pixel values of EGFR 
ubiquitination (n=3) and EGFR-Cbl recruitment (n=3) are plotted as mean±standard error of the 
mean (SEM). Note that the SEM of the EGFR WT+EGF group is equal to zero as this category was 
used for normalization (crMPV=1). Abbreviations: FS-PE (F1041P/S1047E), FL-ST (F1041S/L1042T), 
FLS-STA (F1041S/L1042T/S1047A). (D) Densitometric corrected relative mean pixel values of EGFR
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degradation in EGFR WT (n=3), EGFR FS-PE (F1041P/S1047E) (n=2), and EGFR FLS-STA 
(F1041P/L1042T/S1047A) (n=2) are plotted as mean±standard error of the mean (SEM). Note that 
the SEM at T=0 hour is equal to zero as this category was used for normalization (crMPV=1).
time (min)
Figure 5 Introduction of ErbB2 or ErbB4 Cbl binding sites in EGFR does not affect EGFR
downregulation, EGFR recycling or ligand degradation. NIH3T3 cells were retrovirally infected with 
EGFR wt (closed squares), F1041P/S1047E (= ErbB2 Cbl binding site, open circles) or 
F1041S/L1042T/S1047A (= ErbB4 Cbl binding site, open squares). Data points represent the mean of 
triplicate measurements. Top panel, EGF-induced EGFR downregulation; middle panel, TGFa- 
induced EGFR recycling; and bottom panel, 125I-EGF degradation. Results are representative of 2 
independent experiments.
204 Chapter 7
Discussion
It has previously been reported that ErbB receptors other than the EGFR are poorly 
downregulated. It has been postulated that poor downregulation of these receptors 
correlates with decreased binding to Cbl E3 ligase adaptor proteins [10, 12]. However, this 
hypothesis has not been experimentally verified. Here we demonstrate that the EGFR Cbl 
binding site (residues 1041-1049; residues -4  to +4 relative to pTyr1045) can be readily 
replaced by the evolutionary highly conserved Cbl binding sites of ErbB2 and ErbB4, without 
any profound effect on EGFR-tyrosine phosphorylation, -ubiquitination, -degradation, - 
internalization, downregulation and -recycling or on ligand degradation in NIH3T3 cells. We 
conclude that phosphorylated serine residues located within the EGFR Cbl binding site do 
not affect EGFR downregulation and that the Cbl binding sites of ErbB2 and ErbB4 receptors 
can functionally replace the EGFR Cbl binding site.
EGFR Serine 1046/1047 Phosphorylation
Various EGFR serine residues have been reported to undergo phosphorylation. Specifically, 
the serine residues within the EGFR Cbl binding sites (Ser1046 and Ser1047) have been 
reported to undergo PMA-, PDGF-and EGF-induced phosphorylation in vivo based on 
phosphopeptide mapping data [26, 27]. They were also reported to be efficiently 
phosphorylated by CaM Kinase II in vitro [28, 31]. In contrast to the EGFR Ser1047, the 
corresponding ErbB2 Ser1093 residue is not efficiently phosphorylated by CaM Kinase II in 
vitro [57]. Ouyang et al. [58] reported the generation of ErbB2 phospho-Ser1093 specific 
antibodies and reported ErbB2 Ser1093 phosphorylation in response to EGF-induced EGFR- 
ErbB2 heterodimerization.
The functional significance of EGFR Ser1046 and Ser1047 phosphorylation is a matter of 
debate. Countaway et al. [27] initially reported that single S1046A and S1047A mutations 
did not affect EGFR downregulation in CHO cells. In a subsequent study, Countaway et al. 
[28] reported that EGFR S1046/1047A double mutants showed defective EGFR internaliza­
tion and downregulation at low EGF concentrations, while subsequent studies from the 
same group suggested that moderately expressed EGFR S1046/1047A double mutants 
showed no defects a low EGF concentrations but displayed impaired internalization and 
downregulation at high EGF concentrations [30]. More recently, Oksvold et al. [32] reported 
that the S1046/1047A double mutant (i) does not display the characteristic EGF induced 
mobility shift, (ii) fails to undergo efficient ubiquitination despite normal Cbl recruitment, 
and (iii) shows reduced EGFR degradation based on short term semi-quantitative Western 
blotting and confocal microscopy studies in NIH3T3 cells. In contrast, our results obtained in
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NIH3T3 cells clearly show EGF-induced mobility shift, Cbl recruitment and efficient EGF- 
induced ubiquitination of the EGFR S1046/1047A double mutant (Figure 1). Moreover, 
quantitative analysis of receptor downregulation using 125I-EGF ligand binding assays 
demonstrated no significant differences between wild-type and S1046/1047A in terms of (i) 
EGFR downregulation, (ii) EGFR internalization, (iii) EGFR recycling, and (iv) EGF ligand 
degradation (Figure 3). This was further supported by EGFR degradation assays as assessed 
by Western blotting (Figure 2). The reason for these discrepant results is not clear but may 
be related to the use of different host cell types, read-out assays and/or differences in EGFR 
expression levels.
Thus, our findings indicate that poor downregulation of ErbB2 and ErbB4 relative to the 
EGFR is not due to functional differences in the Cbl binding site of these receptors, but is 
likely due to other differences between these receptors. As previously discussed, the EGFR 
contains additional endosomal sorting signals, including Tyr974 and a dileucine signal at 
1010LL that associate with AP2^ and AP2ß, respectively. Evaluation of the presence of similar 
motifs in vertebrate ErbB receptors reveals that ErbB2 and ErbB4 (but not ErbB3) contain 
evolutionary conserved motifs that resemble the EGFR YxxO AP2^ binding motif 
(Supplementary Table S2). Whether mutation of these sites in ErbB2 and ErbB4 affects their 
endosomal sorting is not clear yet. Interestingly, the EGFR dileucine motif that has been 
hypothesized to affect lysosomal targeting of the EGFR [14] is present only in EGFR 
orthologues but not in ErbB2, ErbB3 or ErbB4 (data not shown). Thus, the absence of this 
motif in ErbB-2, and -4 may be a reason for reduced lysosomal targeting and enhanced 
recycling of these receptors. EGFR orthologues also contain the QQGFF motif 
(Supplementary Table S3), a predicted ß-turn that follows an acidic a-helical region, that 
was previously shown to be functional as an endocytic sorting signal [15,16]. Analysis of 
vertebrate ErbB orthologues reveals that this motif is evolutionary conserved also in ErbB2, 
but this motif is absent in ErbB3 and ErbB4 orthologues. The absence of this motif in ErbB4 
may therefore also reduce the downregulation capacity of ErbB4. Finally, there may be yet 
unidentified endosomal sorting signals that differ between the EGFR, ErbB2 and ErbB4. It is 
clear that multiple endosomal sorting signals cooperate to regulate downregulation of ErbB 
receptors [16], but further studies are required to obtain a complete understanding of the 
molecular basis for the endosomal trafficking of ErbB receptors.
This study was supported by a grant from the Dutch Cancer Society (KUN 2001-2453).
The Supplementary Figures are available at http://www.celbi.science.ru.nl/downloads/ 
thesisdamen.zip.
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In this thesis we have investigated the role of the retromer complex in receptor 
trafficking. When we started this project, not much was known about the role of the 
retromer complex and its individual subunits. The threading searches of the retromer 
subunits and the phylogenetic analysis of all eukaryote kingdoms, as described in Chapter 2 
and 3, respectively, provided us with insight in the function of the retromer subunits and the 
orthologue relationships among the Vps26, Vps29 and Vps35 genes. In Chapter 4 we studied 
the predictive metallo-phosphoesterase function of hVps29 in more detail and 
demonstrated that hVps29 can function as a phosphoesterase for a CI-M6PR derived 
peptide substrate in vitro. In this chapter we also demonstrated that hVps29 is capable of 
binding to zinc molecules. In Chapter 5 we studied interaction proteins of the retromer 
complex. We demonstrated that the retromer components hVps26, hVps29 and hVps35 
interact with a- and ß-tubulins in vivo and with the microtubule-associated Hook proteins in 
vitro. In addition, we described interactions of all three retromer proteins with an as yet 
unidentified protein of approximately 47 kDa. To perform the studies described in this thesis 
various heterologous expression systems and a range of epitope-tags were tested, which are 
described in detail in Chapter 6. In Chapter 7 we studied ErbB downregulation and especially 
the role of the Cbl binding site in this process.
In this chapter we will integrate our results with those published by others and discuss i) 
the structure of retromer subunits, ii) the assembly of the sorting nexin/retromer complex, 
iii) the sorting nexin/retromer complex as vesicular coat complex, iv) the retromer complex 
and endosome-to-Golgi retrieval pathways, v) the retromer complex and cargo selection 
and vi) the role of retromer complex in disease.
8.1 Structure of Retromer Subunits
In order to elucidate the functional role of the retromer complex in receptor trafficking, we 
have used various bioinformatic approaches to predict possible functions of the retromer 
proteins (Chapter 2). Using various fold recognition algorithms, we predicted that Vps26, 
Vps29 and Vps35 show significant similarity to the ß-arrestin fold, the metallo- 
phosphoesterase fold and ARM/HEAT helical repeat fold, respectively. The crystal structure 
of these proteins were subsequently reported [1-5]. Although we did not specifically 
compare our predicted structures with the experimentally determined crystal structures of 
the various retromer subunits, we conclude - in retrospect - that our structure prediction 
analyses have provided us with meaningful insight into the structures of the retromer 
proteins.
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X-ray crystallographic analyses have shown that Vps26 has a two lobed structure with a 
polar core and a flexible linker. This structure is closely similar to the arrestin family of 
trafficking adaptors [4, 5]. As predicted by our threading analysis, Vps26 has the same 
overall arrestin fold and also possesses an extended C-terminal tail and an unusual polar 
core between the N-terminal and C-terminal domain, which suggests that hVps26 may 
similarly be able to adopt different conformations upon interaction with other proteins. The 
exact role of Vps26 has not been determined yet, but the structural relation to arrestins 
suggests potentially analogous functions such as binding to GPCR cargo molecules, 
interaction with phospholipid membranes or recruitment of regulatory proteins to sites of 
retromer function.
As is described in the phylogenetic analysis of Chapter 3, Vps26 has a paralogue, Vps26B. 
The crystal structures of Vps26A and Vps26B appear very similar [4]. Collins et al. [4] 
revealed that only one Vps26 protein can be incorporated in the retromer complex and that 
both proteins compete for a single binding site on Vps35. Both Vps26A and Vps26B are 
expressed during different stages of development. Tissues differ in their expression levels, 
but no clear tissue- or cell-specific pattern is observed that could provide an indication for 
differences in the role of these two proteins [8]. Vps26A and Vps26B are clearly not 
functionally redundant, given the observation that an insertion mutation in Vps26A alone is 
embryonically lethal [9]. While it is clear that the C-terminal subdomain is highly conserved 
between both paralogues, the N-terminal domain appears more divergent. A model has 
been proposed in which Vps26 binds Vps35 through the conserved C-terminal subdomain, 
while the divergent N-terminal domain is free to engage itself with other cellular 
components, which may specify the different functions of the two Vps26 paralogues [2, 4]. 
It is very well possible that both proteins are important for distinct retromer-dependent 
transport processes or alternatively that they might be required in different tissues or at 
different developmental stages.
Vps35
To date, no complete structure exists for the Vps35 subunit, although a C-terminal fragment 
encompassing residues 476-780 of the protein (out of a total of 796 residues) has been 
crystallized in complex with Vps29. The structure of Vps35 revealed an a-solenoid fold that 
curves around Vps29 [2]. The C-terminal fragment of Vps35 possesses a curved all a-helical 
structure composed of HEAT (huntingtin, elongation factor 3, protein phosphatase 2A, 
TOR1)-like helical repeats arranged in a right-handed superhelix, as predicted by our
Vps26
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threading analyses (Chapter 2). Similar helical repeat structures have been found in many 
different proteins with diverse functions [10]. These include the trunk domains of the large 
adaptin subunits of the AP complexes involved in clathrin-mediated transport [11], 
members of the importin-ß protein family involved in nuclear import [12] and the A 
scaffolding subunit and B56y regulatory subunit of the trimeric protein phosphatase 2A 
(PP2A), which has numerous roles in signal transduction [13]. The surface of Vps35 consists 
of a series of ridges separating hydrophobic grooves, which suggests the presence of 
potential cargo-binding sites [2]. This would be in agreement with the function of Vps35 as a 
substrate binding subunit.
Vps29
As predicted from our threading analyses in Chapter 2, the crystal structure of Vps29 
confirmed that this protein has a phosphoesterase fold [1-3], consisting of a globular a/ß 
topology with a central ß-sandwich surrounded by a-helices. Vps29 contains a metal-binding 
site that is very similar to the active sites of some proteins of the phosphoesterase/nuclease 
protein family [1-3]. In line with the overall phosphoesterase fold of Vps29, we 
demonstrated in vitro phosphatase activity of the hVps29 containing retromer complex 
towards a serine phosphorylated peptide SFHDDpSDEDLLHI substrate, containing the acidic- 
cluster dileucine motif of the CI-M6PR tail (Chapter 4). Moreover, we demonstrated by 
affinity precipitations that hVps29 interacts with the other retromer subunits, consistent 
with the observations of Collins et al. [1], and that the addition of hVps26 and hVps35 to the 
reaction mixture greatly enhanced the phosphatase activity. These results suggested that 
the retromer complex functions as a holoenzyme: the complete complex contains all the 
subunits needed for activity. Indeed, using hVps26-GST as a bait, we were able to affinity 
precipitate the hVps29 and hVps35 retromer subunits, which resulted in the formation of a 
complex with phosphatase activity. The requirement of the other retromer subunits may be 
due to the involvement of Vps26 and/or Vps35 in substrate recognition [14-18] or assembly, 
folding or stability of the active retromer complex [17, 19, 20].
In order to reveal the identity of the metal ions in the active site of recombinant hVps29, 
we performed ICP-MS analysis on bacterially expressed and purified hVps29. This analysis 
revealed that hVps29 contains Zn2+, similarly as many other PPP-type phosphatases, 
including purple acid phosphatase (PDB entry 4KBP) [21], calcineurin (1AUI) [22] and 5' 
nucleotidase (1USH) [23]. We demonstrated that zinc binding is involved in the enzymatic 
activity of hVps29 by performing phosphatase assays with the specific zinc metal chelator 
TPEN, which reduces the phosphatase activity. Moreover, we demonstrated that addition of
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ZnCl2 after TPEN treatment restored the phosphatase activity. We performed ICP-MS 
analysis and 65Zn-binding overlay assays on GST-hVps29 catalytic site mutants to investigate 
the zinc-binding capacity in more detail. We also used ICP-MS analyses to test the D8A, 
N39A and D62N mutants of hVps29 and showed impaired zinc binding to approximately 
25%, 50% and 60%, respectively, of the wild-type protein (Chapter 4). The 65Zn-binding 
overlay assays revealed that mutation of metal coordinating Asp8, Asn39, Asp62, His86 and 
His117 residues resulted in severely reduced zinc binding, whereas mutation of Arg14 and 
Asn140, which are not directly involved in metal binding, retained wild-type zinc binding 
capacity. Our findings therefore demonstrate that recombinantly expressed Vps29 contains 
Zn2+ ions, which are bound by the predicted metal coordinating catalytic site residues.
Apart from metal ions the active site of metallo-phosphoesterases also contains water 
molecules. One of these water molecules is invariably involved in the coordination of both 
metal ions in a ^-hydroxo bridge (W1) and frequently a second water molecule (W2) is 
detected bound to metal ion #1. pKa calculations based on our model indicate that the pKa 
of W1 in hVp29 is sufficiently low to be deprotonated and to become a hydroxide ion. W1 in 
hVp29 is opposite of the leaving group and therefore in an ideal position for in-line attack of 
the phosphorus atom (Chapter 4, Figure 4). We therefore favor the hypothesis that the 
hydroxide ion W1 is the nucleophile that attacks the phosphate group. His88 positioned on 
the periphery of the catalytic site, behind His86, has a calculated pKa value of 5.0 in the 
presence of phosphate and a pKa value of 3.0 when the phosphate is removed. Due to its 
location, His88 is not likely to participate directly in the dephosphorylation reaction. 
Nevertheless, His88 may function in concert with His86 as a relay system to transport the 
proton, which results from the deprotonation of W1, away from the active site. Indeed, 
introducing a H88F mutation in hVps29 mutation results in a 40-50% reduction of the 
enzymatic activity of the retromer complex in the phosphatase assays (Chapter 4).
We have also carefully considered the identity of the proton donor that protonates the 
oxy-anion of the leaving group. Unlike most other eukaryotic PPP-type metallo- 
phosphatases, Vps29 lacks a catalytic histidine in motif III. It is not likely that Vps26 and/or 
Vps35 retromer proteins contain the histidine that serves this purpose, since there is very 
little space to insert a histidine in the gap that is formed by the outward movement of 
Phe63 following metal binding (E. Krieger, data not shown). Importantly, despite lacking a 
catalytic histidine in motif III, the archaeal protein MJ0936 is also an active metallo- 
phosphoesterase [24], indicating that a catalytic histidine is not absolutely required for 
phosphoesterase activity. Yet another possibility to be considered is that there is no specific
214 Chapter 8
proton donor for the leaving group, and that the leaving group slowly retrieves a proton 
from the water bulk.
Based on our model of the hVps29 catalytic site, containing metal ions and a phosphate 
group of the cargo substrate peptide, we further proposed that Arg14 in the catalytic site 
might be involved in phosphate binding. Mutation of this residue indeed resulted in reduced 
phosphatase activity to the CI-M6PR based serine-phosphorylated peptide in the 
phosphatase assays without reduction of zinc binding in the 65Zn-binding overlay assay 
(Chapter 4).
Based on these findings, we proposed a working model for the in vivo role of the 
retromer complex in the endosome-to-Golgi transport of the CI-M6PR (Chapter 4, Figure 
12). Trafficking of the CI-M6PR depends on the phosphorylation status of the receptor. After 
binding to mannose 6-phosphate-tagged lysosomal hydrolases in the TGN, the 
phosphorylation of Ser2492 within the acidic-cluster dileucine motif acts as a sorting signal 
for anterograde transport by binding to GGA1 and GGA3 [25]. The GGA proteins will 
transport the CI-M6PR by clathrin-coated pits to the endosome. In the endosome the CI- 
M6PR will dissociate from its ligand, which is subsequently transported to the lysosome. On 
the endosome, the CI-M6PR colocalizes with the retromer complex [14, 18]. It is tempting to 
speculate that after binding of mammalian Vps35 to the CI-M6PR in the endosome, Vps29 
will dephosphorylate the receptor. Dephosphorylation of the serine residue in this 
trafficking motif might be the trigger for the CI-M6PR to recycle back to the TGN to carry out 
additional rounds of enzyme delivery. This model remains to be confirmed by in vivo data of 
dephosphorylation of the CI-M6PR by hVps29. In addition, the exact role of dephos­
phorylation of the CI-M6PR on the transport of the receptor remains to be investigated.
In order to test our model under in vivo conditions we generated phosphatase deficient 
mutants of Vps29 by mutating the catalytic core residues. Unfortunately, the catalytic site 
mutants of hVps29 showed severely decreased expression levels, which did not result from 
their epitope-tag, expression method, expression host, or the detection procedure (Chapter 
6). It appeared that the reduced expression level of the catalytic site mutants results from 
the mutation itself, which hinders the performance of in vivo experiments aimed at 
elucidating the role of Vps29 phosphatase activity on CI-M6PR trafficking. In this context, it 
should be noted that RNA interference analysis directed against Vps29 does not distinguish 
between a scaffolding function of Vps29 and a phosphatase function of Vps29 in CI-M6PR 
trafficking.
After publication of our working model on the role of hVps29 in dephosphorylation 
of the acidic dileucine motif in the CI-M6PR tail [26], Hierro et al. [2] revealed the crystal
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structure of Vps29 in complex with the C-terminal half of the Vps35 protein. Surprisingly, 
the crystal structure revealed a position of hVps35 which covers the active site of hVps29. 
Based on that observation the authors argued that the Vps29 active site is not accessible for 
phosphorylated substrate peptides. They also showed that mutation of amino acids 
predicted to be involved in the Vps29-Vps35 interaction results in retromer assembly errors, 
supporting the in vivo significance of the Vps29-Vps35 crystallographic interface. Hierro et 
al. [2] therefore proposed that the main function of hVps29 is to form a scaffold for the C- 
terminal half of Vps35, whereby the catalytic site of Vps29 has been conserved during 
evolution for stability reasons. However, these authors could not convincingly support this 
theory by protein assembly experiments using mutants of the metallo-phosphoesterase site 
of hVps29, due to the impaired expression of these mutants [2]. The authors also performed 
phosphatase assays with the retromer subunits, using the same substrate as we did but 
then based on purified retromer complexes, but failed to detect phosphatase activity 
towards the CI-M6PR peptide.
There are several differences between our experimental approach and that of Hierro et 
al. [2]: i) Different methods for production of retromer proteins have been used: we used 
the E. coli XL-2 blue strain while Hierro et al. [2] used the E. coli BL21 (DE3) star strain. We 
transformed the host with pGEX-Vps26, -Vps29 or -Vps35 plasmids, while Hierro et al. [2] 
used Pmr101A Vps26 plasmids for the transformation or co-transformed the host with 
Pmr101A Vps29 and pGEX-KG Vps35 plasmids. We lysed the bacteria by freezing and 
sonication while Hierro et al. [2] used high-pressure homogenization. ii) Different methods 
were used to purify the produced proteins: we used gluthathione-Sepharose beads to 
isolate all subunits separately, subsequently combined the proteins, cleaved the GST-fusion 
proteins by thrombin, and used the obtained product without further purification in the 
phosphatase assays. Based on this approach we showed that the subunits in complex can 
perform phosphatase activity in a separate experiment in which Vps26-GST binds to hVps29 
myc-His and hVps35 myc-His (Chapter 4, Figure 3). In contrast, Hierro et al. [2] pooled the 
subunits from the beginning. Since they only used Vps35 proteins with a GST moiety, the 
gluthathione-Sepharose beads selectively isolated either Vps35 alone or Vps35 in complex 
with Vps26 and/or Vps29. The authors further purified the proteins and isolated the trimeric 
Vps26/Vps29/Vps35 complexes by ion exchange and gel filtration chromatography. The use 
of a more purified product seems an improvement but since no phosphatase activity is 
detected with these purified protein complexes, we cannot completely rule out the 
possibility that our protein preparations may be contaminated with a phosphatase. If so, 
however, such a suggestion does not explain why we detected highly impaired phosphatase
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activity with the hVps29 catalytic site mutants for which we have used the same procedure. 
iii) After the purification we used the proteins directly for the phosphatase assay, while 
Hierro et al. [2] used proteins that were stored at -80°C. We have also performed 
experiments with proteins that were stored at -80°C, and were unable to detect 
phosphatase activity in these samples (data not shown). Although we did not investigate 
this in more detail, we decided for further experiments to use our proteins directly after 
purification. In order to exclude the role of any contaminating protein, we should use the 
purification method of Hierro et al. [2] for our preparations, before testing them in our 
phosphatase assay.
8.2 Assembly of the Sorting Nexin/Retromer Complex
The sorting nexin/retromer complex in mammals is a heteropentameric complex which 
consists of a SNX homo- or heterodimer and a Vps26/Vps29/Vps35 heterotrimer. We and 
others have demonstrated that the Vps26/Vps29/Vps35 form a stable complex. Retromer 
subunits that assemble into defective complexes are destroyed [28], which may be the 
mechanism by which proper intracellular stoichiometry of functional retromer-binding 
partners in cells is maintained. This might explain the reduced expression levels, which we 
observed when attempting to express recombinant retromer proteins with mutations in 
their functional domains (Chapter 6).
Protein interaction and crystallographic studies have revealed the binding sites between 
the various sorting nexin/retromer subunits. Vps26 is incorporated into the retromer 
complex via interactions with the Vps35 subunit through its C-terminal lobe, which is 
sufficient to form a complex with Vps35 [4, 5]. Vps29 contains a SNX binding site, as was 
demonstrated by mutational studies [1], but also a Vps35 binding site at the opposite face 
[2]. The C-terminal ~300 residues of Vps35 bind to Vps29, while the N-terminal ~150 
residues are responsible for binding to Vps26 [2, 27]. Ile91 of Vps29, which has previously 
been shown to contact Vps35 [1], interacts extensively with Vps35 near the centre of the 
Vps29-Vps35 interface [2]. The PRLYL motif in the N-terminal portion of Vps35 is required 
for its interaction with Vps26 [27-29]. The location of the PRLYL motif suggests that Vps26 
binds at the opposite face of the a-solenoid to Vps29, based on a structural model of Vps35 
derived from crystal structures, electron microscopy, interaction studies and bioinformatics 
[2]. The retromer cargoes Vps10 and DPAP-A bind to the elongated Vps35 structure near to 
both ends [30, 31]. Binding sites for N-terminal sequences of the SNX subunits [32, 33] are 
also located at both ends of the cargo recognition complex [1, 34], suggesting that the
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Vps26/Vps29/Vps35 cargo recognition complex binds to membranes in a parallel manner 
[2]. The PX domains of the dimerized SNX proteins bind to the endosomal membrane, while 
at the same time the SNX proteins recruit the cargo recognition Vps26/Vps29/Vps35 trimer. 
Based on these findings, Hierro et al. [2] have set up a model how the sorting 
nexin/retromer complex is involved in endosome tubulation. In this model the flexible 
Vps26/Vps29/Vps35 complex might adapt to the shape of the curved tubulovesicular 
membrane and so bind multiple membrane-embedded cargo molecules. This sub-complex 
interacts with a SNX dimer and the two subcomplexes together can, based on their 
calculated size, contour the tubular vesicle.
The publication of the crystal structure of hVps29 in combination with the C-terminal 
half of the hVps35 retromer subunit, as published by Hierro et al. [2], revealed that hVps35 
is positioned around the metal-binding site of hVps29. Due to its position, hVps35 could 
thereby block access of substrate molecules to the active site of the hVps29 
phosphoesterase. Possibly a conformational change in the Vps35-Vps29 interface is required 
to allow access to the active site for phosphorylated peptides. The structure of Vps26 in the 
core retromer complex shows similarities to arrestins [4, 5]. Many arrestins can undergo a 
conformational change upon activation [7], in which the two lobes open up and expose their 
polar core. Although this has not (yet) been demonstrated for hVps26, the similarities in 
structure of both proteins are extensive enough to suggest that hVps26 can undergo a 
similar conformational change, which might affect the overall conformation of the retromer 
core complex. It is also possible that binding of another protein (e.g. CI-M6PR cargo proteins 
which bind to the C-terminal part of hVps35) to the retromer complex induces a 
conformational change that prevents Vps35 from blocking substrate access to the Vps29 
active site. Such a substrate-induced activation mechanism of retromer phosphatase activity 
also provides a plausible explanation for preventing dephosphorylation of inappropriate 
substrates by the retromer complex. SNX1, which binds hVps29 opposite to hVps35 but 
interacts with hVps35 as well, might also influence the conformation of the retromer 
complex.
In this regard, it is interesting to note the strong architectural similarity of the retromer 
core complex with the heterotrimeric PP2A phosphatase holoenzyme, which hints at a 
distant evolutionary relationship between the two assemblies [13]. In both cases, a 
phosphatase or phosphatase-like subunit (Vps29 in retromer and the C subunit in PP2A) is 
associated with C-terminal regions of a large scaffolding subunit composed of HEAT-like 
helical repeats (Vps35 in retromer and the A subunit in PP2A). Following this analogy, Vps26 
subunits would be equivalent to (or have replaced) the diverse family of regulatory B
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subunits of PP2A, which bind to N-terminal regions of the A scaffolding subunit and have 
various roles in controlling substrate specificity, protein binding and intracellular 
localization.
8.3 The Sorting Nexin/Retromer Complex as a Vesicular Coat Complex
For the endosome-to-Golgi retrieval pathway, no specific coat complex has been identified 
with certainty, although the sorting nexin/retromer complex has been hypothesized to 
function as such [36]. However, the localization of the mammalian retromer complex on 
tubular structures of endosomes suggests that retromer-mediated endosome-to-Golgi 
transport might occur along tubules rather than through vesicles. Indeed, the transport of 
CI-M6PR between TGN and endosomes could be mediated by tubular elements [37] while 
microtubules, which are involved in many transport processes in the cell, are also known to 
play a role in retrograde endosome-to-Golgi transport of M6PRs [38]. In addition, the 
retromer cargo protein Shiga toxin normally requires microtubules for its retrograde 
transport to the Golgi complex [39]. Also Rab9, which might play a role in CI-M6PR transport 
in association with TIP47, is present on endosomes that display bidirectional microtubule- 
dependent motility [40]. Furthermore, the small GTPase Rab6A', which interacts with dynein 
and dynactin, is involved in endosome-to-Golgi transport and regulates microtubule- 
dependent recycling at the TGN [41].
Co-immunoprecipitation studies with anti-Vps26 antibodies have demonstrated an 
interaction between the retromer complex and EHD1 (Eps15 homology domain-containing 
protein-1) [42]. This protein has helical, nucleotide-binding/dimerization and EH domains, 
and is known to function in tubule formation in a manner analogous to dynamin [43, 44]. 
EHD1 is required to stabilize SNX1 tubules and to facilitate endosome-to-Golgi transport 
[42]. In mammals long membrane tubules, stabilized by the microtubule cytoskeleton, play a 
significant role in endosome-to-Golgi retrieval [45]. Indeed, EHD1 positive tubular elements 
require microtubules for their stability [42] and EHD1 has previously been implicated in the 
recycling of the transferrin receptor and MHC class I molecules from the endosomes to the 
plasma membrane, thereby also utilizing tubular intermediates [44, 46]. It thus appears that 
EDH1 might be a common mediator of tubular transport in various recycling pathways 
involving the endosomes. It is not clear, however, if the interaction between EHD1 and the 
retromer complex is direct or indirect. We have evidence for an interaction of Vps26 with 
tubulins and Hook proteins (Chapter 5). Possibly there is a connection between EHD1 and
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the retromer complex via tubulins, which serves to stabilize the SNX1-induced endosomal 
membrane tubules.
Our analysis of retromer-interacting proteins by mass spectrometry indicated that 
hVps29 and hVps35 interact with a- and ß-tubulins. In vitro pull-down studies confirmed 
these findings and showed that retromer subunits interact with a-, ß- and y-tubulins 
(Chapter 5). Recently, Kama et al. [47] described a direct interaction of yeast Vps26p to 
Btn2p, which is a putative orthologue of the mammalian microtubule-binding Hook 
proteins. Btn2 facilitates late endosome-to-Golgi transport in yeast [47], while the 
mammalian Hook1 protein has a role in endocytic membrane trafficking in the late 
endosomes and interacts with endocytic Rab proteins [48]. Hook-related protein1 (HkRP1) 
colocalizes with the retromer-associated protein SNX1 on tubular elements of early 
endosomes such that overexpression of its membrane-associated C-terminus results in a 
complete redistribution of SNX1 localization [49]. In Chapter 5, we provided the first 
evidence that mammalian Hook proteins can specifically interact in vitro with the retromer 
complex, in particular the hVps35 subunit. Whether this interaction is direct and also occurs 
in vivo, remains to be established. Seaman [50] reported that SNX1-labelled tubules can be 
ablated in the presence of the microtubule-depolymerizing agent nocodazole, which 
suggests that microtubules are required to stabilize SNX1-labelled tubules. In addition, 
recombinant expression of YFP-hVps35, which is efficiently incorporated in the retromer 
complex, resulted in a punctate distribution of the protein in the cytosol. These YFP-hVps35 
puncta often give rise to long fluorescent tubules, a process that is also prevented by 
treatment with nocodazole [14].
Collectively, these data support our observation for an interaction between retromer 
subunits and tubulins, which might be accomplished by the Hook (related) proteins. 
Association of the sorting nexin/retromer complex with microtubules might be necessary for 
the formation and localization on endosome-related tubules. Thus, the retromer complex 
might couple Vps29-dependent dephosphorylation of acidic dileucine motifs of cycling TGN 
cargo proteins, which prevents them from interacting with GGA proteins, to microtubule- 
dependent endosome-to-TGN transport through interaction with tubulin and/or tubulin- 
associated proteins such as Btn2p/Hook (related) proteins. This process might be further 
aided by membrane curvature that is induced by the BAR domain of sorting nexins. Minus­
end directed microtubule-associated cytoplasmic dynein motor proteins then might provide 
the driving force for the formation of vesiculo-tubular endosomes that are involved in the 
retrograde transport to the Golgi.
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8.4 The Retromer Complex and Endosome-to-Golgi Retrieval Pathways
After studying the retromer complex in more detail, it is important to define the retrieval 
pathway the retromer protein complex is involved in. In the introduction we have 
mentioned a number of other proteins that are involved in the retrograde transport of the 
CI-M6PR, including TIP47, Rab9, PACS-1 and AP-1. We have raised the issue of how the 
retromer complex relates to those other trafficking pathways that exist between the 
endosome and the TGN-Golgi complex. Here we will discuss the possible interactions, 
redundancy and differences of those proteins towards the retromer complex.
The acid hydrolase receptors Vps10p in fungi and CI-M6PR in metazoans are required for 
the transport of newly synthesized acid hydrolase precursors from the early secretory 
pathway to their destination in lysosomes. To perform this conserved function an 
appropriate steady state distribution of these receptors is needed. The retromer complex is 
evolutionary conserved among all eukaryotes and is therefore a candidate for the role of 
retrograde transport of vacuolar receptors in all eukaryotes. In contrast, TIP47 and PACS-1 
are only present in metazoans [51, 52]. In addition, regions of the CI-M6PR tail that bind to 
TIP47 or PACS-1 are not essential for the endosome-to-Golgi retrieval of a CD8-CI-M6PR 
construct [53]. Although there is convincing evidence that PACS-1 has a role in the 
retrograde transport of the CI-M6PR, siRNA depletion experiments demonstrated that 
depletion of PACS-1 disrupts maturation and lysosomal delivery of cathepsin D, while such 
treatment had no effect on CI-M6PR stability [54]. We therefore conclude that PACS-1 is 
most likely not the most important factor in retrograde transport of the CI-M6PR. For 
sorting of CI-M6PR PACS-1 may function upstream or in a pathway distinct from the 
retromer and/or TIP47.
PACS-1 and CI-M6PR show similarity in that they both bind GGA proteins, while on the 
other hand GGA and PACS-1 have overlapping, but not identical, binding sites for CI-M6PR. 
GGA and PACS-1 can both be phosphorylated on serine residues by CKII, but only Ser278 
phosphorylation of PACS-1 within its autoregulatory domain promotes CI-M6PR binding 
[55], while Ser355 phosphorylation of GGA1 or Ser388 phosphorylation of GGA3 results in 
inhibition of CI-M6PR binding [56]. Moreover, Ser2484 phosphorylation of CI-M6PR 
enhances binding to PACS-1 in vitro [54], similarly as has been observed for GGAs. This 
might indicate that PACS-1 acts upstream of the retromer complex, whereby it might be 
deactivated by dephosphorylation of Ser2484 due to the activity of Vps29 in the retromer 
complex (Chapter 4).
PACS-1 might also play a role in the detachment of GGA proteins from CI-M6PR, as a first 
trigger for retrograde transport. In a theoretical working model PACS-1 recruits CKII and
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subsequently binds the GGA protein that is coupled to CI-M6PR in the endosomes. CKII 
phosphorylates the GGA protein, resulting in a phosphorylation-induced auto-inhibited state 
mediated by intra-molecular binding of an AC-LL motif in the hinge region of the GGA to its 
ligand-binding groove in the VHS domain. This subsequently induces the release of the GGA 
protein from the CI-M6PR. This model is supported by experiments which demonstrate that 
mutations in the CKII-binding domain of PACS-1 causes GGA3 to redistribute with CI-M6PR 
to an endosomal population [54]. The observation that GGA3 needs to be phosphorylated in 
order to detach from CI-M6PR and to return to its auto-inhibitory form, also implies that 
binding of another protein to this domain in combination with dephosphorylation of the 
DDSDEDLL motif of CI-M6PR, is involved in dissociation of GGA3 from the CI-M6PR receptor. 
Removal of the phosphate group from the serine residue of the CI-M6PR receptor might be 
mediated by Vps29 of the retromer complex (Chapter 4).
There is controversy in the literature regarding TIP47 and its role in endosome-to-Golgi 
recycling. Using metabolic labelling techniques we have demonstrated interaction of 
retromer components with an unidentified 47 kDa protein, but the accompanying mass 
spectrometry data did not reveal an interaction between retromer components and TIP47 
(Chapter 5). So, there is currently no evidence to suggest that TIP47 and retromer 
components interact directly. Given that i) TIP47 is not conserved among eukaryotes (in 
contrast to the retromer complex), ii) depletion of TIP47 did not substantially change the 
steady state distribution of CI-M6PR or Rab9, but instead resulted in a dramatic reduction of 
the half-life of CI-M6PR [51, 61] and iii) TIP47 is recruited by Rab9 to late endosomes, this 
indicates that TIP47 might function in an additional pathway in which CI-M6PRs that were 
not recycled from early endosomes by the retromer complex, undergo retrograde transport 
from the late endosomes.
The GTPase Rab9 is localized on endosomes and functions in the same pathway as the 
retromer complex. However, no obvious colocalization of GFP-Rab9 and retromer 
components has been observed [18]. It is possible, however, that the retromer complex and 
Rab9 function together, for example in such a way that the retromer complex performs 
cargo selection while Rab9 functions downstream in tethering, docking and/or fusion of 
retrograde vesicles to the Golgi. In addition to Rab9, endosome-to-Golgi retrieval also 
involves Rab6, which is localized at Golgi membranes and might therefore be required for 
docking and fusion of vesicles with the Golgi.
Although PACS-1 and the retromer complex possibly act in the same transport step, so 
far, a direct link between one of the retromer subunits and PACS-1, AP-1, TIP47 or Rab9 has 
not been shown. It is also possible that (some of) these proteins act in another pathway.
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Yeast contains two parallel pathways for endosome-to-Golgi recycling [62] and Mallet and 
Maxfield [63] have shown that at least two distinct endosome-to-Golgi retrieval pathways 
exist in mammalian cells. The existence of parallel pathways in mammalian cells would 
explain why a CD8-furin reporter is properly retrieved after loss of mVps26 expression, 
whereas the CI-M6PR (and the CD8-CI-M6PR reporter) is not [18]. It also seems likely that 
some cargo proteins are preferentially retrieved by one of the pathways, but that inefficient 
retrieval can also occur via the parallel pathway. So although retromer mediates retrieval of 
the CI-M6PR, some CI-M6PR retrieval may still occur in the absence of retromer function 
through the parallel (AP-1-mediated) pathway. Owing to reduced efficiency, however, this 
retrieval would be kinetically slower. Alternatively, cargo proteins may contain multiple 
sorting signals that function in a redundant manner.
Retromer is predominantly localized to early endosomes, suggesting that its function in 
recycling is initiated at this compartment. However, some colocalization has been observed 
with Rab7 [18], which is a marker for late endosomes. It is possible that retromer continues 
to function as endosomes mature, whereby recycling from endosomes occurs up to the 
formation of the lysosome [64]. Furthermore, maturation is coupled to endosome 
acidification and the internal pH of endosomes affects sorting processes mediated by signals 
in the cytoplasmic portion of proteins [64] and dissociation of the hydrolases from M6PRs 
occurs between pH 5.0 and 6.0 [65, 66]. It is possible that some maturation of the early 
endosomes must take place before the retromer can assume its role in the retrieval of the 
unoccupied receptors.
8.5 Retromer Complex and Cargo Selection
In order to understand the function of the retromer complex in the cell, it is important to 
map the interactions with its molecular environment. The retromer has been reported to 
interact with a number of cargo molecules, but it is interesting to note that Vps29 may also 
function as a phosphoesterase for other substrates. Mutational analysis of the serine- 
phosphorylated peptide SFHDDpSDEDLLHI could reveal a minimal sequence motif required 
for Vps29 dependent dephosphorylation.
Vps35p of the yeast retromer complex interacts with the Vps10p receptor, as well as 
with the DPAP-A protein. The FXFXD (in which X represents any amino acid) in DPAP-A was 
found to be required for binding of DPAP-A to retromer, as shown by cross-linking/co- 
immunoprecipitation analyses [30, 31]. The mammalian retromer complex interacts with 
the Vps10p functional homologues: the M6PRs and the sortilins. Arighi et al. [14]
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demonstrated by yeast-2-hybrid analysis that Vps35 could bind to two independent regions 
of the cytoplasmic tail of the CI-M6PR: residues 48-80 and 80-100. Immunoprecipitations 
performed by Seaman [50] confirmed the interaction between these proteins, but according 
to these authors the C-terminal residues 500-693 of Vps35 interact with a 42WLM motif of 
the CI-M6PR, a motif which is also involved in binding to AP-1 [67]. Vps35 also interacts with 
sortilin, a receptor that has been implicated in the trafficking of sphingolipid activator 
proteins (SAPs). The cytosolic tail of sortilin possesses a high degree of homology to the 
M6PR tail. Both the 9FLV [53] and the 14YSVL [68] sequence in the cytoplasmic tail of sortilin 
have been implicated in retromer binding. As for the CI-M6PR, this region of sortilin is also 
implicated in AP-1 binding [68]. This indicates that the same motif may control different 
pathways depending on the (coat) complex that it binds to. The 42WLM motif of the CI- 
M6PR and the 9FLV motif of sortilin can replace each other, while maintaining their protein 
function [53]. Common features of the yeast and mammalian motifs are their high overall 
hydrophobic character and the presence of aromatic amino acid residues [53]. It remains 
unknown, however, whether these motifs conform to a particular consensus sequence. 
Importantly, they are distinct from motifs that interact with the GGA adaptor proteins and 
with the AP complexes, as described in Chapter 1. Finally, the nature of the signal-retromer 
interactions that are involved in the retrograde transport, remains to be fully elucidated.
Similar to the M6PRs, sortilin also sorts lysosomal cargo, contains a cluster of acidic 
residues nearly identical to that described for the CI-M6PR and also binds to GGAs [69, 70] 
and PACS-1 [54]. An identically positioned serine residue next to a DXXLL signal is likely to 
permit the same type of regulation for sortilin as has previously been described for the CI- 
M6PR. The presence of this motif makes sortilin a candidate receptor for hVps29-mediated 
dephosphorylation. The serine residues in other acidic-cluster dileucine containing receptors 
are located further amino-terminally from the DXXLL signals; if and how they regulate signal 
recognition is not yet known. Thus, the mechanism described above for control of CI-M6PR 
trafficking may be common to other acidic-cluster dileucine containing receptors including 
sortilins.
Besides sortilin, mammals express four other proteins of the Vps10-family: sorLA, 
sorCS1, sorCS2 and sorCS3 [71]. These receptors are all type I receptors that are highly 
expressed in brain. It is possible that, in contrast to the above discussed non-neuronal 
mammalian cells, the Vps10 family of receptors might function as cargo for the neuronal 
retromer complex. The SorLA receptor for amyloid precursor protein (APP) might associate 
with retromer, and this interaction could play a role in the onset of Alzheimer disease [72] 
(see below).
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Retromer also plays a role in the transport of Wntless (W ls/Evi/Srt), a seven-pass 
transmembrane protein which is likely to be a chaperone or sorting receptor for Wnt, but 
appears also required for Wnt secretion [73-76]. Impaired function of the retromer 
components results in a rather restricted phenotype, with loss of Wnt activity, which might 
indicate that retromer proteins are part of the machinery for Wnt secretion signaling [76­
79]. Wnt ligands are lipid-modified signaling molecules that control multiple steps during 
embryogenesis and adult-tissue homeostasis. Wnt proteins are secreted by the cell where 
they provide positional information to cells in the developing tissues by forming a 
concentration gradient. Immunoprecipitation experiments have provided evidence for an 
interaction between Wntless and Vps35 [80, 81]. The interaction of CI-M6PR with the 
retromer depends on a highly conserved [W/F]-L-[M/V] tripeptide motif in the cargo protein 
[53] and, interestingly, Wntless contains a similar FLM motif at the end of its third 
intracellular domain [82]. Vps35 depleted cells show a reduction in extracellular Wnt 
proteins and an accumulation of these proteins in the Golgi, indicating a role for Wntless in 
transporting Wnt proteins to the cell membrane. Overexpression of Wntless can restore 
Wnt secretion defects in Vps35-depleted cells, as has been demonstrated by multiple 
groups in Drosophila, C. elegans and human cells [79-83]. In two of these studies it has been 
shown that incubation of tissue cultured cells with antibodies to tagged Wntless results in 
delivery of the antibodies to the Golgi apparatus. This process can be blocked by RNAi- 
mediated knockdown of Vps35 [80, 81], leading to diversion of Wntless via MVBs to the 
lysosome [81, 82]. The current data suggest that Wntless binds Wnt proteins in the Golgi, 
resulting in transport of Wnt to the plasma membrane for allow secretion, while Wntless is 
endocytosed in a clathrin- and dynamin-dependent manner and subsequently transported 
to the endosome [79, 80, 82, 83]. In the endosome, Wntless colocalizes with retromer 
proteins [80, 82], which rescues Wntless from degradation by the lysosome by inducing 
recycling of Wntless to the Golgi where it becomes available for another round of Wnt 
delivery [79-81].
Besides these partially characterized associations, several other cargo receptors have 
been reported to associate with retromer: The cytosolic tail of the polymeric 
immunoglobulin receptor (pIgR) interacts with retromer, which is necessary for transcytosis 
of pIgR and its cargo IgA from the apical to the basolateral membrane in polarized epithelial 
cells [84]. In plants the retromer complex is involved in the retrieval of the polarized plasma 
membrane located pin-formed (PIN) efflux carriers for auxin from a late/pre-vacuolar 
compartment to the recycling pathways. PIN proteins are responsible for the formation of 
spatial and temporal auxin patterns, which plays a role in plant growth and development
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[85-87]. In addition, the vacuolar sorting receptor VSRAT-i in plants co-immunoprecipitates 
with Vps35, suggesting that the retromer might play a role in its retrograde transport [88].
The sorting nexin/retromer complex is likely to play a role in the transport of Shiga toxin, 
although a direct interaction has not been demonstrated. Shiga toxin is an AB5-type toxin, 
similar to cholera toxin, and consists of an enzymatically active A subunit, and a pentamer of 
B subunits that directs association of the toxin with cell-surface receptors, followed by 
endocytosis and transport to the endosomal network. The toxins undergo retrograde 
transport from the endosome to the Golgi and then to the ER before finally being retro- 
translocated to the cytosol. The transport from the endosome-to-TGN of Shiga toxin 
requires a multitude of structural and coat proteins, including clathrin and its adaptor 
protein EpsinR, as well as dynamin Rab6A' and components of the fusion machinery on the 
TGN side, including Golgin-97, Golgin-1 and the SNARE proteins syntaxin 5 and 16. Bujny et 
al. [89] demonstrated that the sorting nexin/retromer complex also plays a role in 
retrograde transport of the Shiga toxin B-subunit, but not of the cholera toxin B-subunit. So 
far there is no evidence to suggest a link between the components described above and the 
retromer sorting machinery. However, the sorting nexin/retromer complex might play a role 
in SNARE transport, as has been shown for the retrieval of Snc1p v-SNARE during yeast 
sporulation [90].
In the presence of a limiting concentration of extracellular iron, the retromer complex 
also plays a role in the endocytic sorting of the yeast high-affinity iron transporter, which is 
composed of the proteins Fet3p and Ftr1p [91]. Grd19, the yeast homologue of SNX3, binds 
to the endocytic recycling signal of Ftr1p and thereby prevents the delivery of the Fet3p- 
Ftr1p complex to the vacuole [91]. Grd19p partly colocalizes with retromer components on 
tubular endosomes and can be chemically cross-linked to the retromer complex in vivo [91]. 
In has been suggested that Grd19p binds to the iron transporter in endosomes and by acting 
as an adaptor recruits retromer to initiate export of the iron transporter from the endosome 
[91]. Fet3p-Ftr1p is subsequently delivered to the TGN for resecretion in order to retain its 
localization at the plasma membrane [91]. Furthermore, retromer is involved in the 
endosome-to-Golgi retrieval of the Golgi resident protein Yif1p by interacting with the 
Hook-related protein Btn2p (see Chapter 5 and see below) [47].
The retromer complex associates with many cargo proteins, which requires a number of 
different interaction sites to allow the retromer to associate with multiple cargo proteins at 
the same time. This is consistent with the observation that the surface of Vps35 consists of a 
series of ridges that separate hydrophobic grooves which constitute the potential cargo- 
binding sites [2].
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8.6 The Role of Sorting Nexin/retromer Complex in Disease 
Alzheimer Disease
Several recent publications indicate a role for the retromer complex in Alzheimer disease. 
The main hallmark of Alzheimer disease is the presence of amyloid plaques. The core of 
these plaques is formed by the amyloid-ß (Aß) peptides, which are formed by cleavage from 
its parent protein, amyloid precursor protein (APP), due to the activity of ß-site APP-cleaving 
enzyme (BACE) and subsequently y-secretase Presenilin 1. Retromer defects were first 
implicated in late-onset Alzheimer disease by a study that combined brain imaging with 
microarray analysis [92]. Such analysis in specimens with and without Alzheimer disease 
revealed that the expression level of Vps35 was abnormal in Alzheimer disease [92]. 
Furthermore, reduced protein levels of Vps26 and Vps35 have been detected in Alzheimer 
disease [92] and siRNA experiments in cell culture models revealed that reduction in the 
level of retromer proteins led to increased concentrations of Aß, while overexpression of 
retromer elements decreased Aß levels [92].
Mammals express a family of five Vps10-containing proteins: sorLA, sortilin, sorCS1, 
sorCS2 and sorCS3 [71]. These receptors are all type I receptors and are highly expressed in 
brain. In contrast to the above discussed non-neuronal mammalian cells, the Vps10 family of 
receptors might function as cargo for the neuronal retromer. Searches in microarray data 
sets for correlations between the expression levels of Vps35 and type I transmembrane 
molecules have identified, among other molecules, sorLA as a candidate cargo for retromer
[93]. SorLA shows reduced expression in late-onset Alzheimer disease and has a key 
physiological role in the differential sorting of the APP holoprotein. SorLA traffics between 
the cell surface, endosomes and the TGN, a process that is mediated by GGA proteins as 
well as by the sorting nexin/retromer complex. It has been demonstarted that Vps35 binds 
sorLA [72] and Vps35 and (in particular) SNX1 deficiency may downregulate SorLA in cells
[94]. In the presence of sorLA, APP holoprotein is recovered via the retromer, while in the 
absence of sorLA, APP is released into late endosomal pathways, where it is subjected to ß- 
secretase cleavage by BACE, and subsequently y-secretase cleavage by Presenilin 1, resulting 
in the formation of Aß.
The cytosolic domain of BACE contains a 496DISLL sequence which obeys the consensus 
for the DXXLL (in which X represents any amino acid) motif. By means of this motif BACE can 
interact with the VHS domain of GGAs, similarly as observed for the M6PRs [95]. 
Phosphorylation of the serine residue in this domain enhances GGA binding to a similar 
intensity as seen for M6PR proteins. Phosphorylation/dephosphorylation affects the 
subcellular localization of BACE: BACE wild-type and an S498D mutant that mimics
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phosphorylated BACE are predominantly located within juxta-nuclear Golgi compartments 
and endosomes, whereas non-phosphorylatable BACE S498A mutant accumulates in 
peripheral EEA1-positive endosomes [96]. Depletion of GGA proteins or Vps26 also blocks 
the retrieval pathway for BACE and causes accumulation of BACE in the endosomes [97]. 
Riemenschneider et al. [98] could not establish a relation between Vps26 gene 
polymorphisms and Alzheimer disease, but it remains unclear if this excludes Vps26 as a 
major positional and functional candidate gene conferring risk to Alzheimer disease.
Besides a direct role in transport of SorLA and/or BACE protein, retromer could also 
contribute in a more indirect manner to Alzheimer disease. It is suggested that this could be 
by means of interacting with Presenilin, a protein which plays a critical role in the Wnt 
signaling pathway and is, in addition to BACE and retromer, differentially expressed in the 
enthorinal cortex [93]. Like retromer Presenilin plays a general role in sorting type I 
transmembrane proteins and disease-causing mutations in Presenilin cause protein 
missorting [93].
The neuronal retromer might be involved, directly or indirectly, via SorLA or other 
Vps10-containing proteins in sorting APP and/or BACE along the endosome-TGN trafficking 
pathway. Retromer could keep Aß peptide production low by retrieving APP, SorLA, BACE 
and/or Presenilin 1 form endosomes to the TGN. Retromer dysfunction would increase the 
resident time of APP and its cleaving enzymes in the same organelle, thereby accelerating 
APP processing which could account for the Aß elevation observed in retromer-deficient 
states. Recently Muhammad et al. [99] demonstrated in two genetically modified animal 
models that retromer deficiency observed in late-onset Alzheimer disease can indeed 
contribute to its pathogenesis.
Batten Disease
Retromer proteins might also play a role in Batten Disease, which belongs to a family of 
autosomal recessive disorders collectively referred to as neuronal ceroid lipofuscinoses 
(NCLs), leading to progressive neurodegeneration and early death in humans. Batten 
Disease is a lysosomal storage disease, hallmarked by a buildup of lipofuscins: lipid- 
containing residues of lysosomal digestion. Mutations in the human CLN3 gene lead to 
juvenile-onset NCL. CLN3 has a yeast orthologue called Btn1; deletions in Btn1 lead to 
defects in vacuolar pH homeostasis and the up-regulation of Btn2. Kama et al. [47] 
demonstrated a possible role for Btn2 in cargo retrieval from late endosomes to the Golgi. 
Moreover, Btn2 co-immunoprecipitates with Vps26 and Vps35, and in vitro binding assays 
confirmed a direct interaction between Btn2 and Vps26 [47]. However, Btn2 deletion did
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not affect CPY or Vps10 trafficking [47], which might imply that there are multiple retromer- 
mediated cargo sorting events occurring at the late endosome.
Yeast Btn2 is a putative orthologue to the mammalian microtubule-binding Hook1 
protein which plays a role in membrane trafficking in the late endosomes and interacts with 
endocytic Rab proteins [48]. Hook-related protein1 (HkRP1) colocalizes with the retromer- 
associated protein SNX1 on tubular elements of early endosomes and overexpression of its 
membrane associated C-terminus resulted in a complete redistribution of SNX1 localization 
[49]. In Chapter 5 we have demonstrated a possible interaction between hVps26 and 
tubulins, indicating an interaction between retromer and the microtubules which has 
already been suggested by others as well [14, 50]. Association of the sorting nexin/retromer 
complex with microtubules might be necessary for the formation and localization on 
endosome related tubules as we modelled in Chapter 5, Figure 9. After binding to cargo 
proteins in the TGN, the CI-M6PR is transported to the endosome. In acidifying endosomes, 
the ligand dissociates from the receptor and after CI-M6PR binding to Vps35, Vps29 is able 
to dephosphorylate the receptor. The retromer complex interacts via Hook1 to microtubules 
and recycles the CI-M6PR to the TGN. Thus, the retromer complex might have a double 
function, i.e. i) to couple Vps29-dependent dephosphorylation of acidic dileucine motifs of 
cycling TGN cargo proteins, which prevents them from interacting with GGA proteins and ii) 
to facilitate microtubule-dependent endosome-to-TGN transport of cargo molecules 
through interaction with tubulin and/or tubulin-associated proteins such as Btn2p/Hook 
(related) proteins. This process might be further aided by the membrane curvature which is 
induced by the BAR domain of sorting nexins. Further studies, e.g. localization studies of 
retromer localization in models with depletion of Btn2p/Hook (related) proteins, are 
required to determine the functional significance of the interactions between the sorting 
nexin/retromer complex and microtubule (-associated) proteins.
In summary, retromer might play a role in Alzheimer and Batten Disease and given its 
role in M6PRs trafficking, it might play a role in other lysosomal storage diseases as well. 
Retromer also plays a role in Wnt signaling (see above) and aberrant Wnt signaling is 
implicated in many developmental disorders, degenerative diseases and cancers. Retromer 
is also involved in transcytosis, and as a consequence, it is involved in IgA mucous immunity. 
As an essential component of the fundamental tubulo-vesicular transport pathway within 
the eukaryotic endomembrane system, it is most likely involved in many more physiological 
processes that are still to be unraveled.
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Summary
Eukaryotic cells contain several membrane-enclosed compartments (organelles), each of 
which has a unique function that is maintained by correct localisation and retention of its 
resident proteins. Eukaryote subcellular organization therefore requires the existence of 
specific protein sorting and transport pathways to and between various organelles. Genetic 
screens in Saccharom yces cerevisiae have identified several Vps (vacuolar sorting proteins) 
genes whose products are involved, directly or indirectly, in anterograde or retrograde 
transport between the Golgi and the lysosome-like vacuole. Three of those gene products 
form the retromer complex in yeast; Vps26, Vps29 and Vps35, which colocalize on early 
endosomes and are involved in retrograde endosome-to-Golgi transport.
Orthologues of the yeast retromer proteins appear to be conserved in nearly all 
eukaryotes. In mammals the heterotrimeric retromer complex associates with sorting nexins 
to regulate endosome-to-TGN (trans-Golgi network) retrograde transport of cargo proteins. 
The mammalian Vps35 subunit interacts with the cation-independent M6PR (CI-M6PR) 
cargo protein. The CI-M6PR is involved in the sorting and transport of newly synthesized 
lysosomal hydrolases that contain mannose 6-phosphate moieties on their N-glycan chains, 
from the TGN to the prelysosomal compartment. In the acidic environment, lysosomal 
hydrolases dissociate from the CI-M6PR and are then transported to the vacuole. In 
contrast, the CI-M6PR is recognized by the Vps35 subunit of the retromer complex, which 
functions in the retrograde transport of the receptor from the prelysosomal compartment 
back to the TGN. In the TGN, CI-M6PR can carry out additional rounds of enzyme delivery.
In this thesis we have investigated the role of the retromer complex in receptor 
trafficking. When we started this project, not much was known about the role of the 
retromer complex and its individual subunits. The threading searches of the retromer 
subunits and the phylogenetic analysis of all eukaryote kingdoms, as described in Chapter 2 
and 3, respectively, provided us with insight in the function of the retromer subunits and the 
orthologue relationships among the Vps26, Vps29 and Vps35 genes.
Protein fold recognition algorithms revealed previously unrecognized similarities of 
Vps26, Vps29 and Vps35 with ß-arrestins, metallo-phosphoesterases and ARM/HEAT helical 
repeat solenoid proteins, respectively. Moreover, we identified Vps29 motifs that are 
characteristic of metallo-phosphoesterases in general, and Vps29 active site residues that 
are predicted to coordinate metal ions and phosphate groups (Chapter 2).
Our studies provide ample evidence for the existence of multiple Vps26, Vps29, and 
Vps35 paralogues which could result in functionally diverse retromer complex isoforms in
Summary 233
234 Summary
vertebrates, mosses, higher plants, and various unicellular protozoans. Distinct retromer 
complex isoforms may regulate transport of different cargo proteins, as well as distinct 
vesicular transport pathways, or they may interact with different protein interaction 
partners for differences in their regulation. Further studies are required to address possible 
functional differences between various retromer subunit isoforms (Chapter 3).
We studied the predictive metallo-phosphoesterase function of hVps29 in more detail in 
Chapter 4 and demonstrated that hVps29 can function as a phosphoesterase for a CI-M6PR 
derived peptide substrate in vitro. Efficient dephosphorylation required the additional 
presence of recombinant hVps26 and hVps35 proteins, which interact with hVps29. 
Phosphatase activity of hVps29 was greatly reduced by alanine substitutions of active site 
residues that are predicted to coordinate metal ions. We also demonstrate that hVps29 is 
capable of binding to zinc molecules. The binuclear Zn2+ centre and phosphate group were 
modelled into the hVps29 catalytic site and pKa calculations provided further insight into 
the molecular mechanisms of Vps29 phosphatase activity.
After binding to mannose 6-phosphate-tagged lysosomal hydrolases in the TGN, the 
phosphorylation of Ser2492 within the acidic-cluster dileucine motif of the CI-M6PR acts as a 
sorting signal for anterograde transport by binding to GGA (Golgi-localizing, gamma-adaptin 
ear domain homology, ARF-binding) proteins. The GGA proteins will transport the CI-M6PR 
via clathrin-coated vesicles to the endosome. The CI-M6PR will dissociate from its ligand, 
which is subsequently transported to the lysosome. On the endosome, the CI-M6PR 
colocalizes with the retromer complex. It is tempting to speculate that after binding of 
mammalian Vps35 to the CI-M6PR in the endosome, Vps29 will dephosphorylate the 
receptor. Dephosphorylation of this trafficking motif might be the trigger for the CI-M6PR to 
recycle back to the TGN to carry out additional rounds of enzyme delivery. This model 
remains to be confirmed by in vivo data of dephosphorylation of the CI-M6PR by hVps29. In 
addition, the exact role of dephosphorylation of the CI-M6PR on the transport of the 
receptor remains to be investigated (Chapter 4).
In Chapter 5 we studied interaction proteins of the retromer complex. We described 
interactions of all three retromer proteins with an as yet unidentified protein of 
approximately 47 kDa. We also demonstrated that the retromer components hVps26, 
hVps29 and hVps35 interact with a- and ß-tubulins in vivo and with the microtubule- 
associated Hook proteins in vitro. Based on these studies, we propose that the retromer 
complex acts as an adaptor between cargo proteins on tubulo-vesicular endosomal 
intermediates and microtubule tracks in order to facilitate their microtubule-dependent 
retrograde transport to the TGN (Chapter 5).
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In order to study the function of the individual retromer proteins in more detail and to 
identify their interaction domains, studies with epitope-tagged mutant versus wild-type 
proteins are essential. To perform the studies described in this thesis various heterologous 
expression systems and a range of epitope-tags were tested. An overview of the expression 
of wild-type and mutant retromer proteins using a range of epitope-tags and heterologous 
expression systems is described in detail in Chapter 6.
In Chapter 7 we studied ErbB downregulation and especially the role of the Cbl binding 
site in the process.
Finally in Chapter 8 we integrate our results with those published by others and discuss 
i) the structure of retromer subunits, ii) the assembly of the sorting nexin/retromer 
complex, iii) the sorting nexin/retromer complex as vesicular coat complex, iv) the retromer 
complex and endosome-to-Golgi retrieval pathways, v) the retromer complex and cargo 
selection and vi) the role of retromer complex in disease.
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Samenvatting
Eukaryotische cellen bevatten meerdere door een membraan omringde compartimenten, 
de zogenaamde organellen. Elk van deze organellen heeft een unieke functie in de cel, die in 
stand wordt gehouden door de aanwezigheid en lokalisering van specifieke eiwitten. Voor 
de subcellulaire organisatie van eukaryoten is de aanwezigheid van specifieke routes voor 
eiwitsortering en -transport naar en tussen deze organellen noodzakelijk. Bij genetische 
screens in bakkersgist zijn er diverse Vps (vacuolaire sorteringseiwitten) genen in kaart 
gebracht, waarvan de producten direct of indirect betrokken zijn bij het heen-transport van 
eiwitten van het Golgi systeem naar de lysosoom-achtige vacuole (anterograde) of juist bij 
het terug-transport (retrograde). Drie van deze genproducten vormen samen het 
retromeer-complex in gist: Vps26, Vps29 en Vps35, die tezamen gelocaliseerd zijn op de 
vroege endosomen en betrokken zijn bij het retrograde transport van endosoom naar Golgi.
Orthologen van de retromeer-eiwitten in gist zijn geconserveerd in nagenoeg alle 
eukaryoten. In zoogdieren gaat dit uit drie eiwitten bestaande retromeer-complex een 
interactie aan met sorting nexin eiwitten om aldus het transport van cargoeiwitten van 
endosomen naar het trans-Golgi netwerk (TGN) te reguleren. Daarnaast gaat de Vps35 
subunit in zoogdieren een interactie aan met het cation-onafhankelijke mannose 6-fosfaat 
receptor (CI-M6PR) cargo eiwit. De CI-M6PR is betrokken bij de sortering en het transport 
van nieuw gesynthetiseerde lysosomale hydrolasen die voorzien zijn van een mannose 6- 
fosfaat molecuul aan hun N-glycaan keten, van het TGN naar het prelysosomale 
compartiment. In de daar aanwezige zure omgeving dissociëren de lysosomale hydrolasen 
van de CI-M6PR en worden zij vervolgens getransporteerd naar de vacuole. Wordt de CI- 
M6PR echter herkend door de Vps35 subunit van het retromeer complex, dan leidt dit tot 
een retrograde transport van deze receptor van het prelysosomale compartiment terug naar 
het TGN. In het TGN kan de CI-M6PR dan opnieuw gebruikt worden voor het afleveren van 
enzymen.
In dit proefschrift hebben wij onderzoek verricht naar de rol van het retromeer -complex 
in het transport van receptoren. Toen wij met dit project begonnen, was er nog maar weinig 
bekend over het retromeer-complex en zijn subunits. In Hoofdstukken 2 en 3 hebben wij via 
bioinformatica-studies geprobeerd om meer inzicht te krijgen in de functie van de 
retromeer subunits en de orthologe relaties tussen de Vps26, Vps29 en Vps35 genen.
Via voorspelling van de 3-dimensionale structuur eiwitten op basis van hun lineaire 
sequentie konden wij aantonen dat er tot dan toe onontdekte overeenkomsten bestonden 
tussen Vps26 en ß-arrestins; tussen Vps29 en metallo-fosfo-esterasen; en tussen Vps35 en
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ARM/HEAT helical repeat solenoid ewitten. Daarnaast hebben wij laten zien dat Vps29 
motieven bevat die karakteristiek zijn voor metallo-fosfo-esterasen, waarbij residuen in het 
actieve centrum een voorspelde functie hebben in het coördineren van metaal-ion en 
fosfaat-groepen (Hoofdstuk 2).
Onze studies leverden ook een uitvoerig bewijs voor het bestaan van meerdere Vps26, 
Vps29 en Vps35 paralogen, hetgeen kan resulteren in een variëteit aan functionele 
retromeer-complexen in vertebraten, mossen, meer ontwikkelde planten en diverse 
eencellige protozoën. Retromeer complex isovormen kunnen verschillen in hun vermogen 
om het transport van cargo eiwitten reguleren. Daarnaast kunnen zij bij andere vesiculaire 
transportwegen betrokken zijn of kunnen zij aan andere eiwit interactiepartners binden. 
Verdere studies zijn noodzakelijk om de mogelijke functionele verschillen tussen de 
verschillende retromeer subunit isovormen te bepalen (Hoofdstuk 3).
Onze voorspelling dat hVps29 een metallo-fosfo-esterase functie heeft, hebben wij in 
meer detail onderzocht in Hoofdstuk 4. Onze gegevens laten zien dat hVps29 in vitro. kan 
functioneren als een fosfo-esterase voor een van de CI-M6PR afgeleid peptide-substraat. 
Efficiënte defosforylatie vereiste de additionele aanwezigheid van recombinant hVps26 en 
hVps35 eiwitten, die een interactie aangaan met hVps29. De fosfatase activiteit van hVps29 
werd aanzienlijk verminderd door alanine substituties van residuen van het actieve 
centrum, die een voorspelde metaal-ion coördinerende functie bezitten. Wij hebben ook 
aangetoond dat hVps29 in staat is om zink ionen te binden. Het binucleaire Zn2+ centrum en 
de fosfaatgroep zijn gemodelleerd in het katalytisch centrum van hVps29 en pKa 
berekeningen hebben ons verder inzicht gegeven in het moleculaire mechanisme van Vps29 
fosfatase activiteit. In het domein van de CI-M6PR dat gekenmerkt wordt door zure residuen 
en een dileucine motief bevindt zich het residu Ser2492. Na binding aan mannose 6- 
phosphate gelabelde lysosomale hydrolasen in het TGN werkt de fosforylatie van Ser2492 
als een sorteersignaal voor anterograde transport door het binden aan GGA eiwitten. De 
GGA eiwitten zullen de CI-M6PR in blaasjes omringd met het clathrine eiwit transporteren 
naar het endosoom. De CI-M6PR zal dissociëren van zijn ligand en het ligand wordt 
vervolgens getransporteerd naar het lysosoom. In het endosoom bevindt de CI-M6PR zich 
op dezelfde locatie als het retromeer-complex. Het is onze speculatie dat, na binding van 
het Vps35 eiwit aan de CI-M6PR in het endosoom, Vps29 verantwoordelijk is voor 
defosforylatie van de receptor. Defosforylatie van het motief van CI-M6PR dat bij transport 
betrokken is, zou de CI-M6PR kunnen aanzetten tot recycling naar het TGN, om daar te 
kunnen starten aan een nieuwe ronde van enzyme-aflevering. Dit model moet nog 
bevestigd worden door in vivo gegevens over de defosforylatie van de CI-M6PR door
Samenvatting 239
hVps29. Ook dient de precieze rol van de defosforylatie van de CI-M6PR in het transport van 
deze receptor verder onderzocht te worden (Hoofdstuk 4).
In Hoofdstuk 5 hebben wij eiwitten bestudeerd die een interactie aan kunnen gaan met 
het retromeer-complex. We hebben aangetoond dat alle drie de retromeer eiwitten een 
interactie aan kunnen gaan met een nog niet geïdentificeerd eiwit van ongeveer 47 kDa. 
Daarnaast hebben wij laten zien dat de retromeer componenten hVps26, hVps29 en hVps35 
een interactie aan kunnen gaan met a- en ß-tubulines in vivo en met de microtubuli- 
geassocieerde Hook eiwitten in vitro. Gebaseerd op deze studies veronderstellen wij dat het 
retromeer-complex functioneert als een adapter-eiwit tussen cargo-eiwitten en 
buisvormige, blaasjesachtige endosomale intermediaire structuren en microtubuli om 
daarmee het retrograde transport over microtubuli naar het TGN mogelijk te maken 
(Hoofdstuk 5).
Om de functie van de individuele retromeer eiwitten in meer detail te onderzoeken en 
om interactie-domeinen tussen de eiwitten in kaart te brengen, zijn studies met epitoop 
gelabelde mutanten versus wild-type eiwitten essentieel. Daartoe hebben wij verschillende 
heterologe expressie systemen alsmede ook een reeks van epitoop-labels getest. Een 
overzicht van de expressie van wild-type en mutante retromeer eiwitten met diverse 
epitoop-labels in verschillende heterologe expressie systemen staat beschreven in 
Hoofdstuk 6.
In Hoofdstuk 7 hebben wij de downregulatie van de ErbB1 receptor bestudeerd en in het 
bijzonder de rol van de het Cbl bindende domein in dit proces.
Tot slot hebben wij in Hoofdstuk 8 onze resultaten geïntegreerd met de resultaten die 
door anderen zijn gepubliceerd en hebben we de volgende punten bediscussieerd: i) de 
structuur van de retromeer subunits, ii) de opbouw van het sorting nexin/retromeer 
complex, iii) vesicle coating door het sorting nexin/retromeer complex, iv) het retromeer 
complex en de endosome naar Golgi retrogade transport routes, v) het retromeer complex 
en cargo selectie en vi) de rol van retromeer complex bij ziekten.
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belangrijk als de rest van dit boekje, een rechtvaardiging voor alle lezers die meteen 
doorgebladerd zijn naar deze sectie. Dit proefschrift had niet tot stand kunnen komen 
zonder de hulp, steun en motiverende woorden van velen. Ik wil daarom ook iedereen die 
hier een bijdrage aan geleverd heeft bedanken.
Graag wil ik nog enkele mensen persoonlijk bedanken:
Joop, ik heb aan jou altijd een waardevolle en betrokken promotor gehad. Jouw deur stond 
altijd voor me open. Bedankt voor de zorgvuldigheid bij al je correcties en kwaliteits­
bewaking van het verrichte werk. Ik heb bewondering voor de manier waarop jij de afdeling 
leidt.
Jeroen, jij was voor mij een gedreven begeleider met een passie voor de wetenschap en een 
indrukwekkende kennis van de vakliteratuur. Bedankt voor de samenwerking en je 
waardevolle bijdrage aan de interpretatie en verwoording van de resultaten.
Suzanne en Laura, jullie hebben me letterlijk van het begin tot het einde geholpen en altijd 
gesteund: met jullie ben ik in dezelfde subgroep gestart en ik ben er trots op dat jullie straks 
naast me staan als paranimfen. We vormen een goed team! Suzanne, bij jou kon ik altijd 
alles kwijt, ook toen je al niet meer op het lab stond, was je er altijd om me advies te geven 
en daarnaast maak jij de beste caipirinha's! Laura, jij ziet altijd de goede en positieve kant 
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jou is altijd gezellig! Bas, jij was echt mijn promotie-maatje, zo fijn om iemand te hebben om 
alle ups en downs mee te kunnen delen. Ik vond het een eer om jouw paranimf te mogen 
zijn! Leonie, jouw "Leonie-Heuver-planning" is een begrip geworden. Bedankt ook voor jullie 
Brabantse gastvrijheid in Lent! Mas, de afstand naar België was altijd met een paar 'klikken' 
verdwenen, jammer dat niet alle werkgevers MSN toestaan. Ik hoop dat ik op de promotie 
jullie kleine kan bewonderen. Sander, jouw hulp met alle computertechnische zaken heeft 
mij enorm geholpen. Heel veel succes met het afronden van jouw promotie! Bart, dank zij 
jou weet ik wat er rijmt op pets-klem. Geweldig dat je zo je draai hebt gevonden in Leuven!
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"Meer-dan-collega's" ik hoop dat er nog veel gezellige verjaardagen en weekendjes weg in 
het verschiet liggen voor ons!
Janny, bedankt voor alle fijne gesprekjes en je steun en geregel bij alle niet- 
wetenschappelijke zaken. Ester, naamgenootje bedankt voor je betrokkenheid. Dorine, 
bedankt voor je geweldige service op het lab, je lieve mailtjes en kaartjes.
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de sfeer was super!
Ook buiten het lab om ben ik gesteund door lieve vrienden die altijd vertrouwen hebben 
gehad in de goede afloop, belangstelling bleven tonen voor de vaak onbegrijpelijke verhalen 
en ook vaak voor de nodige afleiding hebben gezorgd:
Susanne, je bent een geweldige vriendin en ook hierin heb je me weer enorm gesteund. Met 
alles kan ik bij jou terecht. Jouw man (wen er maar aan!) Ton wil ik bedanken voor zijn hulp 
bij de lay-out en de kaft van het boekje. Maartje en Eveline, ook jullie interesse en steun 
was er altijd, bedankt daarvoor. Maartje, heel veel succes met jouw promotie!
Bas en Inez, culinaire gezelligheid is altijd bij jullie te vinden. Inez, mijn "afstuderen" moeten 
we vieren! Jan en Suzanne, na de kerst doorgewerkt te hebben, heb ik er alles uit kunnen 
gooien tijdens jullie "Dutch Gangster Party", legendarisch. Jan, bedankt voor jouw 
motiverende woorden. Robert en Lisette, de wijn staat altijd klaar bij jullie en de dansvloer 
is onveilig met jullie in de buurt. Pim en Heidi, zonder jullie is Gilze-Rijen niet compleet!
Nellie, hulp uit "onverwachte hoek" die mij erg welkom was! Bedankt voor je 
onvoorwaardelijke steun.
Astrid, Gijs en Linda, bedankt voor de fijne band die we hebben, en ik wil jullie en ook mijn 
schoonfamilie bedanken voor alle begrip en steun.
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het leven. Jullie hebben me altijd aangemoedigd om door te blijven leren, zeker omdat deze 
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en vertrouwen in alle keuzes die ik heb gemaakt. Jullie zijn geweldig!
Martijn, voor jou zou ik een heel boek willen schrijven, maar dan nog kan ik niet onder 
woorden brengen hoe gelukkig jij me maakt. Ik heb zoveel van je gevraagd en je was er altijd 
voor me. Ik hou van je en wil met je gaan genieten van al het moois dat de toekomst ons 
gaat brengen...
244 Dankwoord
Curriculum Vitae and Publications 245
Curriculum Vitae
Ester in 't Groen -  Damen werd geboren op 03 maart 1981 te Dongen. Na het behalen van 
haar VWO diploma in 1998 aan het Cambreurcollege te Dongen, begon zij aan de opleiding 
Biomedische Gezondheidswetenschappen aan de Radboud Universiteit Nijmegen. Tijdens 
deze studie heeft zij onderzoeksstages gelopen bij de afdeling Celbiologie aan het 
Nederlands Kanker Instituut te Amsterdam onder begeleiding van dr. Saskia van Es en bij de 
afdeling Biochemie aan het Nijmegen Centre for Molecular Life Sciences onder begeleiding 
van dr. Toon Smetsers. Na het behalen van haar doctoraal diploma in 2002 begon zij aan 
haar promotie onderzoek bij de afdeling Celbiologie van de Faculteit Natuurwetenschappen, 
Wiskunde en Informatica van de Radboud Universiteit Nijmegen op een project dat 
gefinancierd werd door Zon-MW. In 2007 vervolgde zij haar carrière als Clinical Research 
Associate bij de firma Pfizer en sinds december 2009 is zij in dezelfde functie werkzaam bij 
Covance.
Publications
Damen E, Krieger E, Nielsen JE, Eygensteyn J, van Leeuwen JEM. The human Vps29 retromer 
component is a metallo-phosphoesterase for a cation-independent mannose 6-phosphate 
receptor substrate peptide. Biochemical Journal 398(3):399-409 (2006).
Damen E, van de Heuvel LP, Verbeek MLJ, Verhagen H, van Leeuwen JEM. The mammalian 
retromer complex: A link between cargo and microtubule tracks? Manuscript submitted.
Jansen SM, Sleumer LS, Damen E, Meijer IM, van Zoelen EJ, van Leeuwen JE. ErbB2 and 
ErbB4 Cbl binding sites can functionally replace the ErbB l Cbl binding site. Cell Signal 
21(5):810-818 (2009).
